Medicaid Program; Medicaid Fiscal Accountability Regulation, 63722-63785 [2019-24763]
Download as PDF
63722
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
42 CFR Parts 430, 433, 447, 455, and
457
[CMS–2393–P]
RIN 0938–AT50
Medicaid Program; Medicaid Fiscal
Accountability Regulation
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Proposed rule.
AGENCY:
This proposed rule would
promote transparency by establishing
new reporting requirements for states to
provide CMS with certain information
on supplemental payments to Medicaid
providers, including supplemental
payments approved under either
Medicaid state plan or demonstration
authority, and applicable upper
payment limits. Additionally, the
proposed rule would establish
requirements to ensure that state plan
amendments proposing new
supplemental payments are consistent
with the proper and efficient operation
of the state plan and with efficiency,
economy, and quality of care. This
proposed rule addresses the financing of
supplemental and base Medicaid
payments through the non-federal share,
including states’ uses of health carerelated taxes and bona fide providerrelated donations, as well as the
requirements on the non-federal share of
any Medicaid payment.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on January 17, 2020.
ADDRESSES: In commenting, please refer
to file code CMS–2393–P. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY: Centers for Medicare &
Medicaid Services, Department of
Health and Human Services, Attention:
CMS–2393–P, P.O. Box 8016, Baltimore,
MD 21244–8016.
SUMMARY:
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY: Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services, Attention: CMS–2393–P, Mail
Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Andrew Badaracco, (410) 786–4589,
Richard Kimball, (410) 786–2278, and
Daniil Yablochnikov, (410) 786–8912,
for Medicaid Provider Payments,
Supplemental Payments, Upper
Payment Limits, Provider Categories,
Intergovernmental Transfers, and
Certified Public Expenditures.
Timothy Davidson, (410) 786–1167,
Jonathan Endelman, (410) 786–4738,
and Stuart Goldstein, (410) 786–0694,
for Health Care-Related Taxes, ProviderRelated Donations, and Disallowances.
Lia Adams, (410) 786–8258, Charlie
Arnold, (404) 562–7425, Richard Cuno,
(410) 786–1111, and Charles Hines,
(410) 786–0252, for Medicaid
Disproportionate Share Hospital
Payments and Overpayments.
Jennifer Clark, (410) 786–2013, and
Deborah McClure, (410) 786–3128, for
Children’s Health Insurance Program
(CHIP).
SUPPLEMENTARY INFORMATION: Inspection
of Public Comments: All comments
received before the close of the
comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov. Follow the search
instructions on that website to view
public comments.
I. Background
A. Overview
Title XIX of the Social Security Act
(the Act) established the Medicaid
program as a federal-state partnership
for the purpose of providing and
financing medical assistance to
specified groups of eligible individuals.
States have considerable flexibility in
designing their programs, but must
abide by requirements specified in the
federal Medicaid statute and
regulations. Each state is responsible for
administering its Medicaid program in
PO 00000
Frm 00002
Fmt 4701
Sfmt 4702
accordance with an approved state plan,
which specifies the scope of covered
services, groups of eligible individuals,
payment methodologies, and all other
information necessary to assure the state
plan describes a comprehensive and
sound structure for operating the
Medicaid program, and ultimately,
provides a clear basis for claiming
federal matching funds.
As discussed in more detail below,
the goal of this proposed rule is to
strengthen overall fiscal integrity of the
Medicaid program. The proposed rule
focuses on four topic areas that are
frequently discussed as program
vulnerabilities by federal oversight
authorities, including the Government
Accountability Office (GAO), the
Department of Health and Human
Services’ Office of Inspector General
(OIG), and the Medicaid and CHIP
Payment and Access Commission
(MACPAC). These topics include:
Medicaid fee-for-service (FFS) provider
payments; disproportionate share
hospital (DSH) payments; Medicaid
program financing; supplemental
payments; and health care-related taxes
and provider-related donations. Due to
the complex nature of these topic areas,
we have organized this proposed rule to
separately discuss each topic and
describe the programmatic concerns that
we seek to address through this
proposed rule. However, the proposed
provisions would rely on similar
strategies to improve our and states’
abilities to oversee fiscal integrity by
requiring transparency through better
data reporting, clarifying regulatory
payment and financing definitions,
refining administrative procedures used
by states to comply with federal
regulations, clarifying regulatory
language that could be subject to
misinterpretation, and removing
regulatory requirements that have been
difficult to administer and do not
further our oversight objectives. As a
result, the provisions of the proposed
rule aim to address multiple topic areas
as part of the overall strategy to improve
fiscal integrity.
While some of the proposed policies
are new, there are policies within the
proposed rule that CMS has
operationalized through our work with
states and interpretations of the statute
in subregulatory guidance and federal
regulations. We have implemented this
subset of policies using existing legal
authority. Some of the proposed policies
in the proposed rule, such as the nonbona fide provider related donations
provisions, have been reviewed and
upheld by the Departmental Appeals
Board (DAB) and the courts. Therefore,
we are clarifying the regulatory language
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
in this proposed rule that may have
been subject to misinterpretation by
states and other stakeholders, or that
otherwise could benefit from additional
specificity. In these cases, as discussed
below, we are not proposing new
statutory interpretations, but are merely
proposing to codify existing policies
into the Code of Federal Regulations
(CFR) to improve guidance to states and
other stakeholders and, to the extent
possible, help prevent states from
implementing policies that do not
comport with applicable statutory
requirements.
B. General Information on Certain
Medicaid Financial Topics Addressed in
This Proposed Rule
1. Medicaid FFS Provider Payments
a. General Background
States are responsible for developing
FFS rates to pay providers for furnishing
health care services to beneficiaries who
receive covered services through the
FFS delivery system. In recognition of
the states’ front line responsibility, the
statute affords states considerable
flexibility by not prescribing any
particular rate setting approach or
method (for most Medicaid services),
but instead allows states to develop
their own approaches unique to their
local circumstances so long as they are
consistent with applicable statutory
requirements and provide the public
and interested parties an opportunity to
comment and offer input. In particular,
section 4711 of the Balanced Budget Act
of 1997 (BBA 97) (Pub. L. 105–33,
enacted August 5, 1997) amended
section 1902(a)(13)(A) of the Act to give
states greater flexibility to develop their
own payment methods and standards by
replacing prescriptive rate setting
requirements with the present standard
that rates for inpatient hospital, nursing
facility, and intermediate care facility
for individuals with intellectual
disabilities (ICF/IID) services be
established in accordance with a public
process. The public process emphasizes
transparency in how states approach
rate setting by providing stakeholders
with a reasonable opportunity to review
and comment on the proposed FFS
rates, rate setting methodologies, and
justifications before states publish final
rates, underlying methodologies, and
justifications. However, it does not
impose any constraints on states with
respect to the payment methodologies
they may wish to adopt to purchase
Medicaid services.
Similarly, states are free to develop
their own approach to establishing
payment rates for other Medicaid
services and, under longstanding
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
regulations at § 447.205, generally must
publish public notice in advance to
implement new, or change existing,
methods and standards for setting
payment rates for services. For example,
states may decide to use a prospective
payment or a retrospective payment
system and may elect to reimburse on a
per unit, per day, or per discharge basis.
Whatever payment methodology or
system a state elects to implement, the
state must describe the methodology or
system comprehensively in its Medicaid
state plan and submit the proposed
methodology to CMS for review and
approval in a manner consistent with 42
CFR part 430, subpart B.
State payment methodologies
typically provide for a standard
payment to all Medicaid providers on a
per claim basis for services rendered to
a Medicaid beneficiary in a FFS
environment. We refer to these
payments as ‘‘base payments.’’ Base
payments also include any payment
adjustments, add-ons, or other
additional payments received by the
provider that can be attributed to
services identifiable as having been
provided to an individual beneficiary,
including those that are made to
account for a higher level of care or
complexity or intensity of services
provided to an individual beneficiary.
Having established a base payment
system, states may wish to offer extra
compensation to certain providers by
establishing supplemental payments
within the state’s overall approach to
reimbursing Medicaid providers.
‘‘Supplemental payments’’ are payments
made to providers that are in addition
to the base payment the provider
receives for services furnished. They
can be directed to all providers or
directed to a designated set of providers,
with the amount of the payment
depending upon applicable upper
payment limit (UPL) demonstration
requirements in §§ 447.272 and 447.321
for inpatient and outpatient settings,
respectively. Unlike base FFS payments,
which are directly attributable to a
covered service furnished to an
individual beneficiary, supplemental
payments are often made to the provider
in a lump sum on a monthly, quarterly,
or annual basis apart from payments for
a provider claim, and therefore, cannot
be directly linked to a provider claim for
specific services provided to an
individual Medicaid beneficiary.
Effectively, the supplemental payments
serve to increase total Medicaid
payments to a provider for all Medicaid
services furnished over a set period of
time as shown in the state’s UPL
demonstration. The UPL demonstration
is the means by which the state
PO 00000
Frm 00003
Fmt 4701
Sfmt 4702
63723
documents that the Medicaid payments
for the applicable services are below the
aggregate UPL amount. In general,
supplemental payments are recognized
as service payments as they supplement
base payments previously made to
purchase Medicaid services from
providers. Typically, they are made
under FFS state plan authority but,
more recently, states have made similar
types of payments through
demonstration and managed care
authorities.
As discussed previously, for most
services, the Medicaid statute does not
prescribe a particular payment
approach; however, the statute does
contemplate that states will be prudent
purchasers of health care services. More
specific to rate setting, section
1902(a)(30)(A) of the Act requires states
to have methods and procedures to
assure Medicaid payments for services,
including any base and supplemental
payments, are consistent with
efficiency, economy, and quality of care
and are sufficient to enlist enough
providers so that care and services are
available under the plan at least to the
extent that such care and services are
available to the general population in
the geographic area. Under section
1902(a)(30)(A) authority, implementing
federal regulations establish UPLs for
certain services and rely on these limits
to help assure that state Medicaid
payments are consistent with
‘‘efficiency and economy.’’ Federal
financial participation (FFP) is not
available for state Medicaid
expenditures that exceed an applicable
UPL.
Medicaid UPLs are codified in
regulations at §§ 447.272 and 447.321
and apply to payments for Medicaid
inpatient hospital, nursing facility and
ICF/IID services, as well as for
outpatient hospital and clinic services.
For each of these Medicaid benefits, the
UPLs are first constructed by
categorizing providers into groups
(‘‘ownership groups’’) according to the
ownership or operational interests: State
government-owned or operated, nonstate government-owned or operated,
and privately-owned and operated.
States are restricted, in the aggregate for
each ownership group, from paying
more than a reasonable estimate of the
amount Medicare would pay for the
services furnished by the providers in
the applicable ownership group. The
aggregate application of these UPLs has
preserved state flexibility for setting
facility-specific payments while creating
an overall payment ceiling as a
mechanism for determining economy
and efficiency of payment for the
E:\FR\FM\18NOP2.SGM
18NOP2
63724
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
services described above, consistent
with section 1902(a)(30)(A) of the Act.
Where Medicaid base payments are
below the aggregate UPL calculation,
states have the ability to make
supplemental payments to providers, by
ownership group, up to the calculated
limit. With the aggregate UPL
calculations, states have the ability to
pay some providers in excess of a
reasonable amount that Medicare would
pay those individual providers for their
services furnished, so long as the
aggregate Medicaid payments are less
than or equal to the aggregate UPL
amount for the ownership category.
Should states wish to make payments
up to the UPL and have the non-federal
share available to do so, after giving
public notice, they may modify their
state plan payment methodologies to
provide for supplemental payments. We
note that, without a regulatory standard
to govern UPLs for practitioner services,
CMS has allowed states to make
Medicaid supplemental payments for
practitioner services up to Medicare
payment amounts or, based on data
documentation, up to the average
commercial rate (ACR) made to
providers. As discussed later in this
proposed rule, ACRs are payments
developed using the average of some
commercial payers’ payment rates for
medical services to establish a
supplemental Medicaid rate for certain
practitioners, typically physicians,
under the state plan. Unlike other
supplemental payments subject to UPLs,
some of these practitioner supplemental
payments have resulted in payments to
providers in excess of a reasonable
estimate of what Medicare would have
paid for the services furnished, as the
relevant ACRs generally are higher than
Medicare rates. This result is possible
because there currently is no UPL
applicable to payments for practitioner
services based on a reasonable estimate
of what Medicare would pay.
Under our current UPL regulations
and CMS policy, approval of a
supplemental payment is not an
indication that a state’s proposal to use
supplemental payments within its
payment system is the best approach to
setting Medicaid payments. Instead, our
approvals have been based on the state’s
documentation of UPL calculations,
where applicable, showing that the total
Medicaid payments (base and
supplemental) paid to providers under
the state plan are within the federal
limits. Beyond that test and a review of
state plan amendments (SPAs) which
propose to add or amend supplemental
payment methodologies or aggregate
supplemental payments, we have not
closely examined how states distribute
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
Medicaid payments to individual
providers as a matter of routine
oversight.
Through the policies proposed in this
proposed rule, we are seeking to better
understand the relationship between
and among the following: Supplemental
provider payments, costs incurred by
providers, current UPL requirements,
state financing of the non-federal share
of supplemental payments, and the
impact of supplemental payments on
the Medicaid program (such as
improvements in the quality of, or
access to, care). It often appears to us
that most of these payment
methodologies do not result in an
equitable distribution of payments to
improve adequacy of rates across
providers within the service class or
ownership group, or otherwise improve
the Medicaid program in some
measurable, value-added way. Instead,
many supplemental payment strategies
appear to target only those providers
that can participate in financing the
non-federal share funding required to
support a state’s claim for FFP. In
certain circumstances, this practice may
be inconsistent with section 1902(a)(2)
of the Act, which requires states to
assure that a lack of funds from local
sources will not result in lowering the
amount, duration, scope, or quality of
services or level of administration under
the plan, since the payments are only
available to providers with the means to
provide the non-federal share.
For instance, states might use the
entire UPL gap (the difference between
the amounts paid in base payments and
the aggregate UPL) for each service type
and provider ownership group to make
a supplemental payment to only a small
subset of providers in the group. In an
example of this type of supplemental
payment structure, one state
implemented an inpatient hospital
supplemental payment methodology to
make payments up to the UPL for nonstate government operated hospitals.
The supplemental payment was funded
by intergovernmental transfers (IGTs)
from a local (city) government.
Although the total amount of the
supplemental payment was based on the
available UPL room for 26 non-state
government operated hospitals, under
the terms of the methodology, only three
hospitals qualified to receive the
supplemental payment. This resulted in
total payments to those three hospitals
that far exceeded their reported total
cost incurred for all Medicaid services,
which is inconsistent with section
1902(a)(30)(A) of the Act.
Supplemental payments now
comprise a large and growing
percentage of total Medicaid payments.
PO 00000
Frm 00004
Fmt 4701
Sfmt 4702
They are commonly paid both to
institutional providers (for example,
inpatient hospitals, nursing facilities,
and ICF/IIDs) and for outpatient services
(for example, outpatient hospitals,
clinics, and physician services).
Currently, 48 states reported using at
least one type of supplemental payment
methodology under the Medicaid state
plan. As a percentage of total Medicaid
payments for institutional providers,
data from the Medicaid Budget and
Expenditure System (MBES) indicate
that supplemental payments have
steadily increased from 9.4 percent in
FY 2010, the first year in which states
separately reported these payments, to
17.5 percent of all FFS payments to
hospitals, nursing facilities, ICF/IIDs,
and physician service payments in FY
2017. Supplemental payments to
providers under demonstration
authority, which can allow additional
flexibility to cover beneficiaries and
services not usually permitted under
state plan authority, have also grown. In
December 2018, MACPAC released the
‘‘Medicaid Inpatient Hospital Services
Fee-for Service Payment Policy’’ issue
brief where it noted that expenditures
for hospital UPL supplemental
payments increased from 2 to 3 percent
of total expenditures for Medicaid
benefits between 2001 and 2016.1 In the
MACPAC analysis, the totality of
supplemental payments, DSH payments,
and uncompensated care payments
made under demonstration authority, as
a share of the total computable
Medicaid payments to hospitals in FY
2016, was 27 percent. In all, the
MACPAC analysis concluded that the
total expenditures in 2016 for DSH
payments were $16.5 billion, for UPL
supplemental payments were $16.4
billion, and for uncompensated care
payments were $8.5 billion.
b. Current CMS Review of Provider
Payments and Oversight Concerns
The Medicaid statute and regulations
require states to report program-related
information to CMS regarding their
payment methodologies and incurred
expenditures that are claimed for federal
matching funds. Section 1902(a)(6) of
the Act requires the Medicaid agency to
make reports as the Secretary of Health
and Human Services (the Secretary) may
require and to comply with provisions
the Secretary finds necessary to assure
the correctness and verification of such
reports. Implementing regulations at 42
CFR 431.107(b) require states to ensure
that providers maintain auditable
1 https://www.macpac.gov/wp-content/uploads/
2016/03/Medicaid-Inpatient-Hospital-Services-Feefor-Service-Payment-Policy.pdf.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
documentation of the services furnished
to beneficiaries for which the state
makes program expenditures and claims
FFP, to allow the federal government to
ensure that all applicable federal
requirements are met. Additionally, 42
CFR 430.30(c) requires states to submit
the Form CMS–64, which is a quarterly
accounting statement of the state’s
actual recorded expenditures that serves
as the primary basis for Medicaid
payments to states under section
1903(a)(1) of the Act.
The primary means to collect
information on Medicaid program
eligibility, services, and expenditures
has historically been through CMS’
Medicaid Statistical Information System
(MSIS), which is populated by FFS
claims and managed care encounter data
from states’ Medicaid Management
Information Systems (MMIS), which are
an integrated group of procedures and
computer processing operations (subsystems) developed at the general
design level to meet principal
objectives, and CMS’ MBES, which is
the system through which states file
quarterly Medicaid expenditures on the
Form CMS–64. These systems have been
essential to both the states and the
federal government in operating
Medicaid and provide valuable program
information. However, neither the
modern Transformed Medicaid
Statistical Information System (T–
MSIS), which has replaced MSIS,
discussed further below, nor MBES,
separately or together, provides the level
of detail on the payment and financing
of supplemental payments necessary to
effectively monitor and evaluate the use
and impact of those payments.
MSIS is an eligibility and claims data
set that provides a summary of services
and payments linked to specific
beneficiaries on the basis of claims
submitted to the states by providers.
However, the MSIS data include very
little information about the providers
furnishing services. In addition, MSIS is
unable to capture the providers’
supplemental payments since those
payments are not directly tied to
specific beneficiaries, but rather,
typically, are made based on the volume
of Medicaid services rendered and
generally are paid to providers as lump
sums, separately from payments for
service claims. Another often cited
problem with MSIS data is that, in spite
of regulations requiring timely
reporting, there is generally a
considerable time lag between when the
services are paid for by the state and
when data on those payments is
furnished to CMS through MSIS.
To improve the completeness and
timeliness of such data for the purposes
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
of program monitoring and oversight,
we currently are working with states to
collect more robust data through an
expansion and update of MSIS, which is
referred to as the T–MSIS. T–MSIS data
improves our ability to study utilization
patterns and trends, identify high cost
and high needs populations, analyze
expenditures by category of service and
provider type, monitor enrollment and
expenditures within delivery systems,
assess the impact of different types of
delivery system models on beneficiary
outcomes, and examine access to care
issues. However, although we are
currently working to improve T–MSIS’
reporting capability for supplemental
payments, T–MSIS will not capture
supplemental payments at the level of
detail proposed under this proposed
rule. It should be noted that T–MSIS is
capable of capturing the non-federal
share of base rate payments. Currently,
there are significant gaps in state
reporting related to this particular data
element, which we also are working
with states to correct.
MBES data include all state
expenditures filed on the Form CMS–
64. The Form CMS–64 is a summary of
a state’s actual Medicaid expenditures,
for both state program administration
and medical assistance (that is,
payments for services furnished to
beneficiaries), derived from source
documents including invoices, payment
vouchers, governmental funds transfers,
expenditure certifications, cost reports
and settlements, and eligibility records.
This form shows the disposition of
Medicaid grant funds for the quarter
being reported and any prior period
adjustments. It also accounts for any
overpayments, underpayments, refunds
received by the state Medicaid agency,
and income earned on grant funds. With
limited exceptions, MBES does not
contain beneficiary, provider, or claimlevel information for the reported
expenditures, including supplemental
payments. We can only obtain such
information by requesting separate
supporting documentation from the
state. Attempting to improve oversight
and transparency of supplemental
payments, we added expenditure
reporting lines in MBES in 2010 for
states to separately report the amounts
of supplemental payments made for
various types of services. This
information is reported at the aggregate
service level and does not include
details on which providers receive those
payments, the specific amount received
by each, or the source of the non-federal
share that supports those expenditures.
While this reporting requirement
slightly improved transparency, there
PO 00000
Frm 00005
Fmt 4701
Sfmt 4702
63725
were large variations in the total
payment amounts reported through
MBES and the total payment amounts
through UPL demonstrations and we are
concerned that state reporting has not
always been complete and accurate and
should be improved.
We also gather information on the
nature and extent of proposed
supplemental payments during our
review of SPAs. As part of the
documentation submitted with
payment-related SPAs, states must
describe which providers would be
eligible for the payments and how the
payments would be calculated and
distributed, provide an estimate of the
fiscal impact, and disclose the source of
the non-federal share of the proposed
expenditures. The opportunity to
evaluate the permissibility and potential
impact of supplemental payments is
presented when a state submits a
proposal. Current regulations do not
contemplate that, once we have
approved a SPA, as described in part
430, subpart B, we would routinely
monitor the implementation and effects
of the SPA in a formal, systematic way.
The opportunity to review state
payments after the agency has approved
a SPA generally is limited to the
submission of SPAs to update or change
the supplemental payment
methodology. Our other mechanisms for
review are financial management
reviews and audits of state programs
which may cover any area of the
Medicaid program and require advanced
planning and are resource intensive for
CMS and states. We also have relied
upon reviews conducted by other
government oversight bodies. These
reviews are often resource intensive and
require a large amount of data sharing,
consultation, discussions, and policy
reviews. As such, many years may pass
before we are able to finalize the
reviews and revisit supplemental
payment methodologies, either through
financial management review or the
submission of a SPA. Because of this,
we are unable to periodically evaluate
these payment arrangements, including
individual underlying provider payment
amounts, to determine if the payments
have been consistent with economy,
efficiency, quality, access, and
appropriate utilization, as required by
statute. We do not generally collect
further information associated with a
SPA in a centralized manner, and such
information generally is not presented at
the provider level.
In its March 2014 Report to the
Congress on Medicaid and CHIP,
MACPAC noted that supplemental
payments to hospitals, according to
their analysis of supplemental payments
E:\FR\FM\18NOP2.SGM
18NOP2
63726
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
in 5 states, accounted for more than 20
percent of total computable Medicaid
FFS payments to hospitals in those 5
states, and in some states account for
more than 50 percent of such
payments.2 MACPAC has recommended
that the Secretary collect provider-level
data on supplemental payments to,
among other things, provide greater
transparency regarding Medicaid
payments and facilitate assessments of
Medicaid payments and analysis of the
relationship between supplemental
payments and access to care, as well as
the economy and efficiency of Medicaid
payments. In developing this proposed
rule, we also considered the findings
reported by MACPAC in the March 2012
Report to the Congress on Medicaid and
CHIP, which identified data limitations
regarding lump-sum Medicaid
supplemental payments as an
impediment to comparing payment
levels across providers and states,
determining the total amount of
Medicaid spending on specific services
and populations, and evaluating the
impact of Medicaid payment policies.3
Without complete provider-level
payment information, we do not have
sufficient information to evaluate
whether rate methodologies result in
payments within a service type and
provider ownership group that are
economic and efficient as required
under section 1902(a)(30)(A) of the Act.
The GAO has issued a series of reports
which note that the lack of reliable CMS
data about Medicaid payments to
providers and state financing of the nonfederal share hinders our ability to
adequately oversee the Medicaid
program. To help ensure that each state
meets the statutory and regulatory
requirements regarding its oversight
responsibilities, data reporting, and
financial participation, the GAO has
recommended that regulatory and
legislative efforts be strengthened.
Specific to Medicaid supplemental
payments, the GAO has had
longstanding concerns regarding the
need for improved transparency and
accountability. For example, in 2015,
the GAO issued a report entitled,
‘‘Medicaid: CMS Oversight of Provider
Payments Is Hampered by Limited Data
and Unclear Policy,’’ that stated,
‘‘[w]ithout good data on payments to
2 Medicaid and CHIP Payment and Access
Commission, Report to the Congress on Medicaid
and CHIP, March 14, 2014, 184 (2014), https://
www.macpac.gov/wp-content/uploads/2015/01/
2014-03-14_Macpac_Report.pdf.
3 Medicaid and CHIP Payment and Access
Commission, Report to the Congress on Medicaid
and CHIP, March 15, 2012, 167 (2012), https://
www.macpac.gov/wp-content/uploads/2015/01/
State_Approaches_for_Financing_Medicaid_and_
Update_on_Federal_Financing_of_CHIP.pdf.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
individual providers, a policy and
criteria for assessing whether the
payments are economical and efficient,
and a process for reviewing such
payments, the federal government could
be paying states hundreds of millions,
or billions, more than what is
appropriate.’’ 4 As a result, the GAO has
recommended that to better ensure the
fiscal integrity of the program, we
should establish financial reporting at a
provider-specific level and clarify
permissible methods for calculating
Medicaid supplemental payment
amounts.
Since the availability of FFS
supplemental payments under the
aggregate UPL is driven by the volume
of services provided through the FFS
system, a shift to managed care or
certain demonstration projects results in
a lowered UPL estimate and a
corresponding decrease in the level of
FFS supplemental payments that a state
can make. For example, there are
instances when pool payments
established through a demonstration
authorized under section 1115(a) of the
Act pay for uncompensated care costs
for the provision of health care services
to Medicaid beneficiaries, the
underinsured, and the uninsured, or for
state projects that promote delivery
system reforms. States have also
authorized pass-through payments or
incentive arrangements to providers
under managed care contracts that can
operate similarly to existing FFS
supplemental payments. We have
authorized these payments within
certain requirements described in 42
CFR part 438 and demonstration terms
and conditions, as applicable, noting
that the financing requirements in 42
CFR parts 430 and 433 and addressed in
this proposed rule are applicable to FFS,
managed care, and demonstration
authorities.
Given the growing prevalence of
supplemental payments and concerns
raised by federal oversight agencies, we
are concerned that our past practice of
basing approval of SPAs regarding
supplemental payments primarily on
aggregate UPL compliance does not
provide us with sufficient information
to adequately ensure that supplemental
payments are consistent with statutory
requirements for economy and
efficiency, quality of care, and access, or
otherwise with sound program
management principles. As a result, as
discussed in greater detail in section II.
of this proposed rule, the Provisions of
4 U.S. Gov’t Accountability Office, GAO–15–322,
Medicaid: CMS Oversight of Provider Payments Is
Hampered by Limited Data and Unclear Policy, 46
(2015), https://www.gao.gov/assets/670/669561.pdf.
PO 00000
Frm 00006
Fmt 4701
Sfmt 4702
the Proposed Rule section, we are
proposing to gather additional
information to better understand how
states distribute supplemental payments
to individual providers and whether
there are benefits to the Medicaid
program resulting from the
supplemental payments.
2. Disproportionate Share Hospital
(DSH) Payments
a. Background
States have statutory authority to
make DSH payments to qualifying
hospitals. Section 1902(a)(13)(A)(iv) of
the Act requires that states take into
account the situation of hospitals that
serve a disproportionate share of lowincome patients with special needs, in
a manner consistent with section 1923
of the Act. These are not considered part
of the base rate payments or
supplemental payments, as they are
made under distinct statutory authority.
Section 1923 of the Act contains
specific requirements related to DSH
payments, including aggregate annual
state-specific DSH allotments that limit
FFP for statewide total DSH payments
under section 1923(f) of the Act, and
hospital-specific limits on DSH
payments under section 1923(g) of the
Act. Under the hospital-specific limits,
a hospital’s DSH payments may not
exceed the costs incurred by that
hospital in furnishing inpatient and
outpatient hospital services during the
year to Medicaid beneficiaries and the
uninsured, less payments received from
or on behalf of the Medicaid
beneficiaries or uninsured patients. In
addition, section 1923(a)(2)(D) of the
Act requires states to provide an annual
report to the Secretary describing the
DSH payment adjustments made to each
DSH.
Section 1001(d) of the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub.
L. 108–173, enacted December 8, 2003)
added section 1923(j) of the Act to
require states to report additional
information about their DSH programs.
Section 1923(j)(1) of the Act requires
states to submit an annual report
including an identification of each DSH
that received a DSH payment
adjustment during the preceding fiscal
year (FY) and the amount of such
adjustment, and such other information
as the Secretary determines necessary to
ensure the appropriateness of the DSH
payment adjustments for such fiscal
year. Additionally, section 1923(j)(2) of
the Act requires states to submit an
independent certified audit of the state’s
DSH program, including specified
content, annually to the Secretary.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
b. Concerns Raised Regarding
Overpayments Identified Through
Annual DSH Audits
The ‘‘Medicaid Program;
Disproportionate Share Hospital
Payments’’ final rule published in the
December 19, 2008 Federal Register (73
FR 77904) (and herein referred to as the
2008 DSH audit final rule) requires state
reports and audits to ensure the
appropriate use of Medicaid DSH
payments and compliance with the
hospital-specific DSH limits under
section 1923(g) of the Act.
The regulations at 42 CFR part 455,
subpart D, implement section 1923(j)(2)
of the Act. FFP is not available for DSH
payments that are found in the
independent certified audit to exceed
the hospital-specific limit. Amounts in
excess of the hospital-specific limit are
regarded as overpayments to providers,
under 42 CFR part 433, subpart F. The
discovery of overpayments necessitates
the return of the federal share or
redistribution by the state of the
overpaid amounts to other qualifying
hospitals, in accordance with the state’s
approved Medicaid state plan. The
regulations in part 433, subpart F
provide for refunding of the federal
share of Medicaid overpayments paid to
providers. While the preamble to the
2008 DSH audit final rule generally
addressed the return or redistribution of
provider overpayments identified
through DSH audits, it did not include
specific procedural requirements for
returning or redistributing
overpayments. As described below, we
are proposing to incorporate into
regulation procedural requirements
associated with the return and
redistribution of DSH overpayments.
While the information included in the
independent certified audits and
associated reports provides CMS and
states with robust data, we are often
unable to determine whether a DSH
overpayment to a provider has occurred,
the root causes of any overpayments,
and the amount of the overpayments
associated with each cause. Despite the
robust data, potential data gaps may
exist as a result of an auditor identifying
an area, or areas, in which
documentation is missing or unavailable
for certain costs or payments that are
required to be included in the
calculation of the total eligible
uncompensated care costs. Therefore, in
current practice, an auditor may include
a finding (or ‘‘caveat’’) in the audit
stating that the missing information may
impact the calculation of total eligible
uncompensated care costs, instead of
making a determination of the actual
financial impact of the identified issue.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
This lack of transparency results in
uncertainty and restricts CMS’ and
states’ ability to ensure proper recovery
of all FFP associated with DSH
overpayments identified through annual
DSH audits. For example, an audit may
identify that a hospital was unable to
satisfactorily document the outpatient
services it provided to Medicaid-eligible
patients, indicating that charges and
payments were not included in the DSH
uncompensated care calculation. Based
on this lack of documentation, the audit
includes a caveat of its finding
indicating that the hospital’s
uncompensated care cost may be
misstated as a result of this exclusion
and that the impact is unknown. Given
this lack of quantification of the
financial impact of this finding, we are
unable to determine whether an
overpayment, if any, has resulted from
this audit finding. To obtain such
information, either CMS and/or the state
would have to conduct a secondary
review or audit, which would be
burdensome and largely redundant.
Specifically, conducting a secondary
review or audit after the independent
auditors have completed theirs would
lengthen the review process, and
therefore, delay the results of the audit.
It would also require additional time,
personnel, and resources by CMS,
states, and hospitals to participate in a
secondary review or audit.
The OIG and GAO have raised
concerns similar to ours with respect to
our ability to adequately oversee the
Medicaid DSH program. Specifically,
the OIG published the report, ‘‘Audit of
Selected States’ Medicaid
Disproportionate Share Hospital
Programs’’ in March 2006,5 in which the
OIG recommended that we establish
regulations requiring states to
implement procedures to ensure that
future DSH payments are adjusted to
actual incurred costs, incorporate these
adjustment procedures into their
approved state plans, and include only
allowable costs as uncompensated care
costs in their DSH calculations. The
2008 DSH audit final rule addressed the
concerns raised by the OIG in
regulations implementing the
independent certified audit
requirements under section 1923(j) of
the Act, by requiring states to include
data elements as specified in
§ 447.299(c) with their annual audits. In
2012, the GAO published the report,
‘‘Medicaid: More Transparency of and
Accountability for Supplemental
5 Audit of Selected States’ Medicaid
Disproportionate Share Hospital Programs,’’ March
2006 (A–06–03–00031), https://www.oig.hhs.gov/
oas/reports/region6/60300031.pdf.
PO 00000
Frm 00007
Fmt 4701
Sfmt 4702
63727
Payments are Needed,’’ 6 in which the
GAO examined how information on
DSH audits facilitates our oversight of
DSH payments. In the report, GAO
analyzed the 2010 DSH audits
submitted by states. Of the 2,953 audits
submitted to CMS, 228 had data
reliability or documentation issues that
inhibited the auditor’s ability to
determine compliance with DSH audit
requirements. While the independent
certified audit requirements have
allowed us to identify various
compliance issues and quantify some
provider overpayments, in some
instances, audits have identified issues
related to incomplete or missing data
and have failed to make a determination
regarding the financial impact of these
issues. Therefore, we have identified
this area as an opportunity to strengthen
program oversight and integrity
protections, specifically with respect to
the overpayment and redistribution
reporting process and requirements for
identifying the financial impact of audit
findings. In proposing an additional
data element, as discussed below, we
hope to further enhance our oversight to
better ensure the integrity of hospitalspecific limit calculations.
The new data element we are
proposing to add to annual DSH
reporting would require auditors to
quantify the financial impact of any
finding, including those resulting from
incomplete or missing data, which may
affect whether each hospital has
received DSH payments for which it is
eligible within its hospital-specific DSH
limit. We believe that requiring the
quantification of these findings would
limit the burden on both states and CMS
of performing follow-up reviews or
audits and will help ensure appropriate
recovery and redistribution, as
applicable, of all DSH overpayments.
To enhance federal oversight of the
Medicaid DSH program and improve the
accuracy of DSH audit overpayments
identified and collected through annual
DSH audits, we are also proposing to
require states to report overpayments
identified through annual DSH audits
and related payment redistributions on
the Form CMS–64 in a timely and
transparent manner. Specifically, we
propose to clarify the reporting
requirement for overpayments identified
through the annual DSH audits at
§ 447.299(f), by directing states to return
payments in excess of hospital-specific
cost limits to the federal government by
reporting the excess amount on Form
CMS–64, as a decreasing adjustment.
We are proposing to require states to
report these decreasing adjustments to
6 https://www.gao.gov/assets/660/650322.pdf.
E:\FR\FM\18NOP2.SGM
18NOP2
63728
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
correspond with the fiscal year DSH
allotment on the Form CMS–64.
Additionally, we are proposing to
establish reporting requirements on the
redistribution of DSH overpayments, as
determined under § 447.299(g) of this
chapter in accordance with a
redistribution methodology in the
approved Medicaid state plan. We
propose to require states to report the
redistribution of DSH overpayments to
correspond with the fiscal year DSH
allotment and Medicaid state plan rate
year, on the Form CMS–64. This
proposal memorializes our
redistribution policy in regulations and
enhances proper oversight. We are
proposing that overpayment amounts be
redistributed within 2 years from the
date of discovery, as proposed under
§ 447.299(g).
c. Modernizing the Publication of
Annual DSH Allotments
Section 447.297 provides a process
and timeline for CMS to publish
preliminary and final annual DSH
allotments and national expenditure
targets in the Federal Register. The
current requirements specify that we
publish DSH allotments and national
expenditure targets, in preliminary and
final formats, by October 1st
(preliminary target and allotments) and
April 1st (final target and allotments) of
each federal fiscal year. We have found
the current regulatory Federal Register
publication process to be time
consuming and administratively
burdensome and are concerned that the
information is not available to states and
other interested parties in a timely and
easily accessible manner. In this
proposed rule, we propose to make
allotment and national expenditure
targets available more timely by posting
the information on Medicaid.gov and in
MBES, or its successor website or
system, instead of publishing this
information in the Federal Register.
3. Medicaid Program Financing
a. Background
Medicaid expenditures are jointly
funded by the federal and state
governments. Section 1903(a)(1) of the
Act provides for payments to states of a
percentage of medical assistance
expenditures authorized under the
approved state plan. FFP is available
when there is a covered Medicaid
service provided to a Medicaid
beneficiary, which results in a federally
matchable expenditure that is funded in
part through non-federal funds from the
state or a non-state governmental entity
(except when the statute provides a 100
percent federal match rate for specified
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
expenditures). The percentage of federal
funding is the federal medical assistance
percentage (FMAP) that is determined
for each state using a formula set forth
in section 1905(b) of the Act, or other
applicable federal matching rates
specified by the statute.
The foundation of federal-state shared
responsibility for the Medicaid program
is that the state must participate in the
financial burdens and risks of the
program, which provides the state with
an interest in operating and monitoring
its Medicaid program in a manner that
results in receiving the best value for the
funds expended. Sections 1902(a),
1903(a), and 1905(b) of the Act require
states to share in the cost of medical
assistance and in the cost of
administering the state plan. Section
1902(a)(2) of the Act and its
implementing regulation in part 433,
subpart B require states to share in the
cost of medical assistance expenditures
and permit other units of state or local
government to contribute to the
financing of the non-federal share of
medical assistance expenditures. These
provisions are intended to safeguard the
federal-state partnership, irrespective of
the Medicaid delivery system or
authority (for example, FFS, managed
care, and demonstration authorities), by
ensuring that states are meaningfully
engaged in identifying, assessing,
mitigating, and sharing in the risks and
responsibilities inherent in a program as
complex and economically significant
as Medicaid and are accordingly
motivated to administer their programs
economically and efficiently.
Of the permissible means for
financing the non-federal share of
Medicaid expenditures, the most
common is through state general funds,
typically derived from tax revenue
appropriated directly to the Medicaid
agency. Revenue derived from health
care-related taxes can be used to finance
the non-federal share only when
consistent with federal statutory
requirements at section 1903(w) of the
Act and implementing regulations at
part 433, subpart B. The non-federal
share may also be funded in part from
provider-related donations to the state,
but these donations must be ‘‘bona fide’’
in accordance with section 1903(w) of
the Act and implementing regulations,
which means truly voluntary and not
part of a hold harmless arrangement that
effectively repays the donation to the
provider (or to providers furnishing the
same class of items and services).
Non-federal share financing sources
can also come from IGTs or certified
public expenditures (CPEs) from local
units of government or other units of
state government in which non-state
PO 00000
Frm 00008
Fmt 4701
Sfmt 4702
governmental entities contribute
funding of the non-federal share for
Medicaid either by transferring their
own funds to and for the unrestricted
use of the Medicaid agency or by
certifying to the state Medicaid agency
the amount of allowed expenditures
incurred. In each instance, allowable
IGTs and CPEs, as with funds
appropriated to the state Medicaid
Agency, must be derived from state or
local tax revenue or from funds
appropriated to state university teaching
hospitals. IGTs may not be derived from
impermissible health care-related taxes
or provider-related donations (discussed
below); they are subject to all applicable
federal statutory and regulatory
restrictions. Even when using funds
contributed by local governmental
entities, the state must meet the
requirements at section 1902(a)(2) of the
Act and § 433.53 that obligate the state
to fund at least 40 percent of the nonfederal share of total Medicaid
expenditures (both service related and
administrative expenditures) with state
funds. Additionally, these authorities
require states to assure that a lack of
funds from local sources will not result
in lowering the amount, duration,
scope, or quality of services or level of
administration under the plan in any
part of the state.
The extent to which private providers
may participate in the funding of any
Medicaid payment (for example,
managed care, FFS base, or
supplemental payments) is essentially
restricted to the state’s authority to levy
limited health care-related taxes and to
rely on bona fide provider-related
donation in accordance with statutory
and regulatory requirements. Since the
use of IGTs and CPEs are restricted to
governmental entities, states and
providers increasingly have turned to
the use of health care-related taxes to
enable the maintenance of, or increases
to, Medicaid payments to providers. In
addition, several states have explored
the use of provider-related donation
arrangements to further leverage private
provider funding.
b. Current CMS Review of Medicaid
Financing and Oversight Concerns
We employ various oversight
mechanisms to review state methods for
funding the non-federal share of
Medicaid payments including, but not
limited to, reviews of proposed SPAs,
quarterly financial reviews of state
expenditures reported on the Form
CMS–64, focused financial management
reviews, and reviews of state health
care-related tax and provider-related
donation proposals and waiver requests.
As discussed in detail above, states
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
must submit Medicaid SPAs to CMS for
review and approval when adding or
changing FFS provider payment
methodologies. We review the SPAs to
ensure the methodologies meet all
federal requirements and the proposed
payments and sources of the non-federal
share may be approved and serve as the
basis for FFP. In making approval
decisions, we ask for certain
information from states to document the
source of the non-federal share during
our SPA review process.
In response to our inquiries, states
will typically describe whether the nonfederal share is sourced through funds
appropriated by the state legislature
directly to the single state Medicaid
agency, or whether the state relies on
state or local government units to
participate in funding the non-federal
share through IGTs or CPEs.
Additionally, states are asked to
disclose whether the underlying
financing involves a health care-related
tax or a provider-related donation.
When states rely on IGTs and CPEs as
the source of the non-federal share, we
request details on the transferring or
certifying entities that participate in
funding expenditures, including
assurances that the entities are units of
government, and the source of a unit of
government’s IGT. Based on the
information that we receive from states,
we may also ask for additional
documentation to ensure the source of
non-federal share complies with all
applicable federal laws, regulations, and
requirements, particularly those
describing permissible health carerelated taxes and provider-related
donations.
Though our current SPA review
processes allow us to ensure states
identify a permissible source of nonfederal share at the time that we
approve an amendment, we have no
reliable mechanism to track and
understand whether the source of the
non-federal share changes after a SPA
has been approved. Based on studies
conducted by the GAO (see for example,
States’ Increased Reliance on Funds
from Health Care Providers and Local
Governments Warrants Improved CMS
Data Collection, GAO–14–627, July 29,
2014), we are aware that states are
increasingly reliant on non-state units of
government to fund the non-federal
share through IGTs, CPEs, and health
care-related taxes. In fact, the GAO cites
Medicaid supplemental payments and
the associated non-federal share as a
Medicaid High Risk Issue (GAO Report
to Congressional Committees High-Risk
Series Substantial Efforts Needed to
Achieve Greater Progress on High-Risk
Areas, GAO–19–157SP, March 6, 2019)
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
and has called for CMS to implement
improved oversight and data collection
processes to track sources of non-federal
share.
It is important to acknowledge that
section 1903(w)(6)(A) of the Act
specifically permits state and local units
of government to share in financing the
Medicaid program through IGTs and
CPEs. Such local participation is
inherent in the Medicaid program and
recognizes the shared role that state and
local government units can play in
delivering Medicaid services. Nothing
in this proposed rule would result in
limiting state and local government
units from contributing to the Medicaid
program through allowable IGT and CPE
funding sources. However, as discussed
in the GAO’s studies, the increasing
reliance on Medicaid funding derived
from units of state and local government
may serve to undermine the state and
federal financing partnership, as where
states establish payment methodologies
that favor certain providers solely on the
basis of whether a unit of state or local
government can provide the non-federal
share to support Medicaid supplemental
payments. Notably, section 1902(a)(2) of
the Act requires states to assure that a
lack of funds from local sources will not
result in lowering the amount, duration,
scope, or quality of services or level of
administration under the plan. We have
concerns that, in certain circumstances,
increased reliance on units of states or
local government to fund the nonfederal share may result in conflicts
with section 1902(a)(30)(A) of the Act.
For example, we have identified and
worked to address various Medicaid
financing arrangements that appear
designed to increase the federal share of
Medicaid funding without a
commensurate state or local
contribution as required by sections
1902(a), 1903(a), and 1905(b) of the Act,
which require states to share in the cost
of medical assistance and in the cost of
administering the state plan. We have
identified manipulations of Medicaid
UPL demonstration calculations that
would serve to increase a state’s ability
to make supplemental payments above
a reasonable Medicare estimate in states
that have used, or proposed to use, an
unallowable IGT to fund the state share
of a Medicaid supplemental payment.
We have also identified the
manipulation of cost identification data
providers rely on to certify Medicaid
expenditures through a CPE process
that, whether intentional or not, results
in the federal government paying for
costs that are unallowable under the
Medicaid program.
Some of the more complicated, and
unallowable, Medicaid financing
PO 00000
Frm 00009
Fmt 4701
Sfmt 4702
63729
arrangements we have reviewed
resulted from public-private partnership
arrangements between private entities
and units of government. These
arrangements attempt to mask non-bona
fide provider-related donations as an
allowable IGT and result in increased
supplemental payments to the donating
private entity or entities. Discussed in
detail in State Medical Director Letter
(SMDL) 14–004 and elsewhere in this
preamble, partnership arrangements
between a private provider and a
government entity have involved the
private provider providing cash, a
service, or other in-kind donation to the
government entity that is seemingly
unrelated to the Medicaid program. In
exchange for the private provider’s
contribution, the government entity will
make an IGT to the Medicaid agency,
which is then used as the non-federal
share of supplemental Medicaid
payments which are then returned to
the private entity to repay them for the
non-bona fide provider-related donation
consistent with the underlying hold
harmless agreement. The IGT is derived
from funds that the government entity
previously would have spent on the
medical services (or other obligation)
that are now being provided or paid for
by the private entity. These funds would
not be available to use as state share of
Medicaid expenditures, if not for the
public-private partnership arrangement,
since the funds are derived from the
non-bona fide provider-related donation
(and not derived from state or local tax
revenue or from funds appropriated to
the state university teaching hospitals).7
The provisions of this proposed rule
seek to address these and similar
financing concerns through a number of
strategies. Proposed improvements to
state reporting associated with
supplemental payments and sources of
the non-federal share would allow CMS
to monitor changes in non-federal share
funding after a SPA is approved and any
associated increases in federal
expenditures for supplemental
payments, relative to state expenditures.
Additional specificity in definitions
relevant to Medicaid financing
arrangements and in requirements for
information states must provide to
support various funding mechanisms
and supplemental payments would
strengthen oversight of program
expenditures by us and the states.
Finally, we propose to address certain
egregious funding schemes that mask
7 Dep’t of Health & Human Servs., CMS, State
Medicaid Director Letter 14–004, Accountability #2:
Financing and Donations, 3, (2014), https://
www.medicaid.gov/Federal-Policy-Guidance/
Downloads/SMD-14-004.pdf.
E:\FR\FM\18NOP2.SGM
18NOP2
63730
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
non-bona fide donations as allowable
IGTs by clarifying where an indirect
hold harmless arrangement may exist
and by expressly prohibiting
supplemental payments that support
these schemes. Together, proposed new
policies and the proposed codification
of existing policies related to Medicaid
financing aim to provide CMS and states
with better information and guidance to
identify existing and emerging financing
issues, provide more clarity on
allowable financing arrangements,
promote state accountability, and
strengthen the fiscal integrity of the
Medicaid program.
4. Health Care-Related Taxes and
Provider-Related Donations
a. Background
States first began to use health carerelated taxes and provider-related
donations in the mid-1980s as a way to
finance the non-federal share of
Medicaid payments (Congressional
Research Service, ‘‘Medicaid Provider
Taxes’’, August 5, 2016, p.2). Providers
would agree to make a donation or
would support (or not oppose) a tax
upon their activities or revenues, and
these mechanisms would generate funds
that could then be used to raise
Medicaid payment rates to the
providers. Frequently, these programs
were designed to hold Medicaid
providers ‘‘harmless’’ for the cost of
their donation or tax payment. As a
result, federal expenditures rapidly
increased without any corresponding
increase in state expenditures, since the
funds used to increase provider
payments came from the providers
themselves and were matched with
federal funds. In 1991, the Congress
passed the Medicaid Voluntary
Contribution and Provider-Specific Tax
Amendments (Pub. L. 102–234, enacted
December 12, 1991) to curb the use of
provider-related donations and health
care-related taxes to finance the nonfederal share of Medicaid expenditures.
Section 1903(w)(1)(A) of the Act
specifies that, for purposes of
determining the federal matching funds
to be paid to a state, the total amount
of the state’s Medicaid expenditures
must be reduced by the amount of
revenue the state collects from
impermissible health care-related taxes
and non-bona fide provider-related
donations.
The statute requires that taxes be
imposed on a permissible class of health
care items or services; and be broad
based, meaning that all non-federal,
nonpublic providers and all items and
services within a class of health care
items or services would be taxed, as
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
well as uniform, meaning that the tax
rate would be the same for all health
care items or services in a class, as well
as providers of such items or services.
The statute prohibits hold harmless
arrangements in which collected taxes
are returned directly or indirectly to
taxpayers. The Secretary is required by
section 1903(w)(3)(E) of the Act to
waive either the broad based and/or
uniformity requirements as long as the
state establishes, to the Secretary’s
satisfaction, that the net impact of the
tax and associated expenditures is
generally redistributive in nature, and
the amount of the tax is not directly
correlated to Medicaid payments for
items and services with respect to
which the tax is imposed.
Section 1903(w)(2)(A) of the Act
defines a provider-related donation as
any donation or other voluntary
payment (in-cash or in-kind) made
directly or indirectly to a state or unit
of a local government by a health care
provider, an entity related to a health
care provider, or an entity providing
goods or services under the state plan
for which payment is made under
section 1903(a)(2), (3), (4), (6), or (7) of
the Act (generally, administrative goods
and services). Section 1903(w)(2)(B) of
the Act defines a bona fide providerrelated donation as a provider-related
donations that has no direct or indirect
relationship (as determined by the
Secretary) to payments made under title
XIX to that provider, to providers
furnishing the same class of items and
services as the donating provider, or to
any related entity, as established to the
satisfaction of the Secretary. The statute
gives the Secretary the authority to
specify, by regulation, types of providerrelated donations that will be
considered to be ‘‘bona fide.’’
Regulations at part 433, subpart B
describe the requirements necessary,
irrespective of the Medicaid delivery
system authority (for example, FFS,
managed care, or demonstration
authorities), for a donation to be
considered bona fide.
In response to the Medicaid Voluntary
Contribution and Provider-Specific Tax
Amendments of 1991, we published the
‘‘Medicaid Program; Limitations on
Provider-Related Donations and Health
Care-Related Taxes; Limitations on
Payments to Disproportionate Share
Hospitals’’ interim final rule with
comment period in the November 24,
1992 Federal Register (57 FR 55118)
(November 1992 interim final rule) and
the subsequent final rule published in
the August 13, 1993 Federal Register
(58 FR 43156) (August 1993 final rule)
establishing when states may receive
funds from provider-related donations
PO 00000
Frm 00010
Fmt 4701
Sfmt 4702
and health care-related taxes without a
reduction in medical assistance
expenditures for the purposes of
calculating FFP. These rules established
the statistical tests used to judge
requests for waivers of the broad-based
and uniformity requirements and
defined bona fide provider-related
donations.
After the publication of the August
1993 final rule, we revisited the issue of
health care-related taxes and providerrelated donations in the ‘‘Medicaid
Program; Health-Care Related Taxes’’
final rule (73 FR 9685) which published
in the February 22, 2008 Federal
Register (February 2008 final rule). The
February 2008 final rule, in part,
implemented section 1903(w)(7)(A)(viii)
of the Act by expanding the Medicaid
managed care organization (MCO) class
of health care items and services (73 FR
9698) to include all MCOs specified in
section 6051 of the Deficit Reduction
Act of 2005 (DRA) (Pub. L. 109–171,
enacted February 8, 2006). Specifically,
it amended the class of health care
services and providers specified in
§ 433.56(a)(8) from services of Medicaid
MCOs to services of MCOs including
health maintenance organizations
(HMOs) and preferred provider
organizations (PPOs). As a result of this
change, states could no longer impose a
tax solely on MCOs providing services
to only Medicaid beneficiaries.
The regulation also made explicit that
certain practices would constitute a
hold harmless arrangement, in response
to certain state tax programs that we
believed contained hold harmless
provisions. Five states had imposed a
tax on nursing homes and
simultaneously created programs that
awarded grants or tax credits to private
pay residents of nursing facilities that
enabled these residents to pay increased
charges imposed by the facilities, which
thereby recouped their own tax costs.
We believed that these payments held
the taxpayers (the nursing facilities)
harmless for the cost of the tax, as the
tax program compensated the facilities
indirectly, through the intermediary of
the nursing facility residents. However,
in 2005, the DAB (Decision No. 1981)
ruled that such an arrangement did not
constitute a hold harmless arrangement
under the regulations then in place. To
clarify agency interpretation that this
practice does constitute a hold harmless
arrangement, the February 2008 final
rule clarified the direct guarantee test
found at § 433.68(f) by specifying that a
direct guarantee to hold the taxpayer
harmless for the cost of the tax through
a direct or indirect payment will be
found when, ‘‘a payment is made
available to a taxpayer or party related
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
to a taxpayer’’ so that a reasonable
expectation exists that the taxpayer will
be held harmless for all or part of the
cost of the tax as a result of the payment
(73 FR 9694). As an example of a party
related to the taxpayer, the preamble
cited the example of, ‘‘as a nursing
home resident is related to a nursing
home (73 FR 9694). As a result,
whenever there existed a ‘‘reasonable
expectation’’ (73 FR 9695) that the
taxpayer would be held harmless for the
cost of the tax, a hold harmless situation
would exist and the tax would be
impermissible.
b. Concerns Relating to Health CareRelated Tax Waivers
States and their units of local
government have the ability to impose
broad-based and uniform health carerelated taxes without explicit CMS
approval. However, if the tax
implemented by the state or unit of local
government is not broad-based and/or
uniform, the state must apply to CMS
for a waiver of the applicable tax
requirements. As part of these
requirements, the state must
demonstrate to the satisfaction of the
Secretary that the tax passes a statistical
test specified in regulation to waive
either the broad-based requirement, or
the uniformity requirement, or both, as
specified in § 433.68(e)(1) or (2). These
tests were designed to evaluate whether
or not a proposed tax would be
‘‘generally redistributive,’’ as required
by section 1903(w)(3)(E)(ii)(I) of the Act.
The preamble to the November 1992
interim final rule indicated that, in
interpreting the statutory phrase
‘‘generally redistributive,’’ we
‘‘attempted to balance our desire to give
states some degree of flexibility in
designing tax programs with our need to
preclude use of revenues derived from
taxes imposed primarily on Medicaid
providers and activities’’ (57 FR 55128).
In the preamble of August 1993 final
rule, we interpreted ‘‘generally
redistributive’’ to mean ‘‘the tendency of
a state’s tax and payment program to
derive revenues from taxes imposed on
non-Medicaid services in a class and to
use these revenues as the state’s share
of Medicaid payments’’ (57 FR 55128).
At the time of these rules, we
anticipated the two mathematical tests
in § 433.68(e)(1) and (2) would be
sufficient to ensure that a proposed tax
would be ‘‘generally redistributive,’’ as
we interpret that statutory language.
Specifically, the first test known as the
‘‘P1/P2 test’’ in § 433.68(e)(1) is required
for taxes that are uniform, but not broad
based. At the time of these rules, we
anticipated the two mathematical tests
in § 433.68(e)(1) and (2) would be
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
sufficient to ensure that a proposed tax
would be ‘‘generally redistributive,’’ as
we interpret that statutory language.
Specifically, the first test known as the
‘‘P1/P2 test’’ in § 433.68(e)(1) is required
for taxes that are uniform, but not broad
based. As described in the November
1992 interim final rule (57 FR 55128),
the test requires the State to calculate
the proportion of the tax applicable to
Medicaid under a broad-based tax
(designated as P1), and the proportion
applicable to Medicaid under the tax as
imposed by the State (called P2). By
dividing P1 by P2, the test was intended
to measure whether or not the uniform,
but non-broad based tax was
redistributive. Resulting values higher
than one indicated the tax was more
redistributive than a broad-based and
uniform tax, while values less than one
would indicate it was less redistributive
and placed a disproportionate share of
the tax burden on the Medicaid program
(57 FR 55128).
The November 1992 interim final rule
(57 FR 55128) also described the second
test known as the ‘‘B1/B2 test,’’
applying in situations when the state
requests a waiver of the uniformity
requirement whether or not the tax is
broad-based. In this test, the State
would calculate the slope of two linear
regressions: One for the tax program for
which waiver is requested, and one for
the tax if it were applied uniformly and
as a broad-based tax where the slope
(that is, the X coefficient) of the linear
regression applicable to the hypothetical
broad-based uniform tax (called B1) is
divided by the slope of the linear
regression applicable to the tax for
which a waiver is sought (called B2) (57
FR 55128). Similar to the P1/P2 test for
uniform taxes that are not broad based,
the B1/B2 test was designed to show
that values higher than one indicate the
non-uniform tax was more redistributive
than a broad-based and uniform tax,
while values less than one would
indicate that it was less redistributive
and disproportionately burdened the
Medicaid program (57 FR 55128).
However, subsequent experience has
proven that the two mathematical tests
do not ensure, in all cases, that
proposed taxes that pass the applicable
test are generally redistributive. Certain
states have identified a loophole where
taxes can pass the statistical test(s)
despite their imposition of undue
burden on the Medicaid program. For
example, several states have imposed
taxes on managed care entities that, by
design, clearly impose a greater and
undue tax burden on the Medicaid
program than other payers. States have
structured the taxes by dividing the
universe of entities subject to taxation
PO 00000
Frm 00011
Fmt 4701
Sfmt 4702
63731
into smaller taxpayer groups based on
various attributes, such as annual
member-months by payer. In this
example, states have imposed
significantly higher rates on some
taxpayer groups defined by a relatively
higher number of Medicaid membermonths than on commercial payer
member-months, with some Medicaid
activity (member-months in this
example) subject to taxation at a rate
more than 25 times higher than the rate
for otherwise similar commercial
activity. Counterintuitively, these taxes
are able to pass the statistical tests
designed to ensure that the tax is
generally redistributive, despite the
states’ own information indicating, in
one state, that plan revenue from
Medicaid paid 88 percent of the
assessed tax even though only 45
percent of the member months subject
to the tax were attributable to Medicaid
beneficiaries. Under these tax
conditions, the proposed rule would
give CMS the authority to determine
that the tax is not generally
redistributive, despite the fact that it
could pass the applicable statistical test
under current regulations, because it
places an undue burden on the
Medicaid program (as indicated in the
example by the disproportionate share
of the tax attributable to Medicaid
relative to Medicaid’s share of total
member months). The August 1993 final
rule noted that, ‘‘to the extent a tax is
imposed more heavily on low Medicaid
utilization than high Medicaid
providers, the tax would be considered
redistributive,’’ in that case, there would
be a ‘‘tendency of a state’s tax and
payment program to derive revenues
from taxes imposed on non-Medicaid
services in a class and to use these
revenues as the state’s share of Medicaid
payments’’ (57 FR 55128). However, in
the situations involving the type of
statistical manipulation described
above, the exact opposite is the case. In
these instances, states are imposing
taxes that place a greater tax burden on
Medicaid-reimbursed health care items
and services, and providers of such
items and services, than on comparable
entities not reimbursed by Medicaid.
Such a tax is not generally redistributive
in nature.
In an effort to more effectively
prohibit tax arrangements that are not
generally redistributive, for us to
approve a waiver of the broad based
and/or uniformity requirements, this
proposed rule would require that a tax
must not impose undue burden on
health care items or services paid for by
Medicaid or on providers of such items
and services that are reimbursed by
E:\FR\FM\18NOP2.SGM
18NOP2
63732
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
Medicaid. Generally, as discussed in
greater detail below, we would provide
that the tax may not be structured in a
way that places a greater tax burden on
taxpayer groups that have a greater level
of Medicaid activity, as proposed to be
defined below, than those that have less
or no Medicaid activity.
Some states have designed non-broad
based and/or non-uniform tax structures
that exclude, or lower tax rates on,
taxpayers grouped together on the basis
of their lack of or low levels of Medicaid
activity compared to other taxpayers in
the class. We believe that such tax
structures inherently impose undue
burden on the Medicaid program, and
therefore, do not meet the statutory
generally redistributive requirement.
Similarly, we are concerned that some
states might provide tax relief to
taxpayers grouped together ostensibly
on a basis other than Medicaid activity,
but that the specific basis for the
grouping is designed to obscure a true
purpose to define the group based on
lack of or relatively low Medicaid
activity. For example, a state could
attempt to exclude from taxation or
place a lower tax rate on all hospitals
within a certain geographic area that has
certain demographic characteristics,
such as all counties with populations
between 40,000 and 85,000 residents.
Under the particular conditions in the
state, it could result that this
commonality serves as a substitute for
the included hospitals having low or no
Medicaid activity. In this example, the
commonality could be viewed as a
substitute for Medicaid activity if only
two counties in the state met this
criteria, and the hospitals in these two
counties had relatively low Medicaid
activity compared to hospitals in the
other counties in the state, as might
occur in the case of a county with
relatively low Medicaid enrollment in
the county and surrounding counties.
Such a tax program likely would result
in the Medicaid program funding a
disproportionate share of tax revenues,
as counties containing hospitals with
low levels of Medicaid activity would
be excluded by the structure of the tax.
In that case, the burden of the tax would
fall upon hospitals with higher
Medicaid activity. Therefore, as
discussed below, we are proposing to
consider tax structures not to be
generally redistributive when taxpayers
are grouped together in a manner that
isolates taxpayers with relatively higher
or lower levels of Medicaid activity and
when taxpayers with relatively higher
Medicaid activity are taxed relatively
more heavily. We propose to consider
the totality of the circumstances when
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
deciding whether the tax program
involves taxpayer groupings that, by
proxy, have the effect of sorting
taxpayers by relatively higher or lower
levels of Medicaid activity. The
proposed rule would retain the two
statistical tests currently at § 433.68
when determining whether or not the
proposed tax waiver would be generally
redistributive as required by statute.
However, in determining whether or not
a tax program is generally redistributive,
consideration would also be given to
examine the totality of the
circumstances in addition to the
applicable statistical test.
We aim to balance preserving state
flexibility in designing tax programs
with ensuring health care-related taxes
meet statutory generally redistributive
requirements. We do not intend to
interfere with states’ ability to exclude
from taxation or impose lower tax rates
on health care items and services or on
providers based on genuine
commonalities that meet legitimate
policy objectives. However, it is
incumbent upon us to prevent tax
structures designed to impose an undue
burden on the Medicaid program,
including on participating providers
and/or health care items and services for
which Medicaid pays, in contravention
of federal statutory requirements.
c. Concerns Relating to the Definition of
a Health Care-Related Tax
Section 1903(w)(3)(A)(i) of the Act
defines a health care-related tax using
multiple tests that must be applied to
tax proposals. Section 1903(w)(3)(A)(i)
of the Act stipulates health care-related
taxes are related to: (1) Health care items
or services; (2) the provision of, or the
authority to provide, health care items
or services; or (3) payment for health
care items or services. Section
1903(w)(3)(A)(ii) of the Act further
stipulates that a tax is a health carerelated tax when it is not limited to
health care-related items or services, but
provides for treatment of individuals or
entities that provide or pay for health
care-related items or services that is
different than treatment of ‘‘other
individuals or entities.’’ Any tax must
be fully evaluated against all
components of the statutory definition
to determine whether it qualifies as a
health care-related tax.
In determining whether a tax is
related to health care items or services,
section 1903(w)(3)(A) of the Act also
specifies that if at least 85 percent of the
tax burden falls on health care
providers, it is considered to be related
to health care items or services.
However, this provision does not
establish a safe harbor for any tax on
PO 00000
Frm 00012
Fmt 4701
Sfmt 4702
health care providers that falls below
the threshold. Section 433.55(c)
specifies that if less than 85 percent of
the tax burden falls on health care items
or services, the tax may still be
considered to be health care-related if
differential treatment exists for entities
providing or paying for health care
items or services relative to other
entities. If less than 85 percent of the tax
burden falls on health care items or
services, the treatment of those entities
must still be analyzed to determine if
the tax treats them equally.
Outside oversight bodies have raised
concerns that states have attempted to
subvert federal regulations regarding
health care-related taxes by masking
them as part of larger non-health carerelated taxes. States may do so by
including impermissible health carerelated taxes inside larger tax programs
that include non-health care-related
taxes in such a way so as to avoid being
considered a health care-related tax in
accordance with § 433.55. The OIG
identified one such attempt in a May
2014 report (A–03–13–00201),8 in
which the OIG described a state that
appeared to be taxing only income from
Medicaid MCO services by
incorporating only Medicaid MCOs into
larger (often existing) state and local
taxes otherwise unrelated to Medicaid,
despite the DRA provisions which
prohibited taxation of only Medicaid
MCOs. Specifically, section 6051 of the
DRA amended section 1903(w)(7)(A) of
the Act to change the relevant
permissible class of health care items
and services from ‘‘[M]edicaid managed
care organizations’’ to MCOs generally.
In its report, the OIG recommended that
CMS issue clarification to states
regarding its interpretation of statute
and regulations regarding health carerelated taxes as soon as possible and
warned that failure to do so could result
in a proliferation of similar Medicaid
MCO taxes if states believed that it was
permissible to incorporate otherwise
impermissible health care-related taxes
into pre-existing, non-health carerelated tax programs as long as less than
85 percent of the tax burden fell on
health care providers. Absent clarifying
guidance, we were also concerned that
states could mistakenly believe that
selectively incorporating a tax on health
care items or services for which
Medicaid is a significant payer, like
home and community-based services
(HCBS), into a broader state tax program
would result in the HCBS tax not being
defined as health-care related.
8 https://oig.hhs.gov/oas/reports/region3/
31300201.pdf.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
In July 2014, we issued State Health
Official (SHO) letter #14–001 (SHO #14–
001) on health care-related taxes. This
guidance clarified that even in cases
where less than 85 percent of a tax falls
on health care items or services, the tax
can be considered health care-related. If
a tax treats health care items or services
differently, the tax is still considered a
health care-related tax. Specifically,
SHO #14–001 stated that taxing a subset
of health care services or providers at
the same rate as a statewide sales tax,
for example, does not result in equal
treatment if the tax is applied
specifically to a subset of health care
services or providers (such as only
Medicaid MCOs), since the providers or
users of those health care services are
being treated differently than others
who are not within the specified
universe. Despite this guidance, some
states have continued to selectively
incorporate health care items or services
into larger tax programs that also levy
taxes on goods and services unrelated to
health care in an apparent attempt to
circumvent the statutory restrictions on
health care-related taxes. These
impermissible tax arrangements have
not been limited to states incorporating
only Medicaid MCOs into broader state
or local taxes, but have included other
health care items or services, such as
private non-medical institution services.
Often, the health care items and
services (or providers) subject to such
taxes are subsets of health care items
and services (or providers) highly
utilized by Medicaid beneficiaries and/
or do not meet the permissible class
definition in § 433.56. For example, a
state may try to impose a tax on a
service that is mostly (if not entirely)
reimbursed by Medicaid, which does
not fall under an existing permissible
class at § 433.56, such as HCBS. A state
may include a service like this among
other goods and services that are taxed
under a larger tax program that is not
explicitly related to health care, such as
a tax program principally concerned
with natural resources or
telecommunications. The proposed rule
clarifies that by targeting a specific type
of health care-related item or service
and incorporating it into a larger tax (the
HCBS portion of this tax to continue
with the above example) would be
considered health care-related—even if
85 percent of the revenue from the tax
overall did not come from health carerelated items or services or providers of
such items or services.
The preamble to the November 1992
interim final rule with comment period
discussed the circumstances in which
health care items and services included
within a larger non-health care related-
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
tax would cause the tax to be considered
health care-related in situations where
they did not constitute 85 percent of the
tax revenue. To illustrate when such
taxes would or would not be considered
health care-related, the preamble gave
the hypothetical example of a 5 percent
tax on the gross revenues of hospitals
and gas stations that generated $100
million dollars in tax revenue. The
preamble stated that if the hospitals
paid $90 million of the tax, then the tax
would be considered to be health carerelated because this would exceed the
85 percent threshold. However, if the
hospitals paid only $60 million dollars,
then the tax would not be considered
health care-related because the tax rate
is the same for health care items or
services and non-health care items or
services and the hospitals would be
taxed at under the 85 percent threshold
established in regulation.
We are aware that this example may
not have been as clear as possible and
could have led to confusion as to what
different treatment for health care items
and services means in the context of
§ 433.55(c). Specifically, we are
concerned some parties misinterpreted
this example as indicating approval of
states selecting specific health carerelated items and services for inclusion
within a broader tax program without
the tax being considered health carerelated as long as less than 85 percent
of the tax burden falls on such items
and services. We believe this potential
misinterpretation is inconsistent with
section 1903(w)(3)(A)(ii) of the Act,
§ 433.55(c), and the preamble to the
August 1993 final rule, which stated in
response to a commenter, ‘‘We believe
section 1903(w)(3)(A)(ii) [of the Act]
prevents the state from implementing a
tax that may be masked by an existing
non-health care-related tax’’ (58 FR
43160). In the aforementioned preamble
example, a tax in which hospitals paid
$60 million and gas stations paid $40
million under a flat 5 percent gross
revenues tax was not necessarily
considered health care-related because
the burden on providers of health care
items and services is less than 85
percent. While § 433.55(c) states that in
situations where less than 85 percent of
the tax burden falls on health care items
or services the tax may still be
considered health care-related if
differential treatment exists for entities
providing or paying for health care
items or services. However, § 433.55(c)
does not specify the reference group
against which one should measure
differential treatment.
While statute and regulation specify
that differential treatment results in a
tax being considered health care-related,
PO 00000
Frm 00013
Fmt 4701
Sfmt 4702
63733
existing law and regulations do not
explicitly describe what constitutes
differential treatment. Therefore, we are
proposing to clarify what constitutes
differential treatment to clarify when
taxes are health care-related and when
they are not. We believe this
clarification would assist in prohibiting
state or local units of government from
incorporating an impermissible tax on
health care items or services into a
larger existing tax, such as a state-wide
sales tax, or creating a new tax that
treats health care items or services
differently to avoid federal statutory and
regulatory requirements related to
health care-related taxes. Therefore, we
are proposing to clarify that differential
treatment occurs when a tax program
treats some individuals or entities that
are providing or paying for health care
items or services differently than (1)
individuals or entities that are providers
or payers of any health care items or
services that are not subject to the tax
or (2) other individuals or entities that
are subject to the tax.
Due to the complexity of this issue,
we are providing a few illustrative
examples of when a tax program does or
does not constitute differential
treatment. First, we are providing
examples relating to evaluating
differential treatment of individuals or
entities that are providing or paying for
health care items or services that are
subject to the tax compared to
individuals or entities that are providers
or payers of any health care items or
services that are not subject to the tax.
For example, if the state imposes a tax
on telecommunication services, but also
includes inpatient hospital services, this
would constitute differential treatment.
Given that inpatient hospital services
are not reasonably related to the other
services subject to taxation (that is,
telecommunication services), as
discussed below, we would consider the
tax to be treating inpatient hospital
services differently than other
individuals or entities providing or
paying for health care items or services,
which are not included in the tax. While
some might consider this example as
being similar to the example involving
a tax on gas stations and hospitals in the
November 1992 interim final rule, we
are taking this opportunity to clarify our
interpretation of section
1903(w)(3)(A)(ii) of the Act. We have
never ruled out the extistence of
differential treatment in all instances
where health care items or services are
included in a larger non-health carerelated tax program, even where less
than 85 percent of the tax burden falls
on health care providers and all entities
E:\FR\FM\18NOP2.SGM
18NOP2
63734
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
and services are subject to the same tax
rate. As we emphasized in the 2014
SHO letter, taxes where less than 85
percent of the tax burden falls on health
care items or services may still be
considerd health care-related if only a
subset of health care items or services
are taxed, even if they are taxed at the
same rate as items or services not
related to health care that are also
included in the tax. Prior to the issuance
of the 2014 SHO letter, several states
attempted to mask taxes on such
subsets, including Medicaid-only
MCOs, by including them within larger,
non-exclusively health care-related tax
programs. Notably, the taxes on
Medicaid-only MCOs would not have
been approvable on their own, if
implemented by the state separately
from the taxation of items and services
unrelated to health care. States included
taxes on Medicaid-only MCOs within
larger, non-exclusively health carerelated tax programs, such as sales taxes
and gross receipts taxes, in an attempt
to bypass federal statutory and
regulatory prohibitions by effectively
masking the health care-related
component of the tax. We have worked
with the OIG to ensure that these and
similar practices that ran counter to the
letter and spirit of federal statute and
regulation were stopped. We view this
proposed rule as a continuation of our
efforts to ensure that health care-related
taxes follow all applicable requirements.
In instances where a state or other
unit of government imposes a tax on
reasonably related items or services that
includes some non-health care items or
services and some health care items or
services, we would not consider
differential treatment to occur if all
health care items or services that are
reasonably related to the taxed universe
are included in the tax and all health
care items and services subject to the tax
are taxed at the same rate as the nonhealth care items or services subject to
the tax. We will consider items or
services within the tax to be reasonably
related if there exists a logical or
thematic connection between the items
or services or individuals or entities
being taxed. Examples of such a
connection could include, but would
not be not limited to, industry, such as
electronics; geographical area, such as
city or county; net revenue volume; or
number of employees. When
determining whether or not individuals,
entities, items, or services are
reasonably related, we will examine the
parameters of the given tax. In this
context, the parameters of the tax means
the grouping of individuals, entities,
items or services, on which the tax is
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
imposed. For example, if a state or unit
of government imposed a one percent
tax on all revenue from licensed
professional services (for example,
accounting services, legal services, etc.),
including revenue from services
provided by medical professionals, this
would not constitute differential
treatment, because all health care items
or services reasonably related to the
universe of items and services subject to
the tax are themselves subject to the tax,
and such services are taxed at the same
rate as the included non-health care
items or services. Provided that less
than 85 percent of the tax burden falls
on health care providers, the tax in this
example would not be considered a
health care-related tax. However, if the
state or unit of government imposing the
tax structures the parameters of the tax
in such a way to include items or
services that are not reasonably related
and only selected health care items or
services are included in the tax while
others are excluded, the tax would be
considered health care-related, as in the
above example of a tax on
telecommunications services and
inpatient hospital services.
When determining whether or not
differential treatment occurs, we
evaluate the totality of the
circumstances of the arrangement. For
example, under some circumstances, it
could be permissible for the state or unit
of government to impose a tax on
businesses employing 50 to 500 fulltime equivalent (FTE) employees; such
that the tax likely would include a
number of entities providing or paying
for health care items and services, and
a number of entities selling non-health
care items and services, within its
parameters. However, it could be that,
within a certain geographical area of the
state, most businesses employing 50 to
500 FTE employees are entities
providing or paying for health care
items and services. If the tax were
geographically targeted to include this
area but not other areas of the state or
unit of government’s jurisdiction with a
more diverse mix of businesses
employing 50 to 500 FTE employees,
this targeting could be evidence that the
state or unit of government is using the
numeric FTE employee parameter as a
proxy to concentrate the tax burden on
certain entities providing or paying for
health care items or services.
While the examples given above
illustrate hypothetical taxes we would
consider to be health care-related where
less than 85 percent of the tax falls on
providers of health care items or
services, they do not represent an
exhaustive list of all possible forms of
differential treatment, as we cannot
PO 00000
Frm 00014
Fmt 4701
Sfmt 4702
foresee every possible arrangement.
Differential treatment may still exist
even in situations other than those
described previously and identified in
proposed § 433.55(c)(1) and (2).
Therefore, we are also proposing to
examine the parameters of the tax as
defined by the state or other unit of
government, as well as the totality of the
circumstances relevant to which
individuals, entities, items, or services
are subject (and not subject) to the tax,
and the tax rate applicable to each, in
determining whether the tax program
involves differential treatment as
provided in section 1903(w)(3)(A)(ii) of
the Act. The proposed rule aims to
preserve appropriate state flexibility on
tax and health care policy, while
clarifying what constitutes differential
treatment within the meaning of section
1903(w)(3)(A)(ii) of the Act and
§ 433.55(c) and helping ensure that
states do not design tax structures to
circumvent statutory requirements.
d. Concerns About Hold Harmless and
Health Care-Related Taxes
We have become aware of
impermissible arrangements that exist
where a state or other unit of
government imposes a health-care
related tax, then uses the tax revenue to
fund the non-federal share of Medicaid
payments back to the taxpayers. The
taxpayers enter into an agreement,
which may or may not be written, to
redistribute these Medicaid payments to
ensure that taxpayers, when accounting
for both the original Medicaid payment
(from the state, unit of local
government, or MCO) and any
redistribution payment from another
taxpayer or taxpayers, receive all or any
portion of their tax amount back. The
net effect of the arrangement is clear
evidence that taxpayers have a
reasonable expectation that their
forthcoming Medicaid payment
(including any redistribution), which
results in participating taxpayers being
held harmless for all or a portion of the
tax amount. Regardless of whether the
taxpayers participate voluntarily,
whether the taxpayers receive the
Medicaid payments from a MCO, or
whether taxpayers themselves make
redistribution payments from funds
other than Medicaid to other taxpayers,
the net effect of the arrangement is the
same: The taxpayers have a reasonable
expectation to be held harmless for all
or a portion of their tax amount.
Such arrangements undermine the
fiscal integrity of the Medicaid program
and are inconsistent with existing
statutory and regulatory requirements
prohibiting hold harmless arrangements.
The February 2008 final rule on health
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
care-related taxes and provider-related
donations specified that hold harmless
arrangements prohibited by
§ 433.68(f)(3) exist ‘‘. . . when a state
payment is made available to a taxpayer
or a party related to the taxpayer (for
example, as a nursing home resident is
related to a nursing home), in the
reasonable expectation that the payment
would result in the taxpayer being held
harmless for any part of the tax’’ (73 FR
9694). Despite the statutory and
regulatory prohibitions, we are
concerned that states, local units of
government, and/or providers continue
to design and execute hold harmless
practices that are antithetical to federal
law and regulation. To aid in preventing
and ending such complex financing
arrangements, the proposed rule would
add clarifying language to the hold
harmless definition in § 433.68(f)(3) to
specify that CMS considers a ‘‘net
effect’’ standard in determining whether
or not a hold harmless arrangement
exists.
In the example cited above involving
some taxpayers that received more in
Medicaid reimbursement (from the
state, unit of local government, or MCO)
than the amount of tax paid which they
then transfered to other taxpayers that
did not, we would consider such an
arrangement to include a hold harmless
arrangement because the taxpayers had
a reasonable expectation to be held
harmless from all or a portion of the cost
of their tax through either or both of the
Medicaid payments from the state or
other unit of government or from MCOs,
and redistribution payments from other
taxpayers participating in the
arrangement whose payments from the
state or other unit of government or
from MCOs met or exceeded their own
tax cost. The fact that a private entity
makes the redistribution payment does
not change the essential nature of the
payment, which constitutes an indirect
payment from the state or unit of
government to the entity being taxed
that holds it harmless for the cost of the
tax. As noted in the February 2008 final
rule, ‘‘An indirect payment to the
taxpayer would also constitute a direct
guarantee’’ (73 FR 9896). When looking
for the presence or absence of a hold
harmless arrangement in health carerelated taxes, conclusive evidence lies
not in the presence or absence of
individual elements, but the sum total
of all the elements when viewed
collectively. While the presence or
absence of a single individual factor
may not be sufficient to establish
conclusively that such an arrangement
exists, the cumulative effect of many
such factors may be sufficient to make
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
such a determination. Only after
reviewing the totality of the
circumstances and making a judgment
about how the overall arrangement
operates are we able to determine
whether or not the state provides for a
direct or indirect payment, offset, or
waiver that holds the taxpayer harmless
for any portion of the tax. This proposal
does not reflect any change in policy or
approach, but merely codifies currently
prohibited practices, and would provide
further clarification to states regarding
how they may finance the non-federal
share of Medicaid expenditures.
e. Concerns Regarding Permissible Tax
Classes of Health Care Services and
Providers
Over the past several years, we have
become aware that several states have
instituted taxes on health insurers or
health insurance premiums. In an effort
to maintain consistent federal oversight
of health care-related taxes, modernize
the permissible class definitions, and
permit states additional flexibility to
implement health care-related taxes,
this rule proposes to add services of
health insurers, other than MCOs listed
in § 433.56 (a)(8), as permissible classes
of health care items or services under
§ 433.56, under section
1903(w)(7)(A)(ix) of the Act. In an effort
to avoid being overly prescriptive, we
have decided against proposing a
narrow definition of the term ‘‘health
insurer.’’ However, the definition of
‘‘health insurance issuer’’ at 45 CFR
144.103 provides a helpful point of
reference. That regulation defines a
health insurance issuer as an insurance
company, insurance service, or
insurance organization (including an
HMO) that is required to be licensed to
engage in the business of insurance in
a state and that is subject to state law
that regulates insurance (within the
meaning of section 514(b)(2) of ERISA).
However, the term health insurer in the
proposed additional class at § 433.56,
explicitly excludes MCOs such as
HMOs because these organizations are
already included under section
1903(w)(7)(A)(viii) of the Act, unlike the
term health insurance issuer at
§ 144.103. The proposed class would
include insurers that issue policies for
the group market and/or the individual
market, including such coverage with
high-deductible or ‘‘catastrophic’’ plans.
The proposed class would also include
issuers of short-term limited-duration
policies as defined in § 144.103, as well
as issuers of coverage for ‘‘excepted
benefits’’ defined in 45 CFR 146.145 in
the group market and the individual
market at 45 CFR 148.220, such as
dental-only and vision-only policies.
PO 00000
Frm 00015
Fmt 4701
Sfmt 4702
63735
Such a health care-related tax could
include, but need not be limited to, an
assessment on health insurance
premiums, covered lives, or revenue.
The class may include cost sharing
measures, including premiums, from
Medicare, such as private FFS plans
under Medicare Advantage offered as
part of Medicare Part C or prescription
drug insurance plans as part of
Medicare Part D, as well as any
premiums paid by individuals as part of
a section 1115 waiver where Medicaid
funding is used for premium assistance
to help beneficiaries purchase
commercial health insurance plans.
Such a tax cannot include CMS or any
state agencies involved in administering
title XVIII, title XIX, or title XXI,
including state Medicaid agencies. We
are soliciting comments on the
definition of this permissible class to
ensure that the appropriate entities and
services are included.
f. Concerns Regarding Non-Bona Fide
Provider-Related Donations
We are concerned that certain states,
localities, and private health care
providers have designed complex
financing structures to mask non-bona
fide, provider-related donations used to
fund the non-federal share of Medicaid
payments. States, localities, and private
providers appear to be utilizing these
complex arrangements to obfuscate the
source of non-federal share and avoid
the statutorily-required reduction to
state medical assistance expenditures.
They also appear to violate a variety of
requirements in section 1903(w) of the
Act and its implementing regulations,
which mandate that the state’s Medicaid
expenditures for which FFP is provided
shall be reduced by the sum of any
revenues resulting from provider-related
donations received by the state during
the fiscal year other than bona fide
provider-related donations. Such
practices may also run afoul of section
1902(a)(30)(A) of the Act, which
requires that payments be made
consistent with efficiency, economy and
quality of care. Additionally, they may
result in payments that are inconsistent
with the proper and efficient operation
of the state plan (see section 1902(a)(4)
of the Act) and its design for a
cooperative state-federal partnership by
generating increases in federal spending
without a corresponding increase in
state financial participation, with no
direct link to additional services
furnished, beneficiaries assisted, or
other benefit to the Medicaid program.
Often, these arrangements involve a
transfer of value of some kind from a
private provider to a governmental
entity and the governmental entity does
E:\FR\FM\18NOP2.SGM
18NOP2
63736
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
not reimburse the private entity at fair
market value. For example, the transfer
may involve the private provider
assuming an obligation previously
performed by a governmental entity
without being reimbursed fair market
value, performing services previously
performed by a governmental entity
without being reimbursed at fair market
value, or renting real property from a
governmental entity at a price above fair
market value. In such cases, the
difference between the fair market value
of the assumption of the obligation,
performance of the services, or rental
value of the property and the value
actually transferred is in effect a
donation by the private provider to the
governmental entity. The governmental
entity then executes an IGT, funded by
the donation, to the state Medicaid
agency, which is then used to fund the
non-federal share of Medicaid
expenditures. The Medicaid agency
then makes a supplemental payment to
the private donating provider, which
effectively compensates it for the value
it transferred to the governmental entity
(the assumption of an obligation,
performance of services, or excess rent
paid). Often, this arrangement will not
be executed as a contract or other formal
business arrangement, or otherwise
reduced to writing of which evidence is
available to us. Instead, it will be based
on a series of reciprocal actions
performed by each party. As a result of
such an arrangement, the private
provider makes a direct or indirect
donation, and the state returns all or a
portion of the value of the donation to
the private provider effectively using
only federal dollars without a
corresponding outlay in state
expenditures, and such an arrangement
constitutes a non-bona fide donation
becase there is a pre-existing hold
harmless agreement. The net effect of
such an arrangement is to artificially
inflate the state Medicaid expenditures
eligible for FFP, sometimes up to 100
percent, in a manner inconsistent with
statute and regulation.
Recently, we have identified and
taken action to prevent or end
impermissible financing practices in
which states have attempted to mask
non-bona fide provider-related
donations. Some of these arrangements
include instances where transfers of
licenses occur without consideration of,
or below, fair market value from a
private provider to a unit of government
to enable formerly private providers to
receive certain supplemental payments
available to governmental providers. In
other situations, governmental entities
have leased the same facilities back to
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
private providers at rents above fair
market value as a way of allowing the
private facilities to make non-bona fide
donations to the governmental entity,
which then transfers the funds to the
state Medicaid agency through IGTs.
Ultimately, these schemes have the net
effect of reducing the overall percentage
of total computable Medicaid
expenditures funded with state dollars,
while at the same time causing a
corresponding increase in federal
funding.
We have taken several steps to curtail
public-private partnerships that lead to
non-bona fide provider-related
donations. In 2014, we issued SMDL
#14–004, the second in a series of two
SMDLs that discuss mutual obligations
and accountability with respect to the
Medicaid program for the federal
government and states. SMDL #14–004
addressed the deleterious impact that
public-private partnerships designed to
skirt federal requirements concerning
provider-related donations can have on
fiscal integrity. In 2016, we issued a
disallowance to recover FFP associated
with impermissible provider-related
donations where private providers
assumed financial obligations of local
governmental entities to free up
government funds, and the freed up
funds were then used as the state’s share
of supplemental payments to the
donating provider. The CMS
disallowance was upheld when the state
appealed to the DAB (DAB No. 2886,
Texas Health and Human Services
Commission (2018)).
This proposed rule would clarify the
hold-harmless definition related to
donations to account for the net effect
of complex donation arrangements,
including where the donation takes the
form of the assumption of governmental
responsibilities. In the provisions of
§ 433.54 addressing when a guarantee
would exist to hold the provider
harmless for value related to a donation
to the governmental entity, this
proposed rule would establish a net
effect standard. Any exchange of value
that constitutes a governmental entity
reimbursing a private entity for value
related to the private entity’s donation
need not arise to the level of a legally
enforceable obligation, but must be
considered in terms of its net effect,
thus incorporating the language in DAB
No. 2886, Texas Health and Human
Services Commission (2018). In that
case, the DAB held that ‘‘the net effect
of the arrangements under review
amounted to impermissible provider
donations’’ and that as a result, the
supplemental payments made by state
Medicaid agency to the private provider
were impermissible (p.25). The DAB
PO 00000
Frm 00016
Fmt 4701
Sfmt 4702
also found that it is not necessary for a
legally enforceable obligation to exist,
such as under a statute or contract, for
a donation to be found. In line with the
Board’s reasoning, we are proposing to
establish a net effect standard to look at
the overall arrangement in terms of the
totality of the circumstances to judge if
a non-bona fide donation of cash,
services or other transfer of value to a
unit of government has occurred. In
§ 433.52, the proposed definition of
‘‘provider-related donation’’ would
clarify that the assumption by a private
entity of an obligation formerly
performed by a unit of government
where the unit of government fails to
compensate the private entity at fair
market value would be considered an
indirect donation made from the private
entity to the unit of government. This
proposed rule would also clarify that
such an exchange need not arise to the
level of a legally enforceable obligation.
C. Previous CMS Efforts To Understand
and Monitor Medicaid Payments and
Financing
We have already taken action to
strengthen our approach to authorizing,
monitoring, and evaluating Medicaid
payments and financing to ensure that
statutory and regulatory requirements
are satisfied. To monitor supplemental
payments made under state plan
authority, in 2010, we began requiring
states to separately report through
MBES amounts paid for the most
common and largest supplemental
payments in accordance with
§ 430.30(c). States report statewide
aggregate amounts for only some
supplemental payments and do not
include provider-level detail. In 2013,
we issued SMDL #13–003, which
discussed a submission process to
comply with the UPL requirements in
§§ 447.272 and 447.321. This SMDL
discussed methods of complying with
these two regulations through annual
UPL submissions apart from the normal
state plan process, as the regulations do
not specify time frames for the
submission of UPL demonstrations. The
SMDL also provided further guidance
regarding UPL calculation
methodologies and requested that states
identify the source of non-federal
funding for the payments described in
the UPL demonstration. This guidance
improved our ability to analyze
supplemental payments and validate
that aggregate supplemental payments
for each class of provider ownership
group do not exceed what Medicare
would have paid for the services or, in
an alternative approach that may be
selected by the states, do not exceed the
cost of providing those services.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
We have also intensified our
examination of SPAs proposing
supplemental payments, and their
associated funding arrangements, and
have developed a greater understanding
of how to ensure that payment and
financing arrangements comply with
statutory requirements. These reviews
focus on ensuring more transparency for
supplemental payments by requiring
more comprehensive SPA language so
that providers and other stakeholders
can fully understand how providers will
receive payment and any conditions on
those payments. We are also asking
more questions regarding states’
assumptions about the value that
proposed supplemental payments
would bring to the Medicaid program,
including in terms of improving access
and quality of care outcomes, in our
efforts to ensure that states’ payment
systems are consistent with section
1902(a)(30)(A) of the Act.
Although we made improvements to
the parameters around aggregate
payment levels as reflected in UPL
demonstrations, there have been
concerns from oversight entities, noted
elsewhere in the preamble, regarding
payments to individual providers,
including concern that some
governmental providers were being paid
Medicaid payments far in excess of the
costs incurred in providing the
underlying services. In response to
those concerns, we issued the
‘‘Medicaid Program; Cost Limit for
Providers Operated by Units of
Government and Provisions to Ensure
the Integrity of Federal-State Financial
Partnership’’ final rule with comment
period in the May 29, 2007 Federal
Register (72 FR 29748), which limited
payments to any governmentally
operated provider to the cost incurred
for delivery of Medicaid services. The
May 29, 2007 final rule with comment
period was challenged by states and
health care providers. After a series of
Congressional moratoria against its
implementation, Congress stated its
sense that it should not be
implemented. In 2010, the final rule was
rescinded (75 FR 73972) and we have
not moved forward with this or any
similar approach.
We have previously recognized the
need in other instances to obtain
provider-level payment reporting.
Section 1923(j) of the Act and its
implementing regulations delineate
annual DSH audit and reporting
requirements. To ensure that Medicaid
DSH payments are in compliance with
federal statutory requirements, we
published the 2008 DSH audit rule,
which requires that states report and
account for certain provider-level
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
information on the hospitals receiving
these payments. The rule also requires
states to have their DSH payment
programs independently audited to
verify that the payments comply with
applicable hospital-specific DSH limits.
Such information includes reporting of
supplemental payments and ensuring
that such payments are factored into the
hospital-specific DSH limit. However,
this data set is limited in that it only
includes reporting for those hospitals
that receive Medicaid DSH payments
and are due to us more than 3 years after
the completion of each state plan rate
year. Therefore, in § 447.288 of this
proposed rule, to help ensure timely
and comprehensive reporting on the
Medicaid financing for all payments to
hospitals, we are proposing to require
the annual amount of total Medicaid
DSH payments made to any provider be
reported in the annual provider-level
payment data report for this regulation,
along with all Medicaid supplemental
payments.
II. Provisions of the Proposed Rule
A. Proposed Provisions
1. Disallowance of Claims for FFP
(§ 430.42)
Section 1116(d) and (e)(1) of the Act
outline the disallowance
reconsideration process and provide
that a state may request administrative
reconsideration of a disallowance if
such a request is made within a 60-day
period that begins on the date the state
receives notice of the disallowance.
However, the statute does not specify
the format of the notice of disallowance
or request for reconsiderations. We are
proposing to amend § 430.42 to alter the
means of communication with regard to
the disallowance reconsideration
process from one based on registered or
certified mail to one based on electronic
mail or another electronic system as
specified by the Secretary. When
§ 430.42 as now in effect was finalized,
certified mail was considered to be the
optimal way to establish the dates on
which a communication was sent and
received, which is important to
establish compliance with timeframes
specified in regulation. However, email
is a preferred form of communication
today in the normal course of agency
business and can be used to establish
the time when a communication is sent
and received, since email messages
typically are transmitted nearinstantaneously. Further, by eliminating
mailing and paper costs, the use of
email could slightly reduce the
administrative burden associated with
the disallowance process under
§ 430.42. As a result, we are proposing
PO 00000
Frm 00017
Fmt 4701
Sfmt 4702
63737
to revise all of the references to
registered or certified mail or to
‘‘written requests’’ to make clear that
such requests need not be in a physical,
as opposed to an electronic format in
§ 430.42(b)(2)(i)(A) introductory text,
(b)(2)(i)(B) and (C), (c)(3), (c)(4)(i), (c)(6),
and (d)(1) to replace references to
registered or certified mail with
references to electronic mail (email) or
another electronic system as specified
by the Secretary. In addition, we
propose to remove the word ‘‘written’’
from § 430.42(b)(2)(i)(A) and (B) to
avoid a possible misunderstanding that
the request must be in the form of a
physical writing, since we propose to
adopt an electronic process. The date
that the communication is successfully
sent or received by electronic mail
(email) or electronic system as specified
by the Secretary would be substituted
for current references to the date that
the communication was sent or received
by registered or certified mail.
2. State Share of Financial Participation
(§ 433.51)
We are proposing to amend § 433.51
to more clearly define the allowable
sources of the non-federal share to more
closely align with the provisions in
section 1903(w) of the Act. In
§ 433.51(a) and (c), we are proposing to
replace the current reference to ‘‘public
funds’’ with ‘‘state or local funds’’
which is consistent with statutory
language as in section 1903(w)(6)(A) of
the Act. Public funds is not a phrase
used in section 1903(w) of the Act, and
the use of this phrase in regulation has
caused confusion with respect to
permissible sources of non-federal
share. We are proposing to revise
§ 433.51(b) by similarly replacing the
current reference to public funds and by
specifying more precisely the funds that
states may use as state share. Although
we have applied the statutory language
to our review and approval of state
financing mechanisms, the term public
funds in the regulatory text has created
confusion among states, and has led to
state requests to derive IGTs from
sources other than state or local tax
revenue (or funds appropriated to state
university teaching hospitals), which is
not permitted under the statute in
section 1903(w)(6)(A) of the Act. The
proposed amendment to paragraph (b)
would clearly limit permissible state or
local funds that may be considered as
the state share to state general fund
dollars appropriated by the state
legislature directly to the state or local
Medicaid agency; IGTs from units of
government (including Indian tribes),
derived from state or local taxes (or
funds appropriated to state university
E:\FR\FM\18NOP2.SGM
18NOP2
63738
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
teaching hospitals), and transferred to
the state Medicaid Agency and under its
administrative control, except as
provided in proposed § 433.51(d); or
CPEs, which are certified by the
contributing unit of government as
representing expenditures eligible for
FFP and reported to the state as
provided in proposed § 447.206.
We are proposing these revisions to
specifically align the allowable sources
of the non-federal share with the statute.
The proposed provisions would make
clear that allowable state general fund
appropriations under § 433.51(b)(1) are
those made directly to the state or local
Medicaid agency, and are differentiated
from appropriations made to other units
of government that otherwise may be
tangentially involved in financing
Medicaid payments through IGTs or
CPEs. We would describe allowable
IGTs and CPEs in proposed
§ 433.51(b)(2) and (3), respectively. The
statute clearly differentiates between
these sources of funds. Specifically,
section 1903(w)(6)(A) of the Act
provides that states generally may
finance the state share using funds
derived from state or local taxes (or
funds appropriated to state university
teaching hospitals) transferred from or
certified by units of government within
a state as the non-federal share of
Medicaid expenditures. The phrase
‘‘transferred from or certified by’’ refers
to the IGT and CPE, respectively, and
the statute clearly indicates that those
funding mechanisms must be derived
from state or local taxes (or funds
appropriated to state university teaching
hospitals). The inclusion of the above
reference to ‘‘funds appropriated to state
university teaching hospitals’’ in
§ 433.51(b)(2) is a direct reference to
language in section 1903(w)(6)(A) of the
Act to more precisely implement the
Act in this regulatory provision.
We are proposing to identify
‘‘certified public expenditures’’
specifically in regulation as an
allowable source of state share in a
manner consistent with section 1903 of
the Act, and to describe the protocols
states may use to identify allowable
Medicaid expenditures associated with
the use of a CPE as the source of nonfederal share. Thus, we propose to
include a reference in § 433.51(b)(3) to
proposed § 447.206 to require that, for a
state to use a CPE as a source of state
share, the state must meet the
requirements of proposed § 447.206,
discussed in detail below, with respect
to payments funded by the CPE. In
particular, in § 447.206(b)(1), we
propose that such payments, to a
provider that is a unit of government,
would be limited to the state or non-
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
state government provider’s actual,
incurred cost of providing covered
services to Medicaid beneficiaries using
reasonable cost allocation methods.
Lastly, we are proposing to add
paragraph (d) to this section to clearly
indicate that state funds provided as an
IGT from a unit of government but that
are contingent upon the receipt of funds
by, or are actually replaced in the
accounts of, the transferring unit of
government from funds from
unallowable sources, would be
considered to be a provider-related
donation that is non-bona fide under
§§ 433.52 and 433.54. This language is
intended to implement the preclusion
under section 1903(w)(6)(A) of the Act
on the use of IGTs where the IGT is
derived from a non-bona fide providerrelated donation by making it
abundantly clear that, as indicated in
the statute, the IGT must come from
state or local tax revenue (or funds
appropriated to state university teaching
hospitals), and any IGTs that are derived
from, or are related to, non-bona fide
provider-related donations would be
prohibited.
3. General Definitions (§ 433.52)
The terms ‘‘Medicaid activity’’ and
‘‘non-Medicaid activity’’ are used in the
proposed § 433.68(e)(3), discussed in
detail below, in determining whether a
health care-related tax program is
generally redistributive in nature in
accordance with section
1903(w)(3)(E)(ii)(I) of the Act. The
definitions for ‘‘Medicaid activity’’ and
‘‘non-Medicaid activity’’ in this
proposed rule would apply only to
determining whether a state or other
unit of government tax program is
generally redistributive as required in
section 1903(w)(3)(E)(ii)(I) of the Act.
We are proposing to define ‘‘Medicaid
activity’’ to mean any measure of the
degree or amount of health care items or
services related to the Medicaid
program or utilized by Medicaid
beneficiaries, including, but not limited
to, Medicaid patient bed days, the
percentage of an entity’s net patient
revenue attributable to Medicaid,
Medicaid utilization, units of medical
equipment sold to individuals utilizing
Medicaid to pay for or supply such
equipment or Medicaid member months
covered by a health plan.
We are proposing to define ‘‘nonMedicaid activity’’ to mean any measure
of the degree or amount of health care
items or services not related to the
Medicaid program or utilized by
Medicaid beneficiaries. Such a measure
could include, but would not
necessarily be limited to, non-Medicaid
patient bed days, percentage of an
PO 00000
Frm 00018
Fmt 4701
Sfmt 4702
entity’s net patient revenue not
attributable to Medicaid, the percentage
of patients not utilizing Medicaid to pay
for health care items or services, units
of medical equipment sold to
individuals not utilizing Medicaid
funds to pay for or supply such
equipment, or non-Medicaid member
months covered by a health plan.
We are proposing to define the term
‘‘net effect’’ to mean the overall impact
of an arrangement, considering the
actions of all of the entities participating
in the arrangement, including all
relevant financial transactions or
transfers of value, in cash or in kind,
among participating entities. The net
effect of an arrangement is determined
in consideration of the totality of the
circumstances, including the reasonable
expectations of the participating
entities, and may include consideration
of reciprocal actions without regard to
whether the arrangement or a
component of the arrangement is
reduced to writing or is legally
enforceable by any entity.
The term ‘‘parameters of a tax’’ is
used in the proposed § 433.55(c),
discussed in detail below, in
determining whether a tax is health
care-related as provided in section
1903(w)(3)(A) of the Act. We are
proposing to define ‘‘parameters of a
tax’’ to mean the grouping of
individuals, entities, items or services,
on which a state or unit of government
imposes a tax.
Currently, § 433.52 specifies a
definition of ‘‘Provider-related
donation’’ that includes an introductory
paragraph and three numbered
paragraphs. We propose to redesignate
paragraphs (2) and (3) as paragraphs (3)
and (4), respectively, and to add a new
paragraph (2). Proposed paragraph (2)
would specify that any transfer of value
where a health care provider or
provider-related entity assumes an
obligation previously held by a
governmental entity and the
governmental entity does not
compensate the private entity at fair
market value would be considered a
donation made indirectly to the
governmental entity. We are proposing
that such an assumption of obligation
need not rise to the level of a legally
enforceable obligation to be considered
a donation, but would be considered by
examining the totality of the
circumstances and judging the
arrangement’s net effect. For example, if
a private provider assumes any
contractual obligation, such as staffing
costs for accounting services, of a nonstate governmental entity without a
corresponding transfer of value at
market value, we would consider that to
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
be a provider-related donation from the
private provider to the unit of
government.
This proposal does not represent a
new policy, but a clarification of current
law designed to aid in preventing and,
where they currently may exist,
terminating impermissible financing
practices involving provider-related
donations. The current definition does
not explicitly address circumstances
involving the assumption of a
governmental obligation, or our policy
to determine the net effect of an
arrangement in determining whether or
not a donation has occurred.
We are also proposing to revise newly
redesignated paragraphs (3) and (4) by
changing the term ‘‘health care related’’
to ‘‘provider-related’’ to align with usage
where provider-related donations are
addressed throughout part 433, subpart
B, and by changing the language in
newly redesignated paragraph (4) from
‘‘the percentage of donations the
organization received from the
providers during that period’’ to ‘‘the
percentage of the organization’s revenue
during that period that was received as
donations from providers or providerrelated entities.’’ We are proposing this
change because we believe that this
language is clearer and more transparent
for states.
Some health care-related tax programs
exclude certain items, services, or
providers from taxation or impose
variable rates. To do so, states or nonstate units of government often divide
the universe of entities subject to
taxation into groups based on various
attributes. We are proposing to define
‘‘taxpayer group’’ to mean one or more
entities grouped together based on one
or more common characteristics for
purposes of imposing a tax on a class of
items or services specified under
§ 433.56. This term is used in proposed
§ 433.56(e)(3), which is discussed in
detail below, in determining whether or
not a tax program is generally
redistributive in nature, in accordance
with section 1903(w)(3)(E)(ii)(I) of the
Act.
4. Bona Fide Donations (§ 433.54)
Section 1903(w)(2)(B) of the Act
provides that the Secretary may by
regulation specify types of providerrelated donations described in that
subparagraph that will be considered to
be bona fide provider-related donations.
The statute requires that bona fide
provider-related donations may have no
direct or indirect relationship (as
determined by the Secretary) to
Medicaid payments to the provider,
providers furnishing the same class of
items and services as the provider, or to
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
any related entity, as established by the
state to the satisfaction of the Secretary.
Accordingly, implementing regulations
in § 433.54(b) require that bona fide
provider-related donations must not be
returned to the individual provider,
provider class, or related entity under a
hold harmless provision or practice as
described in § 433.54(c). We are
proposing to revise § 433.54(c)(3) to
clarify the standard used to determine
whether the state (or other unit of
government) receiving a donation
provides for any direct or indirect
payment, offset, or waiver, such that the
provision of that payment, offset, or
waiver directly or indirectly guarantees
the return of any portion of the donation
to the provider (or other party or parties
responsible for the donation). The
clarification would make express our
current policy of examining the totality
of the circumstances that determine the
net effect of an arrangement between the
state (or other unit of government) and
the provider, provider class, or
provider-related entity responsible for
the donation. Specifically, we are
proposing that a direct guarantee of the
return of all or part of a donation would
be found to exist where, considering the
totality of the circumstances, the net
effect of an arrangement between the
state (or other unit of government) and
the provider (or other party or parties
responsible for the donation) results in
a reasonable expectation that the
provider, provider class, or related
entity will receive a return of all or a
portion of the donation either directly or
indirectly. As noted in the 2008 final
rule on Health Care-Related Taxes, ‘‘An
indirect payment to the taxpayer would
also constitute a direct guarantee’’ (73
FR 9698). Section 433.68 at paragraphs
(f)(1), (2) and (3) describe the three
situations that constitute a direct hold
harmless arrangement. Paragraphs
(f)(3)(i)(A) and (B) detail the two
‘‘prongs’’ of the indirect hold-harmless
guarantee test. These two ‘‘prongs’’
constitute the ‘‘safe harbor threshold’’ of
6 percent and the ‘‘75/75’’ test. The safe
harbor threshold states that taxes that
are under 6 percent of net patient
revenue attributable to an assessed
permissible class pass the indirect hold
harmless test. If a tax collection exceeds
the 6 percent net patient revenue
threshold, the second prong is applied.
This prong is known as the ‘‘75/75’’ test
and states that CMS will consider an
indirect hold harmless arrangement to
exist if 75 percent or more of the
taxpayers receive 75 percent or more of
their total tax costs back in enhanced
Medicaid payments or other state
payments. If the tax fails this prong,
PO 00000
Frm 00019
Fmt 4701
Sfmt 4702
63739
CMS considers an indirect hold
harmless arrangement to exist. Direct
and indirect payments are used in the
proposed rule in the same way as they
are used currently in § 433.68(f). This
clarification is designed to aid in
preventing and, where they may
currently exist, eliminating complex
financing arrangements designed to
obfuscate the fact that non-bona fide
provider-related donations are the
source of the non-federal share of
certain Medicaid payments. This is
consistent with our current policy,
which we have applied in the past and
discussed in SMDL 14–004 on
impermissible provider-related
donations. We are also proposing to
revise paragraph (c)(3) to clarify that a
singular party, not just multiple
‘‘parties,’’ could be responsible for a
provider-related donation described in
this paragraph.
5. Health Care-Related Taxes Defined
(§ 433.55)
Section 1903(w)(3)(A) of the Act
defines a health care-related tax as a tax
that is (1) related to health care items or
services, or to the provision of, the
authority to provide, or payment for,
such items or services; or (2) is not
limited to such items or services but
provides for treatment of individuals or
entities that are providing or paying for
such items or services that is different
from the treatment provided to other
individuals or entities. In the case of (1),
a tax is considered related to health care
items or services if at least 85 percent
of the tax burden falls on health care
providers. Implementing regulations are
codified in § 433.55(c). This proposed
rule would amend § 433.55(c) by
clarifying that differential treatment
occurs when a tax program treats some
individuals or entities that are providing
or paying for health care items or
services differently than (1) individuals
or entities that are providers or payers
of any health care items or services not
subject to the tax or (2) other
individuals or entities subject to the tax.
Additionally, we would amend
§ 433.55(c) to clarify that we examine
the parameters of the tax as defined by
the state or other unit of government, as
well as the totality of the circumstances
relevant to which individuals, entities,
items, or services are subject (and not
subject) to the tax and at which rate, in
determining whether the tax program
involves differential treatment as
provided in section 1903(w)(3)(A)(ii) of
the Act. Finally, the proposed rule
would also add paragraphs (c)(1) and (2)
to clarify when CMS would consider the
treatment of individuals or entities
providing or paying for health care
E:\FR\FM\18NOP2.SGM
18NOP2
63740
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
items or services to be different from the
treatment provided to other individuals
or entities.
In the proposed § 433.55(c)(1), we
propose to clarify that differential
treatment for providers of health care
items or services would occur where the
state or other unit of government
imposing the tax makes some
individuals or entities providing or
paying for health care items or services
subject to the tax, but excludes others.
For example, a state imposing a tax on
telecommunication services and
inpatient hospital services would
constitute differential treatment because
some providers or payers of health care
items or services subject to the tax are
being treated differently than providers
or payers of health care items or services
not subject to the tax. States or local
units of government imposing a tax
cannot structure the parameters of the
tax in such a way as to include items or
services that are not reasonably related
so that only selected health care items
or services are included in the tax while
others are excluded. Selective
incorporation would also occur when
the state or other unit of government
imposing the tax structures the
parameters of the tax in a way that has
the effect of specifically excluding or
including certain providers of health
care items or services from the tax. This
would constitute differential treatment
because it would have the same effect as
selecting certain health care items or
services for inclusion in the tax when
such items or services are not
reasonably related to the other items
being taxed.
Additionally, we propose in
§ 433.55(c)(2) to specify that differential
treatment would result when entities
providing or paying for health care
items or services are treated differently
than other entities also included in the
tax. For example, if the state taxes all
businesses in the state, but places a
higher tax rate on hospitals and nursing
facilities than on other businesses, this
would result in differential treatment.
We are concerned that taxes of the
sort described in proposed § 433.55(c)(1)
and (2) are not consistent with
applicable statutory (and current
regulatory) requirements because they
may include individuals or entities
providing or paying for health care
items or services that receive high levels
of reimbursement from Medicaid for
such items or services, and that may
receive a return of their tax costs in the
form of increased Medicaid payments.
In particular, we are concerned about
tax programs that treat health care items
or services that are mostly reimbursed
by Medicaid differently than other
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
health care items or services with low
Medicaid reimbursement. For example,
a statewide revenue tax of 5 percent of
net revenue on all businesses in the
state that includes only a subset of
health care items or services that
happens to be reimbursed heavily by
Medicaid, such as HCBS, but which is
designed to exclude other providers of
health care items or services with lower
rates of Medicaid reimbursement such
as continuing care retirement facilities
(CCRCs), would result in differential
treatment. Any time a tax structure
selectively incorporates a subset of
health care items or services for
inclusion in a tax and excludes others,
we would consider this differential
treatment, as reflected in proposed
§ 433.55(c)(1). Selective incorporation
generally occurs in two situations: First,
when the state or unit of government
includes some, but not all, health carerelated items or services and those items
or services are not reasonably related to
the other items being taxed. Second,
when the state or other unit of
government structures the parameters of
the tax in such a way that has the effect
of such selective incorporation
described above. Reasonably related
means there exists a logical or thematic
connection between the items or
services being taxed. Examples of such
a connection include, but are not
limited to, industry, such as electronics;
geographical area, such as city or
county; net revenue volume; or number
of employees.
Additionally, any time the tax treats
individuals or entities providing or
paying for health care items or services
differently than other entities also
included in the tax, we would also
consider this to be differential
treatment, as reflected in proposed
§ 433.55(c)(2). We note that the
examples provided in these proposed
paragraphs do not constitute an
exhaustive list of all possible
manifestations of differential treatment.
Other circumstances constituting
differential treatment for health care
items or services, or entities providing
or paying for health care items or
services, would result in the tax being
considered health care-related based on
the differential treatment provisions in
§ 433.55(c).
The proposed language related to
selective incorporation does not mean
that the state or other unit of
government must tax every provider of
health care items or services within its
jurisdiction to avoid its tax being
considered health-care related in
situations where less than 85 percent of
the tax burden falls on health care items
or services. It does mean that the state
PO 00000
Frm 00020
Fmt 4701
Sfmt 4702
or other unit of government cannot
include in or exclude from the tax only
certain providers, or a class or classes of
providers, by its own specification of
the parameters of the tax. In addition,
the state cannot structure the parameters
of the tax in such a way so as to have
the same effect of carving out or in only
certain providers, or a class or classes of
provider.
6. Classes of Health Care Services and
Providers Defined (§ 433.56)
Section 1903(w)(7)(A)(ix) of the Act
provides that the permissible classes of
health care items and services include
such other classifications consistent
with section 1903(w)(7)(A) of the Act as
the Secretary may establish by
regulation. In addition to the specific
classifications that Congress identified
in statute, current regulations in
§ 433.56(a) specify certain additional
classes established by the Secretary. We
are proposing to add a new class of
health care items and services to the list
of permissible classes at § 433.56(a) by
redesignating paragraph (a)(19) as
paragraph (a)(20), revising paragraph
(a)(18), and adding a new paragraph
(a)(19). We propose to strike ‘‘and’’ from
paragraph (a)(18), to accommodate the
proposed paragraph (a)(20). In new
proposed paragraph (a)(19), we would
permit states and units of local
government to impose taxes on services
of health insurers beside those already
identified in paragraph (a)(8) of the
same section.
We have become aware that a number
of states may be imposing taxes on
health insurers in the form of a tax on
health insurance premiums or volume
of services. Section 1903(w)(7)(A)(ix) of
the Act delegates to the Secretary the
power to specify such other
classification of health care items and
services consistent with the paragraph
as the Secretary may establish by
regulation. We are proposing to expand
the permissible class list to provide
states with additional flexibility, while
maintaining the fiscal integrity of the
Medicaid program by ensuring that the
proposed new permissible class would
not be limited to items or services that
are primarily or exclusively provided or
paid for by the Medicaid program. Taxes
imposed on health care items or services
or providers of such items or services
financed primarily or exclusively by
Medicaid would harm the fiscal
integrity of the Medicaid program by
imposing a higher tax burden on the
program and would not be generally
redistributive as required by section
1903(w)(3)(E)(ii)(I) of the Act.
Specifically, we are proposing to
establish services of health insurers,
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
besides services of MCOs (including
HMOs and PPOs), as a new permissible
class. Services of MCOs (including
HMOs and PPOs) are already a
permissible class of services identified
in § 433.56(a)(8). Some examples of
possible metrics that could be used to
assess a tax on services of health
insurers include health care premiums,
covered lives, or revenue. The proposed
class would include health insurers
offering plans to Medicaid beneficiaries
under a section 1115 demonstration for
a premium assistance program to such
beneficiaries to purchase qualified
health plans through the Health
Insurance Exchange. We are seeking
comment on the exact scope of this
permissible class to ensure all
appropriate services of health insurers
are included within this class. As with
other permissible classes, taxes imposed
on this proposed category of health care
services would be subject to applicable
legal requirements, including the broadbased requirements in § 433.68(b)(1), the
uniformity requirements in
§ 433.68(b)(2), and the hold harmless
provisions in § 433.68(f).
The preamble of the August 1993 final
rule listed criteria that should be met by
any additional class of health care items
and services under consideration to be
added to the permissible classes under
section 1903(w)(7)(A) of the Act. The
preamble stated three criteria: The
revenue of the class is not
predominantly from Medicaid and
Medicare (not more than 50 percent
from Medicaid and not more than 80
percent from Medicaid, Medicare, and
other federal programs combined); the
class must be clearly identifiable, such
as through designation for state
licensing purposes, recognition for
federal statutory purposes, or being
included as a provider in state plans;
and the class must be nationally
recognized and not be unique to a state
(58 FR 43162). We believe that the class
of providers of health care items or
services which we are proposing to add
to § 433.56 meets all of these
requirements. First, according to the
most recent data available from the U.S.
Census Bureau (See Health Insurance
Coverage in the United States,
September 12, 2018, Report Number P–
60 264, Edward R. Berchick, Emily
Hood, and Jessica C. Barnett, p. 1–2),
67.2 percent of individuals in the
United States that are insured have
private health insurance, whereas 37.7
percent have government coverage
including 19.3 percent that have
Medicaid and 17.2 percent that have
Medicare. In addition, not all Medicaid
or Medicare beneficiaries must pay
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
premiums or cost sharing, and the
amounts that they do pay, when
required, are generally limited by
federal statute and regulation and
typically are lower than premiums and
cost sharing amounts paid by enrollees
in private insurance coverage. As a
result, we do not believe that revenue
from the proposed class, services of
health insurers besides services of
MCOs (including HMOs and PPOs) is
predominantly from Medicaid and
Medicare. Specifically, we believe that
such revenue is not more than 50
percent from Medicaid and not more
than 80 percent from Medicaid,
Medicare, and other federal programs
combined. Second, each state already
defines and regulates health insurers in
the state, through state law. As a result,
the class is clearly identifiable. To the
extent that state law specifically
includes or excludes certain types of
issuers of health insurance policies as
health insurers, we propose deferring to
the state in determining which such
entities are included within the
proposed class and which are not. For
example, certain groups of businesses
may band together to offer health
insurance plans to their employees, a
practice known as association health
plans under section 3(5) of the
Employee Retirement Income and
Security Act (ERISA) (Pub. L. 93–406,
enacted September 2, 1974). The degree
to which an issuer of an association
health plan is considered to be a health
insurer depends on state law. Finally,
health insurers exist nationwide, and
are not particular to any individual
state. Neither we (that is, CMS, either
with respect to our administration of
Medicare or Medicaid), the state
Medicaid agency, or any agency
involved in administering title XVIII,
title XIX, or title XXI is considered to be
a health insurer in terms of the
proposed class to be added at § 433.56.
As a result, the proposed class meets all
of the criteria specified in the 1993 final
rule and is appropriate to add to the
classes of health care items and services
upon which states may impose health
care-related taxes without a reduction in
FFP, subject to all applicable federal
statutory and regulatory requirements.
7. Permissible Health Care-Related
Taxes (§ 433.68(e) and (f))
Section 1903(w)(3)(E)(ii)(I) of the Act
provides that the Secretary shall
approve a state’s application for a
waiver of the broad based and/or
uniformity requirements for a health
care-related tax, if the state
demonstrates to the Secretary’s
satisfaction that the tax meets specified
criteria, including that the net impact of
PO 00000
Frm 00021
Fmt 4701
Sfmt 4702
63741
the tax and associated Medicaid
expenditures as proposed by the state is
generally redistributive in nature.
Implementing regulations in § 433.68(e)
specify a statistical test for evaluating
whether a proposed tax is generally
redistributive: If the state is seeking only
a waiver of the broad based
requirement, paragraph (e)(1) specifies a
test referred to as ‘‘P1/P2’’ described
above, while a state seeking a waiver of
the uniformity requirement or both the
broad-based and uniformity
requirements must meet the test
specified in paragraph (e)(2), referred to
as ‘‘B1/B2’’, also described above.
Although these tests were designed to
ensure that a proposed tax is generally
redistributive in accordance with
section 1903(w)(3)(E)(ii)(I) of the Act,
we have found that these tests alone
have been insufficient in some
circumstances as described above. As a
result, we are proposing to add
§ 433.68(e)(3), to ensure that a proposed
tax is truly generally redistributive.
Specifically, we are proposing to
amend § 433.68(e) to provide that a
proposed tax must satisfy both
paragraph (e)(3) of this section, and, as
applicable, paragraph (e)(1) or (2) of this
section. At paragraph (e)(3), we propose
that a tax must not impose undue
burden on health care items or services
paid for by Medicaid or on providers of
such items and services that are
reimbursed by Medicaid. We would
consider a tax to impose undue burden
under this paragraph if taxpayers are
divided into taxpayer groups and any
one or more of the following conditions
apply: (1) The tax excludes or places a
lower tax rate on any taxpayer group
defined by its level of Medicaid activity
than on any other taxpayer group
defined by its relatively higher level of
Medicaid activity; (2) within each
taxpayer group, the tax rate varies based
on the level of Medicaid activity, and
the tax rate imposed on any Medicaid
activity is higher than the tax rate
imposed on any non-Medicaid activity
(except as a result of excluding from
taxation Medicare revenue or payments
as described in § 433.68(d)); (3) the tax
excludes or imposes a lower tax rate on
a taxpayer group with no Medicaid
activity than on any other taxpayer
group, unless all entities in the taxpayer
group with no Medicaid activity meet at
least one of four specified exceptions; or
(4) the tax excludes or imposes a lower
tax rate on a taxpayer group defined
based on any commonality that,
considering the totality of the
circumstances, CMS reasonably
determines to be used as a proxy for the
taxpayer group having no Medicaid
E:\FR\FM\18NOP2.SGM
18NOP2
63742
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
activity or relatively lower Medicaid
activity than any other taxpayer group.
These four conditions represent specific
parameters of tax structures that, in
addition to those identified through the
P1/P2 and B1/B2 test, inherently result
in undue burden on the Medicaid
program. CMS considers taxes that pose
an undue burden on the Medicaid
program to be inherently not generally
redistributive because they impose a
higher tax burden on health care items
or services, or providers of such items
and services, that are financed by
Medicaid than those not financed by
Medicaid, as explained in the preamble
to the August 1993 final rule, discussed
above.
We are proposing to require states to
ensure compliance with the proposed
requirement at paragraph (e)(3) to avoid
placing an undue burden on the
Medicaid program beginning on the
effective date of any final rule for tax
waivers that have not yet been approved
before the effective date of any final
rule. For tax waivers approved before
the effective date of any final rule, we
are proposing that states must come into
compliance with this requirement when
submitting a new waiver request. As
described below, in § 433.72, we are
proposing to add new paragraphs (c)(3)
and (4) to specify the date on which a
waiver approved under § 433.72(b) will
no longer be effective. We are proposing
that an approved waiver would have a
3-year term; for a waiver approved
before the effective date of the final rule
the 3-year term would run from the
effective date of the final rule. A state
would be free to apply for renewal of an
expired or expiring waiver, subject to
the same approval criteria applicable to
an initial waiver request under
§ 433.72(b). As a result, for existing tax
waivers, we are proposing to require
states to come into compliance with
proposed § 433.68(e)(3) when they
submit a new tax waiver request, which
we are proposing would be no later than
3 years after the effective date of any
final rule, depending on whether the
state makes any substantial changes to
the health care-related tax as specified
in proposed § 433.72(d). We believe that
this time frame would ensure our goal
of supporting the fiscal integrity of the
Medicaid program while giving states
the necessary time to comply with the
proposed regulatory amendments.
It is important to note that nothing in
this proposed rule would interfere with
states’ permissible use of tax revenues to
fund provider payments or reliance on
such use of tax revenues to justify or
explain the tax in the legislative
process, as provided in section
1903(w)(4) of the Act. Tax structures
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
that place an undue burden on
Medicaid, however, would not be
considered to be generally redistributive
for the purposes of § 433.68(e). We seek
comment on our proposed amendments
to § 433.68(e), and on additional
conditions that could result in a tax
program imposing undue burden on the
Medicaid program, and therefore, failing
to be generally redistributive in nature
that are not included in this proposed
list.
Section 1903(w)(1)(A)(iii) of the Act
states that the total amount expended
during the fiscal year as medical
assistance under the state plan shall be
reduced by the sum of any revenues
received by the state during the fiscal
year from a broad-based health carerelated tax if there is in effect a hold
harmless provision with respect to the
tax. Section 1903(w)(4)(C) of the Act
states that there is in effect a hold
harmless provision with respect to a
health care-related tax if the state or
other unit of government imposing the
tax provides directly or indirectly for
any payment, offset, or waiver that
guarantees to hold the taxpayer
harmless for any portion of the costs of
the tax. Section 433.68(f)(3) echoes this
language. The proposed rule would add
a net effect standard to § 433.68(f)(3).
This proposed change represents a
clarification of existing policy and
would not impose any new obligations
or place any new restrictions on states
that do not currently exist. The language
added by the proposed rule would
specify that a direct or indirect hold
harmless guarantee will be found to
exist where, considering the totality of
the circumstances, the net effect of an
arrangement between the state (or other
unit of government) and the taxpayer
results in a reasonable expectation that
the taxpayer will receive a return of all
or any portion of the tax amount as
discussed above. We propose that the
net effect of such an arrangement may
result in the return of all or any portion
of the tax amount, regardless of whether
the arrangement is reduced to writing or
is legally enforceable by any party to the
arrangement.
Proposed § 433.68(f)(3) aims to thwart
efforts by states to skirt hold harmless
provisions by paying supplemental
payments to private entities, who then
pass these funds on to other private
entities that have lost gross revenue due
to a health care-related tax. The use of
an intermediary does not change the
essential nature of the transaction: That
it is a payment made by a state or unit
of government to a provider that holds
that provider harmless for the cost of the
tax. While states are free to impose
broad-based and uniform health care-
PO 00000
Frm 00022
Fmt 4701
Sfmt 4702
related taxes, or generally redistributive
health care-related taxes that meet
applicable requirements for a waiver of
either or both of these requirements, to
fund the non-federal share of Medicaid
expenditures, states may not do so in a
way that guarantees to return all or part
of the cost of the tax to the taxpayers.
The proposed language adding the net
effect standard to the direct hold
harmless guarantee test at § 433.68(f)(3)
clarifies to states the range of
permissible tax and reimbursement
arrangements for health care-related
taxes. Such clarifying language allows
states and CMS to work more
harmoniously together by solidifying a
shared understanding regarding what
constitutes a guarantee to hold
taxpayers harmless for the cost of a
health care-related tax and reduces the
likelihood of disagreement concerning
the interpretation of the regulation. As
such, the proposed amendment would
allow states to operate their Medicaid
financing programs with greater clarity
and consistency than before.
We seek comment on our proposed
amendments to § 433.68(f)(3).
Additionally, we are soliciting
comments on other qualitative or
quantitative measures that could further
safeguard the fiscal health and integrity
of the Medicaid program through
modifications to the provisions of
§ 433.68.
8. Waiver Provisions Applicable to
Health Care-Related Taxes (§ 433.72)
In § 433.72, we are proposing to add
new paragraphs (c)(3) and (4) to specify
the date on which a waiver approved
under paragraph (b) of this section
would no longer be effective. We are
proposing that an approved waiver
should have a 3-year term; for a waiver
already approved before the effective
date of the final rule, if this proposal is
finalized, the 3-year term would run
from the effective date of the final rule.
A state would be free to apply for
renewal of an expired or expiring
waiver, subject to the same approval
criteria applicable to an initial waiver
request under § 433.72(b). We are
proposing a 3-year limit to ensure the
tax program continues to meet all
applicable requirements under part 433,
subpart B, including whether or not the
tax program continues to meet generally
redistributive requirements at
§ 433.68(e)(1) and (2) and proposed
paragraph (e)(3).
We are proposing to limit waiver
approvals to 3 years because the
provider data that states provide to CMS
for use in the statistical tests at § 433.68
and the providers in the class subject to
the waiver change over time. As a result,
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
while a tax may be generally
redistributive when the state first
requests the waiver, it may cease to be
so as the composition of the providers
or payers, or the volume of items or
services subject to the tax changes. In an
effort to ensure consistent fiscal
oversight of the non-federal share of
Medicaid expenditures and to ensure
that health care items and services, and
providers of health care items or
services, financed by Medicaid are not
taxed more heavily than those not
financed by Medicaid, we believe that
this proposed time period would aid in
ensuring state tax programs are and
remain consistent with section
1903(w)(3)(E)(ii) of the Act. This
provision establishes that the Secretary
will approve waivers if the state
establishes to the satisfaction of the
Secretary that the net impact of the tax
is generally redistributive in nature and
the amount of the tax is not directly
correlated to Medicaid payments. We
believe it is necessary for the proper and
efficient operation of the Medicaid
program to establish that a tax for which
a state seeks a waiver meets statutory
requirements not just when the waiver
is initially approved, but on an ongoing
basis as well. We propose to allow states
with already existing health care-related
tax waivers 3 years from the effective
date of the final rule, as stated in
proposed § 433.72(c)(4), to seek
reapproval of their waivers, in an effort
to provide states with sufficient time to
evaluate and, as may be necessary,
modify existing tax programs to comply
with applicable requirements.
We are proposing to add new
§ 433.72(d), to ensure ongoing
compliance of tax waivers with the
original conditions of the waiver
approval. In this proposed paragraph,
we would specify that, for a state to
continue to receive tax revenue (within
specified limitations) under an
approved waiver without a reduction in
FFP as would otherwise be required
under section 1903(w)(1)(A)(ii) of the
Act and § 433.70, the state must: (1)
Ensure that the tax program for which
CMS approved the waiver continues to
meet the waiver conditions identified in
§ 433.72(b)(1) through (3) at all times
during which the waiver is in effect; and
(2) request a new waiver if the state or
other unit of government imposing the
tax modifies the tax program in
specified ways. We propose that, if the
state or other unit of government
imposing the tax modifies the tax in a
non-uniform manner, meaning the
change in tax or tax rate does not apply
in an equal dollar amount or percentage
change to all taxpayers, the state would
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
be required to request a new waiver
subject to effective date requirements in
§ 433.72(c). If the state or other unit of
government imposing the tax modifies
the criteria for defining the taxpayer
group or groups subject to the tax, the
state would be required to request a new
waiver subject to effective date
requirements in § 433.72(c). As with the
3-year waiver validity period at
proposed § 433.72(c)(3) and (4), the
proposed new requirements at
paragraph (d) would help ensure that
the tax remains generally redistributive
while the waiver is in effect, since these
changes could affect the determination
whether it meets applicable
requirements. States would be permitted
to make changes that would not affect
the compliance of the tax with all
applicable broad-based and uniformity
standards (including waiver standards)
without receiving a new approval of a
tax waiver from CMS. However, states
wishing to make changes to their tax
structures that modify any of the
proposed, specified elements would be
required to submit a new tax waiver
request and obtain approval from us
before beginning to collect such a tax.
States may not make changes to the tax
structure that result in taxpayers being
held harmless for some or all of the cost
of the tax without experiencing a
reduction in their amount of medical
assistance expenditures for purposes of
claiming FFP as specified by section
1903(w)(1)(A) of the Act.
9. When Discovery of Overpayment
Occurs and its Significance (§ 433.316)
Section 1903(d)(2)(C) of the Act
provides that, when an overpayment by
a state is discovered, the state has a 1year period to recover or attempt to
recover the overpayment before an
adjustment is made to FFP to account
for the overpayment. Currently,
regulations in § 433.316 provide for
determining the date of discovery of an
overpayment, which is necessary to
determine the statutory 1-year period, in
three distinct cases: When the
overpayment results from a situation
other than fraud, under § 433.316(c);
when the overpayment results from
fraud, under § 433.316(d); and when the
overpayment is identified through a
federal review, under § 433.316(e). It is
not explicitly clear in the current
regulations how the date of discovery is
determined when an overpayment is
discovered through the annual DSH
independent certified audit required
under § 455.304. Therefore, we believe
an amendment is appropriate to specify
the date of discovery of overpayments as
it relates to the annual DSH
independent certified audit.
PO 00000
Frm 00023
Fmt 4701
Sfmt 4702
63743
Accordingly, we are proposing to
redesignate paragraphs (f), (g), and (h) as
paragraphs (g), (h), and (i), respectively,
and to add new proposed paragraph (f).
In new paragraph (f), we are proposing
that in the case of an overpayment
identified through the DSH independent
certified audit required under part 455,
subpart D, we will consider the
overpayment as discovered on the
earliest of the date that the state submits
the DSH independent certified audit
report required under § 455.304(b) to
CMS, or any of the dates specified in
§ 433.316: Paragraph (c)(1) (the date on
which any Medicaid agency official or
other state official first notifies a
provider in writing of an overpayment
and specifies a dollar amount that is
subject to recovery); paragraph (c)(2)
(the date on which a provider initially
acknowledges a specific overpaid
amount in writing to the Medicaid
agency); and paragraph (c)(3) (the date
on which any state official or fiscal
agent of the state initiates a formal
action to recoup a specific overpaid
amount from a provider without having
first notified the provider in writing).
10. State Plan Requirements (§ 447.201)
We are proposing to add new
§ 447.201(c) to specify that the state
plan may not provide for variation in
FFS payment for a Medicaid service on
the basis of a beneficiary’s Medicaid
eligibility category, enrollment under a
waiver or demonstration, or federal
matching rate available for services
provided to a beneficiary’s eligibility
category under the plan. As discussed
below, this provision would implement
sections 1902(a)(4) and (a)(30)(A) of the
Act, and codify our current practice, by
prohibiting variations in service
payments on the basis of available FFP.
States seeking to increase payments
only on the basis of a higher available
FFP for the relevant beneficiary
population creates inequity in the
Medicaid program. By approving
Medicaid state plan payments, we are
making an administrative decision that
the payment rates are consistent with
section 1902(a)(30)(A) of the Act;
specifically, that such payments are
consistent with efficiency, economy,
and quality of care and are sufficient to
enlist enough providers so that care and
services are available under the plan at
least to the extent that such care and
services are available to the general
population in the geographic area. In the
absence of an access issue, it would not
be consistent with efficiency and
economy to pay providers more, only
because the federal matching rate is
increased with respect to certain
categories of beneficiaries. In addition,
E:\FR\FM\18NOP2.SGM
18NOP2
63744
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
where payment rates under the state
plan do result in insufficient access for
Medicaid beneficiaries, the state must
increase rates to rectify the access
problem for all Medicaid beneficiaries,
not only those for whom the statute
provides for an increased FMAP.
We have allowed states to set
payment rates based on higher costs for
the delivery of care (for example,
difference in acuity or particular health
needs); however, we have not allowed
states to pay higher rates based on
policies that are unrelated to actual
increases in the cost of furnishing
services to the relevant beneficiaries.
For example, we have allowed states to
pay higher rates to a provider based
upon a higher provider qualifications,
which may be equated with a higher
cost of furnishing services, but that
payment difference is for all Medicaid
beneficiaries that receive services
provided by that provider. Similarly, we
have not allowed states to target higher
payments based on eligibility status or
enhanced matching rates, since those
factors are not established to have any
relationship to the cost of delivering
care. Rates that are structured without
regard to service costs and care delivery
are not economic and efficient and are
inconsistent with section 1902(a)(30)(A)
of the Act. This proposed provision is
intended to make clear that variation in
payment rates solely on the basis of FFP
is prohibited, as it would be
inconsistent with efficiency and
economy to allow states to pay
providers more, only because such
payments can be funded by drawing
down additional federal dollars at a
marginally increased cost to the state
(and at net savings to the state, versus
the costs the state would incur if the
relevant beneficiary population
qualified for standard FMAP). We
believe that this proposed provision is
necessary to ensure the proper and
efficient operation of the Medicaid state
plan, in a manner that complies with
the requirements of section 1902(a)(4)
and (a)(30)(A) of the Act.
This proposed approach would be
consistent across both FFS and managed
care. Specifically, in the 2016 Medicaid
managed care final rule, we articulated
in § 438.4(b)(1) that any differences
among capitation rates according to
covered populations must be based on
valid rate development standards and
not be based on the FFP associated with
the covered populations (81 FR 27566).
We also considered proposing a rule
that would require states to pay the
same rate to a facility for all
beneficiaries, unless the state could
demonstrate that different case mixes or
health care needs, or other reasons
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
consistent with economy, efficiency,
quality of care, and access justified
paying a different rate for a different
group of beneficiaries. We decided
instead to propose that the plan must
provide for no variation in FFS payment
for a Medicaid service on the basis of a
beneficiary’s Medicaid eligibility
category, enrollment under a waiver or
demonstration project, or FMAP rate
available for services provided to an
individual in the beneficiary’s eligibility
category, because, as stated above,
where payment rates under the state
plan do result in insufficient access for
Medicaid beneficiaries, the state must
increase rates to rectify the access
problem for all Medicaid beneficiaries,
not only those for whom the statute
provides for an increased FMAP. We
seek comment on proposed § 447.201.
11. Payments Funded by Certified
Public Expenditures Made to Providers
That are Units of Government
(§ 447.206)
We are proposing to add § 447.206 to
codify longstanding policies
implementing the following sections of
the statute: Section 1902(a)(4) for proper
and efficient operation of the state plan;
section 1902(a)(30)(A) requiring that
payments be economic and efficient;
and section 1903(w)(6)(A) permitting
states to use CPEs, which are
expenditures certified by units of
government within a state, as a source
of non-federal share. The specific
standards for states to document
Medicaid expenditures that units of
government may certify through a CPE
for a claim for FFP has not previously
been defined in regulation. While CPEs
are not necessarily ‘‘payments’’ in the
usual sense of the term, instead they are
transactions which take the place of
regular FFS payment. However, we refer
to payments generally to mean the total
computable amount the provider
receives for performing Medicaid
services. We are proposing in
§ 447.206(a) to specifiy that § 447.206
applies only to payments made to
providers that are state government
providers or Non-state government
providers, as defined in proposed
§ 447.286, where such payments to such
providers are funded by a CPE, as
specified in § 433.51(b)(3), as proposed
by this rule. Further, we are proposing
in § 447.206(b)(1) that CPE-funded
payments made to state government
providers or non-state government
providers would be limited to
reimbursement not in excess of the
provider’s actual, incurred cost of
providing covered services to Medicaid
beneficiaries using reasonable cost
allocation methods as specified in 45
PO 00000
Frm 00024
Fmt 4701
Sfmt 4702
CFR part 75 and 2 CFR part 200, or, as
applicable, to Medicare cost principles
specified in 42 CFR part 413.
In the case of CPEs, states allow
providers that are state or local
government entities to expend funds in
order to provide services to Medicaid
beneficiaries. These providers document
that the monies were spent furnishing
covered services to Medicaid
beneficiaries and certify their
expenditures to the state. Without any
funds actually changing hands between
the state or local government entity that
is the provider, and the Medicaid
agency (such as via an IGT), and
without the state appropriating
associated funds directly to the
Medicaid agency, the state uses the
amount of the CPE as non-federal share
to claim FFP.
To document the expenditure, we are
proposing to add new § 447.206(b),
which would define general rules for
these CPE cost protocols. We are
proposing to codify our practice of
relying upon the cost allocation
principles in federal regulations in 45
CFR part 75, 2 CFR part 200, and, as
applicable, Medicare cost principles
specified in part 413, as the methods
and principles to identify Medicaid
program expenditures eligible to
support a CPE. First, we propose that
Medicaid payments funded by a CPE
would be limited to reimbursement not
in excess of the provider’s actual,
incurred cost of providing covered
services to Medicaid beneficiaries using
reasonable methods of identifying and
allocating costs to Medicaid, as stated
above. We recommend that states use
the Medicare cost reports as the basis for
determining Medicaid cost where
available for an applicable service (for
example, Medicare 2552–10 Hospital
Cost Report or the Medicare 2540–10
Skilled Nursing Facility Cost Report).
However, since a number of states
already have developed and currently
use a state-developed cost report that is
based on the Medicare cost report,
meaning that the state cost report uses
data taken from the calculations in the
Medicare cost report, we are not
requiring that states only use the
Medicare cost report as we do not desire
to increase state burden in this area.
Section 447.206(b)(2), as proposed,
would provide that the state must
establish and implement documentation
and audit protocols, which must
include an annual cost report to be
submitted by the state government
provider or non-state government
provider to the state agency that
documents the provider’s costs incurred
in furnishing services to Medicaid
beneficiaries during the provider’s fiscal
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
year. Section 447.206(b)(3) would
provide that only the certified amount
of the expenditure may be claimed for
FFP. The claimed amount is limited
because the CPE must only represent
amounts that were spent providing the
Medicaid services, as authorized by
sections 1903(a)(1) and (w)(6)(A) of the
Act, which authorize federal matching
funds for state Medicaid expenditures
and allows funds certified by units of
government within a state as the nonfederal share of expenditures,
respectively.
Proposed § 447.206(b)(4) would
require the certifying entity of the CPE
to receive and retain the full FFP
associated with the Medicaid payment,
consistent with the cost identification
protocols in the Medicaid state plan and
in accordance with proposed § 447.207.
We are proposing to require that
certifying entities receive and retain the
FFP a state claims from CMS to prevent
inappropriate recycling of federal funds
and any other potential redirection of
federal funds that would be prohibited
under the statute. In recent years, we
have found that states have been
drawing down FFP to match CPEs,
retaining the federal share and using
these federal funds as the non-federal
share for other Medicaid payments. This
practice is not consistent with the
existing § 433.51(c), which generally
prohibits the use of federal funds to
match other federal funds. When a state
makes a claim for FFP on a medical
assistance expenditure, that claim for
the FFP is singularly for that medical
assistance expenditure and a
recognition of the state and federal
partnership of the Medicaid program.
To claim and receive FFP for an
expenditure, and to reuse that FFP to
claim additional federal matching funds
or to otherwise redirect the FFP to pay
costs unrelated to the expenditure for
which the FFP was claimed results, in
effect, in the federal government alone
funding the full Medicaid payment to
the provider that originally certified the
CPE, or, viewed another way, covering
costs ineligible for FFP. Such a result is
not consistent with sections 1902(a)(2),
1902(a)(4), and 1903 of the Act.
Proposed § 447.206(c) would specify
other criteria for states when a CPE is
used to fund a Medicaid payment.
Under paragraph (c)(1), the state would
be required to implement processes by
which all claims for medical assistance
would be processed through the MMIS
in a manner that identifies the specific
Medicaid services provided to specific
enrollees. Paragraph (c)(2) would
provide that the state is required to
utilize most recently filed cost reports as
specified in proposed paragraph (b)(2)
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
to develop interim payments rates,
which may be trended by an applicable
health care-related index. Interim rates
are rates that reflect the provider’s
expected cost of providing services
throughout the year. Requiring states to
establish interim rates ensures that
providers would receive payments
throughout the year, calculated to
closely reflect the provider’s
expenditures in furnishing services to
Medicaid beneficiaries. This would
provide cash flow to support the
provider’s ongoing operations, and, with
the interim rates based on the provider’s
most recent filed cost reports (trended
forward by an applicable health carerelated index, at state option), would
potentially minimize reconciliation
payments to providers (in the case of
underpayment) or collections from
providers (in the case of overpayments)
at the end the year during the
reconciliation process. The term ‘‘health
care-related index’’ means a trend factor
which would project increases or
decreases in expected costs, so as to
minimize potential over- or underpayments to the provider certifying the
CPE. One such index is the CMS Market
Basket, which we publish for purposes
related to the Medicare program.
However, states could also propose to
use an alternative health-care related
index, provided the state demonstrates
that the alternative is likely to reliably
project increases or decreases in
providers’ costs of furnishing covered
services to Medicaid beneficiaries in the
upcoming year. In reviewing a stateproposed health-care related index, we
would require the state to identify the
index in the state plan and provide a
justification for the use of this index
rather than other national indices, such
as the CMS Market Basket.
We propose that reconciliations
would be performed by reconciling
payments made during the year based
on the interim Medicaid payment rates,
to the provider’s filed cost report for the
state plan rate year in which interim
payments were made. Section 455.301
defines the state plan rate year as the 12month period defined by a state’s
approved Medicaid state plan in which
the state estimates eligible
uncompensated care costs and
determines corresponding DSH
payments, as well as all other Medicaid
payment rates. The period usually
corresponds with the state’s fiscal year
or the federal fiscal year but can
correspond to any 12-month period
defined by the state as the Medicaid
state plan rate year (73 FR 77951).
Proposed paragraph (c)(3) would require
that final settlement be performed
PO 00000
Frm 00025
Fmt 4701
Sfmt 4702
63745
annually by reconciling any interim
payments to the finalized cost report for
the state plan rate year in which any
interim payment rates were made. Final
settlement would be required to be
made no more than 24 months from the
relevant cost report year end, except
under circumstances identified in 45
CFR 95.19. The 24-month period was
chosen to comply with the generally
applicable 2-year time limit for claiming
payment for expenditures in 45 CFR
95.7.
During the reconciliation and final
settlement process, we expect that the
state would receive the provider’s cost
report and review the reported
expenditures via a desk review process.
As part of the desk review, the state
would gather, organize, and analyze the
provider’s cost report, including by
comparing current period expenditures
to prior period expenditures to identify
audit risks. During the desk review, we
expect that the state may request
explanations of or adjustments to the
reported cost based upon generally
accepted accounting principles (GAAP).
Upon finalization of the desk review,
the state would notify the provider of
the final determination of total cost.
Once the state has made a final
determination of the provider’s final
cost, if the provider’s actual total cost is
not equal to the sum of its interim rate
payments for the period, one of two
actions may occur. If the provider has
been underpaid, meaning the total
interim rate payments were less than the
total calculated cost amount, the state
may draw down and pay to the provider
FFP associated with the total
computable expenditure certified by the
provider as a prior period adjustment to
the CMS 64, equal to the difference
between the total interim payments and
total cost. In the event the provider was
overpaid, meaning the interim rate
payments exceeded the provider’s total
cost, the state would calculate the
overpayment, which would be equal to
the difference between the total interim
payments and the provider’s total cost,
and return the federal share of that
amount to CMS as a prior period
adjustment under part 433 subpart F. In
the event of an overpayment, the state
is obligated to return the FFP whether
or not the state seeks a return of
payment from the provider as
articulated in § 433.316. All of these
steps would establish an auditable basis
for the state’s claims for FFP associated
with the CPEs, as contemplated under
section 1902(a)(42)(A) of the Act, which
requires that the state plan must provide
that the records of any entity
participating in the plan and providing
E:\FR\FM\18NOP2.SGM
18NOP2
63746
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
services reimbursable on a cost-related
basis will be audited as the Secretary
determines to be necessary to insure
that proper payments are made under
the plan.
Proposed § 447.206(d) would specify
requirements for the state plan when the
state proposes to use a CPE to fund a
Medicaid payment. We propose that, if
CPEs are used as a source of non-federal
share under the state plan, the state plan
would be required to specify cost
protocols in the service payment
methodology applicable to the certifying
provider, such protocols would be
required to meet all of the following
criteria: (1) Identify allowable cost using
either a Medicare cost report, or a statedeveloped Medicaid cost report
prepared in accordance with the cost
principles in 45 CFR part 75 and 2 CFR
part 200; (2) define an interim rate
methodology that would be used to pay
a provider on an interim basis; (3)
describe an attestation process by which
the certifying entity would attest that
the costs are accurate and consistent
with 45 CFR part 75 and 2 CFR part 200;
(4) include, as necessary, a list of the
covered Medicaid services being
furnished by each provider certifying a
CPE; and (5) define a reconciliation and
settlement process consistent with
proposed § 447.206(c)(3) and (4).
Regarding the inclusion in paragraph
(d)(4) of a list of the covered Medicaid
services being furnished by each
provider, CMS is referring to instances
where the services included in a cost
report either extend across multiple
Medicaid benefit categories or do not
encompass all services within a benefit
category. In such circumstances, we
believe that this information is
necessary to determine the services for
which FFP is available. For example, in
a setting where some but not all services
within a Medicaid benefit category are
furnished, such as a residential
rehabilitation hospital that does not
furnish all inpatient hospital services,
the state would be required to document
the services for which the state will be
claiming FFP with respect to the
provider. In most settings where the
provider certifies a CPE, this step is not
necessary, since the services furnished
by the provider certifying the CPE will
be coextensive with a Medicaid benefit
category (for example, the ‘‘inpatient
hospital services’’ Medicaid benefit
category typically is coextensive with
the services furnished by an inpatient
hospital that might certify a CPE).
We are soliciting comment on our
overall proposal, including the
proposed cost reporting and process
requirements, state plan requirements,
and whether to require the use of the
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
Medicare cost report where one exists
for an applicable service for which the
provider certifies a CPE. We believe
requiring the use of a Medicare cost
report where one exists for CPE
protocols would allow for a consistent
application of allowable cost principles,
however, Medicare cost reports only
exist for a relatively small number of
services that states may cover in their
Medicaid programs and requiring the
use of Medicare cost reports would
remove some state flexibility in
determining the appropriate cost
reporting mechanism for providers
certifying CPEs in the state’s Medicaid
program.
12. Retention of Payments (§ 447.207)
In § 447.207, we propose to require
that payment methodologies must
permit the provider to receive and retain
the full amount of the total computable
payment for services furnished under
the approved state plan (or the approved
provisions of a waiver or demonstration,
if applicable). This provision is
intended to implement sections
1902(a)(4) and (a)(32) of the Act. These
provisions respectively require that the
state plan for medical assistance provide
such methods of administration as are
found by the Secretary to be necessary
for the proper and efficient operation of
the plan, and generally provide that no
payment under the plan for any care or
service provided to an individual shall
be made to anyone other than such
individual or the person or institution
providing such care or service, under an
assignment or power of attorney or
otherwise, unless certain enumerated
exceptions apply as described in more
detail below. Payment arrangements
that comply with an exception in
section 1902(a)(32) of the Act and the
implementing regulation in § 447.10
would not be deemed out of compliance
with this proposed provision.
The Secretary would determine
compliance with this provision by
examining any associated transactions
that are related to the provider’s total
computable Medicaid payment to
ensure that the state’s claimed
expenditure, which serves as the basis
for FFP, is consistent with the state’s net
expenditure, and that the full amount of
the non-federal share of the payment
has been satisfied. The term ‘‘state’s net
expenditure’’ in this section means a
state’s Medicaid expenditure, less any
returned funds or contributions from the
provider to the state, related to the
Medicaid payment. This view of a
return of any portion of a Medicaid
payment is consistent with the
treatment of provider-related donations
in § 433.54, particularly paragraph (e) of
PO 00000
Frm 00026
Fmt 4701
Sfmt 4702
that section which states CMS will
deduct the amount of an impermissible
provider-related donation from a state’s
medical assistance expenditures before
calculating FFP (73 FR 9698).
Consideration for the state’s net
expenditure would include a review of
potential ‘‘hold harmless’’ arrangements
as described in § 433.54(c), which
provides that an impermissible hold
harmless practice exists if the Medicaid
payment is positively correlated to a
donation, varies based only on the
amount of a donation (including if
payment is conditioned upon the
receipt of a donation), or directly or
indirectly guarantees to return any
portion of a donation to the donating
provider (or other party responsible for
the donation), which implements
section 1903(w)(2)(B) of the Act. We
have noted circumstances in some states
where participation in a Medicaid
supplemental payment under the state
plan is conditioned upon the state
receiving a portion of that payment
back, whether as a direct payment from
the provider or netted from payments to
the provider where the state retains a
portion of the provider’s payment before
sending the remaining payment to the
provider.
We anticipate that ‘‘associated
transactions’’ may include, but would
not necessarily be limited to, the
payment of an administrative fee to the
state as a fee for processing provider
payments or IGTs. For example, in some
states, we have found that the Medicaid
agency has charged a percentage
administrative fee for each Medicaid
claim that was processed. Essentially,
the state was charging providers for
submitting claims to the Medicaid
program, and since the administrative
charge was based on claims volume and
amount of Medicaid payment, this
practice amounted to a tax on Medicaid
claims for services. States are already
able to, and often do, claim
administrative match for Medicaid
claims processing costs; states should be
using the appropriate mechanisms for
claiming where authority exists and not
unnecessarily shifting costs to the
Medicaid providers. We propose that in
no event could administrative fees be
calculated based on the amount a
provider receives through Medicaid
payments or amounts a unit of
government contributes through an IGT
as funds for the state share of Medicaid
payments. Structuring an administrative
fee in this way would be tantamount to
a Medicaid-only provider tax, which is
not allowable under § 433.55, and
would be expressly prohibited under
the proposed § 447.207(a). Conversely, if
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
a state charged a flat fee for claims
processing that did not vary based on
the volume of claims or amount of
Medicaid payments processed, the
payment of such a fee would not be
considered an associated transaction.
Likewise, the use of Medicaid revenues
to fund payments that are normal
operating expenses of conducting
business, such as payments related to
taxes (including permissible healthcare-related taxes), fees, or business
relationships with governments
unrelated to Medicaid in which there is
no connection to Medicaid payment
would not be considered an associated
transaction.
We are soliciting comment on all of
§ 447.207, including comments on the
types of transactions that we propose
would and would not be considered
‘‘associated transactions’’ for the
purpose of this section.
13. State Plan Requirements (§ 447.252)
We are proposing to add paragraphs
(d) and (e) to § 447.252 regarding state
plan requirements for payments for
inpatient hospital and long-term care
facility services, to implement new
approval requirements for state plans
and any SPAs proposing to make
supplemental payments to providers of
these services and to define a transition
period for currently authorized
supplemental payments to begin to meet
the proposed new requirements. In
§ 447.302, we propose similar
requirements for supplemental
payments proposed for outpatient
hospital services, as described in more
detail below. We are proposing to limit
approval for any Medicaid
supplemental payments to a period of
not more than 3 years, and to require
states to monitor a supplemental
payment program during the term of its
approval to ensure that the
supplemental payment remains
consistent with section 1902(a)(30)(A) of
the Act. As discussed in this section and
other sections of this preamble, the
proposed revisions to §§ 447.252,
447.288(b), and 447.302 include
considerable data reporting
requirements which would implement
section 1902(a)(6) of the Act which
provide that the state agency will make
such reports, in such form and
containing such information, as the
Secretary may from time to time require,
and comply with such provisions as the
Secretary may from time to time find
necessary to assure the correctness and
verification of such reports. We believe
the robust payment data we propose to
require is necessary to ensure the proper
and efficient administration of the plan;
to ensure that payments are consistent
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
with efficiency, economy, and quality of
care; and otherwise to assist us in
appropriately overseeing the Medicaid
program.
Specifically, we propose in
§ 447.252(d) that CMS may approve a
supplemental payment, as defined in
§ 447.286, provided for under the state
plan or a SPA for a period not to exceed
3 years. A state whose supplemental
payment approval period has expired or
is expiring may request a SPA to renew
the supplemental payment for a
subsequent period not to exceed 3 years,
consistent with the requirements of
§ 447.252. A time-limited supplemental
payment allows CMS and the state an
opportunity to revisit state plan
supplemental payments to ensure that
they remain consistent with efficiency,
economy, and quality of care, as
required under section 1902(a)(30)(A) of
the Act. Over the years, CMS and
various oversight bodies conducting
financial management reviews and
audits have identified areas where
unchecked supplemental payments
have resulted in payments that appeared
to be excessive, and CMS had little
recourse to take action. Such audits and
financial reviews conducted by CMS or
other oversight agencies could take
years and require a large number of state
and federal resources to complete, and
ultimately resolve. As noted earlier in
this preamble, in 2015, the GAO issued
a report entitled, ‘‘Medicaid: CMS
Oversight of Provider Payments Is
Hampered by Limited Data and Unclear
Policy,’’ in which it concluded that,
‘‘[w]ithout good data on payments to
individual providers, a policy and
criteria for assessing whether the
payments are economical and efficient,
and a process for reviewing such
payments, the federal government could
be paying states hundreds of millions,
or billions, more than what is
appropriate.’’ 9 As a result, the GAO has
recommended that, to better ensure the
fiscal integrity of the program, we
should establish financial reporting at a
provider-specific level and clarify
permissible methods for calculating
Medicaid supplemental payment
amounts. Based on this and other
oversight entity recommendations, and
CMS’ experience administering the
Medicaid program at the federal level,
we believe that the time-limited
approval of supplemental payments is
necessary for the proper and efficient
administration of state Medicaid plans
to ensure the continuing consistency of
9 U.S. Gov’t Accountability Office, GAO–15–322,
Medicaid: CMS Oversight of Provider Payments Is
Hampered by Limited Data and Unclear Policy, 46
(2015), https://www.gao.gov/assets/670/669561.pdf.
PO 00000
Frm 00027
Fmt 4701
Sfmt 4702
63747
supplemental payments with applicable
statutory requirements and generally to
ensure appropriate oversight.
We are not proposing to limit the
number of times a state may request,
and receive approval for renewal of, a
supplemental payment program,
provided that each request meets all
applicable requirements. We propose
that a state plan or SPA that would
provide for a supplemental payment
would be required to include: (1) An
explanation of how the state plan or
SPA will result in payments that are
consistent with section 1902(a)(30)(A) of
the Act, including that provision’s
standards with respect to efficiency,
economy, quality of care, and access,
along with the stated purpose and
intended effects of the supplemental
payment, for example, with respect to
the Medicaid program, providers, and
beneficiaries; (2) the criteria to
determine which providers are eligible
to receive the supplemental payment;
(3) a comprehensive description of the
methodology used to calculate the
amount of, and distribute, the
supplemental payment to each eligible
provider, including specified content;
(4) the duration of the supplemental
payment authority (not to exceed 3
years); (5) a monitoring plan to ensure
that the supplemental payment remains
consistent with the requirements of
section 1902(a)(30)(A) of the Act and to
enable evaluation of the effects of the
supplemental payment on the Medicaid
program, for example, with respect to
providers and beneficiaries; and (6) for
a SPA proposing to renew a
supplemental payment for a subsequent
approval period, an evaluation of the
impacts on the Medicaid program
during the current or most recent prior
approval period, for example, with
respect to providers and beneficiaries,
and including an analysis of the impact
of the supplemental payment on
compliance with section 1902(a)(30)(A)
of the Act. For the state’s
comprehensive description of the
methodology used to calculate the
amount of, and distribute, the
supplemental payment to each eligible
provider as required under item (3), we
would require the state to provide all of
the following: (i) The amount of the
supplemental payment made to each
eligible provider, if known, or, if the
total amount is distributed using a
formula based on data from one or more
fiscal years, the total amount of the
supplemental payments for the fiscal
year or years available to all providers
eligible to receive a supplemental
payment; (ii) if applicable, the specific
criteria with respect to Medicaid
E:\FR\FM\18NOP2.SGM
18NOP2
63748
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
service, utilization, or cost data from the
proposed state plan rate year to be used
as the basis for calculations regarding
the amount and/or distribution of the
supplemental payment; (iii) the timing
of the supplemental payment to each
eligible provider; (iv) an assurance that
the total Medicaid payment to an
inpatient hospital provider, including
the supplemental payment, will not
exceed the upper limits specified in
§ 447.271; and (v) if not already
submitted, an UPL demonstration as
required by § 447.272 and described in
proposed § 447.288.
We already request the information
specified in items (1) through (3), above,
from states when a state makes a state
plan submission that includes a
supplemental payment. Currently, we
request this information either
informally, by seeking assurances from
the state in connection with the request
for a SPA, or more formally, by
requesting changes to the language of
the proposed SPA itself. These
requirements also are consistent with
§ 430.10, which requires a state plan to
be a comprehensive written statement
which serves as the basis for FFP; as
such, we are proposing to specify in
regulation the essential elements of a
comprehensive written methodology for
a Medicaid supplemental payment.
Consistent with longstanding policy, for
a state plan to be comprehensive, it
must include the detailed
methodologies by which the state makes
payments, such that we and the state
have the information necessary to
determine which providers qualify for a
payment, the amount of each provider’s
payment, and the manner in which
payments are distributed to the
qualifying providers.
While items (1) through (3), above,
would codify our current practice in the
regulation, items (4) through (6) would
be new requirements. Item (4) would
require the state to identify an
expiration date, or sunset date, for the
supplemental payment, not to exceed a
duration of 3 years. A 3-year approval
period would also be consistent with
our general approach with respect to
demonstration projects under section
1115 of the Act, which often are
approved for 3-year periods to allow for
adequate time for the implementation
and testing, supported by ongoing
monitoring, and which culminate in an
evaluation of the effects of the
demonstration. Each time a state
submits a SPA to renew a supplemental
payment, the state would be able to
request a new approval period of up to
3 years. The state could submit a SPA
for CMS consideration to renew a
supplemental payment at any point
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
during the 3-year approval period,
according to the state’s chosen
timeframe, which the state should
determine to allow sufficient time for
our review and approval. We considered
using a tiered approval time period,
such as an initial approval period of up
to 5 years followed by renewal periods
of up to 3 years, but decided not to
propose this policy due to the increased
burden that it could cause.
We have found that supplemental
payments that are established under the
state plan and not reviewed for a long
period of time may result in issues of
compliance with applicable statutory
and regulatory requirements that do not
promptly come to our, or the state’s,
attention. For example, as discussed
elsewhere in this preamble, particularly
with respect to proposed § 447.288, the
issue of fluidity of provider ownership
can result in issues involving UPL
supplemental payments, and where
payments are made improperly, can
require extensive federal and state
resources to resolve. In the example
discussed in connection with proposed
§ 447.288, the qualifying criteria for
providers made all ‘‘non-state
government owned or operated’’
facilities eligible for supplemental
payments up to the UPL for those
providers. A few years after this
supplemental payment structure was
approved, the state was approached by
providers who wanted to change their
ownership or operational categorization
to meet the ‘‘non-state government’’
criteria, apparently so that they could
qualify for the UPL supplemental
payments under the state plan. The state
allowed the providers to make the
change without prior CMS review or
approval, and subsequently began
making UPL supplemental payments to
the newly recategorized providers.
Upon review of the supplemental
payment program in question, CMS
found that none of the asserted changes
in ownership or operations supported
the providers’ recategorization, and that
the providers therefore were ineligible
for the UPL supplemental payments the
state had been making. In this example,
the state was also using funds
impermissibly transferred from private
entities, which the state characterized as
IGTs as a result of the asserted
recategorization of the provider as nonstate government-owned or operated. To
resolve the identified issue, CMS had to
undergo a thorough financial
management review, which involved
numerous CMS staff reviewing financial
statements, provider payments, provider
records, and interviewing numerous
state and provider staff members to
PO 00000
Frm 00028
Fmt 4701
Sfmt 4702
determine the provider’s eligibility for
the payment under the approved state
plan. CMS formally issued the financial
management review in November 2015
for claims for services provided in state
FYs 2010 and 2011, and ultimately
issued a disallowance in September
2018. If CMS had the ability routinely
to re-review state supplemental
payment programs, we would not have
approved the expansion of this payment
to non-qualifying providers under the
plan because the private providers were
also funding the non-federal share of a
Medicaid payment, which is
unallowable under the statute. Because
of situations like this and related
concerns, we believe it is necessary for
the proper and efficient administration
of state Medicaid plans to require that
supplemental payment programs be
submitted for CMS review and approval
at least every 3 years, to ensure they are
and remain consistent with the
efficiency, economy, and quality
requirements under section
1902(a)(30)(A) of the Act and the
parameters concerning permissible
sources of non-federal share under
section 1903(w) of the Act.
In our experience, a number of states
that seem to effectively use
supplemental payments re-submit their
supplemental payment programs to
CMS on an annual basis, as the pools
funded by the supplemental payments
are annually re-authorized by the state
legislature. Such supplemental payment
programs would not be impacted by the
proposed 3-year limit. States submitting
annual updates to supplemental
payment programs, like other states
with supplemental payment programs,
would however newly be required to
comply with the other proposed
requirements, including items (5) and
(6), discussed above. Proposed
§ 447.252(d)(5) and (6) concern
monitoring and evaluation requirements
to assess the effects of the state’s
supplemental payment program.
Specifically, paragraph (d)(5) would
require the state to submit a monitoring
plan to ensure the supplemental
payment remains consistent with the
requirements of section 1902(a)(30)(A)
of the Act and to enable evaluation of
the supplemental payment’s effects on
the Medicaid program, for example,
with respect to providers and
beneficiaries. For a SPA proposing to
renew a supplemental payment for a
subsequent approval period, paragraph
(d)(6) would require the state to submit
such an evaluation and to include an
analysis of the impact of the
supplemental payment on the state’s
compliance with section 1902(a)(30)(A)
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
of the Act. For example, a state could
seek a 3-year approval period for a
supplemental payment to increase
payments to rural hospitals, with the
goal of increasing beneficiary access to
services provided by rural hospitals.
Over the next 3 years, the state would
monitor the effects of the program, to
determine whether the supplemental
payment is meeting its goals and
remains consistent with applicable
requirements. At the end of the 3-year
period, if the state wished to renew the
supplemental payment, it would submit
its evaluation and analysis with its
renewal request to us, which would
inform our determination of whether
payments under a renewed
supplemental payment program would
be consistent with applicable
requirements, including those in section
1902(a)(30)(A) of the Act. We anticipate
that there may be cases in which the
state’s evaluation of a supplemental
payment program’s effectiveness in
meeting its stated goals requires more
time to evaluate; in such cases, provided
we are able to determine that the
supplemental payment meets all
applicable statutory and regulatory
requirements, we would anticipate
approving the renewal. Notably, even
for a state requesting to renew a
supplemental payment program with no
changes, we would require the state to
submit the evaluation and analysis
required under proposed § 447.252(d)(6)
as part of our review of the
supplemental payment for consistency
with applicable statutory and regulatory
requirements.
Finally, in considering the 3-year
approval period for supplemental
payments, we developed a transition
plan to provide states with an adequate
opportunity to come into compliance
with the proposed requirements. To
accomplish the policy objectives
described above, we believe we must
begin to apply the proposed policies to
current state plan provisions that
authorize supplemental payments that
are approved as of the effective date of
the final rule. It is no less necessary to
ensure the proper and efficient
administration of the state plan and
ensure that applicable requirements
continue to be met, to rigorously
evaluate currently existing
supplemental payment programs, as it is
to do so for new supplemental payment
programs that may be approved
prospectively. Accordingly, in proposed
§ 447.252(e), for state plan provisions
approved 3 or more years prior to the
effective date of the final rule, we
propose that the state plan authority
would expire 2 calendar years following
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
the effective date of the final rule. For
state plan provisions approved less than
3 years prior to the effective date of the
final rule, we propose that the state plan
authority would expire 3 years
following the effective date of the final
rule. We believe this is a generous
timeline for transitioning to the
proposed 3-year time limit for
supplemental payments under the state
plan. This timeline provides states with
currently approved supplemental
payment programs with at least 2 years,
and as many as 3 years, before a state
wishing to continue the supplemental
payment program would need to seek
renewal or a new approval.
We are soliciting comment on this
entire section, including the proposed
state plan elements for supplemental
payments and the proposed provisions
that would place a limited approval
timeframe on state’s proposed
supplemental payments. For the
timeframes, we are seeking input on
both the length of 3-year approval
period and the length of the proposed
transition period for currently approved
supplemental payments. We considered
proposing a 5-year compliance
transition period instead of the
proposed 3-year compliance transition
period in § 447.252(e). This would have
extended the amount of time states
would have to bring existing, approved
supplemental payment methodologies
into compliance with the provisions of
the proposed rule in §§ 447.252 and
447.302, but determined that the
shortened timeframe would be easier to
administer as many states already
submit annual supplemental payment
proposals. We decided to propose a 3year transition period to account for
states where changes may require
legislative action as some legislatures
meet on a biennial basis and such a
timeframe would provide an
opportunity for all legilslatures to
address existing supplemental payment
programs. We are requesting comment
on whether or not to pursue this or a
lengthier transition and approval/
renewal timeline for supplemental
payments.
14. Inpatient Services: Application of
UPLs (§ 447.272)
To promote improved oversight of
Medicaid program FFS expenditures for
services subject to the UPL, we are
proposing changes to § 447.272. Many of
the proposed changes to § 447.272
would formally codify our current
policy in regulation text, while others
are newly proposed standards. We have
long relied upon the UPL requirements
in § 447.272, and the related review of
total inpatient hospital Medicaid
PO 00000
Frm 00029
Fmt 4701
Sfmt 4702
63749
payments in relation to a provider’s cost
or a reasonable estimate of what
Medicare payment amounts would have
been, as implementing section
1902(a)(30)(A) of the Act, which
requires that states assure that payments
are consistent with efficiency, economy,
and quality of care. As stated earlier in
the preamble, the aggregate application
of these UPLs has preserved state
flexibility for setting provider-specific
payments while creating an overall
payment ceiling as a mechanism for
determining economy and efficiency of
payment for services, consistent with
section 1902(a)(30)(A) of the Act.
We are proposing to amend paragraph
(a) to revise the current ownership
groups (state government-owned or
operated, non-state government owned
or operated, and privately-owned and
operated facilities) used to establish the
UPL. We propose to replace these
provider designations with ‘‘state
government providers,’’ ‘‘non-state
government providers,’’ and ‘‘private
providers.’’ We propose to codify the
substantive definitions of these provider
designations in proposed § 447.286. As
discussed below, we would define
‘‘state government provider’’ to refer to
a health care provider as defined in
§ 433.52, including those defined in
§ 447.251, that is a unit of state
government or state university teaching
hospital. In determining whether a
provider is a unit of state government,
we would consider the totality of the
circumstances, including but not
limited to specific considerations
identified in proposed § 447.286.
Similarly, we would define ‘‘non-state
government provider’’ to refer to a
health care provider as defined in
§ 433.52, including those defined in
§ 447.251, that is a unit of local
government in a state, including a city,
county, special purpose district, or other
governmental unit in the state that is not
the state, which has access to and
exercises administrative control over
state funds appropriated to it by the
legislature and/or local tax revenue,
including the ability to expend such
appropriated or tax revenue funds. In
determining whether a provider is nonstate government provider, we would
consider the totality of the
circumstances, including but not
limited to specific considerations
identified in proposed § 447.286. We
would define a ‘‘private provider’’ to
mean a health care provider as defined
in § 433.52, including those defined in
§ 447.251, that is not a state government
provider or a non-state government
provider.
The proposed changes in provider
designations would reinforce the
E:\FR\FM\18NOP2.SGM
18NOP2
63750
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
relationship between a provider’s
designation and its ability (or inability)
to provide the source of non-federal
share for Medicaid payments. Under the
current system of categorization by
ownership or operational interests, there
can be ambiguity with respect to the
appropriate category for a provider
when certain responsibilities of
ownership or operation are divided
between more than one entity. For
example, there is currently the
possibility that a private nursing facility
could transfer the deed to its real
property to the county government, but
the private entity would continue to
administer all functions of the provider
as though it were the actual owner,
leaving the county government as the
owner only in name but not any
function. For the provider to make an
IGT, the private entity would give funds
to the county government, such as
through a lease payment for the real
property, to be used as the source of the
non-federal share of Medicaid payments
that the state could then make back to
the provider in the form of
supplemental payments. This effective
self-funding of the non-federal share of
the supplemental payments by the
provider would not have been possible
if the provider were categorized as
privately owned and operated, since it
would have been unable to make the
IGT to support the supplemental
payments back to it. In this situation, we
view this transferred amount (for
example, the lease payment) as an
impermissible source of the non-federal
share, since the funds used to support
the IGT are not obtained from state or
local tax revenue and, as discussed
elsewhere in this preamble, would
constitute a non-bona fide providerrelated donation.
Through the state plan review process
and our review of UPL demonstrations,
we have observed that some states have
re-categorized a number of providers
from privately-owned or operated
facilities to a governmentally owned or
operated designation, either state
government-owned or operated facilities
or non-state government-owned or
operated facilities. In some instances,
the change in ownership category
appears to be only a device to permit the
state to make supplemental payments to
a provider and demonstrate compliance
with the UPL, rather than reflective of
an actual change in the provider’s true
ownership or operational interests, in
view of the apparent continuity of the
provider’s business structure and
activities. We believe this shift in
designation has facilitated higher
supplemental payments to certain
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
providers, without the state incurring
additional cost to fund the non-federal
share of payment where the private
operator passes funds to the new
governmental owner and those funds
are either used: (1) To make an IGT or
(2) supplant funds that are otherwise
used to make an IGT to the state in order
to make a supplemental payment
targeted toward the private entity. We
are concerned that this type of
arrangement is not consistent with the
basic construct of the Medicaid program
as a cooperative federal-state
partnership where each party shares in
the cost of providing medical assistance
to beneficiaries.
We propose to amend § 447.272(b) by
clarifying that the UPL refers to a
reasonable estimate of the amount that
would be paid for the services furnished
by the group of facilities under
Medicare payment principles in 42 CFR,
chapter IV, subchapter B; or allowed
costs established in accordance with
Medicaid cost principles as specified in
45 CFR part 75 and 2 CFR part 200, or,
as applicable, Medicare cost principles
specified in part 413. The specific data
sources, methodology parameters, and
acceptable UPL demonstration
methodologies are specified in proposed
§ 447.288(b).
The existing regulations simply state
that the UPL refers to a reasonable
estimate of the amount that would be
paid for the services furnished by the
group of facilities under Medicare
payment principles in subchapter B of
this chapter, pursuant to which we have
defined UPLs as a payment limit set at
the aggregate amount that Medicare
would have paid for the same Medicaid
services, using either a Medicare
payment methodology or Medicare cost
principles. These two methods are
employed because these are the two
methods that Medicare has historically
used to pay for services as authorized in
chapter 42, subchapter B. In establishing
these UPL methodologies, we have
required that states set the UPL using
the Medicare equivalent payment or
cost amount, then compare the aggregate
Medicaid payments for the defined
period to the UPL. For purposes of this
proposed rule and to be consistent with
prior regulatory action, the term
‘‘Medicare equivalent’’ means the
Medicare equivalent to the Medicaid
payment, data, or services. For example,
the Medicare equivalent payment means
the amount that would be paid for
Medicaid services furnished by the
group of providers if those services were
provided to Medicare beneficiaries and
paid under Medicare payment
principles. We are proposing to codify
our existing policy related to the use of
PO 00000
Frm 00030
Fmt 4701
Sfmt 4702
the two methods of demonstrating the
Medicaid UPL, by using the Medicare
equivalent payment amount or cost
amount, and the process for establishing
and demonstrating compliance with the
UPL in § 477.288(b) of this proposed
rule.
We considered proposing to define
specific methods by which states would
be required to demonstrate compliance
with the UPL in each of §§ 447.272 and
447.321, but determined that the
proposed § 447.288 would allow us to
define necessary data elements,
parameters, and methodologies for
demonstrating compliance with UPLs in
one location, for purposes of both the
inpatient and outpatient UPLs under
§§ 447.272 and 447.321, respectively. To
summarize briefly, proposed § 447.288
describes the data sources, data
parameters, and methodologies that
must be considered and used in
demonstrating compliance with the
UPL. It describes the appropriate
Medicare data and the creation of ratios
using either cost or payment data
calculations, the Medicaid charge data
to be multiplied by a ratio either of
Medicare costs-to-charges or of
Medicare payments-to-charges to
calculate the UPL amount, any
associated considerations (such as
inflation adjustments, utilization
adjustments, or other cost adjustments),
and the Medicaid payment data. For a
detailed discussion of these proposed
UPL requirements, please refer to the
discussion below related to § 447.288.
We invite comment on all proposed
new provisions and proposed
amendments in this section.
15. Basis and Purpose (§ 447.284)
We are proposing to add subpart D to
part 447 to implement sections
1902(a)(6) and (a)(30)(A) of the Act,
which require, respectively, that a state
plan for medical assistance must
provide that the state agency will make
such reports, in such form and
containing such information, as the
Secretary may from time to time require,
and comply with such provisions as the
Secretary may from time to time find
necessary to assure the correctness and
verification of such reports, and to
assure that payments are consistent with
efficiency, economy, and quality of care.
As discussed in detail above and in
subsequent sections below, this
information would improve the
transparency of Medicaid payments and
provide us with more information to
understand the basis of Medicaid
supplemental payments at the
individual provider level in a manner
consistent with the recommendations of
the oversight bodies as mentioned
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
elsewhere in this preamble. Moreover,
this information would be used in
concert with annual UPL
demonstrations and state expenditure
data to improve our oversight of state
expenditures and FFP. Accordingly, we
are proposing to require states to submit
quarterly and annual reports which
detail the total provider payments,
including base and supplemental
payments, authorized under the state
plan and demonstration authority. We
are also proposing that the states submit
an additional annual report disclosing
the amount of provider contributions
provided to the state to support the nonfederal share of the Medicaid payments
along with the total payments received
by the contributing providers. The
provider contributions include all
provider taxes, IGTs, CPEs, and any
provider-related donations as described
in part 433, subpart B. This new subpart
would provide definitions for terms
critical to the requirements for
supplemental payment programs,
including with respect to UPL
demonstrations (§ 447.286), establish
new data submission requirements for
supplemental payments under the state
plan (§ 447.288), and specify the
consequences that would apply when a
state fails to report required information
(§ 447.290). We believe these proposed
provisions are necessary to ensure the
proper and efficient administration of
state Medicaid plans with respect to
supplemental payment programs, and
generally to better enable us to perform
our oversight function with respect to
the Medicaid program.
We have a long history of establishing
data reporting requirements for states.
For financial data reports such as the
UPL data demonstrations, we have long
relied upon the current language in
§§ 447.272 and 447.321, which we have
discussed in subregulatory guidance in
the form of SMDLs, particularly SMDL
13–003, to provide additional
information regarding required data and
the timeline and manner in which such
data is to be reported. We have also
defined reporting requirements
regarding the Medicaid DSH program
through regulations in § 447.299. Since
codifying the DSH reporting
requirements in regulation, we have
found that data reporting by states has
become far more consistent, and as a
result, we have been able to quickly
identify areas where DSH payments
have been made inappropriately or
when the state has made a payment
outside of the state plan methodology,
and thus we have been able to more
efficiently focus our resources to those
problematic areas. We have also been
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
able to work with states to update state
plan language so that the distribution
methodology for their DSH payments is
comprehensively described in the state
plan, in accordance with federal
requirements. Based in part on this
experience with the usefulness of
comprehensive data reporting about
state payments to providers, we are
proposing uniform reporting
requirements for additional state
Medicaid payments, including
supplemental payments made under the
UPL. Our expectation is that such
reporting would allow CMS to focus our
resources to areas where there appear to
be issues, either in the payment
methodology or the underlying
financing, and provide states with
technical assistance to the extent that
the issues identified may be resolved
through strengthening the state plan
language so that it accurately and
comprehensively describes the state’s
payment rates and methodologies.
In proposed § 447.284(a), we would
specify that proposed new subpart D
would set forth additional requirements
for supplemental payments made under
the state plan, and implement section
1902(a)(6) and (a)(30) of the Act. Section
447.284(b) would provide that the
reporting requirements in subpart D are
applicable to supplemental payments to
which a UPL applies under §§ 447.272
or 447.321.
We are soliciting comments on the
statement of basis and purpose as
proposed in § 447.284.
16. Definitions (§ 447.286)
We are proposing to add § 447.286 to
define the following terms, as they are
used in proposed part 447, subpart D:
Base payment, Non-state government
provider, Private provider, state
government provider, and Supplemental
payment. Clear definitions of these
terms are needed so that states and other
stakeholders can have a clear
understanding of what is required with
respect to the proposed reporting
requirements for supplemental
payments and UPL demonstrations, and
to allow us to clearly track
supplemental payments and ensure a
consistent reporting and UPL
demonstration process.
Specifically, we propose to define the
term ‘‘base payment’’ to mean a
payment, other than a supplemental
payment, made to a provider in
accordance with the payment
methodology authorized in the state
plan or is paid to the provider through
its participation with a Medicaid MCO
entity under the authority in part 438.
Base payments are documented at the
beneficiary level in MSIS or T–MSIS
PO 00000
Frm 00031
Fmt 4701
Sfmt 4702
63751
and include all payments made to a
provider for specific Medicaid services
rendered to individual Medicaid
beneficiaries, including any payment
adjustments, add-ons, or other
additional payments received by the
provider that can be attributed to a
particular service provided to the
beneficiary, such as payment
adjustments made to account for a
higher level of care or complexity of
services provided to the beneficiary. We
believe that, in defining a base payment
to a provider, it is appropriate to start
with the most fundamental component
of the payment that reimburses the
provider for furnishing a specific service
to a particular beneficiary. In some
cases, the base payment may be the only
payment the provider receives. We
considered not including payment
adjustments, which are payments made
to providers based on certain providerspecific criteria, add-on payments, and
other per service payments apart from
the most basic payment, but we
determined that it would be more
appropriate to include all payments
made to a provider for specific Medicaid
services rendered to individual
Medicaid beneficiaries in the proposed
definition. When states pay providers
based on patient acuity, complexity of
services, characteristics of the provider,
or add-on payments, including but not
limited to add-on payments for quality
of services, such payments can be
directly tied to the provision of a service
to an individual Medicaid beneficiary
and are available to all providers within
the Medicaid benefit category. The base
payment, including add-on amounts,
includes all payment amounts intended
to fully reimburse the provider for
furnishing a specific service to a
particular beneficiary, whereas
supplemental payments are made as a
lump sum intended to reimburse for
Medicaid services generally, rather than
particular services furnished to an
individual beneficiary. We are soliciting
comment on this proposed definition
and on the alternative we considered of
not including payment adjustments
such as incentive payments and other
add-on payments that are paid on a per
claim basis.
We propose to define non-state
government provider to mean a health
care provider, as defined in § 433.52,
including those defined in § 447.251,
that is a unit of local government in a
state, including a city, county, special
purpose district, or other governmental
unit in the state that is not the state,
which has access to and exercises
administrative control over stateappropriated funds from the legislature
E:\FR\FM\18NOP2.SGM
18NOP2
63752
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
or local tax revenue, including the
ability to dispense such funds. We
propose to consider the entity’s access
to and administrative control over stateappropriated funds from the legislature
or local tax revenue in this definition to
link the provider category to the ability
of the provider to supply the nonfederal share funds in a manner
consistent with section 1903(w)(6)(A) of
the Act. We anticipate that questions
may arise about whether a provider is a
governmental or a private entity, for
purposes of this definition. To resolve
such questions, we propose that we
would consider the totality of the
circumstances, including, but not
limited to, the identity and character of
any entity or entities other than the
provider that share responsibilities of
ownership or operation of the provider,
and including the nature of any
relationship among such entities and
the relationship between such entity or
entities and the provider. In
determining whether an entity shares
responsibilities of ownership or
operation of the provider, our
consideration would include, but would
not be limited to, whether the entity: (1)
Has immediate authority to make
decisions regarding the operation of the
provider; (2) bears the legal
responsibility for risk from losses from
operations of the provider; (3) has
immediate authority over the
disposition of revenue from operations
of the provider; (4) has immediate
authority with regard to hiring,
retention, payment, and dismissal of
personnel performing functions related
to the operation of the provider; (5)
bears legal responsibility for payment of
taxes on provider revenues and real
property, if any are assessed; or (6) bears
the responsibility of paying any medical
malpractice premiums or other
premiums to insure the real property or
other operations, activities, or assets of
the provider.
In determining whether a relevant
entity (that is, the provider and any
entity or entities other than the provider
that share responsibilities of ownership
or operation of the provider) is a unit of
a non-state government, we would
consider the character of the entity
which would include, but would not be
limited to, whether the entity: (1) Is
described in its communications to
other entities as a unit of non-state
government, or otherwise; (2) is
characterized as a unit of non-state
government by the state solely for the
purposes of Medicaid financing and
payments, and not for other purposes
(for example, taxation); and (3) has
access to and exercises administrative
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
control over state funds appropriated to
it by the legislature and/or local tax
revenue, including the ability to expend
such appropriated or tax revenue funds,
based on its characterization as a
governmental entity.
In recent years, states have proposed
a number of SPAs which sought to redesignate the UPL ownership category
of a provider and to allow that provider
to make an IGT, up to the applicable
UPL, to fund the non-federal portion of
a new Medicaid supplemental payment.
Oftentimes, a hallmark of these
proposals has been the sale of some
asset of the provider (such as the
provider’s license or the facility’s
certification) for some nominal fee, with
the private entity (the ‘‘seller’’)
otherwise retaining critical
responsibilities of ownership, and with
the IGT, in practical reality, coming
from the private entity’s funds. This
approach is inconsistent with the statute
and regulations, particularly sections
1902(a)(30)(A) and 1903(w)(6)(A) of the
Act and implementing regulations at
§§ 433.51, 447.272 and 447.321.
Based on our experience with such
SPAs, it appears that some states have
sought to manipulate the
characterization of providers’ ownership
to achieve problematic Medicaid
financing arrangements. In
arrangements we have observed, the
operator essentially functioned as the
owner and the operator of the facility.
Accordingly, we believe a more effective
approach to appropriately categorizing
providers for purposes of the UPL
would be to consider the totality of the
circumstances relevant to the character
of the provider, rather than attempting
to parse more narrowly whether features
of particular entities purported to be the
provider’s owner and/or operator mean
that the provider is properly categorized
as a unit of non-state government,
which our experience has borne out
may be more susceptible to
manipulation. We understand that the
business models of health care
providers and their facilities are layered
and complex. However, as discussed
above, we are troubled by instances we
have observed in which some states
have attempted to re-characterize
facilities as non-state government
owned or operated, where such
characterization was not supported by
the actual structure and operation of the
facility, in an ultimate effort to generate
more federal Medicaid revenue without
corresponding financial participation
from the state. We believe such
arrangements violate applicable statutes
and regulations, are inconsistent with
the fiscal integrity of the Medicaid
program, and are generally abusive of
PO 00000
Frm 00032
Fmt 4701
Sfmt 4702
the federal-state partnership that
Congress has prescribed for the
Medicaid program.
We propose to define private provider
to mean a health care provider as
defined in § 433.52, including those
defined in § 447.251, that is not a state
government provider or a non-state
government provider. This is intended
to be a catch-all for remaining health
care providers in the state, that are not
state government providers or non-state
government providers, for purposes of
this section. We are soliciting comments
on this proposed definition of private
provider.
We propose to define state
government provider to mean a health
care provider, as defined in § 433.52,
including those defined in § 447.251,
that is a unit of state government or a
state university teaching hospital.
Similar to the proposed definition of
non-state government provider, we
propose that, in determining whether a
provider is a state government provider,
we would consider the totality of the
circumstances, including, but not
limited to, the identity and character of
any entity or entities other than the
provider that share responsibilities of
ownership or operation of the provider,
and including the nature of any
relationship among such entities and
the relationship between such entity or
entities and the provider. The factors
that we propose to consider, without
limitation, include those discussed
above regarding the proposed definition
of non-state government provider. And
similar to that proposed definition, in
determining whether a relevant entity is
a state government or state university
teaching hospital, we propose that our
consideration would include, without
limitation, the factors discussed above
in connection with the proposed
definition of non-state government
provider.
Regarding the proposed definitions of
non-state government provider, private
provider, and state government
provider, we understand that health
care facilities often enter into business
relationships with other entities to
perform various functions, including,
but not limited to, the care of
beneficiaries. We recognize, and do not
wish to interfere with, legitimate
business relationships between
providers and other entities, or among
such other entities in relation to the
provider. In fact, we believe that the
current definitions of non-state
government-owned or operated, state
government-owned or operated, and
privately-owned and operated may have
inadvertently distorted such
relationships by encouraging new or
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
different business relationships between
providers and other entities, or among
such other entities in relation to a
provider, with no useful purpose other
than to manipulate Medicaid financing
in problematic ways. As such, we are
proposing to identify a provider as a
non-state government provider or state
government provider in consideration of
the totality of the circumstances,
including, but not limited to, the
identity and character of any entity or
entities other than the provider that
share responsibilities of ownership or
operation of the provider, and including
the nature of any relationship among
such entities and the relationship
between such entity or entities and the
provider. These proposed definitions
are intended to work together with the
UPL rules and the provisions governing
non-federal share financing and
provider-related donations to safeguard
the fiscal integrity of the Medicaid
program.
We propose to define ‘‘supplemental
payment’’ to mean a Medicaid payment
to a provider that is in addition to the
base payments to the provider, other
than DSH payments under part 447,
subpart E, made under state plan
authority or demonstration authority.
Supplemental payments cannot be
attributed to a particular provider claim
for specific services provided to an
individual recipient and are often made
to the provider in a lump sum on a
monthly, quarterly, or annual basis
apart from payments for a provider
claim, and therefore, cannot be directly
linked to a provider claim for specific
services provided to an individual
Medicaid beneficiary. In short,
supplemental payments are any
payments to a provider other than Base
payments or DSH payments under part
447, subpart E. Supplemental payments
are lump sum payments made to the
provider at various intervals depending
on the state program, including
supplemental payments made through
section 1115 demonstrations such as
uncompensated care pools and delivery
system reform incentive payments
(DSRIP). We are not making
determinations about those particular
intervals at which payments are
distributed to providers other than to
require that states specify such
information as proposed in § 447.252(d)
of this proposed rule. We have
historically considered DSH payments
under part 447, subpart E as being
distinct payments authorized separately
in the statute in section 1923 of the Act
which are separate from Medicaid
supplemental payments. The DSH
payments serve the specific purpose of
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
taking into account the situation of
hospitals that serve a disproportionate
number of low-income patients with
special needs, including Medicaid
beneficiaries and the uninsured. Serving
these patients may cause hospitals to
incur higher costs, including significant
uncompensated care costs for serving
low income populations. Supplemental
payments and DSH payments are paid
under separate authorities in the Act.
Supplemental payments are authorized
in section 1902(a)(30)(A) of the Act,
which requires that the state plan
provide methods and procedures to
assure that payments are consistent with
efficiency, economy, and quality of care
and DSH payments are authorized in
section 1923 of the Act. Therefore,
supplemental payments and DSH
payments are not required to be tied to
the same statutory purpose.
We are requesting comment on the
revisions to § 447.272, including each of
the revised provider category definitions
included in this section.
17. Reporting Requirements for UPL
Demonstrations and Supplemental
Payments (§ 447.288)
We are proposing to add § 447.288 to
define documentation requirements for
UPL demonstrations and for states that
make supplemental payments. As noted
several times elsewhere in this
preamble, the GAO has frequently cited
the lack of adequate Medicaid provider
payment data as a deficiency that
compromises CMS oversight and
recommended we take concrete steps to
ensure the timely submission of
accurate state payment data. In 2015,
one GAO report concluded that
‘‘[w]ithout good data on payments to
individual providers, a policy and
criteria for assessing whether the
payments are economical and efficient,
and a process for reviewing such
payments, the federal government could
be paying states hundreds of millions,
or billions, more than what is
appropriate’’ (U.S. Gov’t Accountability
Office, GAO–15–322, Medicaid: CMS
Oversight of Provider Payments Is
Hampered by Limited Data and Unclear
Policy, 46 (2015)). Accordingly, this
proposals represents an effort to address
the concerns raised by GAO and to
create a more robust audit trail for state
payments to providers to allow for
better CMS oversight. We believe that
this proposed provision is necessary to
ensure the proper and efficient
operation of the Medicaid state plan, in
a manner that complies with the
requirements of sections 1902(a)(4),
(a)(6) and (a)(30)(A) of the Act. In new
§ 447.288(a), we propose that, beginning
October 1, of the first year following the
PO 00000
Frm 00033
Fmt 4701
Sfmt 4702
63753
year in which the final rule may take
effect, and annually thereafter, by
October 1 of each year, in accordance
with the requirements of § 447.288 and
in the manner and format specified by
the Secretary, each state would be
required to submit a demonstration of
compliance with the applicable UPL for
each of the following services for which
the state makes payment: Inpatient
hospital, as specified in § 447.272;
outpatient hospital, as specified in
§ 447.321; nursing facility, as specified
in § 447.272; ICF/IID, as specified in
§ 447.272; and institution for mental
diseases (IMD), as specified in
§ 447.272. The submission of UPLs for
these facilities and services is consistent
with existing CMS regulations in
§§ 447.272 and 447.321, as well as CMS
guidance document SMDL #13–003.
Under these regulations and policy
guidance, states are already providing
UPL demonstrations for the above
referenced services to demonstrate that
payments are consistent with economy,
efficiency, and quality of care as
required in section 1902(a)(30)(A) of the
Act. These demonstrations are
submitted annually, or any time a state
submits a SPA that proposes to amend
the payment rate or methodology for
one of the aforementioned facilities or
service categories. Of note, as discussed
in greater detail below, we are
proposing to remove the psychiatric
residential treatment facilities (PRTF)
and clinic UPLs, which would not be
included in the annual reporting
requirements.
We are proposing to add § 447.288(b)
to define UPL demonstration standards.
When demonstrating the UPL, states
would be required to use the data
sources and adhere to the data
standards, and acceptable UPL
methodologies specified in this section.
We believe that these proposed
requirements would assist CMS and
states in determining the Medicaid
inpatient and outpatient facility
payment rates are consistent with
economy, efficiency and quality of care
under section 1902(a)(30)(A) of the Act.
Over time, we have received
numerous requests for feedback on the
use of specific data elements and on
acceptable UPL methodologies. We are
hopeful these proposed provisions,
which, except as noted below, would
codify current policy, would enhance
states’ understanding of acceptable UPL
demonstration standards, as well as
improve the quality of UPL
submissions.
We are proposing no longer to require
states to submit UPL demonstrations for
PRTFs and clinics. PRTFs are facilities
subject to the payment limits defined in
E:\FR\FM\18NOP2.SGM
18NOP2
63754
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
§ 447.325, which states that the state
Medicaid agency may pay the
customary charges of the provider but
must not pay more than the prevailing
charges in the locality for comparable
services under comparable
circumstances. The reason for this
proposed change is two-fold. First, the
payment limit in § 447.325 limits the
state’s payment to a provider to the
provider’s customary charges or, if less,
the prevailing charges in the locality for
comparable services under comparable
circumstances. Providers determine
what they will charge for items and
services furnished. To pay a provider’s
charge under the state plan, a state plan
could simply provide that its payments
will not exceed the provider’s
customary charge, provided the state
plan also describes a comprehensive
methodology for ensuring that payments
do not exceed the prevailing charges in
the locality for comparable services
under comparable circumstances.
Second, in our experience, states do not
make supplemental payments to these
facilities, and such provider’s base
payments are generally equal to the
provider’s charge. As such, the UPL is
less of a calculation, as with other
inpatient-type services, and more of a
confirmation the state pays no more
than the provider’s charge under the
state plan, which can be accomplished
through a review of the state plan. We
will continue to review compliance
with the § 447.325 through a review of
the SPA submissions as has been our
historical practice. The removal of the
clinic UPL is discussed in more detail
below under § 447.321 of this preamble.
In proposed § 447.288(b), we propose
to specify detailed UPL demonstration
standards for demonstrating that
Medicaid FFS payments are made in
aggregate amounts that are less than or
equal to the aggregate cost or Medicare
payment amounts. The purpose of the
proposed provisions is to ensure
uniform reporting of UPL data and a full
picture of Medicaid payments within
each provider category for each category
of services subject to a UPL in a given
year. The proposed provisions are
intended to specify that states may not
pick-and-choose the most beneficial
data for each provider within a provider
category, but instead to select a UPL
methodology and apply a single
methodology to all providers within a
UPL provider category and service type.
In proposed paragraph (b)(1), we
propose defining the data sources for
the UPL calculations, which is the
Medicare-equivalent cost and charge
data and Medicare-equivalent payment
and charge data for purposes of the UPL
as our primary data sources for the UPL.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
As noted elsewhere in this proposed
rule, the term ‘‘Medicare equivalent’’
means the Medicare equivalent to the
Medicaid data, payment, or services.
Therefore, the term Medicare equivalent
payment means the amount that would
be paid for Medicaid services furnished
by the group of providers if those
services were provided to Medicare
beneficiaries and paid under Medicare
payment principles. Likewise, a
reference to Medicare equivalent
charges in reference to a UPL
calculation means the Medicare charges
for the same Medicaid services subject
to the UPL.
In proposed paragraph (b)(1)(i), we
would require that cost and charge data
for all providers must be from either
Medicare cost reports, or statedeveloped cost reports using either
Medicare cost reporting principles
specified in part 413 or the cost
allocation requirements specified in 45
CFR part 75, which implements
requirements in 2 CFR part 200, as
specified in 2 CFR 200.106. Cost and
charge data must: Include only data
with dates of service that are no more
than 2 years prior to the dates of service
covered by the UPL demonstration; and
represent costs and charges specifically
related to the service subject to the UPL
demonstration. As such, each UPL must
use costs and charges related to the
relevant category of Medicaid services
listed in paragraph (a) of § 447.288; and
include either Medicare costs and
Medicare charges, or total provider costs
and total charges, in order to develop a
cost-to-charge ratio as described in
paragraph (b)(3)(i). The selection must
be consistently applied for all providers
within the provider category subject to
the UPL so that all costs and charges for
all providers within a provider category
are uniform in the UPL demonstration
to ensure uniformity in reporting as
discussed above. These requirements
are consistent with historical practices
related to the collection of information
for UPLs and were part of the CMS UPL
templates submitted to OMB for
approval under control number 0938–
1148 (CMS–10398 #13 and #24).
At paragraph (b)(1)(ii), we propose to
define Medicare payment
demonstrations as using Medicare
payment and charge data for all
providers from either Medicare cost
reports, Medicare payment systems for
the specific provider type specified in
title 42, chapter IV, subchapter B of the
CFR, as applicable, or imputed per diem
rates based on Medicare provider
payments. ‘‘Imputed’’ per diem rates, as
discussed in more detail in paragraph
(b)(3)(ii)(C), are payments that are
calculated by dividing total Medicare
PO 00000
Frm 00034
Fmt 4701
Sfmt 4702
payments by Medicare days from the
provider census data to calculate an
estimated Medicare price per day. The
state then is able to multiply this
Medicare price per day for each
provider by the provider’s Medicaid
days (also from the provider census),
and then sum these products within a
service class and provider category to
calculate a Medicaid UPL.
The proposed provision goes on to
specify that when using Medicare
payment and charge data, the data must:
Include only data with dates of service
that are no more than 2 years prior to
the dates of service covered by the UPL
demonstration; include only Medicare
payments and charges, or Medicare
payment and the provider’s Medicare
census data, specifically related to the
service subject to the UPL
demonstration; and use either gross
Medicare payments and Medicare
charges, which includes deductibles
and co-insurance but excludes
reimbursable bad debt from the
Medicare payment, or net Medicare
payments and Medicare charges, which
excludes deductibles and coinsurance
and includes reimbursable bad debt, as
reported on a Medicare cost report. The
selection of gross or net Medicare
payment must be consistent within the
ratio for each provider category subject
to the UPL. These requirements are
consistent with historical practices
related to the collection of information
for UPLs and were part of the CMS UPL
templates submitted to OMB for
approval under control number 0938–
1148 (CMS–10398 #13 and #24).
For the Medicare payment systems for
the specific provider type, we are
referring to the prospective payment
systems (PPS) in effect for the Medicare
program such as the inpatient
prospective payment system (IPPS),
outpatient prospective payment system
(OPPS), skilled nursing facility (SNF)
PPS, and any future applicable
Medicare PPSs such as the patient
driven payment model (PDPM) for
SNFs. The requirement that the
payment data use data with dates of
service that are no more than 2 years
prior to the dates of service covered by
the UPL demonstration would allow
states to use Medicare payment data
from a prior period to demonstrate the
UPL, particularly in years where
Medicare is transitioning to a new
payment system. Because states have
the flexibility to use data that is no more
than 2 years old, states using Medicare
payment-based demonstrations would
not be required to immediately switch
over to using data from a newly
implemented Medicare payment system,
such as PDPM, to demonstrate
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
compliance with the UPL if the state is
not in a position to do so, but would be
able to transition to using that system
over a 2-year period. There is no
requirement in statute or regulations
that mandates states use specific
Medicare payment systems in Medicaid
for provider payments. Since the UPL is
an estimate of the amount that Medicare
would have paid for the service, we
have always offered states some
flexibility to determine UPLs using
recent data that is no more than 2 years
old, which, in years where Medicare has
transitioned to a new payment system,
means that states could use data from
the prior payment system for up to 2
years after the Medicare transition for
purposes of the Medicaid UPL
compliance demonstration.
In paragraph (b)(1)(iii), we propose to
require that the Medicaid charge data
used in calculating the UPL must be
derived from the state’s Medicaid billing
system for services provided during the
same dates of service as the Medicare
cost or Medicare payment data, as
defined above. The Medicare cost and
charge or payment and charge data, as
applicable, is used to create a ratio with
the Medicare cost or payment being the
numerator and the Medicare charges are
the denominator. Once that ratio is
created, the Medicaid charges are
multiplied by that ratio. This is
discussed in more detail below, but the
requirement that the time period of the
Medicaid charge data be from the same
time period of the Medicare-equivalent
data, as defined above, is due to the fact
that providers determine what they will
charge for items and services furnished
to patients, which may change from
time to time. If the charges are the same
for all payers, then a reasonable estimate
of the amount that Medicare would pay
for the service would require the use of
the Medicaid charge data from the same
time period as the Medicare data to
calculate the UPL. As discussed in
connection with paragraph (b)(3)(i), we
propose that a cost-based methodology
could only be used for services where a
provider applies uniform charges to all
payers.
At paragraph (b)(1)(iv), we propose to
require Medicaid payment data from a
state’s Medicaid billing system for
services provided during the same dates
of service as the Medicare cost or
Medicare payment data, as specified in
paragraph (b)(1)(i) or (ii) of this section,
as applicable, or from the most recent
state plan rate year for which a full 12
months of data are available. As with
the data requirements in paragraphs
(b)(1)(i) and (ii), Medicaid payment data
must: Include only data with dates of
service that are no more than 2 years
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
prior to the dates of service covered by
the UPL; include all actual payments, as
well as all projected base and
supplemental payments, excluding any
payments made for services for which
Medicaid is not the primary payer,
expected to be made during the time
period covered by the UPL
demonstration to the providers within
the provider category, as applicable; and
only be trended by an amount equal to
the changes in the Medicaid state plan
payment for the applicable service.
Using either the most recent Medicaid
payment data for the time period subject
to the UPL or the payment data from the
same time period as the Medicaid
charge data (meaning also from the same
time period as the Medicare data) is up
to the state. Under all circumstances,
the Medicaid payment data must
include all payments made to the
providers, including any proposed
payments or projected payments that
have not yet been made. This way, the
UPL will reflect an accurate depiction of
the state’s Medicaid payments during
the period of the UPL demonstration.
In paragraph (b)(2), we propose to
require states to apply certain UPL
methodology parameters in calculating
the UPL. Specifically, the proposed UPL
methodology parameters include the
following considerations. First,
projected changes in utilization must be
accounted for and reflected in the
demonstration. If no service-specific
utilization projections are available,
then projections for enrollment must
reflect programmatic changes such as
reasonable utilization changes due to
managed care enrollment projections.
For example, a state may be aware that
in the upcoming state-fiscal year, there
will be a shift to increase beneficiary
enrollment in managed care plans.
Projected utilization changes to account
for such large programmatic shifts may
be used instead of individually
determined, service-specific utilization
changes, such as inpatient hospital
utilization, which may result in a
percentage increase or decrease in
expected utilization for the relevant
services undergoing a shift to managed
care. Medicare data may also be
projected using Medicare trend factors
appropriate to the service and
demonstration methodology, which are
Medicare payment- or cost-based, with
such trend factors being uniformly
applied to all providers within a
provider category. In this way, states
can anticipate and project program
changes or changes in expected costs or
payments in the UPL that may either
increase or decrease the UPL or
expected Medicaid payments. For
PO 00000
Frm 00035
Fmt 4701
Sfmt 4702
63755
example, an appropriate trend factor
with respect to inpatient hospital
services, outpatient hospital services,
and SNFservices could be the CMS
Market Basket rate. This proposed
change, which represents a departure
from current policy, is proposed in
paragraph (b)(2)(ii), which would
require uniform application of the
trending factor within the provider
category. Prior to this proposed rule, we
had not formally articulated an
expectation of uniform trending of data
within a provider category and had
accepted UPL demonstrations that did
not apply trend factors in a uniform
manner. CMS could not determine
whether the applied inflation
adjustments in those UPLs were always
appropriate based on our review. This
proposed provision is intended to
establish the requirements in regulation
for uniform inflation adjustments to the
UPLs.
Additionally, we propose that when
calculating the aggregate UPL using a
cost-based demonstration as described
in paragraph (b)(3)(i), the state may
include the cost of provider assessments
(such as health care-related taxes) paid
by each provider in the provider
category that is reasonably allocated to
Medicaid as an adjustment to the UPL,
to the extent that such costs were not
already included in the cost-based UPL.
For example, many states calculate their
provider taxes on inpatient services as
a per day payment amount or a per
discharge payment amount. The state
would calculate the portion of such a
tax allocable to Medicaid by multiplying
the per day or per discharge tax amount
by Medicaid days or Medicaid
discharges, as applicable, and include
the product of that amount in the UPL
for each provider in the provider
category. When calculating the aggregate
UPL using a cost-based demonstration,
states may include the Medicaidallocated cost of health care related
taxes as an adjustment to the UPL
amount on a per provider basis. The
Medicare cost report does not require
states to account for expenses related to
health care related taxes as an allowable
cost, as this reporting is optional. In the
Medicaid program, such expenditures
may be included as an allowable cost
provided that the portion of the cost
allocated to Medicaid can be isolated
from the aggregate health care related
tax payment.
For example, if a provider has 100
total bed days of which 85 were
Medicaid bed days and the provider
paid $100 in health care related taxes,
the provider could account for $85 of
the total tax payment. Our current
policy permits states to include the cost
E:\FR\FM\18NOP2.SGM
18NOP2
63756
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
of Medicaid’s portion of health care
related taxes as an allowed cost for cost
based demonstrations, but not payment
based demonstrations; we are proposing
to codify that existing policy in
regulation because, historically, the
Medicaid taxes have not been
specifically included in the Medicare
cost report calculations. The Medicare
2552 (Hospital Cost Report) now
includes an option to include provider
taxes paid under the authority in section
1903(w) of the Act. To the extent that
such taxes are not included in the cost
calculation in the Medicare cost report,
those costs should be included in the
UPL. If the provider taxes are included
in the Medicare cost report, the state
should not add these costs back into the
UPL calculation, which would result in
double-counting the tax payments. Our
goal in allowing Medicaid provider tax
costs to be added back into the costbased UPL calculations is to ensure that
allowable costs incurred by the
providers when furnishing services to
Medicaid beneficiaries are applied to
the UPL calculations to the extent that
they were not already captured in the
Medicare cost report data, but we do not
want such costs to be duplicated
through the UPL and the Medicare cost
report. This provision only applies to
cost-based UPL demonstrations because
cost-based demonstration are reflections
of the provider’s expenses related to the
provision of medical services and such
amounts may vary based upon factors
including health care related-taxes in
the state or other relevant jurisdiction,
while payment-based UPL
demonstrations reflect only the
Medicare payment for services under
the specific Medicare payment system,
and therefore, only adjustments which
affect the overall payment under the
Medicare payment system can be
factored into the UPL demonstration.
Finally, we propose codifying the
current policy that the Medicaid
payments, in paragraph (b)(1)(iv),
included in the UPL calculation must
only include payments made for
Medicaid services under the specific
Medicaid service type at issue in the
UPL. For example, the state must not
include payments for services other
than inpatient hospital services in the
inpatient hospital UPL calculation.
In paragraph (b)(3), we propose
acceptable methods of demonstrating
the UPL. First, we propose that to make
a cost-based demonstration in
compliance with an applicable UPL,
Medicaid covered charges are
multiplied by a cost-to-charge ratio
developed for the period covered by the
UPL demonstration. The state may use
a ratio of Medicare costs to Medicare
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
charges, or total provider costs to total
provider charges in developing the costto-charge ratio, but the selection must be
applied consistently to each provider
within a provider type, which
references the listing of provider types
in paragraph (a) of the section. The
product of Medicaid covered charges
and the cost-to-charge ratio for each
provider is summed to determine the
aggregate UPL. The demonstration must
show that Medicaid payments will not
exceed this aggregate UPL for the
demonstration period. As explained in
more detail below, this methodology
may only be used for services where a
provider applies uniform charges to all
payers. Reported cost must be
appropriately allocated between payers
so that only costs properly allocated to
Medicaid services are included in the
demonstration.
In paragraph (b)(3)(i)(A), we propose
that states may make a retrospective,
cost-based demonstration showing that
aggregate Medicaid payments paid to
the providers within the provider
category during the prior state plan rate
year did not exceed the costs incurred
by the providers furnishing Medicaid
services within the prior state plan rate
year period. The term ‘‘retrospective’’
simply refers to Medicaid payments that
have already been paid for the prior
state plan rate year that has already
ended, and for which the state does not
anticate making any new Medicaid
payments. Most often these
demonstrations come from states where
providers are paid using a reconciled
cost methodology under the approved
Medicaid state plan, in which case the
Medicaid provider payments would be
equal to those providers’ cost of
Medicaid services, and the UPL would
demonstrate that payments to providers
did not exceed their costs.
In paragraph (b)(3)(i)(B), we propose
that states may make a prospective, costbased demonstration showing that
prospective Medicaid payments would
not exceed the estimated, prospective
cost of furnishing the services for the
upcoming state plan rate year period. As
explained in more detail below, this
methodology may only be used for
services where a provider applies
uniform charges to all payers. The
prospective cost demonstration is a
common UPL methodology reviewed by
CMS and is often used by states to
demonstrate that proposed or projected
Medicaid payments are less than a
provider cost trended forward from a
prior period.
In addition to these cost-based
demonstrations, we also propose that
states could use payment-based
demonstrations to show compliance
PO 00000
Frm 00036
Fmt 4701
Sfmt 4702
with an applicable UPL, including
retrospective and prospective
methodologies and including flexibility
for the state to determine an imputed
Medicare payment rate to apply in
either a retrospective or prospective
payment-based demonstration. We
propose that the payment-based
demonstration data sources would be
those identified in paragraphs (b)(1)(ii),
(iii), and (iv), and the data standards
defined in paragraph (b)(2) would
apply. States could make a retrospective
payment-to-charge UPL demonstration,
where Medicaid covered charges are
multiplied by a ratio of Medicare
payments to Medicare charges
developed for the period covered by the
UPL demonstration. The product of
Medicaid covered charges and the
Medicare payment-to-charge ratio for
each provider would be summed to
determine the aggregate UPL, and the
demonstration must show that Medicaid
payments did not exceed this aggregate
UPL. Alternatively, we propose that
states could make a prospective
payment-to-charge UPL demonstration,
where Medicaid covered charges are
multiplied by a ratio of Medicare
payments to Medicare charges
developed for the period covered by the
UPL demonstration. The product of
Medicaid covered charges and the
Medicare payment-to-charge ratio for
each provider would be summed to
determine the aggregate UPL. The
demonstration must show that proposed
Medicaid payments would not exceed
this aggregate UPL within the next state
plan rate year immediately following
the demonstration period. Regardless of
whether a state is using a retrospective
or prospecftive payment-to-charge
demonstration methodology, we
propose that states could use an
imputed Medicare per diem payment
rate determined by dividing total
Medicare prospective payments paid to
the provider by the provider’s total
Medicare patient days, which are
derived from the provider’s Medicare
census data. Each provider’s imputed
Medicare per diem payment rate would
be multiplied by the total number of
Medicaid patient days for the provider
for the period. The products of this
operation for each provider are summed
to determine the aggregate UPL. The
demonstration must show that Medicaid
payments are not in excess of the
aggregate UPL, calculated on either a
retrospective or prospective basis,
consistent with the applicable proposed
methodology. This imputed Medicare
payment rate methodology is commonly
used by long-term care facilities in
Medicaid, such as SNFs and IMDs, or in
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
states whose Medicaid payments are
based upon existing Medicare payment
systems. For example, a state which
uses the Medicare SNF PPS to
demonstrate a SNF UPL would divide
total Medicare payments by total
Medicare SNF bed days. That product,
per facility, would be multiplied by the
Medicaid bed days, the aggregate of
which would be the aggregate UPL. The
Medicaid payments for the same time
period must not exceed the aggregate
UPL.
It is important to note that any UPL
methodology that requires the use of a
provider’s charges to calculate the UPL
may only be used to the extent that the
provider applies uniform charges to all
payers. This is because when
developing a cost to charge ratio or a
payment to charge ratio, the initial ratio
is multiplied by Medicaid charges to
determine the UPL amount. ‘‘Charges’’
are the amount a hospital or provider
bills for medical services, and should be
the same for all patients regardless of
payer. If the charges used in the cost to
charge or Medicare payment to charge
ratio are not the same as the Medicaid
charges, the calculation of the UPL
would be either over- or under-stated.
We intend the UPL demonstrations to
accurately depict the Medicare cost, or
what Medicare would have paid, for the
same services, and that is diminished
when the underlying data is not
accurate.
In new § 447.288(c)(1), we propose
that, at the time the state submits its
quarterly CMS–64 under § 430.30(c), the
state would be required to report certain
information for each supplemental
payment included on the CMS–64. The
proposed reporting elements would not
be reported on the CMS–64 itself, but
would accompany that submission on a
separate, supplemental report. We
propose to require states to report
information sufficient to identify which
providers receive which supplemental
payments under the state plan and any
demonstration authority, and to enable
us to ensure that such payments to the
providers are consistent with economy,
efficiency, and quality of care, as
required under section 1902(a)(30)(A) of
the Act. These data submission
requirements would include providerlevel data on base and supplemental
payments made under state plan and
demonstration authority by service type.
This data would also be required to
include the following: The SPA
transaction number or demonstration
authority number which authorizes the
supplemental payment; a listing of each
provider that received a supplemental
payment under state plan and/or
demonstration authority, and, for each:
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
The provider’s legal name; the primary
physical address of the location or
facility where services are provided,
including street address, city, state, and
ZIP code; the National Provider
Identifier (NPI); the Medicaid
identification number; the employer
identification number (EIN); the service
type for which the reported payment
was made; the provider specialty type
(if applicable, for example, critical
access hospital (CAH), pediatric
hospital, or teaching hospital); the
provider category (that is, state
government provider, non-state
government provider, or private
provider); and the specific amount of
the supplemental payment paid to each
provider, including the total
supplemental payment made to the
provider authorized under the specified
state plan and the total Medicaid
supplemental payment made to the
provider under the specified
demonstration authority, as applicable.
The specific data elements described
above are intended to identify the
individual providers receiving
payments, the authority for the
payments, and the sum of all payments
received by the individual providers.
Information such as the provider’s legal
name, primary physical location or
facility location where services were
provided, NPI, Medicaid identification
number, and EIN are needed to identify
the specific provider accurately. When
the regulation refers to the ‘‘legal’’
name, it means the business name of the
facility which appears on the provider’s
license and other legal documentation
authorizing the health care operations of
the provider. The NPI is required for
providers, and EINs are assigned to all
businesses by the Internal Revenue
Service, and must be on all Health
Insurance Portability and
Accountability Act (HIPAA) electronic
transactions. An NPI is a unique 10-digit
number used to identify health care
providers. The Medicaid identification
number is assigned by the state and is
a unique identifier for providers
participating in the Medicaid program.
In addition to the provider-identifying
information, proposed § 447.288(c)(1)
would require the state to report the
service type, provider specialty type,
and provider category. These data
elements are intended to be linked to
the payment methodology in the state
plan. This information follows how
states must describe supplemental
payments in the state plan, which is,
first, organized by service type, then by
provider-specific information, such as
specialty type and provider category. If
a state establishes a specific
methodology or proposes to make a
PO 00000
Frm 00037
Fmt 4701
Sfmt 4702
63757
supplemental payment to a specific
‘‘type’’ of hospital using specified
criteria, such as a non-state government
teaching hospital or CAH, such
information must appear in the state
plan. As the proposed data elements are
aligned with how analogous information
is recorded in the state plan, we
anticipate that this information will
help us ensure that supplemental
payments are being made to providers
in accordance with the qualifying
criteria as established in the state plan.
Finally, we propose to require the state
to report the specific amount of the
supplemental payment made to the
provider, including the total
supplemental payment amount
authorized under the specified state
plan, as applicable, and the total
supplemental payment amount
authorized under the demonstration
authority, as applicable.
In § 447.288(c)(2), we propose that not
later than 60 days after the end of the
state fiscal year, each state must
annually report aggregate expenditure
data for all data elements included in
§ 447.288(c)(1) plus the following: The
state reporting period (state fiscal year
start and end dates); the specific amount
of Medicaid payments made to each
provider, including, as applicable: The
total FFS base payments made to the
provider authorized under the state
plan, the total Medicaid payments made
to the provider under demonstration
authority, the total amount received
from Medicaid beneficiary cost-sharing
requirements, donations, and any other
funds received from third parties to
support the provision of Medicaid
services, the total supplemental
payment made to the provider
authorized under the specified state
plan, the total Medicaid supplemental
payment made to the provider under the
specified demonstration authority, and
an aggregate total of Medicaid payments
listed above made to the provider.
Section 447.288(c)(2)(iii) would also
require the aggregate reporting of the
total DSH payments made to the
provider, and the Medicaid units of care
furnished by the provider (for example,
on a provider-specific basis, total
Medicaid discharges, days of care, or
any other unit of measurement as
specified by the Secretary). This
proposed data collection effort is
designed to allow us to conduct efficient
oversight of all payments made to
providers on an annual aggregate basis.
The data, as reported, would be used to
conduct quarterly and annual reviews of
state payments as related to payments
reported under UPL demonstrations and
under the Medicaid state plan.
E:\FR\FM\18NOP2.SGM
18NOP2
63758
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
In § 447.288(c)(3), we propose that,
not later than 60 days after the end of
the state fiscal year, each state must
annually report aggregate and providerlevel information on each provider
contributing to the state or any unit of
local government any funds that are
used as a source of non-federal share for
any Medicaid supplemental payment.
This proposed data submission
requirement would include all of the
data elements listed in § 447.288(c)(1)
and (2), but would also require
information related to financial
contributions to the state Medicaid
program, specifically including: The
total of each health care-related tax
collected from the provider by any state
authority or unit of local government;
the total of any costs certified as a CPE
by the provider; the total amount
contributed by the provider to the state
or a unit of local government in the form
of an IGT; the total of provider-related
donations made by the provider or
entity related to a health care provider,
as defined in § 433.52, including in-cash
and in-kind donations, to the state or a
unit of local government, including state
university teaching hospitals; and the
total funds contributed by the provider
(that is, health care-related taxes, CPEs,
IGTs, provider-related donations, and
any other funds contributed to the state
as the non-federal share of a Medicaid
payment). When a provider-related
entity is related to more than one entity,
the state should report the total amount
of the related entity’s donation for each
associated provider. These proposed
data elements are intended to be
itemized based on all the various
payments to a provider and
contributions from the provider, as
applicable. For example, if a provider
receives base and multiple
supplemental payments under various
SPA authorities and makes a provider
tax contribution and an IGT as a means
of funding the non-federal share, the
state must list each payment and each
provider contribution among the
proposed required data reporting
elements. If there is more than one
payment or more than one type of
provider contribution (for example,
more than one tax or more than one
IGT), the state would be required to
itemize each payment and each
contribution, as applicable. The purpose
of such information from states is to
determine the totality of provider
payments under the Medicaid program
and the extent of provider contributions
to the non-federal share of such
Medicaid payments under the approved
state plan.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
We are seeking comment on all
aspects of the proposals in this section.
We are soliciting comment on the
proposed reporting requirements in
§ 447.288(c), including the specific
proposed data elements in
§ 447.288(c)(1) through (3). In particular,
we invite comment on whether any of
the proposed data elements are
duplicative, and on ways we might be
able to obtain this necessary information
in a manner that appropriately balances
administrative burden on states and on
us while generating the most accurate
data possible.
18. Failure To Report Required
Information (§ 447.290)
To effectively ensure that states
comply with applicable federal statutory
and regulatory requirements, we must
have adequate enforcement mechanisms
in place. The remedy for issues related
to state compliance with regulations is
often the withholding of federal funds to
compel compliance with applicable
federal requirements. We are proposing
to add § 447.290 to specify an
appropriate avenue of enforcement in
the event that a state does not comply
with the proposed data reporting
requirements in § 447.288. As discussed
above, we believe the proposed
information reporting requirement
under § 447.288 is necessary for the
proper and efficient administration of
the state Medicaid plan, especially with
respect to the plan’s compliance with
section 1902(a)(30)(A) of the Act, and
would be properly required under
section 1902(a)(6) of the Act. Therefore,
in proposed § 447.290(a), we propose
that the state must maintain the
underlying information supporting base
and supplemental payments, including
the information required to be reported
under proposed § 447.288, consistent
with the requirements of § 433.32, and
must provide such information for
federal review upon request to facilitate
program reviews or OIG audits
conducted under §§ 430.32 and 430.33.
In proposed § 447.290(b), we propose
that if a state fails to timely, completely
and accurately report information
required under § 447.288 of this chapter,
we may reduce future grant awards
through deferral in accordance with
§ 430.40, by the amount of FFP we
estimate is attributable to payments
made to the provider or providers as to
which the state has not reported
properly, until such time as the state
complies with the reporting
requirements. We propose that we may
defer FFP if a state submits the required
report but the report fails to comply
with applicable requirements.
Otherwise allowable FFP for
PO 00000
Frm 00038
Fmt 4701
Sfmt 4702
expenditures deferred in accordance
with this proposed section would be
released when we determine that the
state has complied with all reporting
requirements under proposed § 447.288.
The enforcement mechanism proposed
in § 447.290 is similar in structure to the
mechanism that applies with respect to
the DSH reporting requirements, in
§ 447.299(e). We are soliciting
comments on the enforcement
mechanism proposed in § 447.290.
19. Limitations on Aggregate Payments
for DSHs Beginning October 1, 1992
(§ 447.297)
Current regulations require CMS to
publish the annual DSH allotments in a
Federal Register. This process is not
only administratively burdensome, but
is unnecessary as we routinely notify
states directly regarding annual
allotment amounts and make such
information publicly available.
Therefore, we are proposing to eliminate
the § 447.297(c) requirement to publish
annual DSH allotments in a Federal
Register notice and to provide that the
Secretary will post preliminary and
final national expenditure targets and
state DSH allotments in the MBES and
at Medicaid.gov (or similar successor
system or website). Additionally, we are
proposing to remove the date in which
final national target and allotments are
published from April 1st to as soon as
practicable. We are also proposing to
remove § 447.297(e), which consists of
redundant publication requirements
already identified in § 447.297(b), (c),
and (d), in its entirety to align with our
proposed changes § 447.297(c). We are
soliciting comments related to these
proposed changes.
20. Reporting Requirements (§ 447.299)
To improve the accuracy of
identification of provider overpayments
discovered through the DSH audit
process, we are proposing in § 447.299
to add an additional reporting
requirement for annual DSH audit
reporting required by § 447.299 and to
provide clarifying guidance on the
reporting of overpayments identified by
the annual DSH audits required under
part 455 subpart D. We are proposing to
redesignate § 447.299(c)(21) as
paragraph (c)(22) of that section, and to
add a proposed new § 447.299(c)(21) to
require an additional data element for
the required annual DSH audit
reporting. This new data element would
require auditors to quantify the financial
impact of any finding which may affect
whether each hospital has received DSH
payments for which it is eligible within
its hospital-specific DSH limit. If it is
not practicable to determine the actual
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
financial impact amount, we propose to
require a statement of the estimated
financial impact for each audit finding
identified in the independent certified
audit that is not reflected in the data
elements identified in § 447.299(c)(6)
through (15). For purposes of this
paragraph, audit finding means an issue
identified in the independent certified
audit required under § 455.304
concerning the methodology for
computing the hospital specific DSH
limit and/or the DSH payments made to
the hospital, including, but not limited
to, compliance with the hospitalspecific DSH limit as defined in
§ 447.299(c)(16). Audit findings may be
related to missing or improper data, lack
of documentation, non-compliance with
federal statutes and/or regulations, or
other deficiencies identified in the
independent certified audit. Actual
financial impact means the total amount
associated with audit findings
calculated using the documentation
sources identified in § 455.304(c) of this
chapter. Estimated financial impact
means the total amount associated with
audit findings calculated on the basis of
the most reliable available information
to quantify the amount of an audit
finding in circumstances where
complete and accurate information
necessary to determine the actual
financial impact is not available from
the documentation sources identified in
§ 455.304(c) of this chapter. We
understand that due to the complexity
of issues that may arise, the actual
financial impact may not always be
calculable; therefore, we propose that,
in the expectedly rare event that the
actual financial impact cannot be
calculated, an estimated financial
impact would be required. The
estimated financial impact would use
the most reliable available information
(for example, related source
documentation such as data from state
systems, hospitals’ audited financial
statements, and Medicare cost reports)
to quantify an audit finding. We believe
this additional data reporting element is
necessary to better enable our oversight
of the Medicaid DSH program to better
ensure compliance with the hospital
specific DSH limit in section 1923(g) of
the Act. Moreover, we believe this
requirement would limit the burden on
both states and CMS of performing
follow-up reviews or audits and will
help ensure appropriate recovery and
redistribution, as applicable, of all DSH
overpayments.
The addition of § 447.299(f) would
clarify reporting requirements of DSH
overpayments identified in the audit
process in accordance with part 433
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
subpart F, including specifying that
states must return DSH payments in
excess of hospital-specific cost limits to
the federal government identified
through annual DSH audits through
quarterly reporting on the Form CMS–
64 as a decreasing adjustment, or
redistributed by the state to other
qualifying hospitals, if redistribution is
provided for under the approved state
plan. Section 447.299(g) would require
states to report overpayment
redistribution amounts corresponding
with the fiscal year DSH allotment, as
applicable and consistent with other
federal requirements, on the Form
CMS–64 within 2 years from the date of
discovery and report such
redistributions through quarterly
reporting on the Form CMS–64 as an
increasing adjustment. We solicit
comments on the proposed rule.
21. State Plan Requirements (§ 447.302)
We are proposing to revise § 447.302
by adding proposed new paragraphs (a)
through (d), which would establish state
plan requirements for payments for
outpatient hospital services, to
implement new approval requirements
for state plans and any SPAs proposing
to make supplemental payments to
providers of these services and to define
a transition period for currently
authorized supplemental payments to
begin to meet the proposed new
requirements. These proposals are
similar to those we are making in
§ 447.252(d) with respect to
supplemental payments for inpatient
hospital, nursing facility, and ICF/IID
services. We are proposing to limit
approval for state plan supplemental
payments for outpatient hospital
services to a period of not more than 3
years, and to require states to monitor a
supplemental payment program during
the term of its approval to ensure that
the supplemental payment remains
consistent with section 1902(a)(30)(A) of
the Act. As discussed in this section and
other sections of this preamble, the
proposed revisions to §§ 447.252,
447.288(b) and 447.302 include
considerable data reporting
requirements which would implement
section 1902(a)(6) of the Act, requiring
the state agency to make such reports,
in such form and containing such
information, as the Secretary may from
time to time require, and comply with
such provisions as the Secretary may
from time to time find necessary to
assure the correctness and verification
of such reports. The submission of more
robust payment data would assist us in
providing proper oversight of the
Medicaid program in determining that
state Medicaid payments are made in a
PO 00000
Frm 00039
Fmt 4701
Sfmt 4702
63759
manner consistent with federal statute
and regulations, including section
1902(a)(30)(A) of the Act and applicable
UPL requirements.
Specifically, we are proposing in
§ 447.302(a) and (b) to codify existing
state plan requirements that the plan
must provide that the requirements of
subpart F are met and that the plan must
specify comprehensively the methods
and standards used by the agency to set
payment rates. We propose in
§ 447.302(c) that CMS may approve a
supplemental payment, as defined in
§ 447.286, provided for under the state
plan or a SPA for a period not to exceed
3 years. A state whose supplemental
payment approval period has expired or
is expiring may request a SPA to renew
the supplemental payment for a
subsequent period not to exceed 3 years,
consistent with the requirements of
§ 447.302. A time limited supplemental
payment allows CMS and the state an
opportunity to revisit state plan
supplemental payments to ensure that
they remain consistent with efficiency,
economy, and quality of care, as
required under section 1902(a)(30)(A) of
the Act. Over the years, CMS and
various oversight bodies conducting
financial management reviews and
audits have identified areas where
unchecked supplemental payments
have resulted in payments that appeared
to be excessive, and CMS had little
recourse to take action. Such audits and
financial reviews conducted by CMS or
other oversight agencies can take years
and require a large number of state and
federal resources to complete, and
ultimately resolve. As noted earlier in
this preamble, in 2015, the GAO issued
a report entitled, ‘‘Medicaid: CMS
Oversight of Provider Payments Is
Hampered by Limited Data and Unclear
Policy,’’ in which it concluded that,
‘‘[w]ithout good data on payments to
individual providers, a policy and
criteria for assessing whether the
payments are economical and efficient,
and a process for reviewing such
payments, the federal government could
be paying states hundreds of millions,
or billions, more than what is
appropriate.’’ 10 As a result, the GAO
has recommended that, to better ensure
the fiscal integrity of the program, we
should establish financial reporting at a
provider-specific level and clarify
permissible methods for calculating
Medicaid supplemental payment
amounts. Based on this and other
oversight entity recommendations, and
10 U.S. Gov’t Accountability Office, GAO–15–322,
Medicaid: CMS Oversight of Provider Payments Is
Hampered by Limited Data and Unclear Policy, 46
(2015), https://www.gao.gov/assets/670/669561.pdf.
E:\FR\FM\18NOP2.SGM
18NOP2
63760
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
CMS’ experience administering the
Medicaid program at the federal level,
we believe that the time-limited
approval of supplemental payments is
necessary for the proper and efficient
operation of state Medicaid plans to
ensure the continuing consistency of
supplemental payments with applicable
statutory requirements and generally to
ensure appropriate oversight.
We are not proposing to limit the
number of times a state may request,
and receive approval for renewal of a
supplemental payment program,
provided that each request meets all
applicable requirements. We propose
that a state plan or SPA that would
provide for a supplemental payment
would be required to include: (1) An
explanation of how the state plan or
SPA will result in payments that are
consistent with section 1902(a)(30)(A) of
the Act, including that provision’s
standards with respect to efficiency,
economy, quality of care, and access
along with the stated purpose and
intended effects of the supplemental
payment, for example, with respect to
the Medicaid program, providers, and
beneficiaries; (2) the criteria to
determine which providers are eligible
to receive the supplemental payment;
(3) a comprehensive description of the
methodology used to calculate the
amount of, and distribute, the
supplemental payment to each eligible
provider, including specified content;
(4) the duration of the supplemental
payment authority (not to exceed 3
years); (5) a monitoring plan to ensure
that the supplemental payment remains
consistent with the requirements of
section 1902(a)(30)(A) of the Act and to
enable evaluation of the effects of the
supplemental payment on the Medicaid
program, for example, with respect to
providers and beneficiaries; and (6) for
a SPA proposing to renew a
supplemental payment for a subsequent
approval period, an evaluation of the
impacts on the Medicaid program
during the current or most recent prior
approval period, for example, with
respect to providers and beneficiaries,
and including an analysis of the impact
of the supplemental payment on
compliance with section 1902(a)(30)(A)
of the Act. For the state’s
comprehensive description of the
methodology used to calculate the
amount, and distribution, of the
supplemental payment to each eligible
provider as required under item (3), we
would require the state to provide all of
the following: (1) The amount of the
supplemental payment made to each
eligible provider, if known, or, if the
total amount is distributed using a
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
formula based on data from one or more
fiscal years, the total amount of the
supplemental payments for the fiscal
year or years available to all providers
eligible to receive a supplemental
payment; (2) if applicable, the specific
criteria with respect to Medicaid
service, utilization, or cost data from the
proposed state plan rate year to be used
as the basis for calculations regarding
the amount and/or distribution of the
supplemental payment; (3) the timing of
the supplemental payment to each
eligible provider; (4) an assurance that
the total Medicaid payment to other
inpatient and outpatient facilities,
including the supplemental payment,
will not exceed the upper limits
specified in § 447.325; and (5) if not
already submitted, an UPL
demonstration as required by § 447.321
and described in proposed § 447.288.
The justification for including the
state plan requirements in § 447.302 are
the same as those justifications and
explanations included in the discussion
with regard to § 447.252. We are
proposing to require states to provide
information necessary to determine that
the supplemental payments proposed in
the state plan are, and remain,
consistent with the efficiency, economy,
and quality requirements under section
1902(a)(30)(A) of the Act and the
parameters concerning permissible
sources of non-federal share under
section 1903(w) of the Act.
Finally, in considering the 3-year
approval period for supplemental
payments, we developed a transition
plan to provide states with an adequate
opportunity to come into compliance
with the proposed requirements. To
accomplish the policy objectives
described above, we believe we must
begin to apply the proposed policies, if
they are finalized, to current state plan
provisions that authorize supplemental
payments that are approved as of the
effective date of the final rule. It is no
less necessary to ensure the proper and
efficient operation of the state plan and
ensure that applicable requirements
continue to be met, to rigorously
evaluate currently existing
supplemental payment programs, as it is
to do so for new supplemental payment
programs approved prospectively.
Accordingly, in proposed § 447.302(d),
for state plan provisions approved 3 or
more years prior to the effective date of
the final rule, we propose that the state
plan authority would expire 2 calendar
years following the effective date of the
final rule. For state plan provisions
approved less than 3 years prior to the
effective date of the final rule, we
propose that the state plan authority
would expire 3 years following the
PO 00000
Frm 00040
Fmt 4701
Sfmt 4702
effective date of the final rule. We
believe this is a generous timeline for
transitioning to the proposed 3-year
time limit for supplemental payments
under the state plan. This timeline
provides states with currently approved
supplemental payment programs with at
least 2, and as many as 3 years before
a state wishing to continue the
supplemental payment program would
need to seek renewal or a new approval.
We are soliciting comment on this
entire section, including the proposed
state plan elements for supplemental
payments, and the proposed approval
timeframe for a state’s proposed
supplemental payments. For the
timeframes, we are seeking input on
both the 3-year approval period and the
proposed transition period for currently
approved supplemental payments. We
considered proposing a 5-year
compliance transition period instead of
the proposed 3-year compliance
transition period in § 447.302(d). This
would have increased the amount of
time states would have to bring existing,
approved supplemental payment
methodologies into compliance with the
provisions of the proposed rule in
§§ 447.252 and 447.302. We decided to
propose a 3-year transition period to
account for states where changes may
require legislative action as some
legislatures meet on a biennial basis and
such a timeframe would provide an
opportunity for all legilslatures to
address existing supplemental payment
programs. We are requesting comment
on whether or not to pursue this or a
lengthier transition and approval
timeline for supplemental payments.
22. Outpatient Hospital Services:
Application of UPLs (§ 447.321)
To promote improved oversight of
Medicaid program FFS expenditures for
services subject to the UPL, we are
proposing changes to § 447.321. Some of
the proposed changes to § 447.321
would formally codify current policy,
while others are newly proposed. We
solicit comment on all proposed
provisions.
CMS has long regarded the UPL
requirements in § 447.321 and the
review of total outpatient hospital
Medicaid payments in relation to a
provider’s cost or the Medicare payment
amounts as implementing section
1902(a)(30)(A) of the Act, which
requires that states assure that payments
are consistent with efficiency, economy,
and quality of care. As stated earlier in
the preamble, the aggregate application
of these UPLs has preserved state
flexibility for setting provider-specific
payments while creating an overall
payment ceiling as a mechanism for
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
determining economy and efficiency of
payment for the services described
above, consistent with section
1902(a)(30)(A) of the Act.
We are proposing to change the title
of this section to ‘‘Outpatient Hospital
Services: Application of upper payment
limits’’ to remove clinic services from
the UPL requirements in § 447.321. The
absence of benefit category in the
Medicare program similar to Medicaid
‘‘clinic services’’ has made establishing
and verifying compliance with a UPL
for clinic services an overly burdensome
task. Without equivalent comparison
data from Medicare, it is difficult or
impossible to establish a reasonable
estimate of what Medicare would pay
for Medicaid clinic services, which
otherwise would supply the UPL for
such services under § 447.321.
Additionally, most often, clinics are
reimbursed according to the practitioner
fee schedule in the same manner as
other practitioners under the Medicaid
state plan. In these circumstances, we
have determined that such payments are
not subject to the clinic UPL in any
event, because these provider payments
are made under the relevant practitioner
benefit in the Medicaid program, such
as physician services or dental services
under sections 1905(a)(5) and (a)(10) of
the Act, respectively, rather than clinic
services under section 1905(a)(9) of the
Act. As with all other inpatient and
outpatient facility services, state
agencies must continue to apply
§ 447.325 under which the agency may
pay the customary charges of the
provider but must not pay more than the
prevailing charges in the locality for
comparable services under comparable
circumstances.
We have proposed to revise this
regulation in the past through other
proposed rules, but were unable to
finalize those proposals. Particularly, in
2007 with the proposed rule Medicaid
Program; Clarification of Outpatient
Clinic and Hospital Facility Services
Definition and Upper Payment Limit (72
FR 55166), we proposed several
practical options for states to comply
with clinic UPL requirements. Namely,
these options included paying at the
Medicare non-facility Resource-Based
Relative Value Units System (RBRVS)
FFS rate for practitioner services in a
clinic setting, or setting the rates for
services provided in the clinic at the
Medicaid state plan rate for the same
services when provided by a
practitioner under the state plan where
there was no Medicare comparable rate.
The difficulty in applying the proposals
in that particular proposed rule, and
difficulties setting and establishing
compliance with clinic UPLs since, has
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
been related to the subjectivity of
establishing appropriate comparison
prices for services where there is no
Medicare equivalent, or limiting
Medicaid providers to cost when
Medicare does not collect or mandate
clinic cost reports for free-standing
clinics, as is done with other inpatient
and outpatient facilities. For these
reasons, we are proposing to remove
clinic services from § 447.321 so the
requirements of the outpatient UPL will
no longer apply to these providers and
we are requesting comment on this
proposed change.
Importantly, this proposal does not
mean that the requirements of section
1902(a)(30)(A) of the Act do not
continue to apply to clinic payments—
emphatically, they do. We simply are
proposing to no longer use the clinic
UPL as the formal metric of compliance
with the efficiency, economy, and
quality of care requirements under the
statute. We will continue to compare the
Medicare RBRVS to Medicaid clinic
reimbursement rates, where applicable,
to inform administrative decisions about
the state’s payment rates under section
1902(a)(30)(A) of the Act, much like we
do with physician reimbursement under
the Medicaid state plan. We are
soliciting comment on this particular
change in the proposed rule.
We are proposing to amend paragraph
(a) to revise the current ownership
groups (state government-owned or
operated, non-state government owned
or operated, and privately-owned and
operated facilities) used to establish the
UPL. We propose to replace these
provider designations with ‘‘state
government providers,’’ ‘‘non-state
government providers,’’ and ‘‘private
providers.’’ We propose to codify the
substantive definitions of these provider
designations in proposed § 447.286. As
discussed below, we would define
‘‘state government provider’’ to refer to
a health care provider as defined in
§ 433.52, including those defined in
§ 447.251, that is a unit of state
government or state university teaching
hospital; in determining whether a
provider is a unit of state government,
we would consider the totality of the
circumstances, including but not
limited to specific considerations
identified in proposed § 447.286.
Similarly, we would define ‘‘non-state
government provider’’ to refer to a
health care provider as defined in
§ 433.52, including those defined in
§ 447.251, that is a unit of local
government in a state, including a city,
county, special purpose district, or other
governmental unit in the state that is not
the state, which has access to and
exercises administrative control over
PO 00000
Frm 00041
Fmt 4701
Sfmt 4702
63761
state funds appropriated to it by the
legislature and/or local tax revenue,
including the ability to expend such
appropriated or tax revenue funds; in
determining whether a provider is nonstate government provider, we would
consider the totality of the
circumstances, including but not
limited to specific considerations
identified in proposed § 447.286. We
would define a ‘‘private provider’’ to
mean a health care provider as defined
in § 433.52, including those defined in
§ 447.251, that is not a state government
provider or a non-state government
provider.
The proposed changes in provider
designations would reinforce the
relationship between a provider’s
designation and its ability (or inability)
to provide the source of non-federal
share for Medicaid payments. Under the
current system of categorization by
ownership or operational interests, there
can be ambiguity with respect to the
appropriate category for a provider
when certain responsibilities of
ownership or operation are divided
between more than one entity. For
example, there is currently the
possibility that a private nursing facility
could transfer the deed to its real
property to the county government, but
the private entity would continue to
administer all functions of the provider
as though it were the actual owner,
leaving the county government as the
owner only in name but not any
function. For the provider to make an
IGT, the private entity would give funds
to the county government, such as
through a lease payment for the facility
real property, to be used as the source
of the non-federal share of Medicaid
payments that the state could then make
back to the provider in the form of
supplemental payments. This effective
self-funding of the non-federal share of
the supplemental payments by the
provider would not have been possible
if the provider were categorized as
privately owned and operated, since it
would have been unable to make the
IGT to support the supplemental
payments back to it. In this situation, we
view this transferred amount as an
impermissible source of the non-federal
share, since the funds used to support
the IGT are not obtained from state or
local tax revenue and, as discussed
elsewhere in this preamble, would
constitute a non-bona fide providerrelated donation.
Through the state plan review process
and our review of UPL demonstrations,
we have observed that some states have
re-categorized a number of providers
from privately-owned or operated
facilities to a governmentally owned or
E:\FR\FM\18NOP2.SGM
18NOP2
63762
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
operated designation, either state
government-owned or operated facilities
or non-state government-owned or
operated facilities. In some instances,
the change in ownership category
appears to be both a non-bona fide
provider-related donation, as well as a
device to permit the state to make
supplemental payments to a provider
and demonstrate compliance with the
UPL, rather than reflective of an actual
change in the provider’s true ownership
or operational interests, in view of the
apparent continuity of the provider’s
business structure and activities. We
believe this shift in designation has
facilitated higher supplemental
payments to certain providers, without
the state incurring additional cost to
fund the non-federal share of payment
where the private operator passes funds
to the new governmental owner, which
constitutes a non-bona fide providerrelated donation, and those funds are
either used to make an IGT or supplant
funds that are otherwise used to make
an IGT to the state to make a
supplemental payment targeted toward
the private entity. We are concerned
that this type of arrangement is not
consistent with the basic construct of
the Medicaid program as a cooperative
federal-state partnership where each
party shares in the cost of providing
medical assistance to beneficiaries.
Similar to our proposal in § 447.272,
we propose to amend § 447.321(b) to
clarify that the UPL refers to a
reasonable estimate of the amount that
would be paid for the services furnished
by the group of facilities under
Medicare payment principles in 42 CFR
chapter IV, subchapter B, or allowed
costs established in accordance with the
cost principles as specified in 45 CFR
part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles
specified in 42 CFR part 413. The
specific data elements, methodology
parameters, and acceptable UPL
demonstration methodologies are
specified in proposed § 447.288(b).
The existing regulations simply state
that the UPL refers to a reasonable
estimate of the amount that would be
paid for the services furnished by the
group of facilities under Medicare
payment principles in subchapter B of
title 42, chapter IV, of the CFR, which
provided CMS with the ability to define
UPLs as a payment limit set at the
aggregate amount that Medicare would
have paid for the same Medicaid
services using either a Medicare
payment methodology or Medicare cost
principles. These two methods are
employed because these are the two
methods that Medicare has historically
used to pay for services as authorized
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
under title 42, chapter IV, subchapter B,
of the CFR. In establishing this limit, we
have required that states set the UPL
using these principles, then compare the
aggregate Medicaid payments for the
defined period to the UPL, which is the
Medicare equivalent payment or cost
amount. We are proposing to codify our
existing policy related to the use of the
two methods of demonstrating the
Medicaid UPL, by using the Medicare
equivalent payment amount or cost
amount, and the process for establishing
and demonstrating compliance with the
UPL in § 477.288(b) of this proposed
rule. As noted elsewhere in this
proposed rule, the term ‘‘Medicare
equivalent’’ means the Medicare
equivalent to the Medicaid data,
payment, or services. Therefore, the
term Medicare equivalent payment
means the amount that would be paid
for Medicaid services furnished by the
group of providers if those services were
provided to Medicare beneficiaries and
paid under Medicare payment
principles. Likewise, a reference to
Medicare equivalent charges in
reference to a UPL calculation means
the Medicare charges for the same
Medicaid services subject to the UPL.
We considered proposing to define
specific methods by which states would
be required to demonstrate compliance
with the UPL in each of §§ 447.272 and
447.321, but determined that the
proposed § 447.288 would allow us to
define necessary data elements,
parameters, and methodologies for
demonstrating compliance with UPLs in
one location, for purposes of both the
inpatient and outpatient UPLs under
§§ 447.272 and 447.321, respectively. To
summarize briefly, proposed § 447.288
describes the data sources, data
parameters, and methodologies that
must be considered and used in
demonstrating compliance with the
UPL. It describes the appropriate
Medicare data and the creation of ratios
using either cost or payment data
calculations, the Medicaid charge data
which multiplied by the either a ratio of
cost-to-charge (total cost or Medicare
cost) or the ratio of Medicare paymentto-charge to calculate the UPL amount
and any associated considerations
(inflation adjustments, utilization
adjustments, or other cost adjustments),
and the Medicaid payment data. For a
detailed discussion of these proposed
UPL requirements, please refer to the
discussion above related to § 447.288.
We invite comment on all proposed
new and revised provisions in this
section.
PO 00000
Frm 00042
Fmt 4701
Sfmt 4702
23. Medicaid Practitioner Supplemental
Payments (§ 447.406)
For a number of years, states have
been making supplemental payments
that are targeted to certain practitioners,
such as physicians and other licensed
professionals, under the Medicaid state
plan. Most commonly, states have
targeted supplemental payments to
practitioners affiliated with and
furnishing services in academic medical
centers and safety net hospitals. These
payments have used what is commonly
described as an ACR calculation. The
ACR is a method of calculating an
average rate paid by commercial third
party payers for specific medical service
codes (usually Current Procedural
Terminology (CPT) codes) to providers
and multiplying that average rate by the
Medicaid claims for each code to
establish an upper limit for these
practitioner supplemental payments.
Predominantly, such ACR payments
are funded by IGTs from local
government sources or state university
teaching hospitals and are generally
made without consideration of
improvements in access to or quality of
care. When payment is made up to the
ACR, states submit data to CMS from
the top (generally five) commercial
payers and provide an explanation of
the data that was extracted from
providers’ accounts receivable systems.
The state compares payment by
Medicaid for each billing code to the
average payment amount allowed by
commercial payers for the same
services. Data from each of the
practitioners, group practices, or
hospital-based practitioner groups
eligible to receive the supplement
payment is included in the submitted
ACR calculation. These calculations are
usually completed by the provider(s)
and sent to CMS by the states through
the submission of SPAs. We are
proposing to end the practically
unrestricted use of ACR supplemental
payments based on concerns that the
payments are not economic and
efficient, consistent with section
1902(a)(30)(A) of the Act, and that they
present a clear oversight risk because
they are based on proprietary
commercial payment data and thus not
verifiable or auditable. As discussed in
detail below, we are proposing to limit
Medicaid practitioner supplemental
payments to 50 percent of FFS base
payments to the eligible provider for
practitioner services, or 75 percent of
such payments for services provided
within HHS’ Health Resources and
Services Administration (HRSA)designated geographic health
professional shortage areas (HPSAs) or
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
Medicare-defined rural areas, as
specified in 42 CFR 412.64(b), as
discussed below.
When ACR-based payments were first
approved in 2000, we found that state
ACR amounts were between 150 percent
and 165 percent of the Medicare rates
for the same services. In recent years,
however, states have sought to make
Medicaid practitioner supplemental
payments based on calculations
reflecting amounts of approximately 300
percent to 400 percent of the Medicare
rate. While these percentage are outliers
among states making ACR payments,
those amounts were considerably larger
than we had otherwise seen. In federal
FY 2018, the most recent full fiscal year
for which data was reported, states
claimed approximately $1.32 billion in
(total computable) expenditures for
supplemental payments made to
physicians and other licensed
practitioners. As states and practitioners
realized that Medicaid payments could
be increased through the use of ACRbased supplemental payment
methodologies and with funding from
IGTs, states began to explore expanding
the ACR-based supplemental payments
to other Medicaid participating
practitioners.
Although we questioned whether
making Medicaid payments at up to 400
percent of Medicare rates was consistent
with economy and efficiency as
required under section 1902(a)(30)(A) of
the Act, we continued to approve ACR
methodologies submitted by states
consistent with our historic view that
such methodologies that relied on
commercial data were permissible
under the relevant statutory standards,
and because we had not established an
upper bound for practitioner
supplemental payments through
rulemaking.
In this rule, except as discussed
below, we are proposing to apply the
definitions applicable to base and
supplemental payments defined under
newly proposed § 447.286—Definitions
and the proposed new requirements in
§ 447.302—State plan requirements. By
aligning these definitions and
requirements, we are ensuring that the
terminology for base and supplemental
payments for practitioner services is
consistent with other service types and
that states apply the same
comprehensive descriptions and time
limits to practitioner supplemental
payments as would be applied to other
Medicaid service supplemental
payments. Further, we are proposing,
within § 447.406(c), to limit Medicaid
practitioner supplemental payments
relative to base payments set under the
Medicaid state plan. Notably, lump sum
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
provider quality incentive supplemental
payments that are targeted to a subset of
providers within the state as part of a
state’s delivery system reform initiative
and paid based on improvements to
reported quality measures are included
in the definition of ‘‘Supplemental
payment’’ under proposed § 447.286, for
purposes of newly proposed § 447.406,
and therefore, would be subject to the
limit proposed in § 447.406. To the
extent that value-based payment
methodologies that are part of a state’s
delivery system reform initiative and
that are available to all providers under
a Medicaid benefit category, including
as an alternative to FFS payment rates
(for example, bundled payment
methodologies, payments for episodes
of care, Medicaid shared savings
methodologies), and otherwise align
with the definition of base payments in
§ 447.286 (for example, the payment can
be attributed to a particular service
provided to a Medicaid beneficiary), we
propose such payments to be base
payments as defined in § 447.286. This
consideration is consistent with the
proposed definitions of base and
supplemental payments and will allow
states sufficient flexibility to promote
quality improvement which may result
in better care and reduced program cost
over time.
The proposed new limits would allow
states to target supplemental payments
to practitioners: (1) Up to 50 percent of
the FFS base payments authorized
under the state plan for the practitioner
services paid to the eligible provider
during the period covered by the
supplemental payment, or (2) for
services provided within HRSAdesignated geographic HPSA or
Medicare-defined rural areas as defined
in § 412.64(b), Medicaid practitioner
supplemental payments could be made
up to 75 percent of the FFS base
payments authorized under the state
plan for the practitioner services paid to
the eligible provider during the period
covered by the supplemental payment.
We are proposing to permit additional
payment for practitioner services in
geopgraphic HPSAs to allow states
flexibility to increase payment rates and
address professional shortages and
access to care concerns in areas where
HHS has determined such shortages
exist. Likewise, we are proposing to
include Medicare-defined rural areas as
defined in § 412.64(b) because states
have frequently identified rural areas,
some of which may not be included in
the geographic HPSAs, as having issues
related to access to care and we want to
provide states with the flexibility to
make increased practitioner
PO 00000
Frm 00043
Fmt 4701
Sfmt 4702
63763
supplemental payments if the state
determines that such increases are
needed in those areas as well.
We believe these percentages are
appropriate because the ACR data from
2016 and 2017 show that, nationally,
among providers receiving an ACR
supplemental payment, total
supplemental payments equaled
approximately 75 percent of the base
payment rates in 2016 to approximately
93 percent of the base payment rates in
2017 (total supplemental payment
divided by total base payments to
qualifying provider) based on data
received through the state UPL
demonstration submissions. By limiting
the total practitioner payment, base and
supplemental payment, to 150 percent
of the base Medicaid practitioner
payment, or 175 percent of the base
Medicaid practitioner payment for
services provided in a HRSA-designated
geographic HPSA or a Medicare-defined
rural area, we believe that the proposed
policy would not diverge excessively
from ACR supplemental payments that
we historically have approved.
However, under the prior structure, the
supplemental payment was not related
to the base Medicaid payment and could
only be increased based on changes to
the commercial payer rates. Therefore,
an increase in the base Medicaid
payment could not result in an increase
in a supplemental payment to eligible
providers, as would be possible under
our proposal. If a state wants to increase
a provider’s supplemental payment
beyond the maximum amount that
would be permissible under the
proposed provision, the state could
increase Medicaid base payment rates,
which could enable the state to pay a
further 50 percent (or 75 percent) of the
increase in FFS base payments to
eligible providers. We believe this
approach is, first, consistent with
section 1902(a)(30)(A) of the Act, and,
second, is sufficiently consistent with
the previously approved Medicaid ACRs
amounts not to excessively disturb total
provider payments being made today
under previously approved ACR
supplemental payment arrangements.
To provide an example of the
application of the proposed Medicaid
practitioner supplemental payment
limit, assume the state has proposed to
make a supplemental payment to a
group of practitioners within an area of
the state that is not a HRSA-designated
geographic HPSA or Medicare-defined
rural area. One of the qualifying
providers received total Medicaid FFS
base payments for practitioner services
of $100,000 and the state wishes to
make a supplemental payment to that
provider. The proposed ceiling
E:\FR\FM\18NOP2.SGM
18NOP2
63764
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
methodology results in the following
calculation: $100,000 total Medicaid
base payments × 0.50 = $50,000, which
could allow the state to make a
Medicaid practitioner supplemental
payment to the provider of up to
$50,000, in addition to the Medicaid
FFS base payment of $100,000, for a
total payment to the provider of up to
$150,000. However, if the Medicaid
practitioner supplemental payment
were made to a provider for services
furnished in one of the HRSAdesignated geographic HPSAs or a
Medicare-defined rural area, the
supplemental payment ceiling would be
75 percent of the total base payment
amount of $100,000, which would result
in the following ceiling calculation:
$100,000 total Medicaid base payment ×
0.75 = $75,000, which could allow the
state to make a Medicaid practitioner
supplemental payment of up to $75,000,
in addition to the Medicaid FFS base
payment of $100,000, for a total
payment to the provider of up to
$175,000.
In this proposed rule, we propose
definitions of the terms ‘‘base payment’’
and ‘‘supplemental payment’’ in
§ 447.286. Per those proposed
definitions, we consider Medicaid
practitioner supplemental payments as
‘‘supplemental’’ payments under the
proposed definitions. The reason is that
the base payments are payments made
to a provider for specific services
provided to an individual beneficiary.
While Medicaid practitioner
supplemental payments could be tied to
individual services, the calculation of
the final payment amount is not
dependent upon specific services
furnished to any individual beneficiary,
or any beneficiary’s acuity or
complexity of care received, nor is the
practitioner supplemental payment
made only for complex cases. Base
payments for all practitioner services
furnished by the eligible provider are
supplemented by the supplemental
payment, regardless of the level of
beneficiary acuity or complexity (as
typically would be relevant to payment
adjustments or add-ons that would be
considered part of the base payment).
The eligible provider qualifies for these
payments based on state-developed
criteria that target certain providers, and
the supplemental payments are often
paid as lump sum at the end of a quarter
or at the end of year.
In proposing these requirements, we
are seeking to establish an appropriate
and auditable upper bound to better
ensure that practitioner payments are
consistent with economy and efficiency
by ensuring the supplemental payments
have a reasonable relationship to the
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
base rate methodologies that have been
approved by CMS on the basis of our
determination that such base rate
methodologies are consistent with
statutory requirements. The ACR
supplemental payments historically
have been established based on the
negotiating power of various actors in
the private market and without regard to
the unique circumstances of the
Medicaid program, including statutory
requirements to ensure efficiency and
economy. That is, higher reported
commercial payment rates are a
function of practitioners’ ability to
negotiate higher rates from certain
commercial payers, rather than a result
of prevailing rates generally paid to
practitioners by all commercial payers,
or all payers generally, and without any
necessary analysis of economy and
efficiency.
In contrast, the proposed provisions
intend to tie the highest practitioner
payments in the state to the lowest (that
is, payments to practitioners that are
limited to the state plan FFS base
payment). States have already
determined and declared as part of their
rate-setting processes that base
payments are consistent with economy
and efficiency, quality of care, and
access to care requirements, as required
under section 1902(a)(30)(A) of the Act.
Therefore, we believe that setting the
upper limit for targeted practitioner
supplemental payments at 50 percent or
75 percent more than the base amounts
is reasonably sufficient to allow states
with flexibility, when needed, to target
payment increases while providing a
basis to gauge that payments are
consistent with efficiency, economy,
and quality of care and are sufficient to
enlist enough providers so that care and
services are available under the plan at
least to the extent that such care and
services are available to the general
population in the geographic area. State
payments must meet both tests of
section 1902(a)(30)(A) of the Act in that
a base payment may be economic and
efficient, but if it is not sufficient to
enlist sufficient providers in a particular
area of the state, then an increase in
payments may be needed to ensure that
the rates are sufficient to enlist adequate
numbers of providers in the Medicaid
program. Further, this proposed policy
may encourage states to evaluate
whether Medicaid payment rates are
generally consistent with section
1902(a)(30)(A) of the Act across all
practitioners within a geographic region
and evaluate whether rate increases for
all practitioners may be necessary to
improve access or quality, rather than
targeting payments to certain
PO 00000
Frm 00044
Fmt 4701
Sfmt 4702
practitioners that may be in a position
to provide the non-federal share in
exchange for supplemental payments.
Our concerns over the growing scope
of practitioner supplemental payments
relate to both the payment amounts
relative to Medicare rates and the
practitioners to which the states are
providing the payments, which appears
to be largely driven by the source of
non-federal share used to fund the
payments. As states typically rely on the
providers that receive the supplemental
payments to fund the non-federal share
through IGTs, there is less incentive for
the states to properly oversee the
payments and ensure that the amounts
are economic and efficient. Typically
when states use appropriated funds as
the source of non-federal share there is
a meaningful state interest in ensuring
value to maintain state budgets;
however, when the non-federal share is
provided by the service provider (and
returned with matched federal funds
through the supplemental payments)
there is an inherent incentive to
maximize the amount of the payments
to providers in the state. In almost all
instances, the providers were supplying
the state with the non-federal share of
the Medicaid physician supplemental
payments. Without the supplemental
payments, it is likely that the
arrangements through which the
providers have been transferring the
state share to the state Medicaid agency
to support current high levels of
Medicaid practitioner supplemental
payments would cease, and therefore,
the net impact on the providers would
be far less than the projected amount of
decrease in practitioner supplemental
payments.
The incentive to maximize federal
funds to providers and lack of oversight
interest from states is particularly
problematic in the case of practitioner
supplemental payments because of the
data sources used for ACR
demonstrations. The data currently used
to determine supplemental payment
amounts is based entirely on proprietary
commercial payment data supplied by
the practitioners who themselves stand
to benefit from the supplemental
payment. In our reviews, we have not
been able to verify that the commercial
payment data is correct or genuinely
representative of rates that the
commercial market will bear. We have
also found, in several instances, that the
data has been manipulated to increase
the potential supplemental payments
by, for instance, using comparisons to
Medicaid rates paid for services within
facilities (which are generally lower
than office settings) compared to nonfacility commercial rates, or by
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
foregoing appropriate adjustments to
ensure that the time and associated
payments for procedures are equivalent
for Medicaid and commercial data.
Since the data within the ACR
demonstrations are produced by
providers (and masked to protect
proprietary information), the
demonstrations are impossible to
validate, difficult to interpret and
ultimately may not be auditable in
accordance with § 430.33. By setting a
limit based on Medicaid-based rates, as
proposed under this rule, data is readily
available within state and CMS claims
systems to validate and audit the
supplemental payment amounts.
We recognize that states that are
already making ACR-based
supplemental payments may need time
to come into compliance with the
proposed new limits, if they are
finalized. For states whose state plans
currently provide for Medicaid
practitioner supplemental payments, we
are proposing in § 447.406(d) to provide
a transition period consistent with the
one defined in § 447.302(d) for the state
to submit a SPA to bring its currently
approved Medicaid supplemental
practitioner payment program into
compliance with the requirements
proposed in this section, including the
cross-referenced requirements in
§ 447.302. Specifically, we propose that,
for Medicaid practitioner supplemental
payments that were approved on or
before the effective date of any final
rule, the state would be required to
submit and obtain CMS approval for a
SPA to comply with the requirements of
this section in order to continue making
such supplemental payments.
Otherwise, the authority for state plan
provisions that authorize the Medicaid
practitioner supplemental payments
that are approved as of the effective date
of any final rule would be limited
according to the timeframe described in
§ 447.302(d). By the end of the
transition period, a state without an
approved SPA bringing the Medicaid
practitioner supplemental payment
program into compliance with the
requirements of this section (and, as
incorporated by cross reference, of
§ 447.302) would not be authorized to
continue making the supplemental
payments. We believe this approach to
a transition period would help
minimize burden on states, as states
with Medicaid practitioner
supplemental payment programs would
have a generous period of time to bring
their state plans into compliance with
the proposed new requirements.
Additionally, we propose that states
would no longer be required to submit
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
annual ACR demonstrations for the
annual UPL submission requirements
outlined in the SMDL 13–003 for states
that make targeted physician
supplemental payments for physician
services, further reducing the associated
state burden. Instead, CMS expects that
the state plan would include a
comprehensive written statement of the
Medicaid FFS base payment and
Medicaid practitioner supplemental
payment methodologies, in a manner
consistent with §§ 447.302, 447.406, and
all other applicable requirements.
We are seeking comment on all
elements of this proposal, including the
level of the proposed ceiling
percentages (and whether they should
be higher or lower), the option of using
the Medicare rural areas and/or HRSAdesignated geographic HPSA to target
eligible providers for supplemental
payments, the language regarding valuebased payment methodologies, and
whether there would be other
appropriate means to give states
flexibility to offer special consideration
for providers in underserved areas.
24. Definitions (§ 455.301)
We are proposing to revise the
definition of the ‘‘independent certified
audit’’ to include the requirement for
auditors to quantify the financial impact
of each audit finding, or caveat, on an
individual basis, for each hospital, per
the reporting requirement in
§ 447.299(c)(21) and under section
1923(j)(1)(B) of the Act. Additionally,
we propose to include in the definition
how a certification of the audit would
include a determination of whether or
not the state made DSH payments that
exceeded any hospital’s specific DSH
limit in the Medicaid state plan rate
year under audit. Specifically, we are
proposing to add to annual DSH
reporting a requirement for auditors to
quantify the financial impact of any
finding, including those resulting from
incomplete or missing data, which may
affect whether each hospital has
received DSH payments for which it is
eligible within its hospital-specific DSH
limit. As previously discussed, based on
the audit results we are often unable to
determine whether a DSH overpayment
to a provider has occurred, the
underlying causes of the overpayments,
and the amount of the overpayments
associated with each cause. This is the
result of an auditor including an audit
finding indicating that the missing
information may have an impact on the
calculation of total eligible
uncompensated care costs while not
making a determination of the actual
financial impact of the identified issue.
As a result of this lack of quantification
PO 00000
Frm 00045
Fmt 4701
Sfmt 4702
63765
of the financial impact of this finding,
we are unable to determine whether an
overpayment, if any, has resulted from
this audit finding. As such, revising the
definition is necessary in promoting
oversight and integrity of the DSH
program and ensuring the audit and
report results allow us to calculate
accurate hospital-specific limits. We are
soliciting comments related to this
proposed change.
25. Process and Calculation of State
Allotments for Fiscal Year After FY
2008 (§ 457.609)
We are using the opportunity within
this regulation to revise the method for
notifying states and the public of
national CHIP allotments. Section 2104
of the Act provides appropriations for
fiscal year CHIP allotments for FYs
1998–2027 as determined under the
methodologies provided in sections
2104(b), 2104(c), and 2104(m) of the Act
as applicable for payments to states as
described in section 2105 of the Act.
Section 457.609 describes the process
and calculation of state allotments for a
fiscal year after FY 2008. Section
457.609(h) provides that CHIP
Allotments for a fiscal year may be
published as preliminary or final
allotments in the Federal Register as
determined by the Secretary. We have
not published CHIP allotments in the
Federal Register since the FY 2013
CHIP allotments. Each year following
FY 2013, states have been notified of
their CHIP allotments through either
email notifications and/or through
MBES/CBES. We propose to remove
from § 457.609 the reference to our
discretionary option to publish in the
Federal Register the national CHIP
allotment amounts as determined on an
annual basis for the fiscal years
specified in statute. Instead, we are
proposing to post CHIP allotments in
the Medicaid and CHIP Budget and
Expenditure System (MBES/CBES) and
at Medicaid.gov (or similar successor
systems or websites) annually. We
believe that posting the CHIP allotment
amounts at Medicaid.gov and in the
MBES/CBES is an efficient way to make
the information more easily accessible
to interested stakeholders and would be
less administratively burdensome for
CMS. We are soliciting any comments
related to these proposed changes.
III. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We would consider all
comments we receive by the date and
time specified in the DATES section of
E:\FR\FM\18NOP2.SGM
18NOP2
63766
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
this preamble, and, when we proceed
with a subsequent document, we would
respond to the comments in the
preamble to that document.
IV. Collection of Information
Requirements
Under the Paperwork Reduction Act
of 1995 (PRA) (44 U.S.C. 3501 et seq.),
we are required to publish a 60-day
notice in the Federal Register and
solicit public comment before a
‘‘collection of information’’ requirement
is submitted to the Office of
Management and Budget (OMB) for
review and approval. For the purposes
of the PRA and this section of the
preamble, collection of information is
defined under 5 CFR 1320.3(c) of the
PRA’s implementing regulations.
To fairly evaluate whether an
information collection should be
approved by OMB, PRA section
3506(c)(2)(A) requires that we solicit
comment on the following issues:
• The need for the information
collection and its usefulness in carrying
out the proper functions of our agency.
• The accuracy of our burden
estimates.
• The quality, utility, and clarity of
the information to be collected.
• Our effort to minimize the
information collection burden on the
affected public, including the use of
automated collection techniques.
We are soliciting public comment on
each of the section 3506(c)(2)(A)required issues for the following
information collection requirements
(ICRs).
A. Wage Estimates
To derive average costs, we used data
from the U.S. Bureau of Labor Statistics’
May 2018 National Occupational
Employment and Wage Estimates for all
salary estimates (https://www.bls.gov/
oes/current/oes_nat.htm). In this regard,
Table 1 presents the mean hourly wage,
the cost of fringe benefits and overhead
(calculated at 100 percent of salary), and
the adjusted hourly wage.
TABLE 1—NATIONAL OCCUPATIONAL EMPLOYMENT AND WAGE ESTIMATES
Occupation
code
Occupation title
Accountants and auditors ................................................................................
Data Entry Keyers ...........................................................................................
Financial Specialist all other ............................................................................
General and Operations Managers .................................................................
Healthcare Support Workers all other .............................................................
Managers all other ...........................................................................................
Social Science Research Assistants ...............................................................
As indicated, we are adjusting our
employee hourly wage estimates by a
factor of 100 percent. This is necessarily
a rough adjustment, both because fringe
benefits and overhead costs vary
significantly from employer to
employer, and because methods of
estimating these costs vary widely from
study to study. Nonetheless, we believe
that doubling the hourly wage to
estimate total cost is a reasonably
accurate estimation method.
B. Proposed Information Collection
Requirements (ICRs)
The following regulatory sections of
this rule contain proposed collection of
information requirements (or ‘‘ICRs’’)
that are subject to OMB approval under
the authority of the PRA: §§ 433.72
(Waiver provision applicable to health
care related taxes), 447.252 and 447.302
(State plan requirements), 447.288
(Reporting requirements for UPL
demonstrations and supplemental
payments), and 447.299 (DSH reporting
requirements). Our analysis of the
proposed requirements and burden
follow.
1. ICRs Regarding Tax Waiver
Requirements (§ 443.72)
The following proposed changes will
be submitted to OMB for approval under
control number 0938–0618 (CMS–R–
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
13–2011
43–9021
13–2099
11–1021
31–9099
11–9199
19–4061
148). Subject to renewal, the control
number is currently set to expire on
February 28, 2021. It was last approved
on February 9, 2018, and remains active.
Section 433.72 of this rule proposes to
add a period of validity for tax waivers
of the broad-based and/or uniformity
requirements, which states that waivers
will cease to be effective 3 years from
CMS’ approval in the case of tax
programs commencing on or after the
rule’s effective date or 3 years from the
rule’s effective date in the case of
waivers approved before the rule’s
effective date. This change is necessary
because the provider data submitted by
states to CMS, for use in the statistical
tests described at § 433.68, may change
over time. As a result, the tax may be
generally redistributive as required by
statute and regulation when the state
requests the waiver, but may
subsequently cease to be so. Currently
there are approximately 35 states that
have broad based or uniformity waivers.
We propose to allow states with existing
health care-related tax waivers up to 3years from the effective date of the final
rule before they must seek re-approval.
This will provide states sufficient time
to evaluate and, if necessary, modify
existing tax programs.
The ongoing burden associated with
the proposed requirements consists of
the time it would take each state that
PO 00000
Frm 00046
Fmt 4701
Sfmt 4702
Mean hourly
wage
($/hr)
37.89
16.22
37.30
59.56
18.80
55.57
24.24
Fringe
benefits and
overhead
($/hr)
37.89
16.22
37.30
59.56
18.80
55.57
24.24
Adjusted
hourly wage
($/hr)
75.78
32.44
74.60
119.12
37.60
111.14
48.48
has an existing tax waiver to submit an
updated version within 3-years after the
effective date of the final rule and to
update the waiver every 3 years. Of the
35 states with tax waivers, we estimate
that there are approximately 60 tax
waivers that will have to be renewed
every 3 years, or about 20 tax waivers
renewed per year by various states (0.4
tax waiver renewals per year per state).
Please note that the proposed waiver
requirements are minimal, as states are
already required to monitor and update
their tax waivers to ensure compliance
with federal requirements.
We estimate it would take 2 hours at
$37.60/hr for a healthcare support
worker to prepare and submit an
updated tax waiver. In aggregate we
estimate an ongoing annual burden of
40 hours (20 tax waiver renewals per
year × 2 hr/renewal) at a cost of $1,504
(40 hr × $37.60/hr) or $30 per state
($1,504/51).
2. ICRs Regarding State Plan
Requirements (§§ 447.252 and 447.302)
The following proposed changes will
be submitted to OMB for approval under
control number 0938–0193 (CMS–179).
Subject to renewal, the control number
is currently set to expire on April 30,
2022. It was last approved on April 9,
2019, and remains active.
E:\FR\FM\18NOP2.SGM
18NOP2
63767
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
The proposed changes to §§ 447.252
and 447.302 would require that states
provide additional descriptors for any
proposed supplemental payments and
would put a 3-year limit on the duration
of all prospectively approved
supplemental payments, with a
transition period for states to seek
renewal of currently approved
supplemental payments in accordance
with the proposed requirements, if the
state desires to continue the
supplemental payment. States would
need to provide the additional
descriptors to receive state plan
authority to disburse their proposed
supplemental payments. Consequently,
currently approved supplemental
payment-related SPAs would have to be
updated by adding the descriptors, as
outlined in section II.A.13. of this
proposed rule, state plan requirements
(§ 447.252), and in § 447.252(d) of the
regulatory text. Supplemental payments
are presently authorized through the
SPA process with CMS.
The ongoing burden associated with
the proposed requirements consists of
the time it would take each of the 50
state Medicaid programs, the District of
Columbia, and the territories Puerto
Rico, US Virgin Islands, and Guam
(hereinafter, ‘‘states’’) to specify six (6)
descriptors for all applicable SPAs that
provide or would provide for a
supplemental payment. The territories
the Commonwealth of the Northern
Mariana Islands (CNMI) and American
Samoa have been excluded to the extent
that Medicaid services are provided
under section 1902(j) waiver. The
additional SPA descriptors include: (1)
An explanation of how the state plan or
SPA will result in payments that are
consistent with section 1902(a)(30)(A) of
the Act; (2) the criteria to determine
which providers are eligible to receive
the supplemental payment; (3) a
comprehensive description of the
methodology used to calculate the
amount of, and distribute, the
supplemental payment to each eligible
provider, including all of the following:
The amount of the supplemental
payment made to each eligible provider,
if known, or, if the total amount is
distributed using a formula based on
data from one or more fiscal years, the
total amount of the supplemental
payments for the fiscal year or years
available to all providers eligible to
receive a supplemental payment, if
applicable, the specific criteria with
respect to Medicaid service, utilization,
or cost data from the proposed SPA year
to be used as the basis for calculations
regarding the amount and/or
distribution of the supplemental
payment, the timing of the
supplemental payment to each eligible
provider, an assurance that the total
Medicaid payment to an inpatient
hospital provider, including the
supplemental payment, will not exceed
the upper limits specified in § 447.271,
and if not already submitted, a UPL
demonstration as required by § 447.272
and described in § 447.288; (4) the
duration of the supplemental payment
authority (not to exceed 3 years); (5) a
monitoring plan to ensure that the
supplemental payment remains
consistent with the requirements of
section 1902(a)(30)(A) of the Act and to
enable evaluation of the effects of the
supplemental payment on the Medicaid
program, for example, with respect to
providers and beneficiaries; and (6) for
a SPA proposing to renew a
supplemental payment for a subsequent
approval period, an evaluation of the
impacts on the Medicaid program
during the current or most recent prior
approval period, for example, with
respect to providers and beneficiaries,
and including an analysis of the impact
of the supplemental payment on
compliance with section 1902(a)(30)(A)
of the Act.
We have attempted to mitigate any
new burden by identifying the essential
descriptors that are necessary during a
SPA review of proposed state
supplemental payments. The more
information and transparency provided
with the SPA to implement new, or
renew existing, supplemental payments
will reduce the number of questions and
requests for additional information from
CMS, and therefore, could result in
more expedited approval along with
increased economy and efficiency of the
Medicaid program.
To estimate the overall burden of
adding the descriptors to all
supplemental payment-related SPAs we
considered the total nationwide number
of active supplemental payments by
states reporting for the current 8 UPL
demonstration service types for the
period 2015–2017 (3 years) in the
proposed 6 UPL service types (see Table
2, line A): (1) Nursing facility; (2)
outpatient hospital; (3) inpatient
hospital; (4) ICF/IID; (5) IMD; and (6)
physician services excluding PRTF and
clinic.
As indicated, the total number of
states reporting supplemental payment
methodologies in the UPL
demonstrations in the Medicaid
program for the following service types
are: 37 for inpatient hospital services
(IP); 29 for outpatient facility services
(OP); 49 for nursing facility services
(NF); 8 for ICF/IIDs (ICF); 0 for IMDs
(IMD); and 17 for physician services
(Phys). We recognize that there are often
more than one supplemental payment
SPA per state for each service type,
especially for states with more providers
and service types like inpatient
hospitals and nursing facilities, while
IMDs have no supplemental payments,
and therefore, no SPAs to renew or
submit. To account for this we
multiplied the number of states
reporting each service type by 2
(approximately 2 SPAs per year for each
service type) to estimate the total
number of SPAs submitted by the states.
In this regard, the total number of
SPAs is estimated to be 280 (Table 2,
line B) or 5.19 (line C) per state (280
SPAs/54 states and territories). We
estimate that each SPA is renewed every
2.5 years (half of the time required in
this proposed rule), for 2.08 (5.19 SPAs
per state/1 SPA renewal every 2.5 years)
SPA renewals per state per year.
TABLE 2—STATE REPORTING OF SUPPLEMENTAL PAYMENT METHODOLOGIES IN THE UPL DEMONSTRATIONS
UPL demonstration types
IP
A. Supplemental Payment Methodologies reported by States
B. SPA multiplier × 2 .................................................................
C. SPAs needed to be renewed per year per state (B/54
states) ....................................................................................
We estimate it would take 30
additional minutes (0.5 hr) at $48.48/hr
for a social science research assistant
(technical staff) to add all 6
supplemental payment SPA
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
OP
NF
ICF
Frm 00047
Phys
Total
37
74
29
58
49
98
8
16
0
0
17
34
140
280
1.37
1.07
1.81
0.30
0.00
0.67
5.19
components from §§ 447.252 and
447.302 for each SPA submission,
noting that a comprehensive payment
methodology is currently required for
all SPA submissions. In aggregate, we
PO 00000
IMD
Fmt 4701
Sfmt 4702
estimate an annual burden of 56.2 hours
(2.08 SPA renewals per state per year ×
0.5 hr for additional descriptors × 54
states and territories) at a cost of $2,725
(56.2 hr × $48.48/hr). This estimate
E:\FR\FM\18NOP2.SGM
18NOP2
63768
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
factors in the burden associated with
supplemental payment SPAs for the 6
service types mentioned above and
summarized in Table 2. Per state, we
estimate an average annual burden of
1.0 hours (56.2 hr/54 states and
territories) at a cost of $50 ($2,725/54
states and territories).
3. ICRs Regarding Reporting for UPL
Demonstrations and Supplemental
Payments (§ 447.288)
The following proposed changes will
be submitted to OMB for approval under
control number 0938–1148 (CMS–10398
#13 and #24). Subject to renewal, the
control number is currently set to expire
on March 31, 2021. It was last approved
on March 1, 2018, and remains active.
Section 447.288 of this rule proposes
to codify our current policy of requiring
states and territories to submit annual
UPL demonstrations.
While the territories Puerto Rico, US
Virgin Islands, and Guam are included
in this estimate, the Commonwealth of
the Northern Mariana Islands (CNMI)
and American Samoa have been
excluded from this estimate because
they provide Medicaid services under
section 1902(j) waivers. The proposed
rule would also add quarterly reporting
requirements (§ 447.288(c)(1)) that
would provide data on each provider
receiving a supplemental payment, the
amount of payment(s), and the state
plan/demonstration authority
authorizing the payment. The proposed
rule would also require an aggregate
report (§ 447.288(c)(2)) of all providers
receiving supplemental payments that
totals all of the supplemental payments
providers receive during the year plus
all Medicaid payments, and Medicaid
utilization data. Lastly, the rule would
also require a report (§ 447.288(c)(3)) of
all of those providers contributing to the
state’s non-federal share for any
supplemental payment, the state plan/
demonstration authority authorizing the
payment, and the amount of the
payment(s).
(1) UPL Demonstrations
The currently approved burden
associated with the requirements we are
revising and putting into regulation in
this proposed rule, consists of the time
it would take each of the 56 Medicaid
programs (50 states, 5 territories, and
the District of Columbia) to submit
annual UPL demonstrations and report
supplemental payments for: Inpatient
hospital; outpatient hospital; nursing
facilities; PRTF; clinic services; other
inpatient & outpatient facility providers
(commonly known as physician
services); ICF/IID; and institutions for
mental disease (IMD) on the currently
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
approved (hereinafter, ‘‘active’’) UPL
templates that are set out under CMS–
10398 #13 and #24.
This proposed rule would reduce
burden by eliminating the UPL
demonstrations for three service types
PRTF, clinic services, and other
inpatient & outpatient facility providers
(physician services) and by eliminating
2 territories from reporting any of the
items required under § 447.288. It also
proposes to codify the requirements for
states to annually report UPL
demonstrations as discussed in SMDL
#13–003 (March 18, 2013),11 which was
associated with OMB approved
templates (OMB Control Number 0938–
1148) and collection of information
requirements approved by OMB under
control number 0938–1148 (CMS–10398
#13 and 24).
For CMS–10398 #13 (Medicaid
Accountability—Nursing Facility,
Outpatient Hospital and Inpatient
Hospital Upper Payment Limits)
eliminating 2 territories from this
reporting would reduce our active
burden estimates by ¥80 hours (40 hr/
response × ¥2 responses) for a burden
reduction of $3,057 ([30 hr × ¥2
responses × $32.44/hr for a data entry
keyer] + [9 hr × ¥2 responses × $48.48/
hr for a social science research assistant]
+ [1 hr × ¥2 responses × $119.12/hr for
a general and operations manager]).
For CMS–10398 #24 (Medicaid
Accountability—Upper Payment Limits
ICF/IID, Clinic Services, Medicaid
Qualified Practitioner Services and
Other Inpatient & Outpatient Facility
Providers) this would reduce our active
burden by ¥80 hours (40 hr/response ×
¥2 responses) at a cost of ¥$3,057 ([30
hr × ¥2 responses × $32.44/hr for a data
entry keyer] + [9 hr × ¥2 responses ×
$48.48/hr for a social science research
assistant] + [1 hr × ¥2 responses ×
$119.12/hr for a general and operations
manager]).
For CMS–10398 #24 this rule would
also reduce our active burden by
eliminating 3 of the 5 UPL
demonstrations for the service types
PRTF, Clinic Services, and Medicaid
Qualified Practitioner Services and
Other Inpatient & Outpatient Facility
Providers (commonly referred to as the
physician ACR). This would reduce our
active burden estimates by ¥1,296
hours (8 hr/response × 3 service types
× 54 states) for a savings of $49,528 ([18
hr × ¥54 states × $32.44/hr for a data
entry keyer] + [5.4 hr × ¥54 states ×
11 Center for Medicaid and CHIP Services, RE:
Federal and State Oversight of Medicaid
Expenditures, State Medicaid Director’s letter SMD
#13–003, accessed 4/9/2019: https://
www.medicaid.gov/Federal-Policy-Guidance/
Downloads/SMD-13-003-02.pdf.
PO 00000
Frm 00048
Fmt 4701
Sfmt 4702
$48.48/hr for a social science research
assistant] + [0.6 hr × ¥54 states ×
$119.12/hr for a general and operations
manager]). This proposed action would
thereby eliminate the PRTF, Clinic
Services, and Medicaid Qualified
Practitioner Services and Other
Inpatient & Outpatient Facility
Providers (commonly referred to as
physician ACR) templates along with
the guidance and instruction documents
that are associated with the templates.
As indicated, the proposed burden
changes will be submitted to OMB for
approval under control number 0938–
1148 (CMS–10398 #13 and #24). Since
the proposed requirements impact two
information collection requests (#13 and
#24), we estimate a total burden
reduction of ¥1,456 hours (¥80 hr ¥80
hr ¥1,296 hr) for a savings of $55,642
(¥$3,057 ¥$3,057 ¥$49,528).
(2) Quarterly Reporting of Expenditures
Claimed for Each Supplemental
Payment (§ 447.288(c)(1))
In addition to the data already
collected in the aggregate for all
supplemental payments and required
annually for UPL demonstrations under
the CMS–10398 #13 and #24, this
proposed rule would require that states
report information quarterly on
expenditures claimed for each
supplemental payment made under
state plan or demonstration authority
including: (1) The SPA transaction
number or demonstration authority
number which authorizes the payment;
(2) a listing of each provider that
received a payment under each
authority by the specialty type (if
applicable, for example, CAH, pediatric
hospital, or teaching hospital); (3) the
specific amount of the supplemental
payment paid to each provider
including the total payment made to the
provider authorized under the specified
state plan; and (4) the total Medicaid
payment made to the provider under the
specified demonstration authority.
This rule would add quarterly data
reported to CMS in the form of 5 new
templates mirroring the UPL
demonstrations reporting by service
type of the provider. For CMS–10398
#13, this would consist of quarterly
report templates for: Nursing facilities,
outpatient hospitals, and inpatient
hospitals. For CMS–10398 #24,
quarterly report templates would be
added for: ICF/IID and IMD.
The quarterly reports would be
required at the time the state submits its
quarterly CMS–64 (OMB control
number 0938–1265) pursuant to
§ 430.30(c), consisting of provider level
information on all providers receiving
supplemental payments, including 11
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
data elements consisting of 8
demographic elements and 3 elements
specific to supplemental payments (see
(§ 447.288(c)(1))). The 8 demographic
elements of each provider that received
a supplemental payment under each
authority consist of: (1) The provider’s
legal name; (2) the physical address of
the location or facility where services
are provided, including street address,
city, state, and ZIP code; (3) the NPI; (4)
the Medicaid identification number; (5)
the EIN; (6) the service type for which
the reported payment was made;(7) the
provider specialty type (if applicable,
for example, CAH, pediatric hospital, or
teaching hospital); and (8) the provider
category (that is, state government, nonstate government, or private). The 3
supplemental payment elements for
payments paid to each provider consist
of the specific amount of the
supplemental payment made to the
provider, including: (1) SPA transaction
number or demonstration authority
number which authorizes the
supplemental payment; (2) the total
supplemental payment made to the
provider authorized under the specified
state plan; (3) the total Medicaid
supplemental payment made to the
provider under the specified
demonstration authority, as applicable.
For the supplemental payment
quarterly reports, annually we estimate
it will take 20 seconds at $32.44/hr for
a data entry keyer to query states’ MMIS
system and/or copy and paste each data
element into the required format for
reporting. The initial quarterly report
would require the full set of 11 data
elements for each provider receiving a
supplemental payment with a burden of
449 hours (7,341 providers with
supplemental payments × 11 data
elements × 1 report/year × 20 seconds/
3,600 seconds in an hour) and a cost of
$14,566 (449 hr × $32.44/hr).
The three (3) subsequent quarterly
reports would only require reporting of
the three (3) supplemental payment data
elements since the eight (8)
demographic data elements would have
already been reported in the initial
quarterly report. The burden associated
with the subsequent reports consists of
367 hours (7,341 providers with
supplemental payment × 3 data
elements × 3 reports/year × 20 seconds/
3,600) at a cost of $11,906 (367 hr ×
$32.44/hr).
In aggregate, we estimate a burden of
816 hours (449 hr + 367 hr) at a cost of
$26,472 ($14,566 + $11,906).
We also expect oversight by social
science research assistants and general
operations managers for each of the
supplemental payment quarterly
reports. We estimate it would take 1
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
hour at $48.48/hr for a social science
research assistant and 30 minutes (0.5
hr) for a general operations manager at
$119.12/hr to review each of the reports.
In this regard we estimate an annual
burden of 306 hours ([1 hr × 4 reports
× 51 states] + [0.5 hr × 4 reports × 51
states]) at a cost of $22,040 ([1 hr × 4
reports × 51 states × $48.48/hr] + [0.5 hr
× 4 reports × 51 states × $119.12/hr]).
Given the aforementioned burden
estimates, we estimate a total of 1,140
hours (816 hr + 324 hr) at a cost of
$49,797 ($26,460 + $23,337) for all of
the information collection requests with
quarterly reporting, including all 5 new
templates. Per state we estimate 21.1
hours (1,140 hrs/54 states) and $922
(49,797/54 states) for all quarterly
reporting.
As indicated, the proposed
requirements and burden will be
submitted to OMB for approval under
control number 0938–1148 (CMS–10398
#13 and #24). Since the proposed
requirements would impact two
information collection requests (CMS–
10398 #13 and #24), the annual
quarterly reporting burden for each is
broken down here: For CMS–10398 #13
(new quarterly report templates for
inpatient hospitals, outpatient hospitals,
and nursing facilities) it is 1,108 hours
(1,122 hr × 0.97 12) at a cost of $48,433
($49,797 × 0.97); for CMS–10398 #24
(new quarterly report templates for ICF/
IID and IMD) the burden is 31.2 hours
(1,122 hr × 0.027 13) at a cost of $1,363
($49,797 × 0.027).
(3) Utilization Reporting Template and
Guidance Documents (§ 447.288(b)(2))
Annually, the proposed reporting of
the specific amount of Medicaid
payments made to each provider would
include: (1) The total FFS base
payments made to the provider
authorized under the state plan; (2) the
total Medicaid payments made to the
provider under demonstration authority;
(3) the total payment or funds received
from Medicaid beneficiary cost-sharing
requirements, donations, and any other
funds received from third parties to
support the provision of Medicaid
services; (4) the total supplemental
payment made to the provider
authorized under the specified state
plan; (5) the total Medicaid
supplemental payment made to the
provider under the specified
demonstration authority, and the total
Medicaid payments made to the
provider as reported in the above areas;
12 97% of UPL providers receiving supplemental
payments are IP, OP, and NF provider types.
13 2.7% of UPL providers receiving supplemental
payments are ICF and IMD provider types.
PO 00000
Frm 00049
Fmt 4701
Sfmt 4702
63769
(6) the total DSH payments made to the
provider; and (7) the Medicaid units of
care (for example, on a provider-specific
basis, total Medicaid discharges, days of
care, or any other measures as specified
by the Secretary).
A utilization report by provider
service type would be required annually
by states in this proposed rule, which
includes all of the providers reported in
the Supplemental Payments Reporting
Templates (that is, all providers
receiving supplemental payments), and
reports all base payments, DSH
payments, and additional utilization
data from those providers. This
Utilization Report includes all base
payments made to each provider in the
state, with the addition of DSH and
Medicaid utilization data (23 data
elements consisting of 9 demographic
elements previously reported in the
quarterly reports, 10 new elements
specific to supplemental and other
payments, and 4 new utilization
elements).
The 9 demographic elements, linked
to the same 8 elements in the quarterly
reports plus 1 element stating the dates
of the supplemental payment period, all
covering the same providers in each
service type, that received a
supplemental payment under each
authority listed in § 447.288(c)(1)
including: (1) The provider’s legal
name; (2) the physical address of the
location or facility where services are
provided, including street address, city,
state, and ZIP code; (3) the NPI; (4) the
Medicaid identification number; (5) the
EIN; (6) the service type for which the
reported payment was made; (7) the
provider specialty type (if applicable,
for example, CAH, pediatric hospital, or
teaching hospital); (8) the provider
category (that is, state government, nonstate government, or private); and (9) the
state reporting period (state fiscal year
start and end dates).
The 14 supplemental payment
elements for Medicaid payments made
to each provider consist of the
following, as applicable: (1) The SPA
transaction number or demonstration
authority number which authorizes the
supplemental payment; The specific
amount of Medicaid payments made to
each provider, including, as applicable;
(2) the total FFS base payments made to
the provider authorized under the state
plan; (3) the total Medicaid payments
made to the provider under
demonstration authority; (4) the total
payment or funds received from
Medicaid beneficiary cost-sharing
requirements; (5) the total payment or
funds received from Medicaid
donations; (6) the total of any other
funds received from third parties to
E:\FR\FM\18NOP2.SGM
18NOP2
63770
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
support the provision of Medicaid
services; (7) the total supplemental
payment made to the provider
authorized under the specified state
plan; (8) the total Medicaid
supplemental payment made to the
provider under the specified
demonstration authority; (9) the total
Medicaid payments made to the
provider as reported above (summation
of 2–8 above); and (10) the total DSH
payments made to the provider. The 4
utilization elements are comprised of:
Up to four (11. through 14.) Medicaid
unit of care metrics (for example, on a
provider-specific basis, total Medicaid
discharges, days of care, or any other
measures as specified by the Secretary).
There are a total of 14 new data
elements. The eight demographic
elements and the SPA transaction
number or demonstration authority
number which authorizes the
supplemental payment were reported
during the previous quarterly CMS–64
reports submitted during the year, and
therefore, are not counted in the
collection of information here.
For the annual utilization report we
estimate it would take 20 seconds at
$32.44/hr for a data entry keyer to query
states’ MMIS system and/or copy and
paste each data element into the
required format for reporting. The
burden associated with preparing and
submitting the annual report consists of
571 hours (7,341 providers reported
with supplemental payments in the UPL
demonstration × 14 new data elements
× 1 report/year × 20 seconds/3,600
seconds per hour) at a cost of $18,523
(571 hr × $32.44/hr).
Additionally, we estimate oversight
by social science research assistants and
general operations managers for the
utilization annual report. We estimate it
would take 1.5 hours at $48.48/hr for a
social science research assistant and 1
hour at $119.12/hr for a general
operations manager to review the report.
In this regard we estimate an annual
burden of 135 hours ([1.5 hr × 1 report
× 54 states] + [1 hr × 1 report × 54
states]) at a cost of $10,359 ([1.5 hr × 1
report × 54 states × $48.48/hr] + [1 hr
× 1 report × 54 states × $119.12/hr]).
Given the aforementioned burden
estimates, we estimate a total of 706
hours (571 hr + 135 hr) at a cost of
$28,882 ($18,522 + $10,359) for all
information collection for the utilization
report. Per state, this amounts to 13.1
hours (706 hrs/54 states) at a cost of
$535 ($28,882/54 states).
Since the proposed requirements
impact two information collection
requests (CMS–10398 #13 and #24), we
break down the cost to each, as above.
The burden for CMS–10398 #13 is 687
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
hours (706 hr × 0.97) at a cost of $28,091
($28,882 × 0.97). For CMS–10398 #24
the burden is 19.3 hours (706 hr × 0.027)
at a cost of $791 ($28,882 × 0.027).
(4) Annual Non-Federal Share Reporting
(§ 447.288(c)(3))
Section 447.288(c)(3), proposes to
require that each state submit an annual
report of the aggregate and providerlevel information on each provider
contributing to the state or any local
unit of government any funds that are
used as a source of the non-federal share
for any Medicaid supplemental
payment, including 17 data elements
consisting of: 8 new demographic
elements; 8 new supplemental and other
payment elements; and 1 new
summation element.
The 8 demographic elements of each
provider that received a non-federal
share for any Medicaid supplemental
payment under each authority listed in
§ 447.288(a) include: (1) The service
type for which the reported payment
was made; (2) the provider specialty
type (if applicable, for example, CAH,
pediatric hospital, or teaching hospital)
(3) the provider’s legal name; (4) the
physical address of the location or
facility where services are provided,
including street address, city, state, and
ZIP code; (5) the NPI; (6) the Medicaid
identification number; (7) the EIN; and
(8) the provider category (that is, state
government, non-state government, or
private).
The 8 supplemental and other
payment elements are comprised of: (1)
The total FFS base payments made to
the provider authorized under the state
plan; (2) the total FFS supplemental
payments made to the provider
authorized under the state plan; (3) the
total Medicaid payments made to the
provider under demonstration authority;
(4) the total DSH payments made to the
provider; (5) the total of each health
care-related tax collected from the
provider by any state authority or local
unit of government; (6) the total of any
costs certified as a CPE by the provider;
(7) the total amount contributed by the
provider to the state or a unit of local
government entity in the form of an IGT;
and (8) the total of provider-related
donations made by the provideror by
entities related to a health care provider,
including in-cash and in-kind
donations, to the state or unit of local
government, including state university
teaching hospitals.
The summation element would
require: (1) The total funds contributed
by the provider (that is, CPEs, IGTs,
provider taxes, donations, and any other
funds contributed) as reported under the
PO 00000
Frm 00050
Fmt 4701
Sfmt 4702
supplemental and other payment
elements.
For the annual non-federal share
report we estimate that all providers
will contribute to the non-federal share.
We believe this to be an overestimate,
but this is the only estimate we have at
this time using the UPL demonstration
data that we have available. We also
estimate that it would take 20 seconds
at $32.44/hr for a data entry keyer to
query states’ MMIS system and/or copy
and paste each of the 17 data elements
into the required format for reporting.
The burden associated with preparing
and submitting the annual report
consists of 2,666 hours (28,232 total
providers × 17 data elements × 1 report/
year × 20 seconds/3,600 seconds per
hour) at a cost of $86,485 (2,666 hr ×
$32.44/hr).
Additionally, we estimate oversight
by social science research assistants and
general operations managers for the
non-federal share annual report. We
estimate it would take 4 hours at
$48.48/hr for a social science research
assistant and 2 hours at $119.12/hr for
a general operations manager to review
the report. In this regard we estimate an
annual burden of 324 hours ([4 hr × 1
report × 54 states] + [2 hr × 1 report ×
54 states]) at a cost of $23,337 ([4 hr ×
1 report × 54 states × $48.48/hr] + [2 hr
× 1 report × 54 states × $119.12/hr]).
Given the aforementioned burden
estimates, we estimate a total of 2,990
hours (2,666 hr + 324 hr) at a cost of
$109,833 ($86,497 + $23,337) for all
information collection requests for the
non-federal share report. Per state, this
amounts to 55.4 hours (2,990 hr/54
states) at a cost of $2,034 ($109,833/54
states).
Since the proposed requirements
impact two information collection
requests (CMS–10398 #13 and #24), the
burden for CMS–10398 #13 is 2,617
hours (2,990 hr × 0.875 14) at a cost of
$94,427 ($109,833 × 0.875). For CMS–
10398 #24 the burden is 373.5 hours
(2,990 hr × 0.125 15) at a cost of $13,717
($109,833 × 0.13).
4. ICRs Regarding DSH Reporting
Requirements (§ 447.299)
The following proposed changes will
be submitted to OMB for approval under
control number 0938–0746 (CMS–R–
266). Subject to renewal, the control
number is currently set to expire on
April 30, 2022. It was last approved on
April 9, 2019, and remains active.
Under § 447.299 this proposed rule
would require states to provide an
14 87.5% of all UPL providers reported are IP, OP,
and NF provider types.
15 12.5% of all UPL providers reported are ICF &
IMD.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
additional data element as part of its
annual DSH audit report. This
additional element would require a state
auditor to quantify the financial impact
of any audit finding not captured within
any other data element under
§ 447.299(c), which may affect whether
each hospital has received DSH
payments for which it is eligible within
its hospital-specific DSH limit.
If the auditor is unable to determine
the actual financial impact amount of an
audit finding, the auditor would be
required to provide a statement of the
estimated financial impact for each
audit finding identified in the
independent certified audit.
The proposed additional data element
requires auditors to indicate the
financial impact of all findings rather
than indicating that the financial impact
of any finding is unknown. We believe
the additional burden associated with
the new data element would be minimal
given that auditors are already engaged
in a focused review of available
documentation to quantify the aggregate
amounts that comprise each of the
existing data elements required under
§ 447.299(c).
The burden consists of the time it
would take each of the states to quantify
any audit finding identified during the
independent certified audit required
under section 1923(j)(2) of the Act. The
territories have been excluded from this
proposed requirement since they do not
receive a DSH allotment under section
1923(f) of the Act.
To estimate the overall burden of
adding this new data element to the
reporting requirement, we considered
the number of annual independent
certified audits received by CMS in
addition to the number of unquantified
audit findings.
This rule would require the
submission of data in an electronic
spreadsheet format that would take
approximately 2 hours, consisting of: 1
hour at $111.14/hr for management and
professional staff to review the report
63771
and 1 hour at $74.60/hr for a financial
specialist to prepare the report. In
aggregate we estimate an ongoing
annual burden of 102 hours (51 states ×
2 hr/response × 1 response/year) at a
cost of $9,473 ((51 states × [(1 hr
$111.14/hr) + (1 hr × $74.60/hr)] or $186
per state ($9,473/51 states). Additionaly
we anticipate that a state auditor would
have to spend an additional hour
quantifying the financial impact of DSH
findings that are classified as unknown.
The estimated annual burden would be
1 hour per state (51 states × 1 hour) 51
hours × 75.78/hr for auditors to
complete the audit at a cost of $3,865
per year (51 states × 1 hour × $75.78 per
hour). The total cost of this proposed
rule would be $13,338 ($9,473 + $3,865)
and 153 hours or $262 per state and 3
hours per state.
C. Summary of Annual Burden
Estimates for Proposed Requirements
Table 3 summarizes the burden for
the aforementioned proposed provisions
TABLE 3—PROPOSED ANNUAL RECORDKEEPING AND REPORTING REQUIREMENTS
Regulation section(s)
under title 42 of the CFR
§ 443.72
tax waiver ......
§§ 447.252 and 447.302
§ 447.288 UPL demo.
(IP, OP, NF).
§ 447.288 UPL demo.
(ICF, IMD).
§ 447.288 SP quarterly
reports (IP, OP, NF).
§ 447.288 SP quarterly
reports (ICF, IMD).
§ 447.288 Utilization annual report (IP, OP,
NF).
§ 447.288 Utilization annual report (ICF, IMD).
§ 447.288 Non-federal
share annual report
(IP, OP, NF).
§ 447.288 Non-federal
share annual report
(ICF, IMD).
§ 447.299 DSH audit ....
Total .........................
OMB control No.
(CMS ID No.)
0938–0618
148).
0938–0193
0938–1148
#13).
0938–1148
#24).
0938–1148
#13).
0938–1148
#24).
0938–1148
#13).
Respondents
Total
responses
Burden per
response
(hours)
Total annual
burden
(hours)
Labor costs
of reporting
Total cost
($)
(CMS–R–
51
0.4
20
2
40
37.60
1,504
(CMS–179) ..
(CMS–10398
54
5
1.9
¥5
126
¥10
0.5
8
63.2
¥80
48.48
varies
3,064
¥3,057
(CMS–10398
5/51
¥5/¥3
¥10/¥162
8/8
¥80/¥1296
varies
¥3,057/¥49,528
(CMS–10398
54
20
1,080
varies
1108
varies
48,433
(CMS–10398
54
20
1,080
varies
31
varies
1,363
(CMS–10398
54
14
756
varies
687
varies
28,091
0938–1148 (CMS–10398
#24).
0938–1148 (CMS–10398
#13).
54
14
756
varies
19
varies
791
54
17
918
varies
2,617
varies
94,427
0938–1148 (CMS–10398
#24).
54
17
918
varies
374
varies
13,717
0938–0746 (CMS–R–
266).
51
1
51
3
153
varies
13,338
varies
95
5,787
varies
3,637
varies
145,221
........................................
For all parts of this proposed rule, we
estimate there would be a total
nationwide burden of 3,637 hours at a
cost of $145,221 and an average of 67
hours (3,637 hr/54 states) at a cost of
$2,847 per state Medicaid agency per
year ($145,221/54 states).
D. Requirements Not Subject to the PRA
The following regulatory sections
propose changes to definitions, policy
guidance, and clarifications of existing
statutes or regulatory provisions. The
changes do not have any collection of
VerDate Sep<11>2014
Responses
(per state)
17:00 Nov 15, 2019
Jkt 250001
information implications, and therefore,
are not subject to the requirements of
the PRA: §§ 430.42 (Disallowance of
claims for FFP), 433.51 (State share of
financial participation), 433.52 (General
definitions), 433.54 (Bona fide
donations), 433.55 (Health care-related
taxes defined), 433.56 (Classes of health
care services and providers defined),
433.68 (Permissible health care-related
taxes), 433.72 (Waiver provisions
applicable to health care-related taxes),
433.316 (When Discovery of
PO 00000
Frm 00051
Fmt 4701
Sfmt 4702
Overpayment occurs and its
Significance), 447.201 (State plan
requirements), 447.207 (Retention of
payments), 447.272 (Inpatient services:
Application of UPLs), 447.284 (Basis
and purpose), 447.286 (Definitions),
447.290 (Failure to Report Required
Information), 447.297 (Limitations on
aggregate payments for DSHs beginning
October 1, 1992), 447.321 (Outpatient
hospital services: Application of UPLs),
455.301 (Definitions), 455.304
(Condition for FFP), and 457.609
E:\FR\FM\18NOP2.SGM
18NOP2
63772
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
(Process and calculation of state
allotments for a fiscal year after FY
2008).
E. Submission of PRA-Related
Comments
We have submitted a copy of this
proposed rule to OMB for its review of
the rule’s ICRs. The requirements are
not effective until they have been
approved by OMB.
To obtain copies of the supporting
statement and any related forms for the
proposed collections discussed above,
please visit the CMS website at
www.cms.hhs.gov/
PaperworkReductionActof1995, or call
the Reports Clearance Office at 410–
786–1326.
We invite public comments on these
potential ICRs. If you wish to comment,
please submit your comments
electronically as specified in the DATES
and ADDRESSES section of this proposed
rule and identify the rule (CMS–2393–
P) the ICR’s CFR citation, and OMB
control number.
V. Regulatory Impact Analysis
A. Statement of Need
This proposed rule would impact
states’ reporting on payment methods
and procedures to assure consistency
with efficiency, economy, and quality of
care as required by section
1902(a)(30)(A) of the Act. CMS, and
other federal oversight entities, have
found that current regulations and
guidance do not adequately assure that
states are complying with the efficiency,
economy and quality of care
requirements of section 1902(a)(30)(A)
of the Act, and this rule is intended to
address those deficiencies. We view this
proposed rule as one approach to add
additional accountability and
transparency for Medicaid payments,
and to provide CMS with certain
information on supplemental payments
to Medicaid providers, including
supplemental payments approved under
either Medicaid state plan or
demonstration authority, establish new
state plan requirements for amendments
proposing supplemental payments, and
otherwise ensure the proper and
efficient operation of the Medicaid state
plan. This proposed rule would address
the funding of these supplemental and
other Medicaid payments through
states’ uses of health care-related taxes
and bona fide provider-related
donations.
Medicaid DSH payments and
requirements are addressed in this
proposed rule. We propose to add
additional specificity to the reporting
requirements of the annual DSH audit
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
conducted by an independent auditor to
enhance federal oversight of the
Medicaid DSH program. Additionally,
we seek to improve the accurate
identification of and collection efforts
related to overpayments identified
through the annual DSH independent
certified audits by specifying the date of
discovery and standards for
redistribution of DSH payments made to
providers in excess of the hospitalspecific limit.
The proposed rule also seeks to
alleviate the administrative burden of
publishing the annual DSH and CHIP
allotments in the Federal Register, of
which we simultaneously notify states
directly by providing notification
through other, more practical means.
Finally, we propose changes to the
disallowance reconsideration
procedures in order to modernize the
process by relying on an electronic,
rather than a hard-copy paper process.
B. Overall Impact
We have examined the impacts of this
proposed rule as required by Executive
Order 12866 on Regulatory Planning
and Review (September 30, 1993),
Executive Order 13563 on Improving
Regulation and Regulatory Review
(January 18, 2011), the Regulatory
Flexibility Act (RFA) (September 19,
1980, Pub. L. 96–354), section 1102(b) of
the Act, section 202 of the Unfunded
Mandates Reform Act of 1995 (March
22, 1995; Pub. L. 104–4), Executive
Order 13132 on Federalism (August 4,
1999), and Executive Order 13771 on
Reducing Regulation and Controlling
Regulatory Costs (January 30, 2017).
Executive Orders 12866 and 13563
direct agencies to assess all costs and
benefits of available regulatory
alternatives and, if regulation is
necessary, to select regulatory
approaches that maximize net benefits
(including potential economic,
environmental, public health and safety
effects, distributive impacts, and
equity). Section 3(f) of Executive Order
12866 defines a ‘‘significant regulatory
action’’ as an action that is likely to
result in a rule: (1) Having an annual
effect on the economy of $100 million
or more in any 1 year, or adversely and
materially affecting a sector of the
economy, productivity, competition,
jobs, the environment, public health or
safety, or state, local or tribal
governments or communities (also
referred to as ‘‘economically
significant’’); (2) creating a serious
inconsistency or otherwise interfering
with an action taken or planned by
another agency; (3) materially altering
the budgetary impacts of entitlement
grants, user fees, or loan programs or the
PO 00000
Frm 00052
Fmt 4701
Sfmt 4702
rights and obligations of beneficiaries
thereof; or (4) raising novel legal or
policy issues arising out of legal
mandates, the President’s priorities, or
the principles set forth in the Executive
Order.
We estimate these provisions to meet
the criteria for economic significance
based upon the analysis of certain
provisions in the proposed rule, as
discussed in more detail below. The
proposed reporting requirements largely
contain data already available to states
in their own fiscal management and
claims processing systems, and merely
requires states to report the data to us.
Additional information on setting goals
for supplemental payments and
evaluating the positive and negative
aspects of these goals over time, while
these requirements are consistent and
necessary to ensure compliance with
section 1902(a)(30)(A) of the Act, which
requires payments be consistent with
efficiency, economy, and quality of care,
they will require state Medicaid
programs to develop and consider
various compliance options. Moreover,
the reporting requirements and
supplemental payment evaluations are
generally consistent with current state
oversight and review activities of each
state’s Medicaid program, and states
have the flexibility within their reviews
to use their existing data or build upon
that data when reviewing supplemental
payments to providers, in order to
formulate goals and evaluate the
effectiveness of these payments. In fact,
the policies in this proposed rule are
intended to focus on state efforts in
monitoring and overseeing data and
methodologies concerning supplemental
and other payments as well as sources
of non-federal share to enhance states’
ability to comply with section
1902(a)(30)(A) of the Act and our ability
to ensure such compliance.
C. Anticipated Effects
1. Effects of Reporting Requirements on
State Medicaid Programs
For all parts of this proposed rule we
estimate there would be a total
nationwide burden of 3,637 hours at a
cost of $145,221 and an average of 67
hours (3,637 hr/54 states) at a cost of
$2,847 per state Medicaid agency per
year ($145,221/54 states) per state and
District of Columbia Medicaid agency
per year (see section IV. of this proposed
rule, Collection of Information
Requirements, for details on this cost
assessment and a breakdown of the
burden from the various parts of this
proposed rule).
The proposed rule adds several
reporting requirements, including:
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
§§ 447.252 and 447.302, which would
add goals, evaluations, and 3-year
renewable authorizations on any
supplemental payment methodology,
providing a transition schedule for SPAs
to be updated. Section 447.288, would
add 4 quarterly reports with data on
expenditures claimed for each
supplemental payment made under
state plan or demonstration authority by
provider, and an annual report with 2
sections—one section with a roll up of
the quarterly data with added Medicaid
utilization measures and one section
with information on all providers
contributing to the state or any other
governmental entity any portion of the
non-federal share of the supplemental
payment and the total of their
contributions.
This regulation codifies states
reporting annual UPL demonstrations
that CMS discussed in an SMDL issued
on March 18, 2013 (SMDL #13–003)
regarding annual submission of
Medicaid UPLs. In this proposed rule,
§ 447.288(a) would decrease burden by
eliminating the UPL demonstrations for
three service types—PRTF, clinic
services, and other inpatient &
outpatient facility providers (physician
services), note that the UPL
demonstrations for the territories the
Commonwealth of the Northern Mariana
Islands (CNMI) and American Samoa
are excluded from this estimate because
they provide Medicaid services under
section 1902(j) waivers. This OMB
approved UPL demonstration (OMB
Control Number: 0938–1148, CMS–
10398 (#13) (#24)) will be updated
accordingly.
For § 447.206 on Payments funded by
CPEs made to providers that are units of
government, states would be required to
develop processes that are already used
by CMS and routinely asked of states to
comply with section 1902(a)(30)(A) of
the Act that requires Medicaid state
plan methods and procedures relating to
the payment for services that are
consistent with efficiency, economy,
and quality of care. These collections of
information are already routinely asked
of states under existing OMB control
numbers, so no additional burden or
economic impact is anticipated.
2. Effects on Small Businesses and
Other Providers
This rule establishes requirements
that are solely the responsibility of state
Medicaid agencies, which are not small
entities. Therefore, the Secretary
certifies this proposed rule would not,
if promulgated, have a significant
economic impact on a substantial
number of small entities.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
3. Effects on the Medicaid Program
The fiscal impact on the Medicaid
program from the implementation of the
policies in the proposed rule is
unknown. The provision that would
have the most direct impact on current
provider payments is the Medicaid
practitioner supplemental payment
requirements proposed in § 447.406. To
summarize, this provision would limit
Medicaid practitioner base plus
supplemental payments to 150 percent
of the FFS base payments authorized
under the state plan for the practitioner
services within a defined geographic
area that would otherwise be paid to the
targeted practitioners, or for services
provided within HRSA-designated
geographic HPSA or Medicare-defined
rural geographical areas, Medicaid
practitioner base plus supplemental
payments may not exceed 175 percent
of the FFS base payments authorized
under the state plan for the practitioner
services within a defined geographic
area that would otherwise be paid to the
targeted practitioners.
To analyze the impact of this
proposed change, CMS reviewed the
2017 Medicaid physician UPL
demonstrations which were submitted
by states that make supplemental
payments to physicians and other
practitioners. In 2017, 21 states made
approximately $478 million in
physician supplemental payments
compared with $512 million in
Medicaid FFS base payments to the
practitioners eligible to receive the
supplemental payments, which equals
$990 million in total payments for the
qualifying providers that received a
supplemental payment. To measure the
impact, we would multiply the total
Medicaid FFS base payments ($512
million) by 150 percent which would
equal $768 million in total Medicaid
FFS payments with the net Medicaid
physician supplemental payment
amount of $256 million. The estimated
impact of this proposed provision is a
reduction in payments of $222 million
in total computable Medicaid
reimbursement ($478 million minus
$256 million equals $222 million).
However, this potential decrease in
Medicaid reimbursements could be
mitigated if states take action to increase
Medicaid provider base payments,
which would thereby increase the
amount that could be paid out in
Medicaid practitioner supplemental
payments. Depending on state action in
response to this provision, we estimate
that the impact on Medicaid
reimbursements could range from $0 to
$222 million. Similarly, we do not have
sufficient data to predict or quantify the
PO 00000
Frm 00053
Fmt 4701
Sfmt 4702
63773
impact of the proposed provisions on
health-care related taxes, although we
would expect that states may modify
existing state tax policy or arrangements
where those taxes or arrangements
would be newly be considered healthcare related under the proposed
provisions. We invite comments from
states, providers, and other stakeholders
on the estimates and potential state
responses to these provisions. There are
some considerations that limit the effect
of the proposed change. First, the
proposed rule phases out these
supplemental payments over a 5 to 7year period based on when the
supplemental payment was last
approved. The supplemental payments,
as currently approved in the plan,
would begin to be incrementally
removed from the state plan after the
provision is finalized. Second, Medicaid
practitioner supplemental payments
would only be limited by the amount of
the Medicaid FFS base payments. If a
state wanted to increase the amount of
the supplemental payment, the state
would have the option under the
proposed rule to increase the base
payment that is paid to all providers
within a geographic area of the state and
thereby also increase what the state
could pay in supplemental payments to
targeted providers under the state plan.
Third, in almost all instances, the
providers were supplying the state with
the non-federal share of the Medicaid
practitioner supplemental payments.
Without the supplemental payments, it
is likely that the arrangements through
which the providers have been
transferring the state share to the state
Medicaid agency to support current
high levels of Medicaid practitioner
supplemental payments would cease,
and therefore, the net impact on the
providers would be far less than the
projected amount of decrease in
practitioner supplemental payments.
Finally, the projected impact does not
include any consideration for Medicaid
physician base plus supplemental
payments that could be paid under the
proposal in HRSA-designated
geographic HPSA or in Medicare’s rural
geographic areas up to 175 percent of
the Medicaid FFS base payment rate. If
any of the providers included in the
state’s physician UPL demonstrations
are in those areas, the net impact of the
proposed change would be reduced.
We would also point out that the data
obtained from the quarterly and annual
reports would support the evaluation of
varying payment streams impacting
providers’ services and quality and
would allow for greater oversight on
supplemental payments, including
E:\FR\FM\18NOP2.SGM
18NOP2
63774
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
payments that could exceed the UPL;
DSH payments; and generally provide
better fiduciary oversight of the
Medicaid program.
D. Alternatives Considered
In developing this proposed rule, the
following alternatives were considered:
1. Not Proposing the Rule
We considered not proposing this rule
and maintaining the status quo.
However, we believe this proposed rule
would lead to better accountability and
transparency for supplemental
payments. We do not currently have the
necessary data at the state and provider
level to perform adequate analysis and
oversight of supplemental payments,
and this proposed rule would allow us
to do so.
2. Eliminating Supplemental Payments
We considered proposing a rule that
would eliminate supplemental
payments. However, this option could
have been a huge burden on states to
revise payment methodologies, cost
reports, and fee schedules. Also, this
option would have eliminated an
important avenue for states potentially
to reward providers that show
improvement in performance or quality
metrics, and to address urgent access
problems that may arise. At this time,
we believe our concerns about
accountability and transparency around
supplemental payments may be
addressed through the proposed policies
and do not require the draconian step of
eliminating state flexibility by
prohibiting such payments altogether.
3. Requiring Equal Distribution of
Supplemental Payments
We considered proposing to require
equal distribution of supplemental
payments to all providers of the relevant
class of services. This option would
have eliminated states’ ability to target
supplemental payments to one or a
small number of providers, and thus
could have more closely linked
supplemental payments to services
provided. However, we opted to not
propose this provision at this time as
this proposal would have increased
burden on state Medicaid agencies by
requiring revision of payment
methodologies and tracking
supplemental payments for all providers
of services within the relevant class.
4. Requiring DSH-Like Audits of
Supplemental Payments
We considered proposing to require
independent certified audits of all
Medicaid supplemental payments,
similar to the audit requirement for all
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
DSH payments. Under this alternative,
for states to receive FFP for
supplemental payments, an
independent certified audit would be
required to verify that all supplemental
payments were appropriate. However,
we decided not to propose this
alternative at this time, due to the need
for more and better data to understand
the complex nature of supplemental
payments so that we may better
understand the particular audit
structure and requirements needed to
effectively monitor supplemental
payment programs.
5. Mandating a Provider-Specific UPL
We considered proposing a providerspecific UPL for certain services.
However, imposing such a provision at
this time could have disrupted current
public financing methods and would
also have imposed a burden on states to
revise longstanding payment
methodologies.
6. Setting 5-Year Renewable
Authorizations for Supplemental
Payments and a 5-Year Compliance
Transition Period
Another alternative we considered
was to propose 5-year renewable
authorizations for supplemental
payments, instead of the proposed 3year renewable authorizations. The 5year renewal period for supplemental
payments would have decreased
administrative burden on both the states
and federal government, as opposed to
the 3-year renewal period, as we would
expect to see less frequent SPA resubmissions and CMS SPA reviews,
respectively; in our judgment, the effort
spent on reviewing, evaluating, and
working with states to improve
supplemental payment SPAs is a
worthwhile effort toward the end of
more fiscal accountability in the
Medicaid program. Also, the 3-year
renewal period is consistent with the 3year approval period for health-care
related tax waivers proposed in § 433.72
of this proposed rule.
We also considered proposing a 5year compliance transition period
instead of the proposed 3-year
compliance transition period in
§§ 447.252(e) and 447.302(d). This
would have increased the amount of
time states would have to bring existing,
approved supplemental payment
methodologies into compliance with the
provisions of the proposed rule in these
two sections. We decided to propose a
3-year transition period to account for
states where changes may require
legislative action as some legislatures
meet on a biennial basis, and therefore,
would make compliance with a 3-year
PO 00000
Frm 00054
Fmt 4701
Sfmt 4702
transition period compatible. We are
requesting comment on whether or not
to pursue an expanded transition period
of 5 years instead of the proposed 3-year
transition period.
7. Setting 5-Year or 1-Year Deadline for
Tax Waiver Renewals
We considered proposing 5 years, or
1 year, as the length of the approval
period for tax waivers before states
would need to submit another request.
However, we settled on 3 years because
we believe that it would help ensure
fiscal accountability and the fiscal
integrity of the Medicaid program by
ensuring that provider data for the
classes to be taxed is up to date, while
at the same time avoiding undue
regulatory burden on states.
8. Requiring Both the P1/P2 and the B1/
B2 Tests for Non-Uniform Health CareRelated Taxes
In evaluating how to eliminate tax
structures that are problematic because
they place an undue burden on the
Medicaid program, we considered
requiring the P1/P2 statistical test in
§ 433.68(e)(1) in addition to the B1/B2
statistical test in § 433.68(e)(2), for states
requesting a waiver of the uniformity
requirement (whether or not the state is
also requesting a waiver of the broadbased requirement). Under this
alternative, a state that requests a waiver
of the uniformity requirement would
need to have its tax pass both the P1/
P2 test in addition to the B1/B2 test
currently required. We believe that this
statistical test could serve as a broad
tool to prohibit tax structures that
would inappropriately burden the
Medicaid program in ways not
explicitly prohibited in current
regulation. However, we decided against
this approach to balance preserving an
appropriate degree of flexibility for
states in designing tax programs with
ensuring that state taxes are not
imposed primarily on Medicaid
providers and services. We believe that
the categorical prohibitions against tax
structures that unduly burden Medicaid
which we are proposing to add in
§ 433.68(e)(3) offer sufficient protection
to the financial health of the title XIX
program.
In addition, we considered proposing
a list of acceptable commonalities that
states could permissibly use to define
taxpayer groups. However, we believe
that this could be overly restrictive to
states and impede their flexibility to
structure their tax programs in ways that
suit local circumstances while still
complying with all applicable federal
requirements. We are soliciting
comment on additional prohibitions
E:\FR\FM\18NOP2.SGM
18NOP2
63775
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
against unduly burdening the Medicaid
program that might also be added to this
section to avoid such arrangements.
10. Clarifying the Discovery Date for
DSH Overpayments and Redistribution
Requirements
9. Audit Requirement To Quantify
Financial Impact of Audit Findings
We considered proposing to use the
date that the auditor submits the
independent certified audit to the state
as the date of discovery for DSH
overpayments identified through the
independent certified audit, but
ultimately decided to consider the date
that a state submits the independent
certified audit to CMS as the discovery
date. The earlier date would start the
clock for state repayment of FFP
without regard to possible work that
may need to occur between states and
auditors to finalize the audit and
associated reporting prior to submission
to CMS.
We considered proposing to require
auditors to clarify the impact of audit
findings and caveats within the existing
data element report by incorporating
finding amounts into existing data
elements (for example, Total Medicaid
Uncompensated Care). However, this
option may not enable auditors to
effectively capture financial impacts of
specific issues and such finding might
not be readily transparent to states,
CMS, and hospitals; therefore, we opted
to include this as an additional data
element on the DSH report.
11. Technical Changes to Publishing
DSH and CHIP Allotments
We considered continuing the
requirement to publish the DSH and
CHIP allotments in the Federal Register.
However, we believe this is unnecessary
as states are already informed regarding
their annual DSH and CHIP allotments
prior to the publication of the Federal
Register notice that we now provide
and, in our experience, we have not
received public comment regarding the
notice.
12. Accounting Statement
As required by OMB Circular A–4
(available at https://
www.whitehouse.gov/omb/circulars_
a004_a-4), we have prepared an
accounting statement in Table 1
showing the classifaction of the
transfers associated with the provisions
of this proposed rule.
TABLE 1—ACCOUNTING STATEMENT: CLASSIFICATION OF ESTIMATED TRANSFERS
[$ In millions]
Units
Category
Lower bound
Upper bound
Year dollars
Discount rate
(%)
Period
covered
Transfers ..............................................................................
Annualized Monetized reductions in Costs .........................
0
0
From Whom to Whom .........................................................
The RFA requires agencies to analyze
options for regulatory relief of small
entities, if a rule has a significant impact
on a substantial number of small
entities. The great majority of hospitals
and most other health care providers
and suppliers are small entities, either
by being nonprofit organizations or by
meeting the SBA definition of a small
business (having revenues of less than
$8.0 million to $41.5 million in any one
year). Individuals and states are not
included in the definition of a small
entity. As its measure of significant
economic impact on a substantial
number of small entities, HHS uses a
change in revenue of more than 3 to 5
percent. We do not believe that this
threshold will be reached by the
provisions in this proposed rule.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 603 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
¥222
¥222
Frm 00055
7
3
2020
2020
Medicaid to Medicaid Providers.
as a hospital that is located outside of
a metropolitan statistical area and has
fewer than 100 beds. This rule will not
have a significant impact on the
operations of a substantial number of
small rural hospitals.
Section 202 of the Unfunded
Mandates Reform Act of 1995 (UMRA)
also requires that agencies assess
anticipated costs and benefits before
issuing any rule whose mandates
require spending in any 1 year of $100
million in 1995 dollars, updated
annually for inflation. In 2018, that
threshold is approximately $150
million. This rule does not contain
mandates that will impose spending
costs on state, local, or tribal
governments in the aggregate, or by the
private sector, in excess of the
threshold.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it issues a proposed
rule that imposes substantial direct
requirement costs on state and local
governments, preempts state law, or
otherwise has Federalism implications.
This rule does not impose substantial
PO 00000
2017
2017
Fmt 4701
Sfmt 4702
direct costs on state or local
governments or preempt state law.
Executive Order 13771, titled
Reducing Regulation and Controlling
Regulatory Costs, was issued on January
30, 2017, requires that the costs
associated with significant new
regulations ‘‘to the extent permitted by
law, be offset by the elimination of
existing costs associated with at least
two prior regulations.’’ This rule, if
promulgated, is not expected to be
subject to the requirements of E.O.
13771 because it is expected to result in
no more than de minimis costs.
E. Conclusion
If the policies in this proposed rule
are finalized, states would be required
to send us more detailed data on
payments, including supplemental and
DSH payments, Medicaid utilization
data, provider taxes and donations, and
CPEs and IGTs; implement new reviews
of supplemental payment
methodologies and tax waivers and
periodically seek authorization for their
renewal (if desired by the state); and
provide a narrative to be sent in along
E:\FR\FM\18NOP2.SGM
18NOP2
63776
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
with supplemental payment SPA
submissions on the goals and evaluation
of the payments.
In addition, states would also be
allowed to tax services of health
insurers excluding services of MCOs, as
a permitted class without experiencing
a reduction in medical assistance
expenditures, be prohibited from
unduly burdening Medicaid with taxes
that are not generally redistributive, and
be required to renew tax waivers every
3 years, with updated provider data, or
sooner if the state changes the
definitions of taxpayer groups or tax
rates in a non-uniform manner.
The analysis above, together with the
remainder of this preamble, provides a
regulatory impact analysis. In
accordance with the provisions of
Executive Order 12866, this proposed
rule was reviewed by the Office of
Management and Budget.
List of Subjects
42 CFR Part 430
Administrative practice and
procedure, Grant programs-health,
Medicaid, Reporting and recordkeeping
requirements.
42 CFR Part 433
Administrative practice and
procedure, Child support, Claims, Grant
programs—health, Medicaid, Reporting
and recordkeeping requirements.
42 CFR Part 447
Accounting, Administrative practice
and procedure, Drugs, Grant programshealth, Health facilities, Health
professions, Medicaid, Reporting and
recordkeeping requirements, Rural
areas.
42 CFR Part 455
Fraud, Grant programs—health,
Health facilities, Health professions,
Investigations, Medicaid, Reporting and
recordkeeping requirements.
42 CFR Part 457
Administrative practice and
procedure, Grant programs—health,
Health insurance, Reporting and
recordkeeping requirements.
For the reasons set forth in the
preamble, the Centers for Medicare &
Medicaid Services proposes to amend
42 CFR chapter IV as set forth below:
PART 430—GRANTS TO STATES FOR
MEDICAL ASSISTANCE PROGRAMS
1. The authority citation for part 430
is revised to read as follows:
■
Authority: 42 U.S.C. 1302.
2. Section 430.42 is amended by
revising paragraphs (b)(2)(i)(A)
■
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
introductory text, (b)(2)(i)(B) and (C),
(c)(3), (c)(4)(i), (c)(6), and (d)(1) to read
as follows:
§ 430.42
Disallowance of claims for FFP.
*
*
*
*
*
(b) * * *
(2) * * *
(i) * * *
(A) A request to the Administrator
that includes the following:
*
*
*
*
*
(B) A copy of the request to the
Regional Office.
(C) Send all requests for
reconsideration via electronic mail
(email) or electronic system specified by
the Administrator. Submissions are
considered made on the date they are
received by the Administrator via email
or electronic system specified by the
Administrator.
*
*
*
*
*
(c) * * *
(3) At the Administrator’s option,
CMS may request from the State any
additional information or documents
necessary to make a decision. The
request for additional information must
be sent via email or electronic system
specified by the Administrator.
Submissions are considered made on
the date they are received by the
Administrator via email or electronic
system specified by the Administrator.
(4) * * *
(i) If the Administrator finds that the
materials are not in readily reviewable
form or that additional information is
needed, he or she must notify the State
via email or electronic system specified
by the Administrator that it has 15
business days from the date of receipt of
the notice to submit the readily
reviewable or additional materials.
Notifications are considered made and
received on the date they are sent by the
Administrator via email or electronic
system specified by the Administrator.
*
*
*
*
*
(6) The final written decision shall
constitute final CMS administrative
action on the reconsideration and shall
be (within 15 business days of the
decision) sent to the State agency via
email or electronic system specified by
the Secretary. Notification is considered
made on the date it is sent by the
Administrator via email or electronic
system specified by the Administrator.
*
*
*
*
*
(d) * * *
(1) A State may withdraw the request
for reconsideration at any time before
the notice of the reconsideration
decision is made without affecting its
right to submit a notice of appeal to the
Board. The request for withdrawal must
PO 00000
Frm 00056
Fmt 4701
Sfmt 4702
be in writing and sent to the
Administrator, with a copy to the
Regional Office, via email or electronic
system specified by the Administrator.
Notification of the State’s withdrawal of
its request for reconsideration is
considered made on the date it is
received by the Administrator via email
or electronic system specified by the
Administrator.
*
*
*
*
*
PART 433—STATE FISCAL
ADMINISTRATION
3. The authority citation for part 433
is revised to read as follows:
■
Authority: 42 U.S.C. 1302.
4. Section 433.51 is revised to read as
follows:
■
§ 433.51 State share of financial
participation.
(a) State or local funds may be
considered as the State’s share in
claiming Federal financial participation
(FFP) if they meet the conditions
specified in paragraphs (b) and (c) of
this section.
(b) State or local funds that may be
considered as the State’s share are any
of the following:
(1) State General Fund dollars
appropriated by the State legislature
directly to the State or local Medicaid
agency.
(2) Intergovernmental transfer of
funds from units of government within
a State (including Indian tribes), derived
from State or local taxes (or funds
appropriated to State university
teaching hospitals), to the State
Medicaid Agency and under its
administrative control, except as
provided in paragraph (d) of this
section.
(3) Certified Public Expenditures,
which are certified by a unit of
government within a State as
representing expenditures eligible for
FFP under this section, and which meet
the requirements of § 447.206 of this
chapter.
(c) The State or local funds are not
Federal funds, or are Federal funds
authorized by Federal law to be used to
match other Federal funds.
(d) State funds that are provided as an
intergovernmental transfer from a unit
of government within a State that are
contingent upon the receipt of funds by,
or are actually replaced in the accounts
of, the transferring unit of government
from funds from unallowable sources,
would be considered to be a providerrelated donation that is non-bona fide
under §§ 433.52 and 433.54.
■ 5. Section 433.52 is amended—
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
a. By adding the definitions of
‘‘Medicaid activity’’, ‘‘Net effect’’, ‘‘NonMedicaid activity’’, and ‘‘Parameters of
a tax’’ in alphabetical order;
■ b. In the definition of ‘‘Providerrelated donation’’ by revising
paragraphs (2) and (3) and adding
paragraph (4); and
■ c. By adding the definition of
‘‘Taxpayer group’’ in alphabetical order.
The additions and revision read as
follows:
■
§ 433.52
General definitions.
*
*
*
*
*
Medicaid activity means any measure
of the degree or amount of health care
items or services related to the Medicaid
program or utilized by Medicaid
beneficiaries. Such a measure could
include, but would not necessarily be
limited to, Medicaid patient bed days,
the percentage of an entity’s net patient
revenue attributable to Medicaid,
Medicaid utilization, units of medical
equipment sold to individuals utilizing
Medicaid to pay for or supply such
equipment or Medicaid member months
covered by a health plan.
Net effect means the overall impact of
an arrangement, considering the actions
of all of the entities participating in the
arrangement, including all relevant
financial transactions or transfers of
value, in cash or in kind, among
participating entities. The net effect of
an arrangement is determined in
consideration of the totality of the
circumstances, including the reasonable
expectations of the participating
entities, and may include consideration
of reciprocal actions without regard to
whether the arrangement or a
component of the arrangement is
reduced to writing or is legally
enforceable by any entity.
Non-Medicaid activity means the
degree or amount of health care items or
services not related to the Medicaid
program or utilized by Medicaid
beneficiaries. Such a measure could
include, but would not necessarily be
limited to, non-Medicaid patient bed
days, percentage of an entity’s net
patient revenue not attributable to
Medicaid, the percentage of patients not
utilizing Medicaid to pay for health care
items or services, units of medical
equipment sold to individuals not
utilizing Medicaid funds to pay for or
supply such equipment, or nonMedicaid member months covered by a
health plan.
Parameters of a tax means the
grouping of individuals, entities, items
or services, on which the State or unit
of government imposes a tax.
Provider-related donation * * *
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
(2) Any transfer of value where a
health care provider or provider-related
entity assumes an obligation previously
held by a governmental entity and the
governmental entity does not
compensate the private entity at fair
market value will be considered a
donation made indirectly to the
governmental entity. Such an
assumption of obligation need not rise
to the level of a legally enforceable
obligation to be considered a donation,
but will be considered by examining the
totality of the circumstances and
judging the arrangement’s net effect.
(3) When an organization receives less
than 25 percent of its revenues from
providers and/or provider-related
entities, its donations will not generally
be presumed to be provider-related
donations. Under these circumstances, a
provider-related donation to an
organization will not be considered a
donation made indirectly to the State.
However, if the donations from a
provider or entities related to a provider
to an organization are subsequently
determined to be indirect donations to
the State or unit of local government for
administration of the State’s Medicaid
program, then such donations will be
considered to be provider-related
donations.
(4) When the organization receives
more than 25 percent of its revenue
from donations from providers or
provider-related entities, the
organization always will be considered
as acting on behalf of health care
providers if it makes a donation to the
State. The amount of the organization’s
donation to the State, in a State fiscal
year, that will be considered to be a
provider-related donation will be based
on the percentage of the organization’s
revenue during that period that was
received as donations from providers or
provider-related entities.
Taxpayer group means one or more
entities grouped together based on one
or more common characteristics for
purposes of imposing a tax on a class of
items or services specified under
§ 433.56.
■ 6. Section 433.54 is amended by
revising paragraph (c)(3) to read as
follows:
§ 433.54
Bona fide donations.
*
*
*
*
*
(c) * * *
(3) The State (or other unit of
government) receiving the donation
provides for any direct or indirect
payment, offset, or waiver, such that the
provision of that payment, offset, or
waiver directly or indirectly guarantees
to return any portion of the donation to
the provider (or other party or parties
PO 00000
Frm 00057
Fmt 4701
Sfmt 4702
63777
responsible for the donation). Such a
guarantee will be found to exist where,
considering the totality of the
circumstances, the net effect of an
arrangement between the State (or other
unit of government) and the provider (or
other party or parties responsible for the
donation) results in a reasonable
expectation that the provider, provider
class, or a related entity will receive a
return of all or a portion of the donation.
The net effect of such an arrangement
may result in the return of all or a
portion of the donation, regardless of
whether the arrangement is reduced to
writing or is legally enforceable by any
party to the arrangement.
*
*
*
*
*
■ 7. Section 433.55 is amended by
revising paragraph (c) to read as follows:
§ 433.55
Health care-related taxes defined.
*
*
*
*
*
(c) A tax is considered to be health
care-related if the tax is not limited to
health care items or services, but the
treatment of individuals or entities
providing or paying for those health
care items or services is different than
the tax treatment provided to
individuals or entities that are providers
or payers of any health care items or
services that are not subject to the tax,
or other individuals or entities that are
subject to the tax. In determining
whether differential treatment exists,
consideration will be given to the
parameters of the tax, as well as the
totality of the circumstances relevant to
which individuals, entities, items, or
services are subject and not subject to
the tax, and the tax rate applicable to
each. Differential treatment includes,
but is not limited to:
(1) Tax programs in which some
individuals or entities providing or
paying for health care items or services
are selectively incorporated, but others
are excluded. Selective incorporation
means that the State or other unit of
government includes some, but not all,
health care-related items or services and
these items or services are not
reasonably related to the other items or
services being taxed. Reasonably related
means that there exists a logical or
thematic connection between the items
or services being taxed. Examples of
such a connection include, but are not
limited to, industry, such as electronics;
geographical area, such as city or
county; net revenue volume; or number
of employees. For example, if the State
imposes a tax on all telecommunication
services and inpatient hospital services,
this would constitute differential
treatment as inpatient hospital services
are selectively incorporated. However, if
the State imposes a tax on revenue from
E:\FR\FM\18NOP2.SGM
18NOP2
63778
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
all professional services, which includes
medical professional service revenue,
this alone would not constitute
differential treatment.
(2) Differential treatment of
individuals or entities providing or
paying for health care items or services
included in the tax, and other entities
also included in the tax. For example,
if the State taxes all businesses in the
State, but places a higher tax rate on
hospitals and nursing facilities than on
other businesses, this would result in
differential treatment.
*
*
*
*
*
■ 8. Section 433.56 is amended—
■ a. In paragraph (a)(18), removing the
phrase ‘‘services; and’’ and adding in its
place the phrase ‘‘services;’’;
■ b. Redesignating paragraph (a)(19) as
paragraph (a)(20); and
■ c. Adding a new paragraph (a)(19).
The addition reads as follows:
§ 433.56 Classes of health care services
and providers defined.
(a) * * *
(19) Services of health insurers (other
than services of managed care
organizations as specified in paragraph
(a)(8) of this section); and
*
*
*
*
*
■ 9. Section 433.68 is amended by—
■ a. Revising paragraph (e) introductory
text;
■ b. Adding paragraph (e)(3); and
■ c. Revising paragraph (f)(3).
The revisions and addition read as
follows:
§ 433.68
taxes.
Permissible health care-related
*
*
*
*
*
(e) Generally redistributive. A tax will
be considered to be generally
redistributive if it meets the
requirements of this paragraph (e). If the
State requests waiver of only the broadbased tax requirement, it must
demonstrate compliance with
paragraphs (e)(1) and (3) of this section.
If the State requests waiver of the
uniform tax requirement, whether or not
the tax is broad-based, it must
demonstrate compliance with
paragraphs (e)(2) and (3) of this section.
*
*
*
*
*
(3) Requirement to avoid imposing
undue burden on health care items or
services reimbursed by Medicaid, as
well as providers of such items or
services. This paragraph (e)(3) applies
on a per class basis. A tax must not
impose undue burden on health care
items or services paid for by Medicaid
or on providers of such items and
services that are reimbursed by
Medicaid. A tax is considered to impose
undue burden under this paragraph if
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
taxpayers are divided into taxpayer
groups and any one or more of the
following conditions apply:
(i) The tax excludes or places a lower
tax rate on any taxpayer group defined
by its level of Medicaid activity than on
any other taxpayer group defined by its
relatively higher level of Medicaid
activity.
(ii) Within each taxpayer group, the
tax rate imposed on any Medicaid
activity is higher than the tax rate
imposed on any non-Medicaid activity
(except as a result of excluding from
taxation Medicare or Medicaid revenue
or payments as described in paragraph
(d) of this section).
(iii) The tax excludes or imposes a
lower tax rate on a taxpayer group with
no Medicaid activity than on any other
taxpayer group, unless all entities in the
taxpayer group with no Medicaid
activity meet at least one of the
following:
(A) Furnish no services within the
class in the State.
(B) Do not charge any payer for
services within the class.
(C) Are Federal provider of services
within the meaning of § 411.6 of this
chapter.
(D) Are a unit of government.
(iv) The tax excludes or imposes a
lower tax rate on a taxpayer group
defined based on any commonality that,
considering the totality of the
circumstances, CMS reasonably
determines to be used as a proxy for the
taxpayer group having no Medicaid
activity or relatively lower Medicaid
activity than any other taxpayer group.
(f) * * *
(3) The State (or other unit of
government) imposing the tax provides
for any direct or indirect payment,
offset, or waiver such that the provision
of that payment, offset, or waiver
directly or indirectly guarantees to hold
taxpayers harmless for all or any portion
of the tax amount. A direct guarantee
will be found to exist where,
considering the totality of the
circumstances, the net effect of an
arrangement between the State (or other
unit of government) and the taxpayer
results in a reasonable expectation that
the taxpayer will receive a return of all
or any portion of the tax amount. The
net effect of such an arrangement may
result in the return of all or any portion
of the tax amount, regardless of whether
the arrangement is reduced to writing or
is legally enforceable by any party to the
arrangement.
■ 10. Section 433.72 is amended by
adding paragraphs (c)(3) and (4) and (d)
to read as follows:
PO 00000
Frm 00058
Fmt 4701
Sfmt 4702
§ 433.72 Waiver provisions applicable to
health care-related taxes.
*
*
*
*
*
(c) * * *
(3) For waivers approved on or after
[final rule effective date] a waiver will
cease being effective 3 years from the
date that the waiver was approved by
CMS.
(4) For waivers approved before [final
rule effective date] a waiver will cease
to be effective [3 years from final rule
effective date].
(d) Ongoing compliance with waiver
conditions. For a State to continue to
receive tax revenue (within specified
limitations) without a reduction in FFP
under a waiver approved under
paragraph (b) of this section, the State
must meet all of the following
requirements:
(1) Ensure that the tax program for
which CMS approved the waiver under
paragraph (b) of this section continues
to meet the waiver conditions identified
in paragraphs (b)(1) through (3) of this
section at all times during which the
waiver is in effect.
(2) Request and receive approval for a
new waiver, subject to effective date
requirements in paragraph (c) of this
section, if either of the following tax
program modifications occurs:
(i) The State or other unit of
government imposing the tax modifies
the tax in a non-uniform manner,
meaning the change in tax or tax rate
does not apply in an equal dollar
amount or percentage change to all
taxpayers.
(ii) The State or other unit of
government imposing the tax modifies
the criteria for defining the taxpayer
group or groups subject to the tax.
■ 11. Section 433.316 is amended by—
■ a. Redesignating paragraphs (f)
through (h) as paragraphs (g) through (i),
respectively; and
■ b. Adding a new paragraph (f).
The addition reads as follows:
§ 433.316 When discovery of overpayment
occurs and its significance.
*
*
*
*
*
(f) Overpayments identified through
the disproportionate share hospital
(DSH) independent certified audit. In
the case of an overpayment identified
through the independent certified audit
required under part 455, subpart D, of
this chapter, CMS will consider the
overpayment as discovered on the
earliest of the following:
(1) The date that the State submits the
independent certified audit report
required under § 455.304(b) of this
chapter to CMS.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
(2) Any of the dates specified in
paragraphs (c)(1) through (3) of this
section.
*
*
*
*
*
PART 447—PAYMENTS FOR
SERVICES
12. The authority citation for part 447
is revised to read as follows:
■
Authority: 42 U.S.C. 1302 and 1396r–8.
13. Section 447.201 is amended by
adding paragraph (c) to read as follows:
■
§ 447.201
State plan requirements.
*
*
*
*
*
(c) The plan must provide for no
variation in fee-for-service payment for
a Medicaid service on the basis of a
beneficiary’s Medicaid eligibility
category, enrollment under a waiver or
demonstration project, or FMAP rate
available for services provided to an
individual in the beneficiary’s eligibility
category.
■ 14. Section 447.206 is added to
subpart B to read as follows:
§ 447.206 Payments funded by certified
public expenditures made to providers that
are units of government.
(a) Scope. This section applies only to
payments made to providers that are
State government providers or non-State
government providers, as defined in
§ 447.286, where such payments to such
providers are funded by a certified
public expenditure, as specified in
§ 433.51(b)(3) of this chapter.
(b) General rules. (1) Payments are
limited to reimbursement not in excess
of the provider’s actual, incurred cost of
providing covered services to Medicaid
beneficiaries using reasonable cost
allocation methods as specified in 45
CFR part 75 and 2 CFR part 200, or, as
applicable, to Medicare cost principles
specified in part 413 of this chapter.
(2) The State must establish and
implement documentation and audit
protocols, which must include an
annual cost report to be submitted by
the State government provider or nonState government provider to the State
agency that documents the provider’s
costs incurred in furnishing services to
beneficiaries during the provider’s fiscal
year.
(3) Only the certified amount of the
expenditure may be claimed for Federal
financial participation.
(4) The certifying entity of the
certified public expenditure must
receive and retain the full amount of
Federal financial participation
associated with the payment, consistent
with the cost identification protocols in
the Medicaid State plan and in
accordance with § 447.207.
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
(c) Other criteria for the use of
certified public expenditures. (1) A State
must implement processes by which all
claims for medical assistance are
processed through Medicaid
management information systems in a
manner that identifies the specific
Medicaid services provided to specific
enrollees.
(2) The most recently filed cost
reports as specified in paragraph (b)(2)
of this section must be used to develop
interim payments rates, which may be
trended by an applicable health carerelated index.
(3) Final settlement must be
performed annually by reconciling any
interim payments to the finalized cost
report for the State plan rate year in
which any interim payment rates were
made, and final settlement must be
made no more than 24 months from the
cost report year end, except under
circumstances identified in 45 CFR
95.19.
(4) If the final settlement establishes
that the provider received an
overpayment, the Federal share in
recovered overpayment amounts must
be credited to the Federal Government,
in accordance with part 433, subpart F,
of this chapter.
(d) State plan requirements. If
certified public expenditures are used as
a source of non-Federal share under the
State plan, the State plan must specify
cost protocols in the service payment
methodology applicable to the certifying
provider that meet all of the following:
(1) Identify allowable cost, using
either of the following:
(i) A Medicare cost report, as
described in part 413 of this chapter.
(ii) A State-developed Medicaid cost
report prepared in accordance with the
cost principles in 45 CFR part 75 and 2
CFR part 200.
(2) Define an interim rate
methodology for interim payments to
providers for services furnished.
(3) Describe an attestation process by
which the certifying entity will attest
that the costs are accurate and
consistent with 45 CFR part 75 and 2
CFR part 200.
(4) Include, as necessary, a list of the
covered Medicaid services being
furnished by each provider certifying a
certified public expenditure.
(5) Define a reconciliation and final
settlement process consistent with
paragraphs (c)(3) and (4) of this section.
■ 15. Section 447.207 is added to
subpart B to read as follows:
§ 447.207
Retention of payments.
(a) Payments. Payment methodologies
must permit the provider to receive and
retain the full amount of the total
PO 00000
Frm 00059
Fmt 4701
Sfmt 4702
63779
computable payment for services
furnished under the approved State plan
(or the approved provisions of a waiver
or demonstration, if applicable). The
Secretary will determine compliance
with this paragraph (a) by examining
any associated transactions that are
related to the provider’s total
computable Medicaid payment to
ensure that the State’s claimed
expenditure, which serves as the basis
for Federal financial participation, is
consistent with the State’s net
expenditure, and that the full amount of
the non-Federal share of the payment
has been satisfied. Associated
transactions may include, but are not
necessarily limited to, the payment of
an administrative fee to the State for
processing provider payments or, in the
case of a non-State government
provider, for processing
intergovernmental transfers. In no event
may such administrative fees be
calculated based on the amount a
provider receives through Medicaid
payments or amounts a unit of
government contributes through an
intergovernmental transfer as funds for
the State share of Medicaid service
payments.
(b) [Reserved]
■ 16. Section 447.252 is amended by
adding paragraphs (d) and (e) to read as
follows:
§ 447.252
State plan requirements.
*
*
*
*
*
(d) CMS may approve a supplemental
payment, as defined in § 447.286,
provided for under the State plan or a
State plan amendment (SPA) for a
period not to exceed 3 years. A State
whose supplemental payment approval
period has expired or is expiring may
request a SPA to renew the
supplemental payment for a subsequent
period not to exceed 3 years, consistent
the requirements of this section. For any
State plan or SPA that provides or
would provide for a supplemental
payment, the plan or plan amendment
must specify all of the following:
(1) An explanation of how the State
plan or SPA will result in payments that
are consistent with section
1902(a)(30)(A) of the Act, including that
provision’s standards with respect to
efficiency, economy, quality of care, and
access, along with the stated purpose
and intended effects of the
supplemental payment, for example,
with respect to the Medicaid program,
providers, and beneficiaries.
(2) The criteria to determine which
providers are eligible to receive the
supplemental payment.
(3) A comprehensive description of
the methodology used to calculate the
E:\FR\FM\18NOP2.SGM
18NOP2
63780
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
amount of, and distribute, the
supplemental payment to each eligible
provider, including all of the following:
(i) The amount of the supplemental
payment made to each eligible provider,
if known, or, if the total amount is
distributed using a formula based on
data from one or more fiscal years, the
total amount of the supplemental
payments for the fiscal year or years
available to all providers eligible to
receive a supplemental payment.
(ii) If applicable, the specific criteria
with respect to Medicaid service,
utilization, or cost data from the
proposed State plan rate year to be used
as the basis for calculations regarding
the amount and/or distribution of the
supplemental payment.
(iii) The timing of the supplemental
payment to each eligible provider.
(iv) An assurance that the total
Medicaid payment to an inpatient
hospital provider, including the
supplemental payment, will not exceed
the upper limits specified in § 447.271.
(v) If not already submitted, an upper
payment limit demonstration as
required by § 447.272 and described in
§ 447.288.
(4) The duration of the supplemental
payment authority (not to exceed 3
years).
(5) A monitoring plan to ensure that
the supplemental payment remains
consistent with the requirements of
section 1902(a)(30)(A) of the Act and to
enable evaluation of the effects of the
supplemental payment on the Medicaid
program, for example, with respect to
providers and beneficiaries.
(6) For a SPA proposing to renew a
supplemental payment for a subsequent
approval period, an evaluation of the
impacts on the Medicaid program
during the current or most recent prior
approval period, for example, with
respect to providers and beneficiaries,
and including an analysis of the impact
of the supplemental payment on
compliance with section 1902(a)(30)(A)
of the Act.
(e) The authority for State plan
provisions that authorize supplemental
payments that are approved as of
[effective date of the final rule], are
limited as follows—
(1) For State plan provisions approved
3 or more years prior to [effective date
of the final rule], the State plan
authority will expire [date that is 2
calendar years following the effective
date of the final rule].
(2) For State plan provisions approved
less than 3 years prior to [effective date
of the final rule], the State plan
authority will expire [date that is 3
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
calendar years following the effective
date of the final rule].
*
*
*
*
*
■ 17. Section 447.272 is amended by
revising paragraphs (a)(1) through (3)
and (b)(1) to read as follows:
§ 447.272 Inpatient services: Application
of upper payment limits.
(a) * * *
(1) State government provider as
defined using the criteria set forth in
§ 447.286.
(2) Non-State government provider as
defined using the criteria set forth at
§ 447.286.
(3) Private provider as defined in
§ 447.286.
(b) * * *
(1) Upper payment limit refers to a
reasonable estimate of the amount that
would be paid for the services furnished
by the group of facilities under
Medicare payment principles in
subchapter B of this chapter, or allowed
costs established in accordance with the
cost principles as specified in 45 CFR
part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles
specified in part 413 of this chapter.
Data elements, methodology parameters,
and acceptable upper payment limit
demonstration methodologies are
specified in § 447.288(b).
*
*
*
*
*
■ 18. Subpart D is added to read as
follows:
Subpart D—Payments for Services
Sec.
447.284 Basis and purpose.
447.286 Definitions.
447.288 Reporting requirements for upper
payment limit demonstrations and
supplemental payments.
447.290 Failure to report required
information.
Subpart D—Payments for Services
§ 447.284
Basis and purpose.
(a) This subpart sets forth additional
requirements for supplemental
payments made under the State plan
and implements sections 1902(a)(6) and
(a)(30) of the Act.
(b) The reporting requirements in this
subpart are applicable to supplemental
payments to which an upper payment
limit applies under § 447.272 or
§ 447.321.
§ 447.286
Definitions.
For purposes of this subpart—
Base payment means a payment, other
than a supplemental payment, made to
a provider in accordance with the
payment methodology authorized in the
State plan or that is paid to the provider
PO 00000
Frm 00060
Fmt 4701
Sfmt 4702
through its participation with a
Medicaid managed care organization.
Base payments are documented at the
beneficiary level in MSIS or T–MSIS
and include all payments made to a
provider for specific Medicaid services
rendered to individual Medicaid
beneficiaries, including any payment
adjustments, add-ons, or other
additional payments received by the
provider that can be attributed to a
particular service provided to the
beneficiary, such as payment
adjustments made to account for a
higher level of care or complexity of
services provided to the beneficiary.
Non-State government provider means
a health care provider, as defined in
§ 433.52 of this chapter, including those
defined in § 447.251, that is a unit of
local government in a State, including a
city, county, special purpose district, or
other governmental unit in the State that
is not the State, which has access to and
exercises administrative control over
State funds appropriated to it by the
legislature or local tax revenue,
including the ability to dispense such
funds. In determining whether an entity
is a non-State government provider,
CMS will consider the totality of the
circumstances, including, but not
limited to, the following:
(1) The identity and character of any
entity or entities other than the provider
that share responsibilities of ownership
or operation of the provider, and
including the nature of any relationship
among such entities and the
relationship between such entity or
entities and the provider. In
determining whether an entity shares
responsibilities of ownership or
operation of the provider, our
consideration would include, but would
not be limited to, whether the entity:
(i) Has the immediate authority for
making decisions regarding the
operation of the provider;
(ii) Bears the legal responsibility for
risk from losses from operations of the
provider;
(iii) Has immediate authority for the
disposition of revenue from operations
of the provider;
(iv) Has immediate authority with
regard to hiring, retention, payment, and
dismissal of personnel performing
functions related to the operation of the
provider;
(v) Bears legal responsibility for
payment of taxes on provider revenues
and real property, if any are assessed; or
(vi) Bears the responsibility of paying
any medical malpractice premiums or
other premiums to insure the real
property or operations, activities, or
assets of the provider.
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
(2) In determining whether a relevant
entity is a unit of a non-State
government, we would consider the
character of the entity which would
include, but would not be limited to,
whether the entity:
(i) Is described in its communications
to other entities as a unit of non-State
government, or otherwise.
(ii) Is characterized as a unit of nonState government by the State solely for
the purposes of Medicaid financing and
payments, and not for other purposes
(for example, taxation).
(iii) Has access to and exercises
administrative control over State funds
appropriated to it by the legislature and/
or local tax revenue, including the
ability to expend such appropriated or
tax revenue funds, based on its
characterization as a governmental
entity.
Private provider means a health care
provider, as defined in § 433.52 of this
chapter, including those defined in
§ 447.251 of this chapter, that is not a
State government provider or a nonState government provider.
State government provider means a
health care provider, as defined in
§ 433.52 of this chapter, including those
defined in § 447.251 of this chapter, that
is a unit of State government or a State
university teaching hospital, which has
access to and exercises administrative
control over State-appropriated funds
from the legislature or State tax revenue,
including the ability to dispense such
funds. In determining whether a
provider is a State government provider,
CMS will consider the totality of the
circumstances, including, but not
limited to, the following:
(1) The identity and character of any
entity or entities other than the provider
that share responsibilities of ownership
or operation of the provider, and
including the nature of any relationship
among such entities and the
relationship between such entity or
entities and the provider. In
determining whether an entity shares
responsibilities of ownership or
operation of the provider, our
consideration would include, but would
not be limited to, whether the entity:
(i) Has the immediate authority for
making decisions regarding the
operation of the provider;
(ii) Bears the legal responsibility for
risk from losses and litigation from
operations of the provider;
(iii) Has immediate authority for the
disposition of revenue and profit from
operations of the provider;
(iv) Has immediate authority with
regard to acquisition, retention,
payment, and dismissal of personnel
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
performing functions related to the
operation of the provider;
(v) Bears legal responsibility for
payment of taxes on provider revenues
and real property, if any are assessed; or
(vi) Bears the responsibility of paying
any medical malpractice premiums or
other premiums to insure the real
property or operations, activities, or
assets of the provider;
(2) In determining whether a relevant
entity is a unit of a State government,
we would consider the character of the
entity which would include, but would
not be limited to, whether the entity:
(i) Is described in its communications
to other entities as a unit of State
government, or otherwise;
(ii) Is characterized as a unit of State
government by the State solely for the
purposes of Medicaid financing and
payments, and not for other purposes
(for example, taxation); and
(iii) Has access to and exercises
administrative control over State funds
appropriated to it by the legislature and/
or local tax revenue, including the
ability to expend such appropriated or
tax revenue funds, based on its
characterization as a governmental
entity.
Supplemental payment means a
Medicaid payment to a provider that is
in addition to the base payments to the
provider, other than disproportionate
share hospital (DSH) payments under
subpart E of this part, made under State
plan authority or demonstration
authority. Supplemental payments
cannot be attributed to a particular
provider claim for specific services
provided to an individual beneficiary
and are often made to the provider in a
lump sum.
§ 447.288 Reporting requirements for
upper payment limit demonstrations and
supplemental payments.
(a) Upper payment limit
demonstration reporting requirements.
Beginning October 1, [first year
following the year the final rule takes
effect] and annually thereafter, by
October 1 of each year, in accordance
with the requirements of this section
and in the manner and format specified
by the Secretary, each State must submit
a demonstration of compliance with the
applicable upper payment limit for each
of the following services for which the
State makes payment:
(1) Inpatient hospital, as specified in
§ 447.272.
(2) Outpatient hospital, as specified in
§ 447.321.
(3) Nursing facility, as specified in
§ 447.272.
(4) Intermediate care facility for
individuals with intellectual disabilities
(ICF/IID), as specified in § 447.272.
PO 00000
Frm 00061
Fmt 4701
Sfmt 4702
63781
(5) Institution for mental diseases
(IMD), as specified in § 447.272.
(b) Upper payment limit
demonstration standards. When
demonstrating the upper payment limit
(UPL), States must use the data sources
identified in paragraph (b)(1) of this
section, adhere to the data standards
specified in paragraph (b)(2) of this
section, and use the acceptable methods
of demonstrating the UPL specified in
paragraph (b)(3) of this section.
(1) UPL methodology data sources.
The data sources identified in this
paragraph (b)(1) are as follows:
(i) Medicare cost demonstrations.
Medicare cost demonstrations use cost
and charge data for all providers, from
either a Medicare cost report or a Statedeveloped cost report which uses either
Medicare cost reporting principles
specified in part 413 of this chapter or
the cost allocation requirements
specified in 45 CFR part 75. Cost and
charge data must:
(A) Include only data with dates of
service that are no more than 2 years
prior to the dates of service covered by
the upper payment limit demonstration;
(B) Represent costs and charges
specifically related to the service subject
to the UPL demonstration; and
(C) Include either Medicare costs and
Medicare charges, or total provider costs
and total provider charges, to develop a
cost-to-charge ratio as described in
paragraph (b)(3)(i) of this section. The
selection must be consistently applied
for all providers within the provider
category subject to the upper payment
limit.
(ii) Medicare payment
demonstrations. Medicare payment
demonstrations use Medicare payment
and charge data for all providers from
Medicare cost reports; Medicare
payment systems for the specific
provider type specified in subchapter B
of this chapter, as applicable; or
imputed provider payments, specified
in paragraph (b)(3)(ii)(C) of this section.
When using Medicare payment and
charge data, the data must:
(A) Include only data with dates of
service that are no more than 2 years
prior to the dates of service covered by
the upper payment limit demonstration;
(B) Include only Medicare payment
and charges, or Medicare payment and
Medicare census data, specifically
related to the service subject to the UPL
demonstration; and
(C) Use either gross Medicare
payments and Medicare charges, which
includes deductibles and co-insurance
in but excludes reimbursable bad debt
from the Medicare payment, or net
Medicare payments and Medicare
charges, which excludes deductibles
E:\FR\FM\18NOP2.SGM
18NOP2
63782
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
and coinsurance from and includes
reimbursable bad debt in the Medicare
payment, as reported on a Medicare cost
report. The selection must be
consistently applied for all providers
within the provider category subject to
the upper payment limit.
(iii) Medicaid charge data and
Medicaid census data from a State’s
Medicaid billing system for services
provided during the same dates of
service as the Medicare cost or Medicare
payment data, as specified in paragraph
(b)(1)(i) or (ii) of this section, as
applicable.
(iv) Medicaid payment data from a
State’s Medicaid billing system for
services provided during the same dates
of service as the Medicare cost or
Medicare payment data, as specified in
paragraph (b)(1)(i) or (ii) of this section,
as applicable, or from the most recent
State plan rate year for which a full 12
months of data are available. Such
Medicaid payment data must:
(A) Include only data with dates of
service that are no more than 2 years
prior to the dates of service covered by
the upper payment limit demonstration;
(B) Include all actual payments and
all projected base and supplemental
payments, excluding any payments
made for services for which Medicaid is
not the primary payer, expected to made
during the time period covered by the
upper payment limit demonstration to
the providers within the provider
category, as applicable, during the State
plan rate year; and
(C) Only be trended to account for
changes in relevant Medicaid State plan
payments, except as provided in
paragraph (b)(2)(i) of this section.
(2) UPL methodology data standards.
The data standards specified in this
paragraph (b)(2) are as follows:
(i) Projected changes in Medicaid
enrollment and utilization must be
reflected in the demonstration. At a
minimum, the demonstration must be
adjusted to account for projected
changes in Medicaid enrollment and
utilization to reflect programmatic
changes, such as reasonable utilization
changes due to managed care
enrollment projections.
(ii) Medicare cost or payment data
may be projected using Medicare trend
factors appropriate to the service and
demonstration methodology, with such
trend factors being uniformly applied to
all providers within a provider category.
(iii) When calculating the aggregate
upper payment limit using a cost-based
demonstration as described in
paragraph (b)(3)(i) of this section, the
State may include the cost of health
care-related taxes paid by each provider
in the provider category that is
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
reasonably allocated to Medicaid as an
adjustment to the upper payment limit,
to the extent that such costs were not
already included in the cost-based UPL.
(iv) Medicaid payment data described
in paragraph (b)(1)(iv) of this section
that is included in the upper payment
limit demonstration must only include
payments made for the applicable
Medicaid services under the specific
Medicaid service type at issue in the
upper payment limit.
(3) Acceptable UPL demonstration
methods. The State must demonstration
compliance with an applicable UPL
using a method described in this
paragraph (b)(3).
(i) Cost-based demonstrations. Costbased demonstration data sources are
identified in paragraphs (b)(1)(i), (iii),
and (iv) of this section and data
standards defined in paragraph (b)(2) of
this section. To make a cost-based
demonstration of compliance with an
applicable upper payment limit,
Medicaid covered charges are
multiplied by a cost-to-charge ratio
developed for the period covered by the
upper payment limit demonstration.
The State may use a ratio of Medicare
costs to Medicare charges, or total
provider costs to total provider charges
in developing the cost-to-charge ratio,
but the selection must be applied
consistently to each provider within a
provider type identified in paragraph (a)
of this section. The product of Medicaid
covered charges and the cost-to-charge
ratio for each provider is summed to
determine the aggregate upper payment
limit. The demonstration must show
that Medicaid payments will not exceed
this aggregate upper payment limit for
the demonstration period. This
methodology may only be used for
services where a provider applies
uniform charges to all payers. This
demonstration may use one of the
following demonstration types:
(A) A retrospective demonstration
showing that aggregate Medicaid
payments paid to the providers within
the provider category during the prior
State plan rate year did not exceed the
costs incurred by the providers
furnishing Medicaid services within the
prior State plan rate year period.
(B) A prospective demonstration
showing that prospective Medicaid
payments would not exceed the
estimated cost of furnishing the services
for the upcoming State plan rate year
period.
(ii) Payment-based demonstrations.
Payment-based demonstration data
sources are identified in paragraphs
(b)(1)(ii), (iii), and (iv) of this section
and data standards defined in paragraph
(b)(2) of this section. To make a
PO 00000
Frm 00062
Fmt 4701
Sfmt 4702
payment-based demonstration of
compliance with an applicable UPL, the
State may use one of the following
demonstration types:
(A) A retrospective payment-to-charge
UPL demonstration where Medicaid
covered charges are multiplied by a
ratio of Medicare payments to Medicare
charges developed for the period
covered by the UPL demonstration. The
product of Medicaid covered charges
and the Medicare payment-to-charge
ratio for each provider is summed to
determine the aggregate UPL. The
demonstration must show that Medicaid
payments did not exceed this aggregate
UPL;
(B) A prospective payment-to-charge
UPL demonstration where Medicaid
covered charges are multiplied by a
ratio of Medicare payments to Medicare
charges developed for the period
covered by the UPL demonstration. The
product of Medicaid covered charges
and the Medicare payment-to-charge
ratio for each provider is summed to
determine the aggregate UPL. The
demonstration must show that proposed
Medicaid payments would not exceed
this aggregate UPL within the next State
plan rate year immediately following
the demonstration period; or
(C) A payment-based UPL
demonstration using an imputed
Medicare per diem payment rate
determined by dividing total Medicare
prospective payments paid to the
provider by the provider’s total
Medicare patient days, which are
derived from the provider’s Medicare
census data. Each provider’s imputed
Medicare per diem payment rate is
multiplied by the total number of
Medicaid patient days for the provider
for the period. The products of this
operation for each provider are summed
to determine the aggregate UPL. The
demonstration must show that Medicaid
payments are not excess of the aggregate
UPL, calculated on either a retrospective
or prospective basis, consistent with the
methodology described in paragraph
(b)(3)(ii)(A) or (B) of this section, as
applicable.
(c) Supplemental payment reporting
requirements. (1) At the time the State
submits its quarterly CMS–64 under
§ 430.30(c) of this chapter, the State
must report all of the following
information for each supplemental
payment included on the CMS–64 on a
supplemental report to accompany the
CMS–64:
(i) The State plan amendment
transaction number or demonstration
authority number which authorizes the
supplemental payment.
(ii) A listing of each provider that
received a supplemental payment under
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
the SPA or demonstration authority, and
for each provider, under each authority
listed in paragraph (a) of this section:
(A) The provider’s legal name.
(B) The physical address of the
location or facility where services are
provided, including street address, city,
State, and ZIP code.
(C) The National Provider Identifier
(NPI).
(D) The Medicaid identification
number.
(E) The employer identification
number (EIN).
(F) The service type for which the
reported payment was made.
(G) The provider specialty type (if
applicable, for example, critical access
hospital (CAH), pediatric hospital, or
teaching hospital).
(H) The provider category (that is,
State government provider, Non-state
government provider, or Private
provider).
(iii) The specific amount of the
supplemental payment made to the
provider, including:
(A) The total supplemental payment
made to the provider authorized under
the specified State plan, as applicable.
(B) The total Medicaid supplemental
payment made to the provider under the
specified demonstration authority, as
applicable.
(2) Not later than 60 days after the end
of the State fiscal year, each State must
annually report aggregate and providerlevel information on base and
supplemental payments made under
State plan and demonstration authority,
as applicable, by service type. This
reporting must include all of the
following:
(i) The SPA transaction number or
demonstration authority number which
authorizes the supplemental payment,
as applicable.
(ii) A listing of each provider that
received a supplemental payment under
each authority listed in paragraph (a) of
this section by:
(A) The provider’s legal name.
(B) The physical address of the
location or facility where services are
provided, including street address, city,
State, and ZIP code.
(C) The NPI.
(D) The Medicaid identification
number.
(E) The EIN.
(F) The service type for which the
reported payment was made.
(G) The provider specialty type (if
applicable, for example, CAH, pediatric
hospital, or teaching hospital).
(H) The provider category (that is,
State government provider, non-State
government provider, or Private
provider).
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
(I) The State reporting period (State
fiscal year start and end dates).
(iii) The specific amount of Medicaid
payments made to each provider,
including, as applicable:
(A) The total fee-for-service base
payments made to the provider
authorized under the State plan.
(B) The total Medicaid payments
made to the provider under
demonstration authority.
(C) The total amount received from
Medicaid beneficiary cost-sharing
requirements, donations, and any other
funds received from third parties to
support the provision of Medicaid
services.
(D) The total supplemental payment
made to the provider authorized under
the specified State plan.
(E) The total Medicaid supplemental
payment made to the provider under the
specified demonstration authority.
(F) The total Medicaid payments
made to the provider as reported under
paragraphs (c)(2)(iii)(A) through (E) of
this section.
(G) The total disproportionate share
hospital (DSH) payments made to the
provider.
(H) The Medicaid units of care
furnished by the provider, as specified
by the Secretary (for example, on a
provider-specific basis, total Medicaid
discharges, days of care, or any other
unit of measurement as specified by the
Secretary).
(3) Not later than 60 days after the end
of the State fiscal year, each State must
annually report aggregate and providerlevel information on each provider
contributing to the State or any unit of
local government any funds that are
used as a source of non-Federal share
for any Medicaid supplemental
payment, by:
(i) The service type for which the
reported payment was made.
(ii) The provider specialty type (if
applicable, for example, CAH, pediatric
hospital, or teaching hospital).
(iii) The provider’s legal name.
(iv) The physical address of the
location or facility where services are
provided, including street address, city,
State, and ZIP code.
(v) The NPI.
(vi) The Medicaid identification
number.
(vii) The EIN.
(viii) The provider category (that is,
State government, non-State
government, or private).
(ix) The total fee-for-service base
payments made to the provider
authorized under the State plan.
(x) The total fee-for-service
supplemental payments made to the
provider authorized under the State
plan.
PO 00000
Frm 00063
Fmt 4701
Sfmt 4702
63783
(xi) The total Medicaid payments
made to the provider under
demonstration authority.
(xii) The total DSH payments made to
the provider.
(xiii) The total of each health carerelated tax collected from the provider
by any State authority or unit of local
government.
(xiv) The total of any costs certified as
a certified public expenditures (CPE) by
the provider.
(xv) The total amount contributed by
the provider to the State or a unit of
local government in the form of an
intergovernmental transfers (IGT).
(xvi) The total of provider-related
donations made by the provider or by
entities related to a health care provider,
including in-cash and in-kind
donations, to the State or a unit of local
government, including State university
teaching hospitals.
(xvii) The total funds contributed by
the provider reported in paragraphs
(c)(3)(xiii) through (xvi) of this section.
§ 447.290 Failure to report required
information.
(a) The State must maintain the
underlying information supporting base
and supplemental payments, including
the information required to be reported
under § 447.288, consistent with the
requirements of § 433.32 of this chapter,
and must provide such information for
Federal review upon request to facilitate
program reviews or Department of
Health and Human Services’ Office of
Inspector General (OIG) audits
conducted under §§ 430.32 and 430.33
of this chapter.
(b) If a State fails to timely,
completely and accurately report
information required under § 447.288,
CMS may reduce future grant awards
through deferral in accordance with
§ 430.40 of this chapter, by the amount
of Federal financial participation (FFP)
CMS estimates is attributable to
payments made to the provider or
providers as to which the State has not
reported properly, until such time as the
State complies with the reporting
requirements. CMS may defer FFP if a
State submits the required report but the
report fails to comply with applicable
requirements. Otherwise allowable FFP
for expenditures deferred in accordance
with this section will be released when
CMS determines that the State has
complied with all reporting
requirements under § 447.288.
§ 447.297
[Amended]
19. Section 447.297 is amended—
a. In paragraph (b) by removing the
phrase ‘‘published by April 1 of each
Federal fiscal year,’’ and adding in its
■
■
E:\FR\FM\18NOP2.SGM
18NOP2
63784
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
place the phrase ‘‘posted as soon as
practicable’’
■ b. In paragraph (c) by removing the
phrase ‘‘publish in the Federal
Register’’ and adding in its place the
phrase ‘‘post in the Medicaid Budget
and Expenditure System and at
Medicaid.gov (or similar successor
system or website)’’ and by removing
the phrase ‘‘publish final State DSH
allotments by April 1 of each Federal
fiscal year,’’ and adding in its place the
phrase ‘‘post final State DSH allotments
as soon as practicable in each Federal
fiscal year,’’
■ c. In paragraph (d)(1) by removing the
phrase ‘‘by April 1 of each Federal fiscal
year’’ and adding in its place the phrase
‘‘as soon as practicable for each Federal
fiscal year’’ and by removing the phrase
‘‘prior to the April 1 publication date’’
and adding in its place the phrase ‘‘prior
to the posting date’’
■ 20. Section 447.299 is amended by—
■ a. Redesignating paragraph (c)(21) as
paragraph (c)(22)
■ b. Adding new paragraph (c)(21) and
paragraphs (f) and (g).
The additions read as follows:
§ 447.299
Reporting requirements.
*
*
*
*
*
(c) * * *
(21) Financial impact of audit
findings. The total annual amount
associated with each audit finding. If it
is not practicable to determine the
actual financial impact amount, state
the estimated financial impact for each
audit finding identified in the
independent certified audit that is not
reflected in data elements described in
paragraphs (c)(6) through (15) of this
section. For purposes of this paragraph
(c)(21), audit finding means an issue
identified in the independent certified
audit required under § 455.304 of this
chapter concerning the methodology for
computing the hospital specific DSH
limit and/or the DSH payments made to
the hospital, including, but not limited
to, compliance with the hospitalspecific DSH limit as defined in
paragraph (c)(16) of this section. Audit
findings may be related to missing or
improper data, lack of documentation,
non-compliance with Federal statutes
and/or regulations, or other deficiencies
identified in the independent certified
audit. Actual financial impact means
the total amount associated with audit
findings calculated using the
documentation sources identified in
§ 455.304(c) of this chapter. Estimated
financial impact means the total amount
associated with audit findings
calculated on the basis of the most
reliable available information to
quantify the amount of an audit finding
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
in circumstances where complete and
accurate information necessary to
determine the actual financial impact is
not available from the documentation
sources identified in § 455.304(c) of this
chapter.
*
*
*
*
*
(f) DSH payments found in the
independent certified audit process
under part 455, subpart D, of this
chapter to exceed hospital-specific cost
limits are provider overpayments which
must be returned to the Federal
Government in accordance with the
requirements in part 433, subpart F, of
this chapter or redistributed by the State
to other qualifying hospitals, if
redistribution is provided for under the
approved State plan. Overpayment
amounts returned to the Federal
Government must be separately reported
on the Form CMS–64 as a decreasing
adjustment which corresponds to the
fiscal year DSH allotment and Medicaid
State plan rate year of the original DSH
expenditure claimed by the State.
(g) As applicable, States must report
any overpayment redistribution
amounts on the Form CMS–64 within 2
years from the date of discovery that a
hospital-specific limit has been
exceeded, as determined under
§ 433.316(f) of this chapter in
accordance with a redistribution
methodology in the approved Medicaid
State plan. The State must report
redistribution of DSH overpayments on
the Form CMS–64 as separately
identifiable decreasing adjustments
reflecting the return of the overpayment
as specified in paragraph (f) of this
section and increasing adjustments
representing the redistribution by the
State. Both adjustments should
correspond to the fiscal year DSH
allotment and Medicaid State plan rate
year of the related original DSH
expenditure claimed by the State.
■ 21. Section 447.302 is revised to read
as follows:
§ 447.302
State plan requirements.
(a) The plan must provide that the
requirements of this subpart are met.
(b) The plan must specify
comprehensively the methods and
standards used by the agency to set
payment rates.
(c) CMS may approve a supplemental
payment, as defined in § 447.286,
provided for under the State plan or a
State plan amendment for a period not
to exceed 3 years. A State whose
supplemental payment approval period
has expired or is expiring may request
a State plan amendment to renew the
supplemental payment for a subsequent
period not to exceed 3 years, consistent
the requirements of this section. For any
PO 00000
Frm 00064
Fmt 4701
Sfmt 4702
State plan or State plan amendment that
provides or would provide for a
supplemental payment, the plan or plan
amendment must specify all of the
following:
(1) An explanation of how the State
plan or State plan amendment will
result in payments that are consistent
with section 1902(a)(30)(A) of the Act,
including that provision’s standards
with respect to efficiency, economy,
quality of care, and access along with
the stated purpose and intended effects
of the supplemental payment, for
example, with respect to the Medicaid
program, providers and beneficiaries.
(2) The criteria to determine which
providers are eligible to receive the
supplemental payment.
(3) A comprehensive description of
the methodology used to calculate the
amount of, and distribute, the
supplemental payment to each eligible
provider, including all of the following:
(i) The amount of the supplemental
payment made to each eligible provider,
if known, or, if the total amount is
distributed using a formula based on
data from one or more fiscal years, the
total amount of the supplemental
payments for the fiscal year or years
available to all providers eligible to
receive a supplemental payment.
(ii) If applicable, the specific criteria
with respect to Medicaid service,
utilization, or cost data from the
proposed State plan payment year to be
used as the basis for calculations
regarding the amount and/or
distribution of the supplemental
payment.
(iii) The timing of the supplemental
payment to each eligible provider.
(iv) An assurance that the total
Medicaid payment to other inpatient
and outpatient facilities, including the
supplemental payment, will not exceed
the upper limits specified in § 447.325.
(v) If not already submitted, an upper
payment limit demonstration as
required by § 447.321 and described in
§ 447.288.
(4) The duration of the supplemental
payment authority (not to exceed 3
years).
(5) A monitoring plan to ensure that
the supplemental payment remains
consistent with the requirements of
section 1902(a)(30)(A) of the Act and to
enable evaluation of the effects of the
supplemental payment on the Medicaid
program, for example, with respect to
providers and beneficiaries.
(6) For a SPA proposing to amend or
renew a supplemental payment for a
subsequent approval period, an
evaluation of the impacts on the
Medicaid program during the current or
most recent prior approval period, for
E:\FR\FM\18NOP2.SGM
18NOP2
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Proposed Rules
example, with respect to providers and
beneficiaries, and including an analysis
of the impact of the supplemental
payment on compliance with section
1902(a)(30)(A) of the Act.
(d) The authority for State plan
provisions that authorize supplemental
payments that are approved as of
[effective date of the final rule], is
limited as follows—
(1) For State plan provisions approved
3 or more years prior to [effective date
of the final rule], the State plan
authority will expire [date that is 2
calendar years following the effective
date of the final rule].
(2) For State plan provisions approved
less than 3 years prior to [effective date
of the final rule], the State plan
authority will expire [date that is 3
calendar years following the effective
date of the final rule].
■ 22. Section 447.321 is amended by
revising the section heading and
paragraphs (a) and (b)(1) to read as
follows:
§ 447.321 Outpatient hospital services:
Application of upper payment limits.
(a) Scope. This section applies to rates
set by the agency to pay for outpatient
services furnished by hospitals within
one of the following categories:
(1) State government provider, as
defined using the criteria set forth at
§ 447.286.
(2) Non-State government provider, as
defined using the criteria set forth at
§ 447.286.
(3) Private provider, as defined using
the criteria set forth at § 447.286.
(b) * * *
(1) Upper payment limit refers to a
reasonable estimate of the amount that
would be paid for the services furnished
by the group of facilities under
Medicare payment principles in
subchapter B of this chapter, or allowed
costs established in accordance with the
cost principles as specified in 45 CFR
part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles
specified at 42 CFR part 413. Data
elements, methodology parameters, and
acceptable upper payment limit
demonstration methodologies are
defined in § 447.288(b).
*
*
*
*
*
■ 23. Section 447.406 is added to read
as follows:
VerDate Sep<11>2014
17:00 Nov 15, 2019
Jkt 250001
§ 447.406 Medicaid practitioner
supplemental payment.
(a) General. This section applies to
Medicaid practitioner supplemental
payments, which, for purposes of this
section, are supplemental payments as
defined in § 447.286 that are authorized
under the State plan for practitioner
services and targeted to specific
practitioners under a methodology
specified in the State plan. This section
does not apply to value-based payment
methodologies that are part of a State’s
delivery system reform initiative, are
attributed to a particular service
provided to a Medicaid beneficiary, and
that are available to all providers,
including as an alternative to fee-forservice payment rates.
(b) Medicaid practitioner
supplemental payment standards. A
Medicaid practitioner supplemental
payment must meet the requirements
specified in § 447.302, including the
transition period requirements in
paragraph (d) of that section, as well as
the requirements specified in this
section.
(c) Medicaid practitioner
supplemental payment limit. Medicaid
practitioner supplemental payments
may not exceed—
(1) 50 percent of the total fee-forservice base payments authorized under
the State plan paid to an eligible
provider for the practitioner services
during the relevant period; or
(2) For services provided within
HRSA-designated geographic health
professional shortage areas (HPSA) or
Medicare-defined rural areas as
specified in 42 CFR 412.64(b), 75
percent of the total fee-for-service base
payments authorized under the State
plan paid to the eligible provider for the
practitioner services during the relevant
period.
PART 455—PROGRAM INTEGRITY:
MEDICAID
24. The authority citation for part 455
continues to read as follows:
■
Authority: 42 U.S.C 1302.
25. Section 455.301 is amended by
revising the definition of ‘‘Independent
certified audit’’ to read as follows:
■
§ 455.301
Definitions.
*
*
*
*
*
Independent certified audit means an
audit that is conducted by an auditor
PO 00000
Frm 00065
Fmt 4701
Sfmt 9990
63785
that operates independently from the
Medicaid agency or subject hospitals
and is eligible to perform the
disproportionate share hospital (DSH)
audit. Certification means that the
independent auditor engaged by the
State reviews the criteria of the Federal
audit regulation and completes the
verification, calculations and report
under the professional rules and
generally accepted standards of audit
practice. This certification includes a
review of the State’s audit protocol to
ensure that the Federal regulation is
satisfied, an opinion for each
verification detailed in the regulation, a
determination of whether or not the
State made DSH payments that
exceeded any hospital’s hospitalspecific DSH limit in the Medicaid State
plan rate year under audit, and the
financial impact of each audit finding
on a hospital-specific basis. The
certification also identifies any data
issues or other caveats or deficiencies
that the auditor identified as impacting
the results of the audit.
*
*
*
*
*
PART 457—ALLOTMENTS AND
GRANTS TO STATES
26. The authority for part 457
continues to read as follows:
■
Authority: 42 U.S.C. 1302.
27. Section 457.609 is amended by
revising paragraph (h) to read as
follows:
■
§ 457.609 Process and calculation of State
allotments for a fiscal year after FY 2008.
*
*
*
*
*
(h) CHIP fiscal year allotment process.
The national CHIP allotment and State
CHIP allotments will be posted in the
Medicaid Budget and Expenditure
System and at Medicaid.gov (or similar
successor system or website) as soon as
practicable after the allotments have
been determined for each Federal fiscal
year.
Dated: September 12, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
Dated: November 7, 2019.
Alex M. Azar II,
Secretary, Department of Health and Human
Services.
[FR Doc. 2019–24763 Filed 11–12–19; 4:15 pm]
BILLING CODE 4120–01–P
E:\FR\FM\18NOP2.SGM
18NOP2
Agencies
[Federal Register Volume 84, Number 222 (Monday, November 18, 2019)]
[Proposed Rules]
[Pages 63722-63785]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24763]
[[Page 63721]]
Vol. 84
Monday,
No. 222
November 18, 2019
Part II
Department of Health and Human Services
-----------------------------------------------------------------------
Centers for Medicare & Medicaid Services
-----------------------------------------------------------------------
42 CFR Parts 430, 433, et al.
Medicaid Program; Medicaid Fiscal Accountability Regulation; Proposed
Rule
Federal Register / Vol. 84 , No. 222 / Monday, November 18, 2019 /
Proposed Rules
[[Page 63722]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
42 CFR Parts 430, 433, 447, 455, and 457
[CMS-2393-P]
RIN 0938-AT50
Medicaid Program; Medicaid Fiscal Accountability Regulation
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: This proposed rule would promote transparency by establishing
new reporting requirements for states to provide CMS with certain
information on supplemental payments to Medicaid providers, including
supplemental payments approved under either Medicaid state plan or
demonstration authority, and applicable upper payment limits.
Additionally, the proposed rule would establish requirements to ensure
that state plan amendments proposing new supplemental payments are
consistent with the proper and efficient operation of the state plan
and with efficiency, economy, and quality of care. This proposed rule
addresses the financing of supplemental and base Medicaid payments
through the non-federal share, including states' uses of health care-
related taxes and bona fide provider-related donations, as well as the
requirements on the non-federal share of any Medicaid payment.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on January 17, 2020.
ADDRESSES: In commenting, please refer to file code CMS-2393-P. Because
of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY: Centers for Medicare & Medicaid Services, Department of
Health and Human Services, Attention: CMS-2393-P, P.O. Box 8016,
Baltimore, MD 21244-8016.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY: Centers for Medicare & Medicaid Services,
Department of Health and Human Services, Attention: CMS-2393-P, Mail
Stop C4-26-05, 7500 Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Andrew Badaracco, (410) 786-4589,
Richard Kimball, (410) 786-2278, and Daniil Yablochnikov, (410) 786-
8912, for Medicaid Provider Payments, Supplemental Payments, Upper
Payment Limits, Provider Categories, Intergovernmental Transfers, and
Certified Public Expenditures.
Timothy Davidson, (410) 786-1167, Jonathan Endelman, (410) 786-
4738, and Stuart Goldstein, (410) 786-0694, for Health Care-Related
Taxes, Provider-Related Donations, and Disallowances.
Lia Adams, (410) 786-8258, Charlie Arnold, (404) 562-7425, Richard
Cuno, (410) 786-1111, and Charles Hines, (410) 786-0252, for Medicaid
Disproportionate Share Hospital Payments and Overpayments.
Jennifer Clark, (410) 786-2013, and Deborah McClure, (410) 786-
3128, for Children's Health Insurance Program (CHIP).
SUPPLEMENTARY INFORMATION: Inspection of Public Comments: All comments
received before the close of the comment period are available for
viewing by the public, including any personally identifiable or
confidential business information that is included in a comment. We
post all comments received before the close of the comment period on
the following website as soon as possible after they have been
received: https://www.regulations.gov. Follow the search instructions on
that website to view public comments.
I. Background
A. Overview
Title XIX of the Social Security Act (the Act) established the
Medicaid program as a federal-state partnership for the purpose of
providing and financing medical assistance to specified groups of
eligible individuals. States have considerable flexibility in designing
their programs, but must abide by requirements specified in the federal
Medicaid statute and regulations. Each state is responsible for
administering its Medicaid program in accordance with an approved state
plan, which specifies the scope of covered services, groups of eligible
individuals, payment methodologies, and all other information necessary
to assure the state plan describes a comprehensive and sound structure
for operating the Medicaid program, and ultimately, provides a clear
basis for claiming federal matching funds.
As discussed in more detail below, the goal of this proposed rule
is to strengthen overall fiscal integrity of the Medicaid program. The
proposed rule focuses on four topic areas that are frequently discussed
as program vulnerabilities by federal oversight authorities, including
the Government Accountability Office (GAO), the Department of Health
and Human Services' Office of Inspector General (OIG), and the Medicaid
and CHIP Payment and Access Commission (MACPAC). These topics include:
Medicaid fee-for-service (FFS) provider payments; disproportionate
share hospital (DSH) payments; Medicaid program financing; supplemental
payments; and health care-related taxes and provider-related donations.
Due to the complex nature of these topic areas, we have organized this
proposed rule to separately discuss each topic and describe the
programmatic concerns that we seek to address through this proposed
rule. However, the proposed provisions would rely on similar strategies
to improve our and states' abilities to oversee fiscal integrity by
requiring transparency through better data reporting, clarifying
regulatory payment and financing definitions, refining administrative
procedures used by states to comply with federal regulations,
clarifying regulatory language that could be subject to
misinterpretation, and removing regulatory requirements that have been
difficult to administer and do not further our oversight objectives. As
a result, the provisions of the proposed rule aim to address multiple
topic areas as part of the overall strategy to improve fiscal
integrity.
While some of the proposed policies are new, there are policies
within the proposed rule that CMS has operationalized through our work
with states and interpretations of the statute in subregulatory
guidance and federal regulations. We have implemented this subset of
policies using existing legal authority. Some of the proposed policies
in the proposed rule, such as the non-bona fide provider related
donations provisions, have been reviewed and upheld by the Departmental
Appeals Board (DAB) and the courts. Therefore, we are clarifying the
regulatory language
[[Page 63723]]
in this proposed rule that may have been subject to misinterpretation
by states and other stakeholders, or that otherwise could benefit from
additional specificity. In these cases, as discussed below, we are not
proposing new statutory interpretations, but are merely proposing to
codify existing policies into the Code of Federal Regulations (CFR) to
improve guidance to states and other stakeholders and, to the extent
possible, help prevent states from implementing policies that do not
comport with applicable statutory requirements.
B. General Information on Certain Medicaid Financial Topics Addressed
in This Proposed Rule
1. Medicaid FFS Provider Payments
a. General Background
States are responsible for developing FFS rates to pay providers
for furnishing health care services to beneficiaries who receive
covered services through the FFS delivery system. In recognition of the
states' front line responsibility, the statute affords states
considerable flexibility by not prescribing any particular rate setting
approach or method (for most Medicaid services), but instead allows
states to develop their own approaches unique to their local
circumstances so long as they are consistent with applicable statutory
requirements and provide the public and interested parties an
opportunity to comment and offer input. In particular, section 4711 of
the Balanced Budget Act of 1997 (BBA 97) (Pub. L. 105-33, enacted
August 5, 1997) amended section 1902(a)(13)(A) of the Act to give
states greater flexibility to develop their own payment methods and
standards by replacing prescriptive rate setting requirements with the
present standard that rates for inpatient hospital, nursing facility,
and intermediate care facility for individuals with intellectual
disabilities (ICF/IID) services be established in accordance with a
public process. The public process emphasizes transparency in how
states approach rate setting by providing stakeholders with a
reasonable opportunity to review and comment on the proposed FFS rates,
rate setting methodologies, and justifications before states publish
final rates, underlying methodologies, and justifications. However, it
does not impose any constraints on states with respect to the payment
methodologies they may wish to adopt to purchase Medicaid services.
Similarly, states are free to develop their own approach to
establishing payment rates for other Medicaid services and, under
longstanding regulations at Sec. 447.205, generally must publish
public notice in advance to implement new, or change existing, methods
and standards for setting payment rates for services. For example,
states may decide to use a prospective payment or a retrospective
payment system and may elect to reimburse on a per unit, per day, or
per discharge basis. Whatever payment methodology or system a state
elects to implement, the state must describe the methodology or system
comprehensively in its Medicaid state plan and submit the proposed
methodology to CMS for review and approval in a manner consistent with
42 CFR part 430, subpart B.
State payment methodologies typically provide for a standard
payment to all Medicaid providers on a per claim basis for services
rendered to a Medicaid beneficiary in a FFS environment. We refer to
these payments as ``base payments.'' Base payments also include any
payment adjustments, add-ons, or other additional payments received by
the provider that can be attributed to services identifiable as having
been provided to an individual beneficiary, including those that are
made to account for a higher level of care or complexity or intensity
of services provided to an individual beneficiary.
Having established a base payment system, states may wish to offer
extra compensation to certain providers by establishing supplemental
payments within the state's overall approach to reimbursing Medicaid
providers. ``Supplemental payments'' are payments made to providers
that are in addition to the base payment the provider receives for
services furnished. They can be directed to all providers or directed
to a designated set of providers, with the amount of the payment
depending upon applicable upper payment limit (UPL) demonstration
requirements in Sec. Sec. 447.272 and 447.321 for inpatient and
outpatient settings, respectively. Unlike base FFS payments, which are
directly attributable to a covered service furnished to an individual
beneficiary, supplemental payments are often made to the provider in a
lump sum on a monthly, quarterly, or annual basis apart from payments
for a provider claim, and therefore, cannot be directly linked to a
provider claim for specific services provided to an individual Medicaid
beneficiary. Effectively, the supplemental payments serve to increase
total Medicaid payments to a provider for all Medicaid services
furnished over a set period of time as shown in the state's UPL
demonstration. The UPL demonstration is the means by which the state
documents that the Medicaid payments for the applicable services are
below the aggregate UPL amount. In general, supplemental payments are
recognized as service payments as they supplement base payments
previously made to purchase Medicaid services from providers.
Typically, they are made under FFS state plan authority but, more
recently, states have made similar types of payments through
demonstration and managed care authorities.
As discussed previously, for most services, the Medicaid statute
does not prescribe a particular payment approach; however, the statute
does contemplate that states will be prudent purchasers of health care
services. More specific to rate setting, section 1902(a)(30)(A) of the
Act requires states to have methods and procedures to assure Medicaid
payments for services, including any base and supplemental payments,
are consistent with efficiency, economy, and quality of care and are
sufficient to enlist enough providers so that care and services are
available under the plan at least to the extent that such care and
services are available to the general population in the geographic
area. Under section 1902(a)(30)(A) authority, implementing federal
regulations establish UPLs for certain services and rely on these
limits to help assure that state Medicaid payments are consistent with
``efficiency and economy.'' Federal financial participation (FFP) is
not available for state Medicaid expenditures that exceed an applicable
UPL.
Medicaid UPLs are codified in regulations at Sec. Sec. 447.272 and
447.321 and apply to payments for Medicaid inpatient hospital, nursing
facility and ICF/IID services, as well as for outpatient hospital and
clinic services. For each of these Medicaid benefits, the UPLs are
first constructed by categorizing providers into groups (``ownership
groups'') according to the ownership or operational interests: State
government-owned or operated, non-state government-owned or operated,
and privately-owned and operated. States are restricted, in the
aggregate for each ownership group, from paying more than a reasonable
estimate of the amount Medicare would pay for the services furnished by
the providers in the applicable ownership group. The aggregate
application of these UPLs has preserved state flexibility for setting
facility-specific payments while creating an overall payment ceiling as
a mechanism for determining economy and efficiency of payment for the
[[Page 63724]]
services described above, consistent with section 1902(a)(30)(A) of the
Act.
Where Medicaid base payments are below the aggregate UPL
calculation, states have the ability to make supplemental payments to
providers, by ownership group, up to the calculated limit. With the
aggregate UPL calculations, states have the ability to pay some
providers in excess of a reasonable amount that Medicare would pay
those individual providers for their services furnished, so long as the
aggregate Medicaid payments are less than or equal to the aggregate UPL
amount for the ownership category. Should states wish to make payments
up to the UPL and have the non-federal share available to do so, after
giving public notice, they may modify their state plan payment
methodologies to provide for supplemental payments. We note that,
without a regulatory standard to govern UPLs for practitioner services,
CMS has allowed states to make Medicaid supplemental payments for
practitioner services up to Medicare payment amounts or, based on data
documentation, up to the average commercial rate (ACR) made to
providers. As discussed later in this proposed rule, ACRs are payments
developed using the average of some commercial payers' payment rates
for medical services to establish a supplemental Medicaid rate for
certain practitioners, typically physicians, under the state plan.
Unlike other supplemental payments subject to UPLs, some of these
practitioner supplemental payments have resulted in payments to
providers in excess of a reasonable estimate of what Medicare would
have paid for the services furnished, as the relevant ACRs generally
are higher than Medicare rates. This result is possible because there
currently is no UPL applicable to payments for practitioner services
based on a reasonable estimate of what Medicare would pay.
Under our current UPL regulations and CMS policy, approval of a
supplemental payment is not an indication that a state's proposal to
use supplemental payments within its payment system is the best
approach to setting Medicaid payments. Instead, our approvals have been
based on the state's documentation of UPL calculations, where
applicable, showing that the total Medicaid payments (base and
supplemental) paid to providers under the state plan are within the
federal limits. Beyond that test and a review of state plan amendments
(SPAs) which propose to add or amend supplemental payment methodologies
or aggregate supplemental payments, we have not closely examined how
states distribute Medicaid payments to individual providers as a matter
of routine oversight.
Through the policies proposed in this proposed rule, we are seeking
to better understand the relationship between and among the following:
Supplemental provider payments, costs incurred by providers, current
UPL requirements, state financing of the non-federal share of
supplemental payments, and the impact of supplemental payments on the
Medicaid program (such as improvements in the quality of, or access to,
care). It often appears to us that most of these payment methodologies
do not result in an equitable distribution of payments to improve
adequacy of rates across providers within the service class or
ownership group, or otherwise improve the Medicaid program in some
measurable, value-added way. Instead, many supplemental payment
strategies appear to target only those providers that can participate
in financing the non-federal share funding required to support a
state's claim for FFP. In certain circumstances, this practice may be
inconsistent with section 1902(a)(2) of the Act, which requires states
to assure that a lack of funds from local sources will not result in
lowering the amount, duration, scope, or quality of services or level
of administration under the plan, since the payments are only available
to providers with the means to provide the non-federal share.
For instance, states might use the entire UPL gap (the difference
between the amounts paid in base payments and the aggregate UPL) for
each service type and provider ownership group to make a supplemental
payment to only a small subset of providers in the group. In an example
of this type of supplemental payment structure, one state implemented
an inpatient hospital supplemental payment methodology to make payments
up to the UPL for non-state government operated hospitals. The
supplemental payment was funded by intergovernmental transfers (IGTs)
from a local (city) government. Although the total amount of the
supplemental payment was based on the available UPL room for 26 non-
state government operated hospitals, under the terms of the
methodology, only three hospitals qualified to receive the supplemental
payment. This resulted in total payments to those three hospitals that
far exceeded their reported total cost incurred for all Medicaid
services, which is inconsistent with section 1902(a)(30)(A) of the Act.
Supplemental payments now comprise a large and growing percentage
of total Medicaid payments. They are commonly paid both to
institutional providers (for example, inpatient hospitals, nursing
facilities, and ICF/IIDs) and for outpatient services (for example,
outpatient hospitals, clinics, and physician services). Currently, 48
states reported using at least one type of supplemental payment
methodology under the Medicaid state plan. As a percentage of total
Medicaid payments for institutional providers, data from the Medicaid
Budget and Expenditure System (MBES) indicate that supplemental
payments have steadily increased from 9.4 percent in FY 2010, the first
year in which states separately reported these payments, to 17.5
percent of all FFS payments to hospitals, nursing facilities, ICF/IIDs,
and physician service payments in FY 2017. Supplemental payments to
providers under demonstration authority, which can allow additional
flexibility to cover beneficiaries and services not usually permitted
under state plan authority, have also grown. In December 2018, MACPAC
released the ``Medicaid Inpatient Hospital Services Fee-for Service
Payment Policy'' issue brief where it noted that expenditures for
hospital UPL supplemental payments increased from 2 to 3 percent of
total expenditures for Medicaid benefits between 2001 and 2016.\1\ In
the MACPAC analysis, the totality of supplemental payments, DSH
payments, and uncompensated care payments made under demonstration
authority, as a share of the total computable Medicaid payments to
hospitals in FY 2016, was 27 percent. In all, the MACPAC analysis
concluded that the total expenditures in 2016 for DSH payments were
$16.5 billion, for UPL supplemental payments were $16.4 billion, and
for uncompensated care payments were $8.5 billion.
---------------------------------------------------------------------------
\1\ https://www.macpac.gov/wp-content/uploads/2016/03/Medicaid-Inpatient-Hospital-Services-Fee-for-Service-Payment-Policy.pdf.
---------------------------------------------------------------------------
b. Current CMS Review of Provider Payments and Oversight Concerns
The Medicaid statute and regulations require states to report
program-related information to CMS regarding their payment
methodologies and incurred expenditures that are claimed for federal
matching funds. Section 1902(a)(6) of the Act requires the Medicaid
agency to make reports as the Secretary of Health and Human Services
(the Secretary) may require and to comply with provisions the Secretary
finds necessary to assure the correctness and verification of such
reports. Implementing regulations at 42 CFR 431.107(b) require states
to ensure that providers maintain auditable
[[Page 63725]]
documentation of the services furnished to beneficiaries for which the
state makes program expenditures and claims FFP, to allow the federal
government to ensure that all applicable federal requirements are met.
Additionally, 42 CFR 430.30(c) requires states to submit the Form CMS-
64, which is a quarterly accounting statement of the state's actual
recorded expenditures that serves as the primary basis for Medicaid
payments to states under section 1903(a)(1) of the Act.
The primary means to collect information on Medicaid program
eligibility, services, and expenditures has historically been through
CMS' Medicaid Statistical Information System (MSIS), which is populated
by FFS claims and managed care encounter data from states' Medicaid
Management Information Systems (MMIS), which are an integrated group of
procedures and computer processing operations (sub-systems) developed
at the general design level to meet principal objectives, and CMS'
MBES, which is the system through which states file quarterly Medicaid
expenditures on the Form CMS-64. These systems have been essential to
both the states and the federal government in operating Medicaid and
provide valuable program information. However, neither the modern
Transformed Medicaid Statistical Information System (T-MSIS), which has
replaced MSIS, discussed further below, nor MBES, separately or
together, provides the level of detail on the payment and financing of
supplemental payments necessary to effectively monitor and evaluate the
use and impact of those payments.
MSIS is an eligibility and claims data set that provides a summary
of services and payments linked to specific beneficiaries on the basis
of claims submitted to the states by providers. However, the MSIS data
include very little information about the providers furnishing
services. In addition, MSIS is unable to capture the providers'
supplemental payments since those payments are not directly tied to
specific beneficiaries, but rather, typically, are made based on the
volume of Medicaid services rendered and generally are paid to
providers as lump sums, separately from payments for service claims.
Another often cited problem with MSIS data is that, in spite of
regulations requiring timely reporting, there is generally a
considerable time lag between when the services are paid for by the
state and when data on those payments is furnished to CMS through MSIS.
To improve the completeness and timeliness of such data for the
purposes of program monitoring and oversight, we currently are working
with states to collect more robust data through an expansion and update
of MSIS, which is referred to as the T-MSIS. T-MSIS data improves our
ability to study utilization patterns and trends, identify high cost
and high needs populations, analyze expenditures by category of service
and provider type, monitor enrollment and expenditures within delivery
systems, assess the impact of different types of delivery system models
on beneficiary outcomes, and examine access to care issues. However,
although we are currently working to improve T-MSIS' reporting
capability for supplemental payments, T-MSIS will not capture
supplemental payments at the level of detail proposed under this
proposed rule. It should be noted that T-MSIS is capable of capturing
the non-federal share of base rate payments. Currently, there are
significant gaps in state reporting related to this particular data
element, which we also are working with states to correct.
MBES data include all state expenditures filed on the Form CMS-64.
The Form CMS-64 is a summary of a state's actual Medicaid expenditures,
for both state program administration and medical assistance (that is,
payments for services furnished to beneficiaries), derived from source
documents including invoices, payment vouchers, governmental funds
transfers, expenditure certifications, cost reports and settlements,
and eligibility records. This form shows the disposition of Medicaid
grant funds for the quarter being reported and any prior period
adjustments. It also accounts for any overpayments, underpayments,
refunds received by the state Medicaid agency, and income earned on
grant funds. With limited exceptions, MBES does not contain
beneficiary, provider, or claim-level information for the reported
expenditures, including supplemental payments. We can only obtain such
information by requesting separate supporting documentation from the
state. Attempting to improve oversight and transparency of supplemental
payments, we added expenditure reporting lines in MBES in 2010 for
states to separately report the amounts of supplemental payments made
for various types of services. This information is reported at the
aggregate service level and does not include details on which providers
receive those payments, the specific amount received by each, or the
source of the non-federal share that supports those expenditures. While
this reporting requirement slightly improved transparency, there were
large variations in the total payment amounts reported through MBES and
the total payment amounts through UPL demonstrations and we are
concerned that state reporting has not always been complete and
accurate and should be improved.
We also gather information on the nature and extent of proposed
supplemental payments during our review of SPAs. As part of the
documentation submitted with payment-related SPAs, states must describe
which providers would be eligible for the payments and how the payments
would be calculated and distributed, provide an estimate of the fiscal
impact, and disclose the source of the non-federal share of the
proposed expenditures. The opportunity to evaluate the permissibility
and potential impact of supplemental payments is presented when a state
submits a proposal. Current regulations do not contemplate that, once
we have approved a SPA, as described in part 430, subpart B, we would
routinely monitor the implementation and effects of the SPA in a
formal, systematic way. The opportunity to review state payments after
the agency has approved a SPA generally is limited to the submission of
SPAs to update or change the supplemental payment methodology. Our
other mechanisms for review are financial management reviews and audits
of state programs which may cover any area of the Medicaid program and
require advanced planning and are resource intensive for CMS and
states. We also have relied upon reviews conducted by other government
oversight bodies. These reviews are often resource intensive and
require a large amount of data sharing, consultation, discussions, and
policy reviews. As such, many years may pass before we are able to
finalize the reviews and revisit supplemental payment methodologies,
either through financial management review or the submission of a SPA.
Because of this, we are unable to periodically evaluate these payment
arrangements, including individual underlying provider payment amounts,
to determine if the payments have been consistent with economy,
efficiency, quality, access, and appropriate utilization, as required
by statute. We do not generally collect further information associated
with a SPA in a centralized manner, and such information generally is
not presented at the provider level.
In its March 2014 Report to the Congress on Medicaid and CHIP,
MACPAC noted that supplemental payments to hospitals, according to
their analysis of supplemental payments
[[Page 63726]]
in 5 states, accounted for more than 20 percent of total computable
Medicaid FFS payments to hospitals in those 5 states, and in some
states account for more than 50 percent of such payments.\2\ MACPAC has
recommended that the Secretary collect provider-level data on
supplemental payments to, among other things, provide greater
transparency regarding Medicaid payments and facilitate assessments of
Medicaid payments and analysis of the relationship between supplemental
payments and access to care, as well as the economy and efficiency of
Medicaid payments. In developing this proposed rule, we also considered
the findings reported by MACPAC in the March 2012 Report to the
Congress on Medicaid and CHIP, which identified data limitations
regarding lump-sum Medicaid supplemental payments as an impediment to
comparing payment levels across providers and states, determining the
total amount of Medicaid spending on specific services and populations,
and evaluating the impact of Medicaid payment policies.\3\
---------------------------------------------------------------------------
\2\ Medicaid and CHIP Payment and Access Commission, Report to
the Congress on Medicaid and CHIP, March 14, 2014, 184 (2014),
https://www.macpac.gov/wp-content/uploads/2015/01/2014-03-14_Macpac_Report.pdf.
\3\ Medicaid and CHIP Payment and Access Commission, Report to
the Congress on Medicaid and CHIP, March 15, 2012, 167 (2012),
https://www.macpac.gov/wp-content/uploads/2015/01/State_Approaches_for_Financing_Medicaid_and_Update_on_Federal_Financing_of_CHIP.pdf.
---------------------------------------------------------------------------
Without complete provider-level payment information, we do not have
sufficient information to evaluate whether rate methodologies result in
payments within a service type and provider ownership group that are
economic and efficient as required under section 1902(a)(30)(A) of the
Act. The GAO has issued a series of reports which note that the lack of
reliable CMS data about Medicaid payments to providers and state
financing of the non-federal share hinders our ability to adequately
oversee the Medicaid program. To help ensure that each state meets the
statutory and regulatory requirements regarding its oversight
responsibilities, data reporting, and financial participation, the GAO
has recommended that regulatory and legislative efforts be
strengthened. Specific to Medicaid supplemental payments, the GAO has
had longstanding concerns regarding the need for improved transparency
and accountability. For example, in 2015, the GAO issued a report
entitled, ``Medicaid: CMS Oversight of Provider Payments Is Hampered by
Limited Data and Unclear Policy,'' that stated, ``[w]ithout good data
on payments to individual providers, a policy and criteria for
assessing whether the payments are economical and efficient, and a
process for reviewing such payments, the federal government could be
paying states hundreds of millions, or billions, more than what is
appropriate.'' \4\ As a result, the GAO has recommended that to better
ensure the fiscal integrity of the program, we should establish
financial reporting at a provider-specific level and clarify
permissible methods for calculating Medicaid supplemental payment
amounts.
---------------------------------------------------------------------------
\4\ U.S. Gov't Accountability Office, GAO-15-322, Medicaid: CMS
Oversight of Provider Payments Is Hampered by Limited Data and
Unclear Policy, 46 (2015), https://www.gao.gov/assets/670/669561.pdf.
---------------------------------------------------------------------------
Since the availability of FFS supplemental payments under the
aggregate UPL is driven by the volume of services provided through the
FFS system, a shift to managed care or certain demonstration projects
results in a lowered UPL estimate and a corresponding decrease in the
level of FFS supplemental payments that a state can make. For example,
there are instances when pool payments established through a
demonstration authorized under section 1115(a) of the Act pay for
uncompensated care costs for the provision of health care services to
Medicaid beneficiaries, the underinsured, and the uninsured, or for
state projects that promote delivery system reforms. States have also
authorized pass-through payments or incentive arrangements to providers
under managed care contracts that can operate similarly to existing FFS
supplemental payments. We have authorized these payments within certain
requirements described in 42 CFR part 438 and demonstration terms and
conditions, as applicable, noting that the financing requirements in 42
CFR parts 430 and 433 and addressed in this proposed rule are
applicable to FFS, managed care, and demonstration authorities.
Given the growing prevalence of supplemental payments and concerns
raised by federal oversight agencies, we are concerned that our past
practice of basing approval of SPAs regarding supplemental payments
primarily on aggregate UPL compliance does not provide us with
sufficient information to adequately ensure that supplemental payments
are consistent with statutory requirements for economy and efficiency,
quality of care, and access, or otherwise with sound program management
principles. As a result, as discussed in greater detail in section II.
of this proposed rule, the Provisions of the Proposed Rule section, we
are proposing to gather additional information to better understand how
states distribute supplemental payments to individual providers and
whether there are benefits to the Medicaid program resulting from the
supplemental payments.
2. Disproportionate Share Hospital (DSH) Payments
a. Background
States have statutory authority to make DSH payments to qualifying
hospitals. Section 1902(a)(13)(A)(iv) of the Act requires that states
take into account the situation of hospitals that serve a
disproportionate share of low-income patients with special needs, in a
manner consistent with section 1923 of the Act. These are not
considered part of the base rate payments or supplemental payments, as
they are made under distinct statutory authority. Section 1923 of the
Act contains specific requirements related to DSH payments, including
aggregate annual state-specific DSH allotments that limit FFP for
statewide total DSH payments under section 1923(f) of the Act, and
hospital-specific limits on DSH payments under section 1923(g) of the
Act. Under the hospital-specific limits, a hospital's DSH payments may
not exceed the costs incurred by that hospital in furnishing inpatient
and outpatient hospital services during the year to Medicaid
beneficiaries and the uninsured, less payments received from or on
behalf of the Medicaid beneficiaries or uninsured patients. In
addition, section 1923(a)(2)(D) of the Act requires states to provide
an annual report to the Secretary describing the DSH payment
adjustments made to each DSH.
Section 1001(d) of the Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) (Pub. L. 108-173, enacted December 8,
2003) added section 1923(j) of the Act to require states to report
additional information about their DSH programs. Section 1923(j)(1) of
the Act requires states to submit an annual report including an
identification of each DSH that received a DSH payment adjustment
during the preceding fiscal year (FY) and the amount of such
adjustment, and such other information as the Secretary determines
necessary to ensure the appropriateness of the DSH payment adjustments
for such fiscal year. Additionally, section 1923(j)(2) of the Act
requires states to submit an independent certified audit of the state's
DSH program, including specified content, annually to the Secretary.
[[Page 63727]]
b. Concerns Raised Regarding Overpayments Identified Through Annual DSH
Audits
The ``Medicaid Program; Disproportionate Share Hospital Payments''
final rule published in the December 19, 2008 Federal Register (73 FR
77904) (and herein referred to as the 2008 DSH audit final rule)
requires state reports and audits to ensure the appropriate use of
Medicaid DSH payments and compliance with the hospital-specific DSH
limits under section 1923(g) of the Act.
The regulations at 42 CFR part 455, subpart D, implement section
1923(j)(2) of the Act. FFP is not available for DSH payments that are
found in the independent certified audit to exceed the hospital-
specific limit. Amounts in excess of the hospital-specific limit are
regarded as overpayments to providers, under 42 CFR part 433, subpart
F. The discovery of overpayments necessitates the return of the federal
share or redistribution by the state of the overpaid amounts to other
qualifying hospitals, in accordance with the state's approved Medicaid
state plan. The regulations in part 433, subpart F provide for
refunding of the federal share of Medicaid overpayments paid to
providers. While the preamble to the 2008 DSH audit final rule
generally addressed the return or redistribution of provider
overpayments identified through DSH audits, it did not include specific
procedural requirements for returning or redistributing overpayments.
As described below, we are proposing to incorporate into regulation
procedural requirements associated with the return and redistribution
of DSH overpayments.
While the information included in the independent certified audits
and associated reports provides CMS and states with robust data, we are
often unable to determine whether a DSH overpayment to a provider has
occurred, the root causes of any overpayments, and the amount of the
overpayments associated with each cause. Despite the robust data,
potential data gaps may exist as a result of an auditor identifying an
area, or areas, in which documentation is missing or unavailable for
certain costs or payments that are required to be included in the
calculation of the total eligible uncompensated care costs. Therefore,
in current practice, an auditor may include a finding (or ``caveat'')
in the audit stating that the missing information may impact the
calculation of total eligible uncompensated care costs, instead of
making a determination of the actual financial impact of the identified
issue. This lack of transparency results in uncertainty and restricts
CMS' and states' ability to ensure proper recovery of all FFP
associated with DSH overpayments identified through annual DSH audits.
For example, an audit may identify that a hospital was unable to
satisfactorily document the outpatient services it provided to
Medicaid-eligible patients, indicating that charges and payments were
not included in the DSH uncompensated care calculation. Based on this
lack of documentation, the audit includes a caveat of its finding
indicating that the hospital's uncompensated care cost may be misstated
as a result of this exclusion and that the impact is unknown. Given
this lack of quantification of the financial impact of this finding, we
are unable to determine whether an overpayment, if any, has resulted
from this audit finding. To obtain such information, either CMS and/or
the state would have to conduct a secondary review or audit, which
would be burdensome and largely redundant. Specifically, conducting a
secondary review or audit after the independent auditors have completed
theirs would lengthen the review process, and therefore, delay the
results of the audit. It would also require additional time, personnel,
and resources by CMS, states, and hospitals to participate in a
secondary review or audit.
The OIG and GAO have raised concerns similar to ours with respect
to our ability to adequately oversee the Medicaid DSH program.
Specifically, the OIG published the report, ``Audit of Selected States'
Medicaid Disproportionate Share Hospital Programs'' in March 2006,\5\
in which the OIG recommended that we establish regulations requiring
states to implement procedures to ensure that future DSH payments are
adjusted to actual incurred costs, incorporate these adjustment
procedures into their approved state plans, and include only allowable
costs as uncompensated care costs in their DSH calculations. The 2008
DSH audit final rule addressed the concerns raised by the OIG in
regulations implementing the independent certified audit requirements
under section 1923(j) of the Act, by requiring states to include data
elements as specified in Sec. 447.299(c) with their annual audits. In
2012, the GAO published the report, ``Medicaid: More Transparency of
and Accountability for Supplemental Payments are Needed,'' \6\ in which
the GAO examined how information on DSH audits facilitates our
oversight of DSH payments. In the report, GAO analyzed the 2010 DSH
audits submitted by states. Of the 2,953 audits submitted to CMS, 228
had data reliability or documentation issues that inhibited the
auditor's ability to determine compliance with DSH audit requirements.
While the independent certified audit requirements have allowed us to
identify various compliance issues and quantify some provider
overpayments, in some instances, audits have identified issues related
to incomplete or missing data and have failed to make a determination
regarding the financial impact of these issues. Therefore, we have
identified this area as an opportunity to strengthen program oversight
and integrity protections, specifically with respect to the overpayment
and redistribution reporting process and requirements for identifying
the financial impact of audit findings. In proposing an additional data
element, as discussed below, we hope to further enhance our oversight
to better ensure the integrity of hospital-specific limit calculations.
---------------------------------------------------------------------------
\5\ Audit of Selected States' Medicaid Disproportionate Share
Hospital Programs,'' March 2006 (A-06-03-00031), https://www.oig.hhs.gov/oas/reports/region6/60300031.pdf.
\6\ https://www.gao.gov/assets/660/650322.pdf.
---------------------------------------------------------------------------
The new data element we are proposing to add to annual DSH
reporting would require auditors to quantify the financial impact of
any finding, including those resulting from incomplete or missing data,
which may affect whether each hospital has received DSH payments for
which it is eligible within its hospital-specific DSH limit. We believe
that requiring the quantification of these findings would limit the
burden on both states and CMS of performing follow-up reviews or audits
and will help ensure appropriate recovery and redistribution, as
applicable, of all DSH overpayments.
To enhance federal oversight of the Medicaid DSH program and
improve the accuracy of DSH audit overpayments identified and collected
through annual DSH audits, we are also proposing to require states to
report overpayments identified through annual DSH audits and related
payment redistributions on the Form CMS-64 in a timely and transparent
manner. Specifically, we propose to clarify the reporting requirement
for overpayments identified through the annual DSH audits at Sec.
447.299(f), by directing states to return payments in excess of
hospital-specific cost limits to the federal government by reporting
the excess amount on Form CMS-64, as a decreasing adjustment. We are
proposing to require states to report these decreasing adjustments to
[[Page 63728]]
correspond with the fiscal year DSH allotment on the Form CMS-64.
Additionally, we are proposing to establish reporting requirements on
the redistribution of DSH overpayments, as determined under Sec.
447.299(g) of this chapter in accordance with a redistribution
methodology in the approved Medicaid state plan. We propose to require
states to report the redistribution of DSH overpayments to correspond
with the fiscal year DSH allotment and Medicaid state plan rate year,
on the Form CMS-64. This proposal memorializes our redistribution
policy in regulations and enhances proper oversight. We are proposing
that overpayment amounts be redistributed within 2 years from the date
of discovery, as proposed under Sec. 447.299(g).
c. Modernizing the Publication of Annual DSH Allotments
Section 447.297 provides a process and timeline for CMS to publish
preliminary and final annual DSH allotments and national expenditure
targets in the Federal Register. The current requirements specify that
we publish DSH allotments and national expenditure targets, in
preliminary and final formats, by October 1st (preliminary target and
allotments) and April 1st (final target and allotments) of each federal
fiscal year. We have found the current regulatory Federal Register
publication process to be time consuming and administratively
burdensome and are concerned that the information is not available to
states and other interested parties in a timely and easily accessible
manner. In this proposed rule, we propose to make allotment and
national expenditure targets available more timely by posting the
information on Medicaid.gov and in MBES, or its successor website or
system, instead of publishing this information in the Federal Register.
3. Medicaid Program Financing
a. Background
Medicaid expenditures are jointly funded by the federal and state
governments. Section 1903(a)(1) of the Act provides for payments to
states of a percentage of medical assistance expenditures authorized
under the approved state plan. FFP is available when there is a covered
Medicaid service provided to a Medicaid beneficiary, which results in a
federally matchable expenditure that is funded in part through non-
federal funds from the state or a non-state governmental entity (except
when the statute provides a 100 percent federal match rate for
specified expenditures). The percentage of federal funding is the
federal medical assistance percentage (FMAP) that is determined for
each state using a formula set forth in section 1905(b) of the Act, or
other applicable federal matching rates specified by the statute.
The foundation of federal-state shared responsibility for the
Medicaid program is that the state must participate in the financial
burdens and risks of the program, which provides the state with an
interest in operating and monitoring its Medicaid program in a manner
that results in receiving the best value for the funds expended.
Sections 1902(a), 1903(a), and 1905(b) of the Act require states to
share in the cost of medical assistance and in the cost of
administering the state plan. Section 1902(a)(2) of the Act and its
implementing regulation in part 433, subpart B require states to share
in the cost of medical assistance expenditures and permit other units
of state or local government to contribute to the financing of the non-
federal share of medical assistance expenditures. These provisions are
intended to safeguard the federal-state partnership, irrespective of
the Medicaid delivery system or authority (for example, FFS, managed
care, and demonstration authorities), by ensuring that states are
meaningfully engaged in identifying, assessing, mitigating, and sharing
in the risks and responsibilities inherent in a program as complex and
economically significant as Medicaid and are accordingly motivated to
administer their programs economically and efficiently.
Of the permissible means for financing the non-federal share of
Medicaid expenditures, the most common is through state general funds,
typically derived from tax revenue appropriated directly to the
Medicaid agency. Revenue derived from health care-related taxes can be
used to finance the non-federal share only when consistent with federal
statutory requirements at section 1903(w) of the Act and implementing
regulations at part 433, subpart B. The non-federal share may also be
funded in part from provider-related donations to the state, but these
donations must be ``bona fide'' in accordance with section 1903(w) of
the Act and implementing regulations, which means truly voluntary and
not part of a hold harmless arrangement that effectively repays the
donation to the provider (or to providers furnishing the same class of
items and services).
Non-federal share financing sources can also come from IGTs or
certified public expenditures (CPEs) from local units of government or
other units of state government in which non-state governmental
entities contribute funding of the non-federal share for Medicaid
either by transferring their own funds to and for the unrestricted use
of the Medicaid agency or by certifying to the state Medicaid agency
the amount of allowed expenditures incurred. In each instance,
allowable IGTs and CPEs, as with funds appropriated to the state
Medicaid Agency, must be derived from state or local tax revenue or
from funds appropriated to state university teaching hospitals. IGTs
may not be derived from impermissible health care-related taxes or
provider-related donations (discussed below); they are subject to all
applicable federal statutory and regulatory restrictions. Even when
using funds contributed by local governmental entities, the state must
meet the requirements at section 1902(a)(2) of the Act and Sec. 433.53
that obligate the state to fund at least 40 percent of the non-federal
share of total Medicaid expenditures (both service related and
administrative expenditures) with state funds. Additionally, these
authorities require states to assure that a lack of funds from local
sources will not result in lowering the amount, duration, scope, or
quality of services or level of administration under the plan in any
part of the state.
The extent to which private providers may participate in the
funding of any Medicaid payment (for example, managed care, FFS base,
or supplemental payments) is essentially restricted to the state's
authority to levy limited health care-related taxes and to rely on bona
fide provider-related donation in accordance with statutory and
regulatory requirements. Since the use of IGTs and CPEs are restricted
to governmental entities, states and providers increasingly have turned
to the use of health care-related taxes to enable the maintenance of,
or increases to, Medicaid payments to providers. In addition, several
states have explored the use of provider-related donation arrangements
to further leverage private provider funding.
b. Current CMS Review of Medicaid Financing and Oversight Concerns
We employ various oversight mechanisms to review state methods for
funding the non-federal share of Medicaid payments including, but not
limited to, reviews of proposed SPAs, quarterly financial reviews of
state expenditures reported on the Form CMS-64, focused financial
management reviews, and reviews of state health care-related tax and
provider-related donation proposals and waiver requests. As discussed
in detail above, states
[[Page 63729]]
must submit Medicaid SPAs to CMS for review and approval when adding or
changing FFS provider payment methodologies. We review the SPAs to
ensure the methodologies meet all federal requirements and the proposed
payments and sources of the non-federal share may be approved and serve
as the basis for FFP. In making approval decisions, we ask for certain
information from states to document the source of the non-federal share
during our SPA review process.
In response to our inquiries, states will typically describe
whether the non-federal share is sourced through funds appropriated by
the state legislature directly to the single state Medicaid agency, or
whether the state relies on state or local government units to
participate in funding the non-federal share through IGTs or CPEs.
Additionally, states are asked to disclose whether the underlying
financing involves a health care-related tax or a provider-related
donation. When states rely on IGTs and CPEs as the source of the non-
federal share, we request details on the transferring or certifying
entities that participate in funding expenditures, including assurances
that the entities are units of government, and the source of a unit of
government's IGT. Based on the information that we receive from states,
we may also ask for additional documentation to ensure the source of
non-federal share complies with all applicable federal laws,
regulations, and requirements, particularly those describing
permissible health care-related taxes and provider-related donations.
Though our current SPA review processes allow us to ensure states
identify a permissible source of non-federal share at the time that we
approve an amendment, we have no reliable mechanism to track and
understand whether the source of the non-federal share changes after a
SPA has been approved. Based on studies conducted by the GAO (see for
example, States' Increased Reliance on Funds from Health Care Providers
and Local Governments Warrants Improved CMS Data Collection, GAO-14-
627, July 29, 2014), we are aware that states are increasingly reliant
on non-state units of government to fund the non-federal share through
IGTs, CPEs, and health care-related taxes. In fact, the GAO cites
Medicaid supplemental payments and the associated non-federal share as
a Medicaid High Risk Issue (GAO Report to Congressional Committees
High-Risk Series Substantial Efforts Needed to Achieve Greater Progress
on High-Risk Areas, GAO-19-157SP, March 6, 2019) and has called for CMS
to implement improved oversight and data collection processes to track
sources of non-federal share.
It is important to acknowledge that section 1903(w)(6)(A) of the
Act specifically permits state and local units of government to share
in financing the Medicaid program through IGTs and CPEs. Such local
participation is inherent in the Medicaid program and recognizes the
shared role that state and local government units can play in
delivering Medicaid services. Nothing in this proposed rule would
result in limiting state and local government units from contributing
to the Medicaid program through allowable IGT and CPE funding sources.
However, as discussed in the GAO's studies, the increasing reliance on
Medicaid funding derived from units of state and local government may
serve to undermine the state and federal financing partnership, as
where states establish payment methodologies that favor certain
providers solely on the basis of whether a unit of state or local
government can provide the non-federal share to support Medicaid
supplemental payments. Notably, section 1902(a)(2) of the Act requires
states to assure that a lack of funds from local sources will not
result in lowering the amount, duration, scope, or quality of services
or level of administration under the plan. We have concerns that, in
certain circumstances, increased reliance on units of states or local
government to fund the non-federal share may result in conflicts with
section 1902(a)(30)(A) of the Act.
For example, we have identified and worked to address various
Medicaid financing arrangements that appear designed to increase the
federal share of Medicaid funding without a commensurate state or local
contribution as required by sections 1902(a), 1903(a), and 1905(b) of
the Act, which require states to share in the cost of medical
assistance and in the cost of administering the state plan. We have
identified manipulations of Medicaid UPL demonstration calculations
that would serve to increase a state's ability to make supplemental
payments above a reasonable Medicare estimate in states that have used,
or proposed to use, an unallowable IGT to fund the state share of a
Medicaid supplemental payment. We have also identified the manipulation
of cost identification data providers rely on to certify Medicaid
expenditures through a CPE process that, whether intentional or not,
results in the federal government paying for costs that are unallowable
under the Medicaid program.
Some of the more complicated, and unallowable, Medicaid financing
arrangements we have reviewed resulted from public-private partnership
arrangements between private entities and units of government. These
arrangements attempt to mask non-bona fide provider-related donations
as an allowable IGT and result in increased supplemental payments to
the donating private entity or entities. Discussed in detail in State
Medical Director Letter (SMDL) 14-004 and elsewhere in this preamble,
partnership arrangements between a private provider and a government
entity have involved the private provider providing cash, a service, or
other in-kind donation to the government entity that is seemingly
unrelated to the Medicaid program. In exchange for the private
provider's contribution, the government entity will make an IGT to the
Medicaid agency, which is then used as the non-federal share of
supplemental Medicaid payments which are then returned to the private
entity to repay them for the non-bona fide provider-related donation
consistent with the underlying hold harmless agreement. The IGT is
derived from funds that the government entity previously would have
spent on the medical services (or other obligation) that are now being
provided or paid for by the private entity. These funds would not be
available to use as state share of Medicaid expenditures, if not for
the public-private partnership arrangement, since the funds are derived
from the non-bona fide provider-related donation (and not derived from
state or local tax revenue or from funds appropriated to the state
university teaching hospitals).\7\
---------------------------------------------------------------------------
\7\ Dep't of Health & Human Servs., CMS, State Medicaid Director
Letter 14-004, Accountability #2: Financing and Donations, 3,
(2014), https://www.medicaid.gov/Federal-Policy-Guidance/Downloads/SMD-14-004.pdf.
---------------------------------------------------------------------------
The provisions of this proposed rule seek to address these and
similar financing concerns through a number of strategies. Proposed
improvements to state reporting associated with supplemental payments
and sources of the non-federal share would allow CMS to monitor changes
in non-federal share funding after a SPA is approved and any associated
increases in federal expenditures for supplemental payments, relative
to state expenditures. Additional specificity in definitions relevant
to Medicaid financing arrangements and in requirements for information
states must provide to support various funding mechanisms and
supplemental payments would strengthen oversight of program
expenditures by us and the states. Finally, we propose to address
certain egregious funding schemes that mask
[[Page 63730]]
non-bona fide donations as allowable IGTs by clarifying where an
indirect hold harmless arrangement may exist and by expressly
prohibiting supplemental payments that support these schemes. Together,
proposed new policies and the proposed codification of existing
policies related to Medicaid financing aim to provide CMS and states
with better information and guidance to identify existing and emerging
financing issues, provide more clarity on allowable financing
arrangements, promote state accountability, and strengthen the fiscal
integrity of the Medicaid program.
4. Health Care-Related Taxes and Provider-Related Donations
a. Background
States first began to use health care-related taxes and provider-
related donations in the mid-1980s as a way to finance the non-federal
share of Medicaid payments (Congressional Research Service, ``Medicaid
Provider Taxes'', August 5, 2016, p.2). Providers would agree to make a
donation or would support (or not oppose) a tax upon their activities
or revenues, and these mechanisms would generate funds that could then
be used to raise Medicaid payment rates to the providers. Frequently,
these programs were designed to hold Medicaid providers ``harmless''
for the cost of their donation or tax payment. As a result, federal
expenditures rapidly increased without any corresponding increase in
state expenditures, since the funds used to increase provider payments
came from the providers themselves and were matched with federal funds.
In 1991, the Congress passed the Medicaid Voluntary Contribution and
Provider-Specific Tax Amendments (Pub. L. 102-234, enacted December 12,
1991) to curb the use of provider-related donations and health care-
related taxes to finance the non-federal share of Medicaid
expenditures. Section 1903(w)(1)(A) of the Act specifies that, for
purposes of determining the federal matching funds to be paid to a
state, the total amount of the state's Medicaid expenditures must be
reduced by the amount of revenue the state collects from impermissible
health care-related taxes and non-bona fide provider-related donations.
The statute requires that taxes be imposed on a permissible class
of health care items or services; and be broad based, meaning that all
non-federal, nonpublic providers and all items and services within a
class of health care items or services would be taxed, as well as
uniform, meaning that the tax rate would be the same for all health
care items or services in a class, as well as providers of such items
or services. The statute prohibits hold harmless arrangements in which
collected taxes are returned directly or indirectly to taxpayers. The
Secretary is required by section 1903(w)(3)(E) of the Act to waive
either the broad based and/or uniformity requirements as long as the
state establishes, to the Secretary's satisfaction, that the net impact
of the tax and associated expenditures is generally redistributive in
nature, and the amount of the tax is not directly correlated to
Medicaid payments for items and services with respect to which the tax
is imposed.
Section 1903(w)(2)(A) of the Act defines a provider-related
donation as any donation or other voluntary payment (in-cash or in-
kind) made directly or indirectly to a state or unit of a local
government by a health care provider, an entity related to a health
care provider, or an entity providing goods or services under the state
plan for which payment is made under section 1903(a)(2), (3), (4), (6),
or (7) of the Act (generally, administrative goods and services).
Section 1903(w)(2)(B) of the Act defines a bona fide provider-related
donation as a provider-related donations that has no direct or indirect
relationship (as determined by the Secretary) to payments made under
title XIX to that provider, to providers furnishing the same class of
items and services as the donating provider, or to any related entity,
as established to the satisfaction of the Secretary. The statute gives
the Secretary the authority to specify, by regulation, types of
provider-related donations that will be considered to be ``bona fide.''
Regulations at part 433, subpart B describe the requirements necessary,
irrespective of the Medicaid delivery system authority (for example,
FFS, managed care, or demonstration authorities), for a donation to be
considered bona fide.
In response to the Medicaid Voluntary Contribution and Provider-
Specific Tax Amendments of 1991, we published the ``Medicaid Program;
Limitations on Provider-Related Donations and Health Care-Related
Taxes; Limitations on Payments to Disproportionate Share Hospitals''
interim final rule with comment period in the November 24, 1992 Federal
Register (57 FR 55118) (November 1992 interim final rule) and the
subsequent final rule published in the August 13, 1993 Federal Register
(58 FR 43156) (August 1993 final rule) establishing when states may
receive funds from provider-related donations and health care-related
taxes without a reduction in medical assistance expenditures for the
purposes of calculating FFP. These rules established the statistical
tests used to judge requests for waivers of the broad-based and
uniformity requirements and defined bona fide provider-related
donations.
After the publication of the August 1993 final rule, we revisited
the issue of health care-related taxes and provider-related donations
in the ``Medicaid Program; Health-Care Related Taxes'' final rule (73
FR 9685) which published in the February 22, 2008 Federal Register
(February 2008 final rule). The February 2008 final rule, in part,
implemented section 1903(w)(7)(A)(viii) of the Act by expanding the
Medicaid managed care organization (MCO) class of health care items and
services (73 FR 9698) to include all MCOs specified in section 6051 of
the Deficit Reduction Act of 2005 (DRA) (Pub. L. 109-171, enacted
February 8, 2006). Specifically, it amended the class of health care
services and providers specified in Sec. 433.56(a)(8) from services of
Medicaid MCOs to services of MCOs including health maintenance
organizations (HMOs) and preferred provider organizations (PPOs). As a
result of this change, states could no longer impose a tax solely on
MCOs providing services to only Medicaid beneficiaries.
The regulation also made explicit that certain practices would
constitute a hold harmless arrangement, in response to certain state
tax programs that we believed contained hold harmless provisions. Five
states had imposed a tax on nursing homes and simultaneously created
programs that awarded grants or tax credits to private pay residents of
nursing facilities that enabled these residents to pay increased
charges imposed by the facilities, which thereby recouped their own tax
costs. We believed that these payments held the taxpayers (the nursing
facilities) harmless for the cost of the tax, as the tax program
compensated the facilities indirectly, through the intermediary of the
nursing facility residents. However, in 2005, the DAB (Decision No.
1981) ruled that such an arrangement did not constitute a hold harmless
arrangement under the regulations then in place. To clarify agency
interpretation that this practice does constitute a hold harmless
arrangement, the February 2008 final rule clarified the direct
guarantee test found at Sec. 433.68(f) by specifying that a direct
guarantee to hold the taxpayer harmless for the cost of the tax through
a direct or indirect payment will be found when, ``a payment is made
available to a taxpayer or party related
[[Page 63731]]
to a taxpayer'' so that a reasonable expectation exists that the
taxpayer will be held harmless for all or part of the cost of the tax
as a result of the payment (73 FR 9694). As an example of a party
related to the taxpayer, the preamble cited the example of, ``as a
nursing home resident is related to a nursing home (73 FR 9694). As a
result, whenever there existed a ``reasonable expectation'' (73 FR
9695) that the taxpayer would be held harmless for the cost of the tax,
a hold harmless situation would exist and the tax would be
impermissible.
b. Concerns Relating to Health Care-Related Tax Waivers
States and their units of local government have the ability to
impose broad-based and uniform health care-related taxes without
explicit CMS approval. However, if the tax implemented by the state or
unit of local government is not broad-based and/or uniform, the state
must apply to CMS for a waiver of the applicable tax requirements. As
part of these requirements, the state must demonstrate to the
satisfaction of the Secretary that the tax passes a statistical test
specified in regulation to waive either the broad-based requirement, or
the uniformity requirement, or both, as specified in Sec. 433.68(e)(1)
or (2). These tests were designed to evaluate whether or not a proposed
tax would be ``generally redistributive,'' as required by section
1903(w)(3)(E)(ii)(I) of the Act. The preamble to the November 1992
interim final rule indicated that, in interpreting the statutory phrase
``generally redistributive,'' we ``attempted to balance our desire to
give states some degree of flexibility in designing tax programs with
our need to preclude use of revenues derived from taxes imposed
primarily on Medicaid providers and activities'' (57 FR 55128). In the
preamble of August 1993 final rule, we interpreted ``generally
redistributive'' to mean ``the tendency of a state's tax and payment
program to derive revenues from taxes imposed on non-Medicaid services
in a class and to use these revenues as the state's share of Medicaid
payments'' (57 FR 55128).
At the time of these rules, we anticipated the two mathematical
tests in Sec. 433.68(e)(1) and (2) would be sufficient to ensure that
a proposed tax would be ``generally redistributive,'' as we interpret
that statutory language. Specifically, the first test known as the
``P1/P2 test'' in Sec. 433.68(e)(1) is required for taxes that are
uniform, but not broad based. At the time of these rules, we
anticipated the two mathematical tests in Sec. 433.68(e)(1) and (2)
would be sufficient to ensure that a proposed tax would be ``generally
redistributive,'' as we interpret that statutory language.
Specifically, the first test known as the ``P1/P2 test'' in Sec.
433.68(e)(1) is required for taxes that are uniform, but not broad
based. As described in the November 1992 interim final rule (57 FR
55128), the test requires the State to calculate the proportion of the
tax applicable to Medicaid under a broad-based tax (designated as P1),
and the proportion applicable to Medicaid under the tax as imposed by
the State (called P2). By dividing P1 by P2, the test was intended to
measure whether or not the uniform, but non-broad based tax was
redistributive. Resulting values higher than one indicated the tax was
more redistributive than a broad-based and uniform tax, while values
less than one would indicate it was less redistributive and placed a
disproportionate share of the tax burden on the Medicaid program (57 FR
55128).
The November 1992 interim final rule (57 FR 55128) also described
the second test known as the ``B1/B2 test,'' applying in situations
when the state requests a waiver of the uniformity requirement whether
or not the tax is broad-based. In this test, the State would calculate
the slope of two linear regressions: One for the tax program for which
waiver is requested, and one for the tax if it were applied uniformly
and as a broad-based tax where the slope (that is, the X coefficient)
of the linear regression applicable to the hypothetical broad-based
uniform tax (called B1) is divided by the slope of the linear
regression applicable to the tax for which a waiver is sought (called
B2) (57 FR 55128). Similar to the P1/P2 test for uniform taxes that are
not broad based, the B1/B2 test was designed to show that values higher
than one indicate the non-uniform tax was more redistributive than a
broad-based and uniform tax, while values less than one would indicate
that it was less redistributive and disproportionately burdened the
Medicaid program (57 FR 55128).
However, subsequent experience has proven that the two mathematical
tests do not ensure, in all cases, that proposed taxes that pass the
applicable test are generally redistributive. Certain states have
identified a loophole where taxes can pass the statistical test(s)
despite their imposition of undue burden on the Medicaid program. For
example, several states have imposed taxes on managed care entities
that, by design, clearly impose a greater and undue tax burden on the
Medicaid program than other payers. States have structured the taxes by
dividing the universe of entities subject to taxation into smaller
taxpayer groups based on various attributes, such as annual member-
months by payer. In this example, states have imposed significantly
higher rates on some taxpayer groups defined by a relatively higher
number of Medicaid member-months than on commercial payer member-
months, with some Medicaid activity (member-months in this example)
subject to taxation at a rate more than 25 times higher than the rate
for otherwise similar commercial activity. Counterintuitively, these
taxes are able to pass the statistical tests designed to ensure that
the tax is generally redistributive, despite the states' own
information indicating, in one state, that plan revenue from Medicaid
paid 88 percent of the assessed tax even though only 45 percent of the
member months subject to the tax were attributable to Medicaid
beneficiaries. Under these tax conditions, the proposed rule would give
CMS the authority to determine that the tax is not generally
redistributive, despite the fact that it could pass the applicable
statistical test under current regulations, because it places an undue
burden on the Medicaid program (as indicated in the example by the
disproportionate share of the tax attributable to Medicaid relative to
Medicaid's share of total member months). The August 1993 final rule
noted that, ``to the extent a tax is imposed more heavily on low
Medicaid utilization than high Medicaid providers, the tax would be
considered redistributive,'' in that case, there would be a ``tendency
of a state's tax and payment program to derive revenues from taxes
imposed on non-Medicaid services in a class and to use these revenues
as the state's share of Medicaid payments'' (57 FR 55128). However, in
the situations involving the type of statistical manipulation described
above, the exact opposite is the case. In these instances, states are
imposing taxes that place a greater tax burden on Medicaid-reimbursed
health care items and services, and providers of such items and
services, than on comparable entities not reimbursed by Medicaid. Such
a tax is not generally redistributive in nature.
In an effort to more effectively prohibit tax arrangements that are
not generally redistributive, for us to approve a waiver of the broad
based and/or uniformity requirements, this proposed rule would require
that a tax must not impose undue burden on health care items or
services paid for by Medicaid or on providers of such items and
services that are reimbursed by
[[Page 63732]]
Medicaid. Generally, as discussed in greater detail below, we would
provide that the tax may not be structured in a way that places a
greater tax burden on taxpayer groups that have a greater level of
Medicaid activity, as proposed to be defined below, than those that
have less or no Medicaid activity.
Some states have designed non-broad based and/or non-uniform tax
structures that exclude, or lower tax rates on, taxpayers grouped
together on the basis of their lack of or low levels of Medicaid
activity compared to other taxpayers in the class. We believe that such
tax structures inherently impose undue burden on the Medicaid program,
and therefore, do not meet the statutory generally redistributive
requirement. Similarly, we are concerned that some states might provide
tax relief to taxpayers grouped together ostensibly on a basis other
than Medicaid activity, but that the specific basis for the grouping is
designed to obscure a true purpose to define the group based on lack of
or relatively low Medicaid activity. For example, a state could attempt
to exclude from taxation or place a lower tax rate on all hospitals
within a certain geographic area that has certain demographic
characteristics, such as all counties with populations between 40,000
and 85,000 residents. Under the particular conditions in the state, it
could result that this commonality serves as a substitute for the
included hospitals having low or no Medicaid activity. In this example,
the commonality could be viewed as a substitute for Medicaid activity
if only two counties in the state met this criteria, and the hospitals
in these two counties had relatively low Medicaid activity compared to
hospitals in the other counties in the state, as might occur in the
case of a county with relatively low Medicaid enrollment in the county
and surrounding counties. Such a tax program likely would result in the
Medicaid program funding a disproportionate share of tax revenues, as
counties containing hospitals with low levels of Medicaid activity
would be excluded by the structure of the tax. In that case, the burden
of the tax would fall upon hospitals with higher Medicaid activity.
Therefore, as discussed below, we are proposing to consider tax
structures not to be generally redistributive when taxpayers are
grouped together in a manner that isolates taxpayers with relatively
higher or lower levels of Medicaid activity and when taxpayers with
relatively higher Medicaid activity are taxed relatively more heavily.
We propose to consider the totality of the circumstances when deciding
whether the tax program involves taxpayer groupings that, by proxy,
have the effect of sorting taxpayers by relatively higher or lower
levels of Medicaid activity. The proposed rule would retain the two
statistical tests currently at Sec. 433.68 when determining whether or
not the proposed tax waiver would be generally redistributive as
required by statute. However, in determining whether or not a tax
program is generally redistributive, consideration would also be given
to examine the totality of the circumstances in addition to the
applicable statistical test.
We aim to balance preserving state flexibility in designing tax
programs with ensuring health care-related taxes meet statutory
generally redistributive requirements. We do not intend to interfere
with states' ability to exclude from taxation or impose lower tax rates
on health care items and services or on providers based on genuine
commonalities that meet legitimate policy objectives. However, it is
incumbent upon us to prevent tax structures designed to impose an undue
burden on the Medicaid program, including on participating providers
and/or health care items and services for which Medicaid pays, in
contravention of federal statutory requirements.
c. Concerns Relating to the Definition of a Health Care-Related Tax
Section 1903(w)(3)(A)(i) of the Act defines a health care-related
tax using multiple tests that must be applied to tax proposals. Section
1903(w)(3)(A)(i) of the Act stipulates health care-related taxes are
related to: (1) Health care items or services; (2) the provision of, or
the authority to provide, health care items or services; or (3) payment
for health care items or services. Section 1903(w)(3)(A)(ii) of the Act
further stipulates that a tax is a health care-related tax when it is
not limited to health care-related items or services, but provides for
treatment of individuals or entities that provide or pay for health
care-related items or services that is different than treatment of
``other individuals or entities.'' Any tax must be fully evaluated
against all components of the statutory definition to determine whether
it qualifies as a health care-related tax.
In determining whether a tax is related to health care items or
services, section 1903(w)(3)(A) of the Act also specifies that if at
least 85 percent of the tax burden falls on health care providers, it
is considered to be related to health care items or services. However,
this provision does not establish a safe harbor for any tax on health
care providers that falls below the threshold. Section 433.55(c)
specifies that if less than 85 percent of the tax burden falls on
health care items or services, the tax may still be considered to be
health care-related if differential treatment exists for entities
providing or paying for health care items or services relative to other
entities. If less than 85 percent of the tax burden falls on health
care items or services, the treatment of those entities must still be
analyzed to determine if the tax treats them equally.
Outside oversight bodies have raised concerns that states have
attempted to subvert federal regulations regarding health care-related
taxes by masking them as part of larger non-health care-related taxes.
States may do so by including impermissible health care-related taxes
inside larger tax programs that include non-health care-related taxes
in such a way so as to avoid being considered a health care-related tax
in accordance with Sec. 433.55. The OIG identified one such attempt in
a May 2014 report (A-03-13-00201),\8\ in which the OIG described a
state that appeared to be taxing only income from Medicaid MCO services
by incorporating only Medicaid MCOs into larger (often existing) state
and local taxes otherwise unrelated to Medicaid, despite the DRA
provisions which prohibited taxation of only Medicaid MCOs.
Specifically, section 6051 of the DRA amended section 1903(w)(7)(A) of
the Act to change the relevant permissible class of health care items
and services from ``[M]edicaid managed care organizations'' to MCOs
generally. In its report, the OIG recommended that CMS issue
clarification to states regarding its interpretation of statute and
regulations regarding health care-related taxes as soon as possible and
warned that failure to do so could result in a proliferation of similar
Medicaid MCO taxes if states believed that it was permissible to
incorporate otherwise impermissible health care-related taxes into pre-
existing, non-health care-related tax programs as long as less than 85
percent of the tax burden fell on health care providers. Absent
clarifying guidance, we were also concerned that states could
mistakenly believe that selectively incorporating a tax on health care
items or services for which Medicaid is a significant payer, like home
and community-based services (HCBS), into a broader state tax program
would result in the HCBS tax not being defined as health-care related.
---------------------------------------------------------------------------
\8\ https://oig.hhs.gov/oas/reports/region3/31300201.pdf.
---------------------------------------------------------------------------
[[Page 63733]]
In July 2014, we issued State Health Official (SHO) letter #14-001
(SHO #14-001) on health care-related taxes. This guidance clarified
that even in cases where less than 85 percent of a tax falls on health
care items or services, the tax can be considered health care-related.
If a tax treats health care items or services differently, the tax is
still considered a health care-related tax. Specifically, SHO #14-001
stated that taxing a subset of health care services or providers at the
same rate as a statewide sales tax, for example, does not result in
equal treatment if the tax is applied specifically to a subset of
health care services or providers (such as only Medicaid MCOs), since
the providers or users of those health care services are being treated
differently than others who are not within the specified universe.
Despite this guidance, some states have continued to selectively
incorporate health care items or services into larger tax programs that
also levy taxes on goods and services unrelated to health care in an
apparent attempt to circumvent the statutory restrictions on health
care-related taxes. These impermissible tax arrangements have not been
limited to states incorporating only Medicaid MCOs into broader state
or local taxes, but have included other health care items or services,
such as private non-medical institution services.
Often, the health care items and services (or providers) subject to
such taxes are subsets of health care items and services (or providers)
highly utilized by Medicaid beneficiaries and/or do not meet the
permissible class definition in Sec. 433.56. For example, a state may
try to impose a tax on a service that is mostly (if not entirely)
reimbursed by Medicaid, which does not fall under an existing
permissible class at Sec. 433.56, such as HCBS. A state may include a
service like this among other goods and services that are taxed under a
larger tax program that is not explicitly related to health care, such
as a tax program principally concerned with natural resources or
telecommunications. The proposed rule clarifies that by targeting a
specific type of health care-related item or service and incorporating
it into a larger tax (the HCBS portion of this tax to continue with the
above example) would be considered health care-related--even if 85
percent of the revenue from the tax overall did not come from health
care-related items or services or providers of such items or services.
The preamble to the November 1992 interim final rule with comment
period discussed the circumstances in which health care items and
services included within a larger non-health care related-tax would
cause the tax to be considered health care-related in situations where
they did not constitute 85 percent of the tax revenue. To illustrate
when such taxes would or would not be considered health care-related,
the preamble gave the hypothetical example of a 5 percent tax on the
gross revenues of hospitals and gas stations that generated $100
million dollars in tax revenue. The preamble stated that if the
hospitals paid $90 million of the tax, then the tax would be considered
to be health care-related because this would exceed the 85 percent
threshold. However, if the hospitals paid only $60 million dollars,
then the tax would not be considered health care-related because the
tax rate is the same for health care items or services and non-health
care items or services and the hospitals would be taxed at under the 85
percent threshold established in regulation.
We are aware that this example may not have been as clear as
possible and could have led to confusion as to what different treatment
for health care items and services means in the context of Sec.
433.55(c). Specifically, we are concerned some parties misinterpreted
this example as indicating approval of states selecting specific health
care-related items and services for inclusion within a broader tax
program without the tax being considered health care-related as long as
less than 85 percent of the tax burden falls on such items and
services. We believe this potential misinterpretation is inconsistent
with section 1903(w)(3)(A)(ii) of the Act, Sec. 433.55(c), and the
preamble to the August 1993 final rule, which stated in response to a
commenter, ``We believe section 1903(w)(3)(A)(ii) [of the Act] prevents
the state from implementing a tax that may be masked by an existing
non-health care-related tax'' (58 FR 43160). In the aforementioned
preamble example, a tax in which hospitals paid $60 million and gas
stations paid $40 million under a flat 5 percent gross revenues tax was
not necessarily considered health care-related because the burden on
providers of health care items and services is less than 85 percent.
While Sec. 433.55(c) states that in situations where less than 85
percent of the tax burden falls on health care items or services the
tax may still be considered health care-related if differential
treatment exists for entities providing or paying for health care items
or services. However, Sec. 433.55(c) does not specify the reference
group against which one should measure differential treatment.
While statute and regulation specify that differential treatment
results in a tax being considered health care-related, existing law and
regulations do not explicitly describe what constitutes differential
treatment. Therefore, we are proposing to clarify what constitutes
differential treatment to clarify when taxes are health care-related
and when they are not. We believe this clarification would assist in
prohibiting state or local units of government from incorporating an
impermissible tax on health care items or services into a larger
existing tax, such as a state-wide sales tax, or creating a new tax
that treats health care items or services differently to avoid federal
statutory and regulatory requirements related to health care-related
taxes. Therefore, we are proposing to clarify that differential
treatment occurs when a tax program treats some individuals or entities
that are providing or paying for health care items or services
differently than (1) individuals or entities that are providers or
payers of any health care items or services that are not subject to the
tax or (2) other individuals or entities that are subject to the tax.
Due to the complexity of this issue, we are providing a few
illustrative examples of when a tax program does or does not constitute
differential treatment. First, we are providing examples relating to
evaluating differential treatment of individuals or entities that are
providing or paying for health care items or services that are subject
to the tax compared to individuals or entities that are providers or
payers of any health care items or services that are not subject to the
tax. For example, if the state imposes a tax on telecommunication
services, but also includes inpatient hospital services, this would
constitute differential treatment. Given that inpatient hospital
services are not reasonably related to the other services subject to
taxation (that is, telecommunication services), as discussed below, we
would consider the tax to be treating inpatient hospital services
differently than other individuals or entities providing or paying for
health care items or services, which are not included in the tax. While
some might consider this example as being similar to the example
involving a tax on gas stations and hospitals in the November 1992
interim final rule, we are taking this opportunity to clarify our
interpretation of section 1903(w)(3)(A)(ii) of the Act. We have never
ruled out the extistence of differential treatment in all instances
where health care items or services are included in a larger non-health
care-related tax program, even where less than 85 percent of the tax
burden falls on health care providers and all entities
[[Page 63734]]
and services are subject to the same tax rate. As we emphasized in the
2014 SHO letter, taxes where less than 85 percent of the tax burden
falls on health care items or services may still be considerd health
care-related if only a subset of health care items or services are
taxed, even if they are taxed at the same rate as items or services not
related to health care that are also included in the tax. Prior to the
issuance of the 2014 SHO letter, several states attempted to mask taxes
on such subsets, including Medicaid-only MCOs, by including them within
larger, non-exclusively health care-related tax programs. Notably, the
taxes on Medicaid-only MCOs would not have been approvable on their
own, if implemented by the state separately from the taxation of items
and services unrelated to health care. States included taxes on
Medicaid-only MCOs within larger, non-exclusively health care-related
tax programs, such as sales taxes and gross receipts taxes, in an
attempt to bypass federal statutory and regulatory prohibitions by
effectively masking the health care-related component of the tax. We
have worked with the OIG to ensure that these and similar practices
that ran counter to the letter and spirit of federal statute and
regulation were stopped. We view this proposed rule as a continuation
of our efforts to ensure that health care-related taxes follow all
applicable requirements.
In instances where a state or other unit of government imposes a
tax on reasonably related items or services that includes some non-
health care items or services and some health care items or services,
we would not consider differential treatment to occur if all health
care items or services that are reasonably related to the taxed
universe are included in the tax and all health care items and services
subject to the tax are taxed at the same rate as the non-health care
items or services subject to the tax. We will consider items or
services within the tax to be reasonably related if there exists a
logical or thematic connection between the items or services or
individuals or entities being taxed. Examples of such a connection
could include, but would not be not limited to, industry, such as
electronics; geographical area, such as city or county; net revenue
volume; or number of employees. When determining whether or not
individuals, entities, items, or services are reasonably related, we
will examine the parameters of the given tax. In this context, the
parameters of the tax means the grouping of individuals, entities,
items or services, on which the tax is imposed. For example, if a state
or unit of government imposed a one percent tax on all revenue from
licensed professional services (for example, accounting services, legal
services, etc.), including revenue from services provided by medical
professionals, this would not constitute differential treatment,
because all health care items or services reasonably related to the
universe of items and services subject to the tax are themselves
subject to the tax, and such services are taxed at the same rate as the
included non-health care items or services. Provided that less than 85
percent of the tax burden falls on health care providers, the tax in
this example would not be considered a health care-related tax.
However, if the state or unit of government imposing the tax structures
the parameters of the tax in such a way to include items or services
that are not reasonably related and only selected health care items or
services are included in the tax while others are excluded, the tax
would be considered health care-related, as in the above example of a
tax on telecommunications services and inpatient hospital services.
When determining whether or not differential treatment occurs, we
evaluate the totality of the circumstances of the arrangement. For
example, under some circumstances, it could be permissible for the
state or unit of government to impose a tax on businesses employing 50
to 500 full-time equivalent (FTE) employees; such that the tax likely
would include a number of entities providing or paying for health care
items and services, and a number of entities selling non-health care
items and services, within its parameters. However, it could be that,
within a certain geographical area of the state, most businesses
employing 50 to 500 FTE employees are entities providing or paying for
health care items and services. If the tax were geographically targeted
to include this area but not other areas of the state or unit of
government's jurisdiction with a more diverse mix of businesses
employing 50 to 500 FTE employees, this targeting could be evidence
that the state or unit of government is using the numeric FTE employee
parameter as a proxy to concentrate the tax burden on certain entities
providing or paying for health care items or services.
While the examples given above illustrate hypothetical taxes we
would consider to be health care-related where less than 85 percent of
the tax falls on providers of health care items or services, they do
not represent an exhaustive list of all possible forms of differential
treatment, as we cannot foresee every possible arrangement.
Differential treatment may still exist even in situations other than
those described previously and identified in proposed Sec.
433.55(c)(1) and (2). Therefore, we are also proposing to examine the
parameters of the tax as defined by the state or other unit of
government, as well as the totality of the circumstances relevant to
which individuals, entities, items, or services are subject (and not
subject) to the tax, and the tax rate applicable to each, in
determining whether the tax program involves differential treatment as
provided in section 1903(w)(3)(A)(ii) of the Act. The proposed rule
aims to preserve appropriate state flexibility on tax and health care
policy, while clarifying what constitutes differential treatment within
the meaning of section 1903(w)(3)(A)(ii) of the Act and Sec. 433.55(c)
and helping ensure that states do not design tax structures to
circumvent statutory requirements.
d. Concerns About Hold Harmless and Health Care-Related Taxes
We have become aware of impermissible arrangements that exist where
a state or other unit of government imposes a health-care related tax,
then uses the tax revenue to fund the non-federal share of Medicaid
payments back to the taxpayers. The taxpayers enter into an agreement,
which may or may not be written, to redistribute these Medicaid
payments to ensure that taxpayers, when accounting for both the
original Medicaid payment (from the state, unit of local government, or
MCO) and any redistribution payment from another taxpayer or taxpayers,
receive all or any portion of their tax amount back. The net effect of
the arrangement is clear evidence that taxpayers have a reasonable
expectation that their forthcoming Medicaid payment (including any
redistribution), which results in participating taxpayers being held
harmless for all or a portion of the tax amount. Regardless of whether
the taxpayers participate voluntarily, whether the taxpayers receive
the Medicaid payments from a MCO, or whether taxpayers themselves make
redistribution payments from funds other than Medicaid to other
taxpayers, the net effect of the arrangement is the same: The taxpayers
have a reasonable expectation to be held harmless for all or a portion
of their tax amount.
Such arrangements undermine the fiscal integrity of the Medicaid
program and are inconsistent with existing statutory and regulatory
requirements prohibiting hold harmless arrangements. The February 2008
final rule on health
[[Page 63735]]
care-related taxes and provider-related donations specified that hold
harmless arrangements prohibited by Sec. 433.68(f)(3) exist ``. . .
when a state payment is made available to a taxpayer or a party related
to the taxpayer (for example, as a nursing home resident is related to
a nursing home), in the reasonable expectation that the payment would
result in the taxpayer being held harmless for any part of the tax''
(73 FR 9694). Despite the statutory and regulatory prohibitions, we are
concerned that states, local units of government, and/or providers
continue to design and execute hold harmless practices that are
antithetical to federal law and regulation. To aid in preventing and
ending such complex financing arrangements, the proposed rule would add
clarifying language to the hold harmless definition in Sec.
433.68(f)(3) to specify that CMS considers a ``net effect'' standard in
determining whether or not a hold harmless arrangement exists.
In the example cited above involving some taxpayers that received
more in Medicaid reimbursement (from the state, unit of local
government, or MCO) than the amount of tax paid which they then
transfered to other taxpayers that did not, we would consider such an
arrangement to include a hold harmless arrangement because the
taxpayers had a reasonable expectation to be held harmless from all or
a portion of the cost of their tax through either or both of the
Medicaid payments from the state or other unit of government or from
MCOs, and redistribution payments from other taxpayers participating in
the arrangement whose payments from the state or other unit of
government or from MCOs met or exceeded their own tax cost. The fact
that a private entity makes the redistribution payment does not change
the essential nature of the payment, which constitutes an indirect
payment from the state or unit of government to the entity being taxed
that holds it harmless for the cost of the tax. As noted in the
February 2008 final rule, ``An indirect payment to the taxpayer would
also constitute a direct guarantee'' (73 FR 9896). When looking for the
presence or absence of a hold harmless arrangement in health care-
related taxes, conclusive evidence lies not in the presence or absence
of individual elements, but the sum total of all the elements when
viewed collectively. While the presence or absence of a single
individual factor may not be sufficient to establish conclusively that
such an arrangement exists, the cumulative effect of many such factors
may be sufficient to make such a determination. Only after reviewing
the totality of the circumstances and making a judgment about how the
overall arrangement operates are we able to determine whether or not
the state provides for a direct or indirect payment, offset, or waiver
that holds the taxpayer harmless for any portion of the tax. This
proposal does not reflect any change in policy or approach, but merely
codifies currently prohibited practices, and would provide further
clarification to states regarding how they may finance the non-federal
share of Medicaid expenditures.
e. Concerns Regarding Permissible Tax Classes of Health Care Services
and Providers
Over the past several years, we have become aware that several
states have instituted taxes on health insurers or health insurance
premiums. In an effort to maintain consistent federal oversight of
health care-related taxes, modernize the permissible class definitions,
and permit states additional flexibility to implement health care-
related taxes, this rule proposes to add services of health insurers,
other than MCOs listed in Sec. 433.56 (a)(8), as permissible classes
of health care items or services under Sec. 433.56, under section
1903(w)(7)(A)(ix) of the Act. In an effort to avoid being overly
prescriptive, we have decided against proposing a narrow definition of
the term ``health insurer.'' However, the definition of ``health
insurance issuer'' at 45 CFR 144.103 provides a helpful point of
reference. That regulation defines a health insurance issuer as an
insurance company, insurance service, or insurance organization
(including an HMO) that is required to be licensed to engage in the
business of insurance in a state and that is subject to state law that
regulates insurance (within the meaning of section 514(b)(2) of ERISA).
However, the term health insurer in the proposed additional class at
Sec. 433.56, explicitly excludes MCOs such as HMOs because these
organizations are already included under section 1903(w)(7)(A)(viii) of
the Act, unlike the term health insurance issuer at Sec. 144.103. The
proposed class would include insurers that issue policies for the group
market and/or the individual market, including such coverage with high-
deductible or ``catastrophic'' plans. The proposed class would also
include issuers of short-term limited-duration policies as defined in
Sec. 144.103, as well as issuers of coverage for ``excepted benefits''
defined in 45 CFR 146.145 in the group market and the individual market
at 45 CFR 148.220, such as dental-only and vision-only policies. Such a
health care-related tax could include, but need not be limited to, an
assessment on health insurance premiums, covered lives, or revenue. The
class may include cost sharing measures, including premiums, from
Medicare, such as private FFS plans under Medicare Advantage offered as
part of Medicare Part C or prescription drug insurance plans as part of
Medicare Part D, as well as any premiums paid by individuals as part of
a section 1115 waiver where Medicaid funding is used for premium
assistance to help beneficiaries purchase commercial health insurance
plans. Such a tax cannot include CMS or any state agencies involved in
administering title XVIII, title XIX, or title XXI, including state
Medicaid agencies. We are soliciting comments on the definition of this
permissible class to ensure that the appropriate entities and services
are included.
f. Concerns Regarding Non-Bona Fide Provider-Related Donations
We are concerned that certain states, localities, and private
health care providers have designed complex financing structures to
mask non-bona fide, provider-related donations used to fund the non-
federal share of Medicaid payments. States, localities, and private
providers appear to be utilizing these complex arrangements to
obfuscate the source of non-federal share and avoid the statutorily-
required reduction to state medical assistance expenditures. They also
appear to violate a variety of requirements in section 1903(w) of the
Act and its implementing regulations, which mandate that the state's
Medicaid expenditures for which FFP is provided shall be reduced by the
sum of any revenues resulting from provider-related donations received
by the state during the fiscal year other than bona fide provider-
related donations. Such practices may also run afoul of section
1902(a)(30)(A) of the Act, which requires that payments be made
consistent with efficiency, economy and quality of care. Additionally,
they may result in payments that are inconsistent with the proper and
efficient operation of the state plan (see section 1902(a)(4) of the
Act) and its design for a cooperative state-federal partnership by
generating increases in federal spending without a corresponding
increase in state financial participation, with no direct link to
additional services furnished, beneficiaries assisted, or other benefit
to the Medicaid program.
Often, these arrangements involve a transfer of value of some kind
from a private provider to a governmental entity and the governmental
entity does
[[Page 63736]]
not reimburse the private entity at fair market value. For example, the
transfer may involve the private provider assuming an obligation
previously performed by a governmental entity without being reimbursed
fair market value, performing services previously performed by a
governmental entity without being reimbursed at fair market value, or
renting real property from a governmental entity at a price above fair
market value. In such cases, the difference between the fair market
value of the assumption of the obligation, performance of the services,
or rental value of the property and the value actually transferred is
in effect a donation by the private provider to the governmental
entity. The governmental entity then executes an IGT, funded by the
donation, to the state Medicaid agency, which is then used to fund the
non-federal share of Medicaid expenditures. The Medicaid agency then
makes a supplemental payment to the private donating provider, which
effectively compensates it for the value it transferred to the
governmental entity (the assumption of an obligation, performance of
services, or excess rent paid). Often, this arrangement will not be
executed as a contract or other formal business arrangement, or
otherwise reduced to writing of which evidence is available to us.
Instead, it will be based on a series of reciprocal actions performed
by each party. As a result of such an arrangement, the private provider
makes a direct or indirect donation, and the state returns all or a
portion of the value of the donation to the private provider
effectively using only federal dollars without a corresponding outlay
in state expenditures, and such an arrangement constitutes a non-bona
fide donation becase there is a pre-existing hold harmless agreement.
The net effect of such an arrangement is to artificially inflate the
state Medicaid expenditures eligible for FFP, sometimes up to 100
percent, in a manner inconsistent with statute and regulation.
Recently, we have identified and taken action to prevent or end
impermissible financing practices in which states have attempted to
mask non-bona fide provider-related donations. Some of these
arrangements include instances where transfers of licenses occur
without consideration of, or below, fair market value from a private
provider to a unit of government to enable formerly private providers
to receive certain supplemental payments available to governmental
providers. In other situations, governmental entities have leased the
same facilities back to private providers at rents above fair market
value as a way of allowing the private facilities to make non-bona fide
donations to the governmental entity, which then transfers the funds to
the state Medicaid agency through IGTs. Ultimately, these schemes have
the net effect of reducing the overall percentage of total computable
Medicaid expenditures funded with state dollars, while at the same time
causing a corresponding increase in federal funding.
We have taken several steps to curtail public-private partnerships
that lead to non-bona fide provider-related donations. In 2014, we
issued SMDL #14-004, the second in a series of two SMDLs that discuss
mutual obligations and accountability with respect to the Medicaid
program for the federal government and states. SMDL #14-004 addressed
the deleterious impact that public-private partnerships designed to
skirt federal requirements concerning provider-related donations can
have on fiscal integrity. In 2016, we issued a disallowance to recover
FFP associated with impermissible provider-related donations where
private providers assumed financial obligations of local governmental
entities to free up government funds, and the freed up funds were then
used as the state's share of supplemental payments to the donating
provider. The CMS disallowance was upheld when the state appealed to
the DAB (DAB No. 2886, Texas Health and Human Services Commission
(2018)).
This proposed rule would clarify the hold-harmless definition
related to donations to account for the net effect of complex donation
arrangements, including where the donation takes the form of the
assumption of governmental responsibilities. In the provisions of Sec.
433.54 addressing when a guarantee would exist to hold the provider
harmless for value related to a donation to the governmental entity,
this proposed rule would establish a net effect standard. Any exchange
of value that constitutes a governmental entity reimbursing a private
entity for value related to the private entity's donation need not
arise to the level of a legally enforceable obligation, but must be
considered in terms of its net effect, thus incorporating the language
in DAB No. 2886, Texas Health and Human Services Commission (2018). In
that case, the DAB held that ``the net effect of the arrangements under
review amounted to impermissible provider donations'' and that as a
result, the supplemental payments made by state Medicaid agency to the
private provider were impermissible (p.25). The DAB also found that it
is not necessary for a legally enforceable obligation to exist, such as
under a statute or contract, for a donation to be found. In line with
the Board's reasoning, we are proposing to establish a net effect
standard to look at the overall arrangement in terms of the totality of
the circumstances to judge if a non-bona fide donation of cash,
services or other transfer of value to a unit of government has
occurred. In Sec. 433.52, the proposed definition of ``provider-
related donation'' would clarify that the assumption by a private
entity of an obligation formerly performed by a unit of government
where the unit of government fails to compensate the private entity at
fair market value would be considered an indirect donation made from
the private entity to the unit of government. This proposed rule would
also clarify that such an exchange need not arise to the level of a
legally enforceable obligation.
C. Previous CMS Efforts To Understand and Monitor Medicaid Payments and
Financing
We have already taken action to strengthen our approach to
authorizing, monitoring, and evaluating Medicaid payments and financing
to ensure that statutory and regulatory requirements are satisfied. To
monitor supplemental payments made under state plan authority, in 2010,
we began requiring states to separately report through MBES amounts
paid for the most common and largest supplemental payments in
accordance with Sec. 430.30(c). States report statewide aggregate
amounts for only some supplemental payments and do not include
provider-level detail. In 2013, we issued SMDL #13-003, which discussed
a submission process to comply with the UPL requirements in Sec. Sec.
447.272 and 447.321. This SMDL discussed methods of complying with
these two regulations through annual UPL submissions apart from the
normal state plan process, as the regulations do not specify time
frames for the submission of UPL demonstrations. The SMDL also provided
further guidance regarding UPL calculation methodologies and requested
that states identify the source of non-federal funding for the payments
described in the UPL demonstration. This guidance improved our ability
to analyze supplemental payments and validate that aggregate
supplemental payments for each class of provider ownership group do not
exceed what Medicare would have paid for the services or, in an
alternative approach that may be selected by the states, do not exceed
the cost of providing those services.
[[Page 63737]]
We have also intensified our examination of SPAs proposing
supplemental payments, and their associated funding arrangements, and
have developed a greater understanding of how to ensure that payment
and financing arrangements comply with statutory requirements. These
reviews focus on ensuring more transparency for supplemental payments
by requiring more comprehensive SPA language so that providers and
other stakeholders can fully understand how providers will receive
payment and any conditions on those payments. We are also asking more
questions regarding states' assumptions about the value that proposed
supplemental payments would bring to the Medicaid program, including in
terms of improving access and quality of care outcomes, in our efforts
to ensure that states' payment systems are consistent with section
1902(a)(30)(A) of the Act.
Although we made improvements to the parameters around aggregate
payment levels as reflected in UPL demonstrations, there have been
concerns from oversight entities, noted elsewhere in the preamble,
regarding payments to individual providers, including concern that some
governmental providers were being paid Medicaid payments far in excess
of the costs incurred in providing the underlying services. In response
to those concerns, we issued the ``Medicaid Program; Cost Limit for
Providers Operated by Units of Government and Provisions to Ensure the
Integrity of Federal-State Financial Partnership'' final rule with
comment period in the May 29, 2007 Federal Register (72 FR 29748),
which limited payments to any governmentally operated provider to the
cost incurred for delivery of Medicaid services. The May 29, 2007 final
rule with comment period was challenged by states and health care
providers. After a series of Congressional moratoria against its
implementation, Congress stated its sense that it should not be
implemented. In 2010, the final rule was rescinded (75 FR 73972) and we
have not moved forward with this or any similar approach.
We have previously recognized the need in other instances to obtain
provider-level payment reporting. Section 1923(j) of the Act and its
implementing regulations delineate annual DSH audit and reporting
requirements. To ensure that Medicaid DSH payments are in compliance
with federal statutory requirements, we published the 2008 DSH audit
rule, which requires that states report and account for certain
provider-level information on the hospitals receiving these payments.
The rule also requires states to have their DSH payment programs
independently audited to verify that the payments comply with
applicable hospital-specific DSH limits. Such information includes
reporting of supplemental payments and ensuring that such payments are
factored into the hospital-specific DSH limit. However, this data set
is limited in that it only includes reporting for those hospitals that
receive Medicaid DSH payments and are due to us more than 3 years after
the completion of each state plan rate year. Therefore, in Sec.
447.288 of this proposed rule, to help ensure timely and comprehensive
reporting on the Medicaid financing for all payments to hospitals, we
are proposing to require the annual amount of total Medicaid DSH
payments made to any provider be reported in the annual provider-level
payment data report for this regulation, along with all Medicaid
supplemental payments.
II. Provisions of the Proposed Rule
A. Proposed Provisions
1. Disallowance of Claims for FFP (Sec. 430.42)
Section 1116(d) and (e)(1) of the Act outline the disallowance
reconsideration process and provide that a state may request
administrative reconsideration of a disallowance if such a request is
made within a 60-day period that begins on the date the state receives
notice of the disallowance. However, the statute does not specify the
format of the notice of disallowance or request for reconsiderations.
We are proposing to amend Sec. 430.42 to alter the means of
communication with regard to the disallowance reconsideration process
from one based on registered or certified mail to one based on
electronic mail or another electronic system as specified by the
Secretary. When Sec. 430.42 as now in effect was finalized, certified
mail was considered to be the optimal way to establish the dates on
which a communication was sent and received, which is important to
establish compliance with timeframes specified in regulation. However,
email is a preferred form of communication today in the normal course
of agency business and can be used to establish the time when a
communication is sent and received, since email messages typically are
transmitted near-instantaneously. Further, by eliminating mailing and
paper costs, the use of email could slightly reduce the administrative
burden associated with the disallowance process under Sec. 430.42. As
a result, we are proposing to revise all of the references to
registered or certified mail or to ``written requests'' to make clear
that such requests need not be in a physical, as opposed to an
electronic format in Sec. 430.42(b)(2)(i)(A) introductory text,
(b)(2)(i)(B) and (C), (c)(3), (c)(4)(i), (c)(6), and (d)(1) to replace
references to registered or certified mail with references to
electronic mail (email) or another electronic system as specified by
the Secretary. In addition, we propose to remove the word ``written''
from Sec. 430.42(b)(2)(i)(A) and (B) to avoid a possible
misunderstanding that the request must be in the form of a physical
writing, since we propose to adopt an electronic process. The date that
the communication is successfully sent or received by electronic mail
(email) or electronic system as specified by the Secretary would be
substituted for current references to the date that the communication
was sent or received by registered or certified mail.
2. State Share of Financial Participation (Sec. 433.51)
We are proposing to amend Sec. 433.51 to more clearly define the
allowable sources of the non-federal share to more closely align with
the provisions in section 1903(w) of the Act. In Sec. 433.51(a) and
(c), we are proposing to replace the current reference to ``public
funds'' with ``state or local funds'' which is consistent with
statutory language as in section 1903(w)(6)(A) of the Act. Public funds
is not a phrase used in section 1903(w) of the Act, and the use of this
phrase in regulation has caused confusion with respect to permissible
sources of non-federal share. We are proposing to revise Sec.
433.51(b) by similarly replacing the current reference to public funds
and by specifying more precisely the funds that states may use as state
share. Although we have applied the statutory language to our review
and approval of state financing mechanisms, the term public funds in
the regulatory text has created confusion among states, and has led to
state requests to derive IGTs from sources other than state or local
tax revenue (or funds appropriated to state university teaching
hospitals), which is not permitted under the statute in section
1903(w)(6)(A) of the Act. The proposed amendment to paragraph (b) would
clearly limit permissible state or local funds that may be considered
as the state share to state general fund dollars appropriated by the
state legislature directly to the state or local Medicaid agency; IGTs
from units of government (including Indian tribes), derived from state
or local taxes (or funds appropriated to state university
[[Page 63738]]
teaching hospitals), and transferred to the state Medicaid Agency and
under its administrative control, except as provided in proposed Sec.
433.51(d); or CPEs, which are certified by the contributing unit of
government as representing expenditures eligible for FFP and reported
to the state as provided in proposed Sec. 447.206.
We are proposing these revisions to specifically align the
allowable sources of the non-federal share with the statute. The
proposed provisions would make clear that allowable state general fund
appropriations under Sec. 433.51(b)(1) are those made directly to the
state or local Medicaid agency, and are differentiated from
appropriations made to other units of government that otherwise may be
tangentially involved in financing Medicaid payments through IGTs or
CPEs. We would describe allowable IGTs and CPEs in proposed Sec.
433.51(b)(2) and (3), respectively. The statute clearly differentiates
between these sources of funds. Specifically, section 1903(w)(6)(A) of
the Act provides that states generally may finance the state share
using funds derived from state or local taxes (or funds appropriated to
state university teaching hospitals) transferred from or certified by
units of government within a state as the non-federal share of Medicaid
expenditures. The phrase ``transferred from or certified by'' refers to
the IGT and CPE, respectively, and the statute clearly indicates that
those funding mechanisms must be derived from state or local taxes (or
funds appropriated to state university teaching hospitals). The
inclusion of the above reference to ``funds appropriated to state
university teaching hospitals'' in Sec. 433.51(b)(2) is a direct
reference to language in section 1903(w)(6)(A) of the Act to more
precisely implement the Act in this regulatory provision.
We are proposing to identify ``certified public expenditures''
specifically in regulation as an allowable source of state share in a
manner consistent with section 1903 of the Act, and to describe the
protocols states may use to identify allowable Medicaid expenditures
associated with the use of a CPE as the source of non-federal share.
Thus, we propose to include a reference in Sec. 433.51(b)(3) to
proposed Sec. 447.206 to require that, for a state to use a CPE as a
source of state share, the state must meet the requirements of proposed
Sec. 447.206, discussed in detail below, with respect to payments
funded by the CPE. In particular, in Sec. 447.206(b)(1), we propose
that such payments, to a provider that is a unit of government, would
be limited to the state or non-state government provider's actual,
incurred cost of providing covered services to Medicaid beneficiaries
using reasonable cost allocation methods.
Lastly, we are proposing to add paragraph (d) to this section to
clearly indicate that state funds provided as an IGT from a unit of
government but that are contingent upon the receipt of funds by, or are
actually replaced in the accounts of, the transferring unit of
government from funds from unallowable sources, would be considered to
be a provider-related donation that is non-bona fide under Sec. Sec.
433.52 and 433.54. This language is intended to implement the
preclusion under section 1903(w)(6)(A) of the Act on the use of IGTs
where the IGT is derived from a non-bona fide provider-related donation
by making it abundantly clear that, as indicated in the statute, the
IGT must come from state or local tax revenue (or funds appropriated to
state university teaching hospitals), and any IGTs that are derived
from, or are related to, non-bona fide provider-related donations would
be prohibited.
3. General Definitions (Sec. 433.52)
The terms ``Medicaid activity'' and ``non-Medicaid activity'' are
used in the proposed Sec. 433.68(e)(3), discussed in detail below, in
determining whether a health care-related tax program is generally
redistributive in nature in accordance with section
1903(w)(3)(E)(ii)(I) of the Act. The definitions for ``Medicaid
activity'' and ``non-Medicaid activity'' in this proposed rule would
apply only to determining whether a state or other unit of government
tax program is generally redistributive as required in section
1903(w)(3)(E)(ii)(I) of the Act. We are proposing to define ``Medicaid
activity'' to mean any measure of the degree or amount of health care
items or services related to the Medicaid program or utilized by
Medicaid beneficiaries, including, but not limited to, Medicaid patient
bed days, the percentage of an entity's net patient revenue
attributable to Medicaid, Medicaid utilization, units of medical
equipment sold to individuals utilizing Medicaid to pay for or supply
such equipment or Medicaid member months covered by a health plan.
We are proposing to define ``non-Medicaid activity'' to mean any
measure of the degree or amount of health care items or services not
related to the Medicaid program or utilized by Medicaid beneficiaries.
Such a measure could include, but would not necessarily be limited to,
non-Medicaid patient bed days, percentage of an entity's net patient
revenue not attributable to Medicaid, the percentage of patients not
utilizing Medicaid to pay for health care items or services, units of
medical equipment sold to individuals not utilizing Medicaid funds to
pay for or supply such equipment, or non-Medicaid member months covered
by a health plan.
We are proposing to define the term ``net effect'' to mean the
overall impact of an arrangement, considering the actions of all of the
entities participating in the arrangement, including all relevant
financial transactions or transfers of value, in cash or in kind, among
participating entities. The net effect of an arrangement is determined
in consideration of the totality of the circumstances, including the
reasonable expectations of the participating entities, and may include
consideration of reciprocal actions without regard to whether the
arrangement or a component of the arrangement is reduced to writing or
is legally enforceable by any entity.
The term ``parameters of a tax'' is used in the proposed Sec.
433.55(c), discussed in detail below, in determining whether a tax is
health care-related as provided in section 1903(w)(3)(A) of the Act. We
are proposing to define ``parameters of a tax'' to mean the grouping of
individuals, entities, items or services, on which a state or unit of
government imposes a tax.
Currently, Sec. 433.52 specifies a definition of ``Provider-
related donation'' that includes an introductory paragraph and three
numbered paragraphs. We propose to redesignate paragraphs (2) and (3)
as paragraphs (3) and (4), respectively, and to add a new paragraph
(2). Proposed paragraph (2) would specify that any transfer of value
where a health care provider or provider-related entity assumes an
obligation previously held by a governmental entity and the
governmental entity does not compensate the private entity at fair
market value would be considered a donation made indirectly to the
governmental entity. We are proposing that such an assumption of
obligation need not rise to the level of a legally enforceable
obligation to be considered a donation, but would be considered by
examining the totality of the circumstances and judging the
arrangement's net effect. For example, if a private provider assumes
any contractual obligation, such as staffing costs for accounting
services, of a non-state governmental entity without a corresponding
transfer of value at market value, we would consider that to
[[Page 63739]]
be a provider-related donation from the private provider to the unit of
government.
This proposal does not represent a new policy, but a clarification
of current law designed to aid in preventing and, where they currently
may exist, terminating impermissible financing practices involving
provider-related donations. The current definition does not explicitly
address circumstances involving the assumption of a governmental
obligation, or our policy to determine the net effect of an arrangement
in determining whether or not a donation has occurred.
We are also proposing to revise newly redesignated paragraphs (3)
and (4) by changing the term ``health care related'' to ``provider-
related'' to align with usage where provider-related donations are
addressed throughout part 433, subpart B, and by changing the language
in newly redesignated paragraph (4) from ``the percentage of donations
the organization received from the providers during that period'' to
``the percentage of the organization's revenue during that period that
was received as donations from providers or provider-related
entities.'' We are proposing this change because we believe that this
language is clearer and more transparent for states.
Some health care-related tax programs exclude certain items,
services, or providers from taxation or impose variable rates. To do
so, states or non-state units of government often divide the universe
of entities subject to taxation into groups based on various
attributes. We are proposing to define ``taxpayer group'' to mean one
or more entities grouped together based on one or more common
characteristics for purposes of imposing a tax on a class of items or
services specified under Sec. 433.56. This term is used in proposed
Sec. 433.56(e)(3), which is discussed in detail below, in determining
whether or not a tax program is generally redistributive in nature, in
accordance with section 1903(w)(3)(E)(ii)(I) of the Act.
4. Bona Fide Donations (Sec. 433.54)
Section 1903(w)(2)(B) of the Act provides that the Secretary may by
regulation specify types of provider-related donations described in
that subparagraph that will be considered to be bona fide provider-
related donations. The statute requires that bona fide provider-related
donations may have no direct or indirect relationship (as determined by
the Secretary) to Medicaid payments to the provider, providers
furnishing the same class of items and services as the provider, or to
any related entity, as established by the state to the satisfaction of
the Secretary. Accordingly, implementing regulations in Sec. 433.54(b)
require that bona fide provider-related donations must not be returned
to the individual provider, provider class, or related entity under a
hold harmless provision or practice as described in Sec. 433.54(c). We
are proposing to revise Sec. 433.54(c)(3) to clarify the standard used
to determine whether the state (or other unit of government) receiving
a donation provides for any direct or indirect payment, offset, or
waiver, such that the provision of that payment, offset, or waiver
directly or indirectly guarantees the return of any portion of the
donation to the provider (or other party or parties responsible for the
donation). The clarification would make express our current policy of
examining the totality of the circumstances that determine the net
effect of an arrangement between the state (or other unit of
government) and the provider, provider class, or provider-related
entity responsible for the donation. Specifically, we are proposing
that a direct guarantee of the return of all or part of a donation
would be found to exist where, considering the totality of the
circumstances, the net effect of an arrangement between the state (or
other unit of government) and the provider (or other party or parties
responsible for the donation) results in a reasonable expectation that
the provider, provider class, or related entity will receive a return
of all or a portion of the donation either directly or indirectly. As
noted in the 2008 final rule on Health Care-Related Taxes, ``An
indirect payment to the taxpayer would also constitute a direct
guarantee'' (73 FR 9698). Section 433.68 at paragraphs (f)(1), (2) and
(3) describe the three situations that constitute a direct hold
harmless arrangement. Paragraphs (f)(3)(i)(A) and (B) detail the two
``prongs'' of the indirect hold-harmless guarantee test. These two
``prongs'' constitute the ``safe harbor threshold'' of 6 percent and
the ``75/75'' test. The safe harbor threshold states that taxes that
are under 6 percent of net patient revenue attributable to an assessed
permissible class pass the indirect hold harmless test. If a tax
collection exceeds the 6 percent net patient revenue threshold, the
second prong is applied. This prong is known as the ``75/75'' test and
states that CMS will consider an indirect hold harmless arrangement to
exist if 75 percent or more of the taxpayers receive 75 percent or more
of their total tax costs back in enhanced Medicaid payments or other
state payments. If the tax fails this prong, CMS considers an indirect
hold harmless arrangement to exist. Direct and indirect payments are
used in the proposed rule in the same way as they are used currently in
Sec. 433.68(f). This clarification is designed to aid in preventing
and, where they may currently exist, eliminating complex financing
arrangements designed to obfuscate the fact that non-bona fide
provider-related donations are the source of the non-federal share of
certain Medicaid payments. This is consistent with our current policy,
which we have applied in the past and discussed in SMDL 14-004 on
impermissible provider-related donations. We are also proposing to
revise paragraph (c)(3) to clarify that a singular party, not just
multiple ``parties,'' could be responsible for a provider-related
donation described in this paragraph.
5. Health Care-Related Taxes Defined (Sec. 433.55)
Section 1903(w)(3)(A) of the Act defines a health care-related tax
as a tax that is (1) related to health care items or services, or to
the provision of, the authority to provide, or payment for, such items
or services; or (2) is not limited to such items or services but
provides for treatment of individuals or entities that are providing or
paying for such items or services that is different from the treatment
provided to other individuals or entities. In the case of (1), a tax is
considered related to health care items or services if at least 85
percent of the tax burden falls on health care providers. Implementing
regulations are codified in Sec. 433.55(c). This proposed rule would
amend Sec. 433.55(c) by clarifying that differential treatment occurs
when a tax program treats some individuals or entities that are
providing or paying for health care items or services differently than
(1) individuals or entities that are providers or payers of any health
care items or services not subject to the tax or (2) other individuals
or entities subject to the tax. Additionally, we would amend Sec.
433.55(c) to clarify that we examine the parameters of the tax as
defined by the state or other unit of government, as well as the
totality of the circumstances relevant to which individuals, entities,
items, or services are subject (and not subject) to the tax and at
which rate, in determining whether the tax program involves
differential treatment as provided in section 1903(w)(3)(A)(ii) of the
Act. Finally, the proposed rule would also add paragraphs (c)(1) and
(2) to clarify when CMS would consider the treatment of individuals or
entities providing or paying for health care
[[Page 63740]]
items or services to be different from the treatment provided to other
individuals or entities.
In the proposed Sec. 433.55(c)(1), we propose to clarify that
differential treatment for providers of health care items or services
would occur where the state or other unit of government imposing the
tax makes some individuals or entities providing or paying for health
care items or services subject to the tax, but excludes others. For
example, a state imposing a tax on telecommunication services and
inpatient hospital services would constitute differential treatment
because some providers or payers of health care items or services
subject to the tax are being treated differently than providers or
payers of health care items or services not subject to the tax. States
or local units of government imposing a tax cannot structure the
parameters of the tax in such a way as to include items or services
that are not reasonably related so that only selected health care items
or services are included in the tax while others are excluded.
Selective incorporation would also occur when the state or other unit
of government imposing the tax structures the parameters of the tax in
a way that has the effect of specifically excluding or including
certain providers of health care items or services from the tax. This
would constitute differential treatment because it would have the same
effect as selecting certain health care items or services for inclusion
in the tax when such items or services are not reasonably related to
the other items being taxed.
Additionally, we propose in Sec. 433.55(c)(2) to specify that
differential treatment would result when entities providing or paying
for health care items or services are treated differently than other
entities also included in the tax. For example, if the state taxes all
businesses in the state, but places a higher tax rate on hospitals and
nursing facilities than on other businesses, this would result in
differential treatment.
We are concerned that taxes of the sort described in proposed Sec.
433.55(c)(1) and (2) are not consistent with applicable statutory (and
current regulatory) requirements because they may include individuals
or entities providing or paying for health care items or services that
receive high levels of reimbursement from Medicaid for such items or
services, and that may receive a return of their tax costs in the form
of increased Medicaid payments. In particular, we are concerned about
tax programs that treat health care items or services that are mostly
reimbursed by Medicaid differently than other health care items or
services with low Medicaid reimbursement. For example, a statewide
revenue tax of 5 percent of net revenue on all businesses in the state
that includes only a subset of health care items or services that
happens to be reimbursed heavily by Medicaid, such as HCBS, but which
is designed to exclude other providers of health care items or services
with lower rates of Medicaid reimbursement such as continuing care
retirement facilities (CCRCs), would result in differential treatment.
Any time a tax structure selectively incorporates a subset of health
care items or services for inclusion in a tax and excludes others, we
would consider this differential treatment, as reflected in proposed
Sec. 433.55(c)(1). Selective incorporation generally occurs in two
situations: First, when the state or unit of government includes some,
but not all, health care-related items or services and those items or
services are not reasonably related to the other items being taxed.
Second, when the state or other unit of government structures the
parameters of the tax in such a way that has the effect of such
selective incorporation described above. Reasonably related means there
exists a logical or thematic connection between the items or services
being taxed. Examples of such a connection include, but are not limited
to, industry, such as electronics; geographical area, such as city or
county; net revenue volume; or number of employees.
Additionally, any time the tax treats individuals or entities
providing or paying for health care items or services differently than
other entities also included in the tax, we would also consider this to
be differential treatment, as reflected in proposed Sec. 433.55(c)(2).
We note that the examples provided in these proposed paragraphs do not
constitute an exhaustive list of all possible manifestations of
differential treatment. Other circumstances constituting differential
treatment for health care items or services, or entities providing or
paying for health care items or services, would result in the tax being
considered health care-related based on the differential treatment
provisions in Sec. 433.55(c).
The proposed language related to selective incorporation does not
mean that the state or other unit of government must tax every provider
of health care items or services within its jurisdiction to avoid its
tax being considered health-care related in situations where less than
85 percent of the tax burden falls on health care items or services. It
does mean that the state or other unit of government cannot include in
or exclude from the tax only certain providers, or a class or classes
of providers, by its own specification of the parameters of the tax. In
addition, the state cannot structure the parameters of the tax in such
a way so as to have the same effect of carving out or in only certain
providers, or a class or classes of provider.
6. Classes of Health Care Services and Providers Defined (Sec. 433.56)
Section 1903(w)(7)(A)(ix) of the Act provides that the permissible
classes of health care items and services include such other
classifications consistent with section 1903(w)(7)(A) of the Act as the
Secretary may establish by regulation. In addition to the specific
classifications that Congress identified in statute, current
regulations in Sec. 433.56(a) specify certain additional classes
established by the Secretary. We are proposing to add a new class of
health care items and services to the list of permissible classes at
Sec. 433.56(a) by redesignating paragraph (a)(19) as paragraph
(a)(20), revising paragraph (a)(18), and adding a new paragraph
(a)(19). We propose to strike ``and'' from paragraph (a)(18), to
accommodate the proposed paragraph (a)(20). In new proposed paragraph
(a)(19), we would permit states and units of local government to impose
taxes on services of health insurers beside those already identified in
paragraph (a)(8) of the same section.
We have become aware that a number of states may be imposing taxes
on health insurers in the form of a tax on health insurance premiums or
volume of services. Section 1903(w)(7)(A)(ix) of the Act delegates to
the Secretary the power to specify such other classification of health
care items and services consistent with the paragraph as the Secretary
may establish by regulation. We are proposing to expand the permissible
class list to provide states with additional flexibility, while
maintaining the fiscal integrity of the Medicaid program by ensuring
that the proposed new permissible class would not be limited to items
or services that are primarily or exclusively provided or paid for by
the Medicaid program. Taxes imposed on health care items or services or
providers of such items or services financed primarily or exclusively
by Medicaid would harm the fiscal integrity of the Medicaid program by
imposing a higher tax burden on the program and would not be generally
redistributive as required by section 1903(w)(3)(E)(ii)(I) of the Act.
Specifically, we are proposing to establish services of health
insurers,
[[Page 63741]]
besides services of MCOs (including HMOs and PPOs), as a new
permissible class. Services of MCOs (including HMOs and PPOs) are
already a permissible class of services identified in Sec.
433.56(a)(8). Some examples of possible metrics that could be used to
assess a tax on services of health insurers include health care
premiums, covered lives, or revenue. The proposed class would include
health insurers offering plans to Medicaid beneficiaries under a
section 1115 demonstration for a premium assistance program to such
beneficiaries to purchase qualified health plans through the Health
Insurance Exchange. We are seeking comment on the exact scope of this
permissible class to ensure all appropriate services of health insurers
are included within this class. As with other permissible classes,
taxes imposed on this proposed category of health care services would
be subject to applicable legal requirements, including the broad-based
requirements in Sec. 433.68(b)(1), the uniformity requirements in
Sec. 433.68(b)(2), and the hold harmless provisions in Sec.
433.68(f).
The preamble of the August 1993 final rule listed criteria that
should be met by any additional class of health care items and services
under consideration to be added to the permissible classes under
section 1903(w)(7)(A) of the Act. The preamble stated three criteria:
The revenue of the class is not predominantly from Medicaid and
Medicare (not more than 50 percent from Medicaid and not more than 80
percent from Medicaid, Medicare, and other federal programs combined);
the class must be clearly identifiable, such as through designation for
state licensing purposes, recognition for federal statutory purposes,
or being included as a provider in state plans; and the class must be
nationally recognized and not be unique to a state (58 FR 43162). We
believe that the class of providers of health care items or services
which we are proposing to add to Sec. 433.56 meets all of these
requirements. First, according to the most recent data available from
the U.S. Census Bureau (See Health Insurance Coverage in the United
States, September 12, 2018, Report Number P-60 264, Edward R. Berchick,
Emily Hood, and Jessica C. Barnett, p. 1-2), 67.2 percent of
individuals in the United States that are insured have private health
insurance, whereas 37.7 percent have government coverage including 19.3
percent that have Medicaid and 17.2 percent that have Medicare. In
addition, not all Medicaid or Medicare beneficiaries must pay premiums
or cost sharing, and the amounts that they do pay, when required, are
generally limited by federal statute and regulation and typically are
lower than premiums and cost sharing amounts paid by enrollees in
private insurance coverage. As a result, we do not believe that revenue
from the proposed class, services of health insurers besides services
of MCOs (including HMOs and PPOs) is predominantly from Medicaid and
Medicare. Specifically, we believe that such revenue is not more than
50 percent from Medicaid and not more than 80 percent from Medicaid,
Medicare, and other federal programs combined. Second, each state
already defines and regulates health insurers in the state, through
state law. As a result, the class is clearly identifiable. To the
extent that state law specifically includes or excludes certain types
of issuers of health insurance policies as health insurers, we propose
deferring to the state in determining which such entities are included
within the proposed class and which are not. For example, certain
groups of businesses may band together to offer health insurance plans
to their employees, a practice known as association health plans under
section 3(5) of the Employee Retirement Income and Security Act (ERISA)
(Pub. L. 93-406, enacted September 2, 1974). The degree to which an
issuer of an association health plan is considered to be a health
insurer depends on state law. Finally, health insurers exist
nationwide, and are not particular to any individual state. Neither we
(that is, CMS, either with respect to our administration of Medicare or
Medicaid), the state Medicaid agency, or any agency involved in
administering title XVIII, title XIX, or title XXI is considered to be
a health insurer in terms of the proposed class to be added at Sec.
433.56. As a result, the proposed class meets all of the criteria
specified in the 1993 final rule and is appropriate to add to the
classes of health care items and services upon which states may impose
health care-related taxes without a reduction in FFP, subject to all
applicable federal statutory and regulatory requirements.
7. Permissible Health Care-Related Taxes (Sec. 433.68(e) and (f))
Section 1903(w)(3)(E)(ii)(I) of the Act provides that the Secretary
shall approve a state's application for a waiver of the broad based
and/or uniformity requirements for a health care-related tax, if the
state demonstrates to the Secretary's satisfaction that the tax meets
specified criteria, including that the net impact of the tax and
associated Medicaid expenditures as proposed by the state is generally
redistributive in nature. Implementing regulations in Sec. 433.68(e)
specify a statistical test for evaluating whether a proposed tax is
generally redistributive: If the state is seeking only a waiver of the
broad based requirement, paragraph (e)(1) specifies a test referred to
as ``P1/P2'' described above, while a state seeking a waiver of the
uniformity requirement or both the broad-based and uniformity
requirements must meet the test specified in paragraph (e)(2), referred
to as ``B1/B2'', also described above. Although these tests were
designed to ensure that a proposed tax is generally redistributive in
accordance with section 1903(w)(3)(E)(ii)(I) of the Act, we have found
that these tests alone have been insufficient in some circumstances as
described above. As a result, we are proposing to add Sec.
433.68(e)(3), to ensure that a proposed tax is truly generally
redistributive.
Specifically, we are proposing to amend Sec. 433.68(e) to provide
that a proposed tax must satisfy both paragraph (e)(3) of this section,
and, as applicable, paragraph (e)(1) or (2) of this section. At
paragraph (e)(3), we propose that a tax must not impose undue burden on
health care items or services paid for by Medicaid or on providers of
such items and services that are reimbursed by Medicaid. We would
consider a tax to impose undue burden under this paragraph if taxpayers
are divided into taxpayer groups and any one or more of the following
conditions apply: (1) The tax excludes or places a lower tax rate on
any taxpayer group defined by its level of Medicaid activity than on
any other taxpayer group defined by its relatively higher level of
Medicaid activity; (2) within each taxpayer group, the tax rate varies
based on the level of Medicaid activity, and the tax rate imposed on
any Medicaid activity is higher than the tax rate imposed on any non-
Medicaid activity (except as a result of excluding from taxation
Medicare revenue or payments as described in Sec. 433.68(d)); (3) the
tax excludes or imposes a lower tax rate on a taxpayer group with no
Medicaid activity than on any other taxpayer group, unless all entities
in the taxpayer group with no Medicaid activity meet at least one of
four specified exceptions; or (4) the tax excludes or imposes a lower
tax rate on a taxpayer group defined based on any commonality that,
considering the totality of the circumstances, CMS reasonably
determines to be used as a proxy for the taxpayer group having no
Medicaid
[[Page 63742]]
activity or relatively lower Medicaid activity than any other taxpayer
group. These four conditions represent specific parameters of tax
structures that, in addition to those identified through the P1/P2 and
B1/B2 test, inherently result in undue burden on the Medicaid program.
CMS considers taxes that pose an undue burden on the Medicaid program
to be inherently not generally redistributive because they impose a
higher tax burden on health care items or services, or providers of
such items and services, that are financed by Medicaid than those not
financed by Medicaid, as explained in the preamble to the August 1993
final rule, discussed above.
We are proposing to require states to ensure compliance with the
proposed requirement at paragraph (e)(3) to avoid placing an undue
burden on the Medicaid program beginning on the effective date of any
final rule for tax waivers that have not yet been approved before the
effective date of any final rule. For tax waivers approved before the
effective date of any final rule, we are proposing that states must
come into compliance with this requirement when submitting a new waiver
request. As described below, in Sec. 433.72, we are proposing to add
new paragraphs (c)(3) and (4) to specify the date on which a waiver
approved under Sec. 433.72(b) will no longer be effective. We are
proposing that an approved waiver would have a 3-year term; for a
waiver approved before the effective date of the final rule the 3-year
term would run from the effective date of the final rule. A state would
be free to apply for renewal of an expired or expiring waiver, subject
to the same approval criteria applicable to an initial waiver request
under Sec. 433.72(b). As a result, for existing tax waivers, we are
proposing to require states to come into compliance with proposed Sec.
433.68(e)(3) when they submit a new tax waiver request, which we are
proposing would be no later than 3 years after the effective date of
any final rule, depending on whether the state makes any substantial
changes to the health care-related tax as specified in proposed Sec.
433.72(d). We believe that this time frame would ensure our goal of
supporting the fiscal integrity of the Medicaid program while giving
states the necessary time to comply with the proposed regulatory
amendments.
It is important to note that nothing in this proposed rule would
interfere with states' permissible use of tax revenues to fund provider
payments or reliance on such use of tax revenues to justify or explain
the tax in the legislative process, as provided in section 1903(w)(4)
of the Act. Tax structures that place an undue burden on Medicaid,
however, would not be considered to be generally redistributive for the
purposes of Sec. 433.68(e). We seek comment on our proposed amendments
to Sec. 433.68(e), and on additional conditions that could result in a
tax program imposing undue burden on the Medicaid program, and
therefore, failing to be generally redistributive in nature that are
not included in this proposed list.
Section 1903(w)(1)(A)(iii) of the Act states that the total amount
expended during the fiscal year as medical assistance under the state
plan shall be reduced by the sum of any revenues received by the state
during the fiscal year from a broad-based health care-related tax if
there is in effect a hold harmless provision with respect to the tax.
Section 1903(w)(4)(C) of the Act states that there is in effect a hold
harmless provision with respect to a health care-related tax if the
state or other unit of government imposing the tax provides directly or
indirectly for any payment, offset, or waiver that guarantees to hold
the taxpayer harmless for any portion of the costs of the tax. Section
433.68(f)(3) echoes this language. The proposed rule would add a net
effect standard to Sec. 433.68(f)(3). This proposed change represents
a clarification of existing policy and would not impose any new
obligations or place any new restrictions on states that do not
currently exist. The language added by the proposed rule would specify
that a direct or indirect hold harmless guarantee will be found to
exist where, considering the totality of the circumstances, the net
effect of an arrangement between the state (or other unit of
government) and the taxpayer results in a reasonable expectation that
the taxpayer will receive a return of all or any portion of the tax
amount as discussed above. We propose that the net effect of such an
arrangement may result in the return of all or any portion of the tax
amount, regardless of whether the arrangement is reduced to writing or
is legally enforceable by any party to the arrangement.
Proposed Sec. 433.68(f)(3) aims to thwart efforts by states to
skirt hold harmless provisions by paying supplemental payments to
private entities, who then pass these funds on to other private
entities that have lost gross revenue due to a health care-related tax.
The use of an intermediary does not change the essential nature of the
transaction: That it is a payment made by a state or unit of government
to a provider that holds that provider harmless for the cost of the
tax. While states are free to impose broad-based and uniform health
care-related taxes, or generally redistributive health care-related
taxes that meet applicable requirements for a waiver of either or both
of these requirements, to fund the non-federal share of Medicaid
expenditures, states may not do so in a way that guarantees to return
all or part of the cost of the tax to the taxpayers. The proposed
language adding the net effect standard to the direct hold harmless
guarantee test at Sec. 433.68(f)(3) clarifies to states the range of
permissible tax and reimbursement arrangements for health care-related
taxes. Such clarifying language allows states and CMS to work more
harmoniously together by solidifying a shared understanding regarding
what constitutes a guarantee to hold taxpayers harmless for the cost of
a health care-related tax and reduces the likelihood of disagreement
concerning the interpretation of the regulation. As such, the proposed
amendment would allow states to operate their Medicaid financing
programs with greater clarity and consistency than before.
We seek comment on our proposed amendments to Sec. 433.68(f)(3).
Additionally, we are soliciting comments on other qualitative or
quantitative measures that could further safeguard the fiscal health
and integrity of the Medicaid program through modifications to the
provisions of Sec. 433.68.
8. Waiver Provisions Applicable to Health Care-Related Taxes (Sec.
433.72)
In Sec. 433.72, we are proposing to add new paragraphs (c)(3) and
(4) to specify the date on which a waiver approved under paragraph (b)
of this section would no longer be effective. We are proposing that an
approved waiver should have a 3-year term; for a waiver already
approved before the effective date of the final rule, if this proposal
is finalized, the 3-year term would run from the effective date of the
final rule. A state would be free to apply for renewal of an expired or
expiring waiver, subject to the same approval criteria applicable to an
initial waiver request under Sec. 433.72(b). We are proposing a 3-year
limit to ensure the tax program continues to meet all applicable
requirements under part 433, subpart B, including whether or not the
tax program continues to meet generally redistributive requirements at
Sec. 433.68(e)(1) and (2) and proposed paragraph (e)(3).
We are proposing to limit waiver approvals to 3 years because the
provider data that states provide to CMS for use in the statistical
tests at Sec. 433.68 and the providers in the class subject to the
waiver change over time. As a result,
[[Page 63743]]
while a tax may be generally redistributive when the state first
requests the waiver, it may cease to be so as the composition of the
providers or payers, or the volume of items or services subject to the
tax changes. In an effort to ensure consistent fiscal oversight of the
non-federal share of Medicaid expenditures and to ensure that health
care items and services, and providers of health care items or
services, financed by Medicaid are not taxed more heavily than those
not financed by Medicaid, we believe that this proposed time period
would aid in ensuring state tax programs are and remain consistent with
section 1903(w)(3)(E)(ii) of the Act. This provision establishes that
the Secretary will approve waivers if the state establishes to the
satisfaction of the Secretary that the net impact of the tax is
generally redistributive in nature and the amount of the tax is not
directly correlated to Medicaid payments. We believe it is necessary
for the proper and efficient operation of the Medicaid program to
establish that a tax for which a state seeks a waiver meets statutory
requirements not just when the waiver is initially approved, but on an
ongoing basis as well. We propose to allow states with already existing
health care-related tax waivers 3 years from the effective date of the
final rule, as stated in proposed Sec. 433.72(c)(4), to seek
reapproval of their waivers, in an effort to provide states with
sufficient time to evaluate and, as may be necessary, modify existing
tax programs to comply with applicable requirements.
We are proposing to add new Sec. 433.72(d), to ensure ongoing
compliance of tax waivers with the original conditions of the waiver
approval. In this proposed paragraph, we would specify that, for a
state to continue to receive tax revenue (within specified limitations)
under an approved waiver without a reduction in FFP as would otherwise
be required under section 1903(w)(1)(A)(ii) of the Act and Sec.
433.70, the state must: (1) Ensure that the tax program for which CMS
approved the waiver continues to meet the waiver conditions identified
in Sec. 433.72(b)(1) through (3) at all times during which the waiver
is in effect; and (2) request a new waiver if the state or other unit
of government imposing the tax modifies the tax program in specified
ways. We propose that, if the state or other unit of government
imposing the tax modifies the tax in a non-uniform manner, meaning the
change in tax or tax rate does not apply in an equal dollar amount or
percentage change to all taxpayers, the state would be required to
request a new waiver subject to effective date requirements in Sec.
433.72(c). If the state or other unit of government imposing the tax
modifies the criteria for defining the taxpayer group or groups subject
to the tax, the state would be required to request a new waiver subject
to effective date requirements in Sec. 433.72(c). As with the 3-year
waiver validity period at proposed Sec. 433.72(c)(3) and (4), the
proposed new requirements at paragraph (d) would help ensure that the
tax remains generally redistributive while the waiver is in effect,
since these changes could affect the determination whether it meets
applicable requirements. States would be permitted to make changes that
would not affect the compliance of the tax with all applicable broad-
based and uniformity standards (including waiver standards) without
receiving a new approval of a tax waiver from CMS. However, states
wishing to make changes to their tax structures that modify any of the
proposed, specified elements would be required to submit a new tax
waiver request and obtain approval from us before beginning to collect
such a tax. States may not make changes to the tax structure that
result in taxpayers being held harmless for some or all of the cost of
the tax without experiencing a reduction in their amount of medical
assistance expenditures for purposes of claiming FFP as specified by
section 1903(w)(1)(A) of the Act.
9. When Discovery of Overpayment Occurs and its Significance (Sec.
433.316)
Section 1903(d)(2)(C) of the Act provides that, when an overpayment
by a state is discovered, the state has a 1-year period to recover or
attempt to recover the overpayment before an adjustment is made to FFP
to account for the overpayment. Currently, regulations in Sec. 433.316
provide for determining the date of discovery of an overpayment, which
is necessary to determine the statutory 1-year period, in three
distinct cases: When the overpayment results from a situation other
than fraud, under Sec. 433.316(c); when the overpayment results from
fraud, under Sec. 433.316(d); and when the overpayment is identified
through a federal review, under Sec. 433.316(e). It is not explicitly
clear in the current regulations how the date of discovery is
determined when an overpayment is discovered through the annual DSH
independent certified audit required under Sec. 455.304. Therefore, we
believe an amendment is appropriate to specify the date of discovery of
overpayments as it relates to the annual DSH independent certified
audit. Accordingly, we are proposing to redesignate paragraphs (f),
(g), and (h) as paragraphs (g), (h), and (i), respectively, and to add
new proposed paragraph (f). In new paragraph (f), we are proposing that
in the case of an overpayment identified through the DSH independent
certified audit required under part 455, subpart D, we will consider
the overpayment as discovered on the earliest of the date that the
state submits the DSH independent certified audit report required under
Sec. 455.304(b) to CMS, or any of the dates specified in Sec.
433.316: Paragraph (c)(1) (the date on which any Medicaid agency
official or other state official first notifies a provider in writing
of an overpayment and specifies a dollar amount that is subject to
recovery); paragraph (c)(2) (the date on which a provider initially
acknowledges a specific overpaid amount in writing to the Medicaid
agency); and paragraph (c)(3) (the date on which any state official or
fiscal agent of the state initiates a formal action to recoup a
specific overpaid amount from a provider without having first notified
the provider in writing).
10. State Plan Requirements (Sec. 447.201)
We are proposing to add new Sec. 447.201(c) to specify that the
state plan may not provide for variation in FFS payment for a Medicaid
service on the basis of a beneficiary's Medicaid eligibility category,
enrollment under a waiver or demonstration, or federal matching rate
available for services provided to a beneficiary's eligibility category
under the plan. As discussed below, this provision would implement
sections 1902(a)(4) and (a)(30)(A) of the Act, and codify our current
practice, by prohibiting variations in service payments on the basis of
available FFP.
States seeking to increase payments only on the basis of a higher
available FFP for the relevant beneficiary population creates inequity
in the Medicaid program. By approving Medicaid state plan payments, we
are making an administrative decision that the payment rates are
consistent with section 1902(a)(30)(A) of the Act; specifically, that
such payments are consistent with efficiency, economy, and quality of
care and are sufficient to enlist enough providers so that care and
services are available under the plan at least to the extent that such
care and services are available to the general population in the
geographic area. In the absence of an access issue, it would not be
consistent with efficiency and economy to pay providers more, only
because the federal matching rate is increased with respect to certain
categories of beneficiaries. In addition,
[[Page 63744]]
where payment rates under the state plan do result in insufficient
access for Medicaid beneficiaries, the state must increase rates to
rectify the access problem for all Medicaid beneficiaries, not only
those for whom the statute provides for an increased FMAP.
We have allowed states to set payment rates based on higher costs
for the delivery of care (for example, difference in acuity or
particular health needs); however, we have not allowed states to pay
higher rates based on policies that are unrelated to actual increases
in the cost of furnishing services to the relevant beneficiaries. For
example, we have allowed states to pay higher rates to a provider based
upon a higher provider qualifications, which may be equated with a
higher cost of furnishing services, but that payment difference is for
all Medicaid beneficiaries that receive services provided by that
provider. Similarly, we have not allowed states to target higher
payments based on eligibility status or enhanced matching rates, since
those factors are not established to have any relationship to the cost
of delivering care. Rates that are structured without regard to service
costs and care delivery are not economic and efficient and are
inconsistent with section 1902(a)(30)(A) of the Act. This proposed
provision is intended to make clear that variation in payment rates
solely on the basis of FFP is prohibited, as it would be inconsistent
with efficiency and economy to allow states to pay providers more, only
because such payments can be funded by drawing down additional federal
dollars at a marginally increased cost to the state (and at net savings
to the state, versus the costs the state would incur if the relevant
beneficiary population qualified for standard FMAP). We believe that
this proposed provision is necessary to ensure the proper and efficient
operation of the Medicaid state plan, in a manner that complies with
the requirements of section 1902(a)(4) and (a)(30)(A) of the Act.
This proposed approach would be consistent across both FFS and
managed care. Specifically, in the 2016 Medicaid managed care final
rule, we articulated in Sec. 438.4(b)(1) that any differences among
capitation rates according to covered populations must be based on
valid rate development standards and not be based on the FFP associated
with the covered populations (81 FR 27566).
We also considered proposing a rule that would require states to
pay the same rate to a facility for all beneficiaries, unless the state
could demonstrate that different case mixes or health care needs, or
other reasons consistent with economy, efficiency, quality of care, and
access justified paying a different rate for a different group of
beneficiaries. We decided instead to propose that the plan must provide
for no variation in FFS payment for a Medicaid service on the basis of
a beneficiary's Medicaid eligibility category, enrollment under a
waiver or demonstration project, or FMAP rate available for services
provided to an individual in the beneficiary's eligibility category,
because, as stated above, where payment rates under the state plan do
result in insufficient access for Medicaid beneficiaries, the state
must increase rates to rectify the access problem for all Medicaid
beneficiaries, not only those for whom the statute provides for an
increased FMAP. We seek comment on proposed Sec. 447.201.
11. Payments Funded by Certified Public Expenditures Made to Providers
That are Units of Government (Sec. 447.206)
We are proposing to add Sec. 447.206 to codify longstanding
policies implementing the following sections of the statute: Section
1902(a)(4) for proper and efficient operation of the state plan;
section 1902(a)(30)(A) requiring that payments be economic and
efficient; and section 1903(w)(6)(A) permitting states to use CPEs,
which are expenditures certified by units of government within a state,
as a source of non-federal share. The specific standards for states to
document Medicaid expenditures that units of government may certify
through a CPE for a claim for FFP has not previously been defined in
regulation. While CPEs are not necessarily ``payments'' in the usual
sense of the term, instead they are transactions which take the place
of regular FFS payment. However, we refer to payments generally to mean
the total computable amount the provider receives for performing
Medicaid services. We are proposing in Sec. 447.206(a) to specifiy
that Sec. 447.206 applies only to payments made to providers that are
state government providers or Non-state government providers, as
defined in proposed Sec. 447.286, where such payments to such
providers are funded by a CPE, as specified in Sec. 433.51(b)(3), as
proposed by this rule. Further, we are proposing in Sec. 447.206(b)(1)
that CPE-funded payments made to state government providers or non-
state government providers would be limited to reimbursement not in
excess of the provider's actual, incurred cost of providing covered
services to Medicaid beneficiaries using reasonable cost allocation
methods as specified in 45 CFR part 75 and 2 CFR part 200, or, as
applicable, to Medicare cost principles specified in 42 CFR part 413.
In the case of CPEs, states allow providers that are state or local
government entities to expend funds in order to provide services to
Medicaid beneficiaries. These providers document that the monies were
spent furnishing covered services to Medicaid beneficiaries and certify
their expenditures to the state. Without any funds actually changing
hands between the state or local government entity that is the
provider, and the Medicaid agency (such as via an IGT), and without the
state appropriating associated funds directly to the Medicaid agency,
the state uses the amount of the CPE as non-federal share to claim FFP.
To document the expenditure, we are proposing to add new Sec.
447.206(b), which would define general rules for these CPE cost
protocols. We are proposing to codify our practice of relying upon the
cost allocation principles in federal regulations in 45 CFR part 75, 2
CFR part 200, and, as applicable, Medicare cost principles specified in
part 413, as the methods and principles to identify Medicaid program
expenditures eligible to support a CPE. First, we propose that Medicaid
payments funded by a CPE would be limited to reimbursement not in
excess of the provider's actual, incurred cost of providing covered
services to Medicaid beneficiaries using reasonable methods of
identifying and allocating costs to Medicaid, as stated above. We
recommend that states use the Medicare cost reports as the basis for
determining Medicaid cost where available for an applicable service
(for example, Medicare 2552-10 Hospital Cost Report or the Medicare
2540-10 Skilled Nursing Facility Cost Report). However, since a number
of states already have developed and currently use a state-developed
cost report that is based on the Medicare cost report, meaning that the
state cost report uses data taken from the calculations in the Medicare
cost report, we are not requiring that states only use the Medicare
cost report as we do not desire to increase state burden in this area.
Section 447.206(b)(2), as proposed, would provide that the state
must establish and implement documentation and audit protocols, which
must include an annual cost report to be submitted by the state
government provider or non-state government provider to the state
agency that documents the provider's costs incurred in furnishing
services to Medicaid beneficiaries during the provider's fiscal
[[Page 63745]]
year. Section 447.206(b)(3) would provide that only the certified
amount of the expenditure may be claimed for FFP. The claimed amount is
limited because the CPE must only represent amounts that were spent
providing the Medicaid services, as authorized by sections 1903(a)(1)
and (w)(6)(A) of the Act, which authorize federal matching funds for
state Medicaid expenditures and allows funds certified by units of
government within a state as the non-federal share of expenditures,
respectively.
Proposed Sec. 447.206(b)(4) would require the certifying entity of
the CPE to receive and retain the full FFP associated with the Medicaid
payment, consistent with the cost identification protocols in the
Medicaid state plan and in accordance with proposed Sec. 447.207. We
are proposing to require that certifying entities receive and retain
the FFP a state claims from CMS to prevent inappropriate recycling of
federal funds and any other potential redirection of federal funds that
would be prohibited under the statute. In recent years, we have found
that states have been drawing down FFP to match CPEs, retaining the
federal share and using these federal funds as the non-federal share
for other Medicaid payments. This practice is not consistent with the
existing Sec. 433.51(c), which generally prohibits the use of federal
funds to match other federal funds. When a state makes a claim for FFP
on a medical assistance expenditure, that claim for the FFP is
singularly for that medical assistance expenditure and a recognition of
the state and federal partnership of the Medicaid program. To claim and
receive FFP for an expenditure, and to reuse that FFP to claim
additional federal matching funds or to otherwise redirect the FFP to
pay costs unrelated to the expenditure for which the FFP was claimed
results, in effect, in the federal government alone funding the full
Medicaid payment to the provider that originally certified the CPE, or,
viewed another way, covering costs ineligible for FFP. Such a result is
not consistent with sections 1902(a)(2), 1902(a)(4), and 1903 of the
Act.
Proposed Sec. 447.206(c) would specify other criteria for states
when a CPE is used to fund a Medicaid payment. Under paragraph (c)(1),
the state would be required to implement processes by which all claims
for medical assistance would be processed through the MMIS in a manner
that identifies the specific Medicaid services provided to specific
enrollees. Paragraph (c)(2) would provide that the state is required to
utilize most recently filed cost reports as specified in proposed
paragraph (b)(2) to develop interim payments rates, which may be
trended by an applicable health care-related index. Interim rates are
rates that reflect the provider's expected cost of providing services
throughout the year. Requiring states to establish interim rates
ensures that providers would receive payments throughout the year,
calculated to closely reflect the provider's expenditures in furnishing
services to Medicaid beneficiaries. This would provide cash flow to
support the provider's ongoing operations, and, with the interim rates
based on the provider's most recent filed cost reports (trended forward
by an applicable health care-related index, at state option), would
potentially minimize reconciliation payments to providers (in the case
of underpayment) or collections from providers (in the case of
overpayments) at the end the year during the reconciliation process.
The term ``health care-related index'' means a trend factor which would
project increases or decreases in expected costs, so as to minimize
potential over- or under-payments to the provider certifying the CPE.
One such index is the CMS Market Basket, which we publish for purposes
related to the Medicare program. However, states could also propose to
use an alternative health-care related index, provided the state
demonstrates that the alternative is likely to reliably project
increases or decreases in providers' costs of furnishing covered
services to Medicaid beneficiaries in the upcoming year. In reviewing a
state-proposed health-care related index, we would require the state to
identify the index in the state plan and provide a justification for
the use of this index rather than other national indices, such as the
CMS Market Basket.
We propose that reconciliations would be performed by reconciling
payments made during the year based on the interim Medicaid payment
rates, to the provider's filed cost report for the state plan rate year
in which interim payments were made. Section 455.301 defines the state
plan rate year as the 12-month period defined by a state's approved
Medicaid state plan in which the state estimates eligible uncompensated
care costs and determines corresponding DSH payments, as well as all
other Medicaid payment rates. The period usually corresponds with the
state's fiscal year or the federal fiscal year but can correspond to
any 12-month period defined by the state as the Medicaid state plan
rate year (73 FR 77951). Proposed paragraph (c)(3) would require that
final settlement be performed annually by reconciling any interim
payments to the finalized cost report for the state plan rate year in
which any interim payment rates were made. Final settlement would be
required to be made no more than 24 months from the relevant cost
report year end, except under circumstances identified in 45 CFR 95.19.
The 24-month period was chosen to comply with the generally applicable
2-year time limit for claiming payment for expenditures in 45 CFR 95.7.
During the reconciliation and final settlement process, we expect
that the state would receive the provider's cost report and review the
reported expenditures via a desk review process. As part of the desk
review, the state would gather, organize, and analyze the provider's
cost report, including by comparing current period expenditures to
prior period expenditures to identify audit risks. During the desk
review, we expect that the state may request explanations of or
adjustments to the reported cost based upon generally accepted
accounting principles (GAAP). Upon finalization of the desk review, the
state would notify the provider of the final determination of total
cost. Once the state has made a final determination of the provider's
final cost, if the provider's actual total cost is not equal to the sum
of its interim rate payments for the period, one of two actions may
occur. If the provider has been underpaid, meaning the total interim
rate payments were less than the total calculated cost amount, the
state may draw down and pay to the provider FFP associated with the
total computable expenditure certified by the provider as a prior
period adjustment to the CMS 64, equal to the difference between the
total interim payments and total cost. In the event the provider was
overpaid, meaning the interim rate payments exceeded the provider's
total cost, the state would calculate the overpayment, which would be
equal to the difference between the total interim payments and the
provider's total cost, and return the federal share of that amount to
CMS as a prior period adjustment under part 433 subpart F. In the event
of an overpayment, the state is obligated to return the FFP whether or
not the state seeks a return of payment from the provider as
articulated in Sec. 433.316. All of these steps would establish an
auditable basis for the state's claims for FFP associated with the
CPEs, as contemplated under section 1902(a)(42)(A) of the Act, which
requires that the state plan must provide that the records of any
entity participating in the plan and providing
[[Page 63746]]
services reimbursable on a cost-related basis will be audited as the
Secretary determines to be necessary to insure that proper payments are
made under the plan.
Proposed Sec. 447.206(d) would specify requirements for the state
plan when the state proposes to use a CPE to fund a Medicaid payment.
We propose that, if CPEs are used as a source of non-federal share
under the state plan, the state plan would be required to specify cost
protocols in the service payment methodology applicable to the
certifying provider, such protocols would be required to meet all of
the following criteria: (1) Identify allowable cost using either a
Medicare cost report, or a state-developed Medicaid cost report
prepared in accordance with the cost principles in 45 CFR part 75 and 2
CFR part 200; (2) define an interim rate methodology that would be used
to pay a provider on an interim basis; (3) describe an attestation
process by which the certifying entity would attest that the costs are
accurate and consistent with 45 CFR part 75 and 2 CFR part 200; (4)
include, as necessary, a list of the covered Medicaid services being
furnished by each provider certifying a CPE; and (5) define a
reconciliation and settlement process consistent with proposed Sec.
447.206(c)(3) and (4). Regarding the inclusion in paragraph (d)(4) of a
list of the covered Medicaid services being furnished by each provider,
CMS is referring to instances where the services included in a cost
report either extend across multiple Medicaid benefit categories or do
not encompass all services within a benefit category. In such
circumstances, we believe that this information is necessary to
determine the services for which FFP is available. For example, in a
setting where some but not all services within a Medicaid benefit
category are furnished, such as a residential rehabilitation hospital
that does not furnish all inpatient hospital services, the state would
be required to document the services for which the state will be
claiming FFP with respect to the provider. In most settings where the
provider certifies a CPE, this step is not necessary, since the
services furnished by the provider certifying the CPE will be
coextensive with a Medicaid benefit category (for example, the
``inpatient hospital services'' Medicaid benefit category typically is
coextensive with the services furnished by an inpatient hospital that
might certify a CPE).
We are soliciting comment on our overall proposal, including the
proposed cost reporting and process requirements, state plan
requirements, and whether to require the use of the Medicare cost
report where one exists for an applicable service for which the
provider certifies a CPE. We believe requiring the use of a Medicare
cost report where one exists for CPE protocols would allow for a
consistent application of allowable cost principles, however, Medicare
cost reports only exist for a relatively small number of services that
states may cover in their Medicaid programs and requiring the use of
Medicare cost reports would remove some state flexibility in
determining the appropriate cost reporting mechanism for providers
certifying CPEs in the state's Medicaid program.
12. Retention of Payments (Sec. 447.207)
In Sec. 447.207, we propose to require that payment methodologies
must permit the provider to receive and retain the full amount of the
total computable payment for services furnished under the approved
state plan (or the approved provisions of a waiver or demonstration, if
applicable). This provision is intended to implement sections
1902(a)(4) and (a)(32) of the Act. These provisions respectively
require that the state plan for medical assistance provide such methods
of administration as are found by the Secretary to be necessary for the
proper and efficient operation of the plan, and generally provide that
no payment under the plan for any care or service provided to an
individual shall be made to anyone other than such individual or the
person or institution providing such care or service, under an
assignment or power of attorney or otherwise, unless certain enumerated
exceptions apply as described in more detail below. Payment
arrangements that comply with an exception in section 1902(a)(32) of
the Act and the implementing regulation in Sec. 447.10 would not be
deemed out of compliance with this proposed provision.
The Secretary would determine compliance with this provision by
examining any associated transactions that are related to the
provider's total computable Medicaid payment to ensure that the state's
claimed expenditure, which serves as the basis for FFP, is consistent
with the state's net expenditure, and that the full amount of the non-
federal share of the payment has been satisfied. The term ``state's net
expenditure'' in this section means a state's Medicaid expenditure,
less any returned funds or contributions from the provider to the
state, related to the Medicaid payment. This view of a return of any
portion of a Medicaid payment is consistent with the treatment of
provider-related donations in Sec. 433.54, particularly paragraph (e)
of that section which states CMS will deduct the amount of an
impermissible provider-related donation from a state's medical
assistance expenditures before calculating FFP (73 FR 9698).
Consideration for the state's net expenditure would include a review of
potential ``hold harmless'' arrangements as described in Sec.
433.54(c), which provides that an impermissible hold harmless practice
exists if the Medicaid payment is positively correlated to a donation,
varies based only on the amount of a donation (including if payment is
conditioned upon the receipt of a donation), or directly or indirectly
guarantees to return any portion of a donation to the donating provider
(or other party responsible for the donation), which implements section
1903(w)(2)(B) of the Act. We have noted circumstances in some states
where participation in a Medicaid supplemental payment under the state
plan is conditioned upon the state receiving a portion of that payment
back, whether as a direct payment from the provider or netted from
payments to the provider where the state retains a portion of the
provider's payment before sending the remaining payment to the
provider.
We anticipate that ``associated transactions'' may include, but
would not necessarily be limited to, the payment of an administrative
fee to the state as a fee for processing provider payments or IGTs. For
example, in some states, we have found that the Medicaid agency has
charged a percentage administrative fee for each Medicaid claim that
was processed. Essentially, the state was charging providers for
submitting claims to the Medicaid program, and since the administrative
charge was based on claims volume and amount of Medicaid payment, this
practice amounted to a tax on Medicaid claims for services. States are
already able to, and often do, claim administrative match for Medicaid
claims processing costs; states should be using the appropriate
mechanisms for claiming where authority exists and not unnecessarily
shifting costs to the Medicaid providers. We propose that in no event
could administrative fees be calculated based on the amount a provider
receives through Medicaid payments or amounts a unit of government
contributes through an IGT as funds for the state share of Medicaid
payments. Structuring an administrative fee in this way would be
tantamount to a Medicaid-only provider tax, which is not allowable
under Sec. 433.55, and would be expressly prohibited under the
proposed Sec. 447.207(a). Conversely, if
[[Page 63747]]
a state charged a flat fee for claims processing that did not vary
based on the volume of claims or amount of Medicaid payments processed,
the payment of such a fee would not be considered an associated
transaction. Likewise, the use of Medicaid revenues to fund payments
that are normal operating expenses of conducting business, such as
payments related to taxes (including permissible health-care-related
taxes), fees, or business relationships with governments unrelated to
Medicaid in which there is no connection to Medicaid payment would not
be considered an associated transaction.
We are soliciting comment on all of Sec. 447.207, including
comments on the types of transactions that we propose would and would
not be considered ``associated transactions'' for the purpose of this
section.
13. State Plan Requirements (Sec. 447.252)
We are proposing to add paragraphs (d) and (e) to Sec. 447.252
regarding state plan requirements for payments for inpatient hospital
and long-term care facility services, to implement new approval
requirements for state plans and any SPAs proposing to make
supplemental payments to providers of these services and to define a
transition period for currently authorized supplemental payments to
begin to meet the proposed new requirements. In Sec. 447.302, we
propose similar requirements for supplemental payments proposed for
outpatient hospital services, as described in more detail below. We are
proposing to limit approval for any Medicaid supplemental payments to a
period of not more than 3 years, and to require states to monitor a
supplemental payment program during the term of its approval to ensure
that the supplemental payment remains consistent with section
1902(a)(30)(A) of the Act. As discussed in this section and other
sections of this preamble, the proposed revisions to Sec. Sec.
447.252, 447.288(b), and 447.302 include considerable data reporting
requirements which would implement section 1902(a)(6) of the Act which
provide that the state agency will make such reports, in such form and
containing such information, as the Secretary may from time to time
require, and comply with such provisions as the Secretary may from time
to time find necessary to assure the correctness and verification of
such reports. We believe the robust payment data we propose to require
is necessary to ensure the proper and efficient administration of the
plan; to ensure that payments are consistent with efficiency, economy,
and quality of care; and otherwise to assist us in appropriately
overseeing the Medicaid program.
Specifically, we propose in Sec. 447.252(d) that CMS may approve a
supplemental payment, as defined in Sec. 447.286, provided for under
the state plan or a SPA for a period not to exceed 3 years. A state
whose supplemental payment approval period has expired or is expiring
may request a SPA to renew the supplemental payment for a subsequent
period not to exceed 3 years, consistent with the requirements of Sec.
447.252. A time-limited supplemental payment allows CMS and the state
an opportunity to revisit state plan supplemental payments to ensure
that they remain consistent with efficiency, economy, and quality of
care, as required under section 1902(a)(30)(A) of the Act. Over the
years, CMS and various oversight bodies conducting financial management
reviews and audits have identified areas where unchecked supplemental
payments have resulted in payments that appeared to be excessive, and
CMS had little recourse to take action. Such audits and financial
reviews conducted by CMS or other oversight agencies could take years
and require a large number of state and federal resources to complete,
and ultimately resolve. As noted earlier in this preamble, in 2015, the
GAO issued a report entitled, ``Medicaid: CMS Oversight of Provider
Payments Is Hampered by Limited Data and Unclear Policy,'' in which it
concluded that, ``[w]ithout good data on payments to individual
providers, a policy and criteria for assessing whether the payments are
economical and efficient, and a process for reviewing such payments,
the federal government could be paying states hundreds of millions, or
billions, more than what is appropriate.'' \9\ As a result, the GAO has
recommended that, to better ensure the fiscal integrity of the program,
we should establish financial reporting at a provider-specific level
and clarify permissible methods for calculating Medicaid supplemental
payment amounts. Based on this and other oversight entity
recommendations, and CMS' experience administering the Medicaid program
at the federal level, we believe that the time-limited approval of
supplemental payments is necessary for the proper and efficient
administration of state Medicaid plans to ensure the continuing
consistency of supplemental payments with applicable statutory
requirements and generally to ensure appropriate oversight.
---------------------------------------------------------------------------
\9\ U.S. Gov't Accountability Office, GAO-15-322, Medicaid: CMS
Oversight of Provider Payments Is Hampered by Limited Data and
Unclear Policy, 46 (2015), https://www.gao.gov/assets/670/669561.pdf.
---------------------------------------------------------------------------
We are not proposing to limit the number of times a state may
request, and receive approval for renewal of, a supplemental payment
program, provided that each request meets all applicable requirements.
We propose that a state plan or SPA that would provide for a
supplemental payment would be required to include: (1) An explanation
of how the state plan or SPA will result in payments that are
consistent with section 1902(a)(30)(A) of the Act, including that
provision's standards with respect to efficiency, economy, quality of
care, and access, along with the stated purpose and intended effects of
the supplemental payment, for example, with respect to the Medicaid
program, providers, and beneficiaries; (2) the criteria to determine
which providers are eligible to receive the supplemental payment; (3) a
comprehensive description of the methodology used to calculate the
amount of, and distribute, the supplemental payment to each eligible
provider, including specified content; (4) the duration of the
supplemental payment authority (not to exceed 3 years); (5) a
monitoring plan to ensure that the supplemental payment remains
consistent with the requirements of section 1902(a)(30)(A) of the Act
and to enable evaluation of the effects of the supplemental payment on
the Medicaid program, for example, with respect to providers and
beneficiaries; and (6) for a SPA proposing to renew a supplemental
payment for a subsequent approval period, an evaluation of the impacts
on the Medicaid program during the current or most recent prior
approval period, for example, with respect to providers and
beneficiaries, and including an analysis of the impact of the
supplemental payment on compliance with section 1902(a)(30)(A) of the
Act. For the state's comprehensive description of the methodology used
to calculate the amount of, and distribute, the supplemental payment to
each eligible provider as required under item (3), we would require the
state to provide all of the following: (i) The amount of the
supplemental payment made to each eligible provider, if known, or, if
the total amount is distributed using a formula based on data from one
or more fiscal years, the total amount of the supplemental payments for
the fiscal year or years available to all providers eligible to receive
a supplemental payment; (ii) if applicable, the specific criteria with
respect to Medicaid
[[Page 63748]]
service, utilization, or cost data from the proposed state plan rate
year to be used as the basis for calculations regarding the amount and/
or distribution of the supplemental payment; (iii) the timing of the
supplemental payment to each eligible provider; (iv) an assurance that
the total Medicaid payment to an inpatient hospital provider, including
the supplemental payment, will not exceed the upper limits specified in
Sec. 447.271; and (v) if not already submitted, an UPL demonstration
as required by Sec. 447.272 and described in proposed Sec. 447.288.
We already request the information specified in items (1) through
(3), above, from states when a state makes a state plan submission that
includes a supplemental payment. Currently, we request this information
either informally, by seeking assurances from the state in connection
with the request for a SPA, or more formally, by requesting changes to
the language of the proposed SPA itself. These requirements also are
consistent with Sec. 430.10, which requires a state plan to be a
comprehensive written statement which serves as the basis for FFP; as
such, we are proposing to specify in regulation the essential elements
of a comprehensive written methodology for a Medicaid supplemental
payment. Consistent with longstanding policy, for a state plan to be
comprehensive, it must include the detailed methodologies by which the
state makes payments, such that we and the state have the information
necessary to determine which providers qualify for a payment, the
amount of each provider's payment, and the manner in which payments are
distributed to the qualifying providers.
While items (1) through (3), above, would codify our current
practice in the regulation, items (4) through (6) would be new
requirements. Item (4) would require the state to identify an
expiration date, or sunset date, for the supplemental payment, not to
exceed a duration of 3 years. A 3-year approval period would also be
consistent with our general approach with respect to demonstration
projects under section 1115 of the Act, which often are approved for 3-
year periods to allow for adequate time for the implementation and
testing, supported by ongoing monitoring, and which culminate in an
evaluation of the effects of the demonstration. Each time a state
submits a SPA to renew a supplemental payment, the state would be able
to request a new approval period of up to 3 years. The state could
submit a SPA for CMS consideration to renew a supplemental payment at
any point during the 3-year approval period, according to the state's
chosen timeframe, which the state should determine to allow sufficient
time for our review and approval. We considered using a tiered approval
time period, such as an initial approval period of up to 5 years
followed by renewal periods of up to 3 years, but decided not to
propose this policy due to the increased burden that it could cause.
We have found that supplemental payments that are established under
the state plan and not reviewed for a long period of time may result in
issues of compliance with applicable statutory and regulatory
requirements that do not promptly come to our, or the state's,
attention. For example, as discussed elsewhere in this preamble,
particularly with respect to proposed Sec. 447.288, the issue of
fluidity of provider ownership can result in issues involving UPL
supplemental payments, and where payments are made improperly, can
require extensive federal and state resources to resolve. In the
example discussed in connection with proposed Sec. 447.288, the
qualifying criteria for providers made all ``non-state government owned
or operated'' facilities eligible for supplemental payments up to the
UPL for those providers. A few years after this supplemental payment
structure was approved, the state was approached by providers who
wanted to change their ownership or operational categorization to meet
the ``non-state government'' criteria, apparently so that they could
qualify for the UPL supplemental payments under the state plan. The
state allowed the providers to make the change without prior CMS review
or approval, and subsequently began making UPL supplemental payments to
the newly recategorized providers. Upon review of the supplemental
payment program in question, CMS found that none of the asserted
changes in ownership or operations supported the providers'
recategorization, and that the providers therefore were ineligible for
the UPL supplemental payments the state had been making. In this
example, the state was also using funds impermissibly transferred from
private entities, which the state characterized as IGTs as a result of
the asserted recategorization of the provider as non-state government-
owned or operated. To resolve the identified issue, CMS had to undergo
a thorough financial management review, which involved numerous CMS
staff reviewing financial statements, provider payments, provider
records, and interviewing numerous state and provider staff members to
determine the provider's eligibility for the payment under the approved
state plan. CMS formally issued the financial management review in
November 2015 for claims for services provided in state FYs 2010 and
2011, and ultimately issued a disallowance in September 2018. If CMS
had the ability routinely to re-review state supplemental payment
programs, we would not have approved the expansion of this payment to
non-qualifying providers under the plan because the private providers
were also funding the non-federal share of a Medicaid payment, which is
unallowable under the statute. Because of situations like this and
related concerns, we believe it is necessary for the proper and
efficient administration of state Medicaid plans to require that
supplemental payment programs be submitted for CMS review and approval
at least every 3 years, to ensure they are and remain consistent with
the efficiency, economy, and quality requirements under section
1902(a)(30)(A) of the Act and the parameters concerning permissible
sources of non-federal share under section 1903(w) of the Act.
In our experience, a number of states that seem to effectively use
supplemental payments re-submit their supplemental payment programs to
CMS on an annual basis, as the pools funded by the supplemental
payments are annually re-authorized by the state legislature. Such
supplemental payment programs would not be impacted by the proposed 3-
year limit. States submitting annual updates to supplemental payment
programs, like other states with supplemental payment programs, would
however newly be required to comply with the other proposed
requirements, including items (5) and (6), discussed above. Proposed
Sec. 447.252(d)(5) and (6) concern monitoring and evaluation
requirements to assess the effects of the state's supplemental payment
program. Specifically, paragraph (d)(5) would require the state to
submit a monitoring plan to ensure the supplemental payment remains
consistent with the requirements of section 1902(a)(30)(A) of the Act
and to enable evaluation of the supplemental payment's effects on the
Medicaid program, for example, with respect to providers and
beneficiaries. For a SPA proposing to renew a supplemental payment for
a subsequent approval period, paragraph (d)(6) would require the state
to submit such an evaluation and to include an analysis of the impact
of the supplemental payment on the state's compliance with section
1902(a)(30)(A)
[[Page 63749]]
of the Act. For example, a state could seek a 3-year approval period
for a supplemental payment to increase payments to rural hospitals,
with the goal of increasing beneficiary access to services provided by
rural hospitals. Over the next 3 years, the state would monitor the
effects of the program, to determine whether the supplemental payment
is meeting its goals and remains consistent with applicable
requirements. At the end of the 3-year period, if the state wished to
renew the supplemental payment, it would submit its evaluation and
analysis with its renewal request to us, which would inform our
determination of whether payments under a renewed supplemental payment
program would be consistent with applicable requirements, including
those in section 1902(a)(30)(A) of the Act. We anticipate that there
may be cases in which the state's evaluation of a supplemental payment
program's effectiveness in meeting its stated goals requires more time
to evaluate; in such cases, provided we are able to determine that the
supplemental payment meets all applicable statutory and regulatory
requirements, we would anticipate approving the renewal. Notably, even
for a state requesting to renew a supplemental payment program with no
changes, we would require the state to submit the evaluation and
analysis required under proposed Sec. 447.252(d)(6) as part of our
review of the supplemental payment for consistency with applicable
statutory and regulatory requirements.
Finally, in considering the 3-year approval period for supplemental
payments, we developed a transition plan to provide states with an
adequate opportunity to come into compliance with the proposed
requirements. To accomplish the policy objectives described above, we
believe we must begin to apply the proposed policies to current state
plan provisions that authorize supplemental payments that are approved
as of the effective date of the final rule. It is no less necessary to
ensure the proper and efficient administration of the state plan and
ensure that applicable requirements continue to be met, to rigorously
evaluate currently existing supplemental payment programs, as it is to
do so for new supplemental payment programs that may be approved
prospectively. Accordingly, in proposed Sec. 447.252(e), for state
plan provisions approved 3 or more years prior to the effective date of
the final rule, we propose that the state plan authority would expire 2
calendar years following the effective date of the final rule. For
state plan provisions approved less than 3 years prior to the effective
date of the final rule, we propose that the state plan authority would
expire 3 years following the effective date of the final rule. We
believe this is a generous timeline for transitioning to the proposed
3-year time limit for supplemental payments under the state plan. This
timeline provides states with currently approved supplemental payment
programs with at least 2 years, and as many as 3 years, before a state
wishing to continue the supplemental payment program would need to seek
renewal or a new approval.
We are soliciting comment on this entire section, including the
proposed state plan elements for supplemental payments and the proposed
provisions that would place a limited approval timeframe on state's
proposed supplemental payments. For the timeframes, we are seeking
input on both the length of 3-year approval period and the length of
the proposed transition period for currently approved supplemental
payments. We considered proposing a 5-year compliance transition period
instead of the proposed 3-year compliance transition period in Sec.
447.252(e). This would have extended the amount of time states would
have to bring existing, approved supplemental payment methodologies
into compliance with the provisions of the proposed rule in Sec. Sec.
447.252 and 447.302, but determined that the shortened timeframe would
be easier to administer as many states already submit annual
supplemental payment proposals. We decided to propose a 3-year
transition period to account for states where changes may require
legislative action as some legislatures meet on a biennial basis and
such a timeframe would provide an opportunity for all legilslatures to
address existing supplemental payment programs. We are requesting
comment on whether or not to pursue this or a lengthier transition and
approval/renewal timeline for supplemental payments.
14. Inpatient Services: Application of UPLs (Sec. 447.272)
To promote improved oversight of Medicaid program FFS expenditures
for services subject to the UPL, we are proposing changes to Sec.
447.272. Many of the proposed changes to Sec. 447.272 would formally
codify our current policy in regulation text, while others are newly
proposed standards. We have long relied upon the UPL requirements in
Sec. 447.272, and the related review of total inpatient hospital
Medicaid payments in relation to a provider's cost or a reasonable
estimate of what Medicare payment amounts would have been, as
implementing section 1902(a)(30)(A) of the Act, which requires that
states assure that payments are consistent with efficiency, economy,
and quality of care. As stated earlier in the preamble, the aggregate
application of these UPLs has preserved state flexibility for setting
provider-specific payments while creating an overall payment ceiling as
a mechanism for determining economy and efficiency of payment for
services, consistent with section 1902(a)(30)(A) of the Act.
We are proposing to amend paragraph (a) to revise the current
ownership groups (state government-owned or operated, non-state
government owned or operated, and privately-owned and operated
facilities) used to establish the UPL. We propose to replace these
provider designations with ``state government providers,'' ``non-state
government providers,'' and ``private providers.'' We propose to codify
the substantive definitions of these provider designations in proposed
Sec. 447.286. As discussed below, we would define ``state government
provider'' to refer to a health care provider as defined in Sec.
433.52, including those defined in Sec. 447.251, that is a unit of
state government or state university teaching hospital. In determining
whether a provider is a unit of state government, we would consider the
totality of the circumstances, including but not limited to specific
considerations identified in proposed Sec. 447.286. Similarly, we
would define ``non-state government provider'' to refer to a health
care provider as defined in Sec. 433.52, including those defined in
Sec. 447.251, that is a unit of local government in a state, including
a city, county, special purpose district, or other governmental unit in
the state that is not the state, which has access to and exercises
administrative control over state funds appropriated to it by the
legislature and/or local tax revenue, including the ability to expend
such appropriated or tax revenue funds. In determining whether a
provider is non-state government provider, we would consider the
totality of the circumstances, including but not limited to specific
considerations identified in proposed Sec. 447.286. We would define a
``private provider'' to mean a health care provider as defined in Sec.
433.52, including those defined in Sec. 447.251, that is not a state
government provider or a non-state government provider.
The proposed changes in provider designations would reinforce the
[[Page 63750]]
relationship between a provider's designation and its ability (or
inability) to provide the source of non-federal share for Medicaid
payments. Under the current system of categorization by ownership or
operational interests, there can be ambiguity with respect to the
appropriate category for a provider when certain responsibilities of
ownership or operation are divided between more than one entity. For
example, there is currently the possibility that a private nursing
facility could transfer the deed to its real property to the county
government, but the private entity would continue to administer all
functions of the provider as though it were the actual owner, leaving
the county government as the owner only in name but not any function.
For the provider to make an IGT, the private entity would give funds to
the county government, such as through a lease payment for the real
property, to be used as the source of the non-federal share of Medicaid
payments that the state could then make back to the provider in the
form of supplemental payments. This effective self-funding of the non-
federal share of the supplemental payments by the provider would not
have been possible if the provider were categorized as privately owned
and operated, since it would have been unable to make the IGT to
support the supplemental payments back to it. In this situation, we
view this transferred amount (for example, the lease payment) as an
impermissible source of the non-federal share, since the funds used to
support the IGT are not obtained from state or local tax revenue and,
as discussed elsewhere in this preamble, would constitute a non-bona
fide provider-related donation.
Through the state plan review process and our review of UPL
demonstrations, we have observed that some states have re-categorized a
number of providers from privately-owned or operated facilities to a
governmentally owned or operated designation, either state government-
owned or operated facilities or non-state government-owned or operated
facilities. In some instances, the change in ownership category appears
to be only a device to permit the state to make supplemental payments
to a provider and demonstrate compliance with the UPL, rather than
reflective of an actual change in the provider's true ownership or
operational interests, in view of the apparent continuity of the
provider's business structure and activities. We believe this shift in
designation has facilitated higher supplemental payments to certain
providers, without the state incurring additional cost to fund the non-
federal share of payment where the private operator passes funds to the
new governmental owner and those funds are either used: (1) To make an
IGT or (2) supplant funds that are otherwise used to make an IGT to the
state in order to make a supplemental payment targeted toward the
private entity. We are concerned that this type of arrangement is not
consistent with the basic construct of the Medicaid program as a
cooperative federal-state partnership where each party shares in the
cost of providing medical assistance to beneficiaries.
We propose to amend Sec. 447.272(b) by clarifying that the UPL
refers to a reasonable estimate of the amount that would be paid for
the services furnished by the group of facilities under Medicare
payment principles in 42 CFR, chapter IV, subchapter B; or allowed
costs established in accordance with Medicaid cost principles as
specified in 45 CFR part 75 and 2 CFR part 200, or, as applicable,
Medicare cost principles specified in part 413. The specific data
sources, methodology parameters, and acceptable UPL demonstration
methodologies are specified in proposed Sec. 447.288(b).
The existing regulations simply state that the UPL refers to a
reasonable estimate of the amount that would be paid for the services
furnished by the group of facilities under Medicare payment principles
in subchapter B of this chapter, pursuant to which we have defined UPLs
as a payment limit set at the aggregate amount that Medicare would have
paid for the same Medicaid services, using either a Medicare payment
methodology or Medicare cost principles. These two methods are employed
because these are the two methods that Medicare has historically used
to pay for services as authorized in chapter 42, subchapter B. In
establishing these UPL methodologies, we have required that states set
the UPL using the Medicare equivalent payment or cost amount, then
compare the aggregate Medicaid payments for the defined period to the
UPL. For purposes of this proposed rule and to be consistent with prior
regulatory action, the term ``Medicare equivalent'' means the Medicare
equivalent to the Medicaid payment, data, or services. For example, the
Medicare equivalent payment means the amount that would be paid for
Medicaid services furnished by the group of providers if those services
were provided to Medicare beneficiaries and paid under Medicare payment
principles. We are proposing to codify our existing policy related to
the use of the two methods of demonstrating the Medicaid UPL, by using
the Medicare equivalent payment amount or cost amount, and the process
for establishing and demonstrating compliance with the UPL in Sec.
477.288(b) of this proposed rule.
We considered proposing to define specific methods by which states
would be required to demonstrate compliance with the UPL in each of
Sec. Sec. 447.272 and 447.321, but determined that the proposed Sec.
447.288 would allow us to define necessary data elements, parameters,
and methodologies for demonstrating compliance with UPLs in one
location, for purposes of both the inpatient and outpatient UPLs under
Sec. Sec. 447.272 and 447.321, respectively. To summarize briefly,
proposed Sec. 447.288 describes the data sources, data parameters, and
methodologies that must be considered and used in demonstrating
compliance with the UPL. It describes the appropriate Medicare data and
the creation of ratios using either cost or payment data calculations,
the Medicaid charge data to be multiplied by a ratio either of Medicare
costs-to-charges or of Medicare payments-to-charges to calculate the
UPL amount, any associated considerations (such as inflation
adjustments, utilization adjustments, or other cost adjustments), and
the Medicaid payment data. For a detailed discussion of these proposed
UPL requirements, please refer to the discussion below related to Sec.
447.288.
We invite comment on all proposed new provisions and proposed
amendments in this section.
15. Basis and Purpose (Sec. 447.284)
We are proposing to add subpart D to part 447 to implement sections
1902(a)(6) and (a)(30)(A) of the Act, which require, respectively, that
a state plan for medical assistance must provide that the state agency
will make such reports, in such form and containing such information,
as the Secretary may from time to time require, and comply with such
provisions as the Secretary may from time to time find necessary to
assure the correctness and verification of such reports, and to assure
that payments are consistent with efficiency, economy, and quality of
care. As discussed in detail above and in subsequent sections below,
this information would improve the transparency of Medicaid payments
and provide us with more information to understand the basis of
Medicaid supplemental payments at the individual provider level in a
manner consistent with the recommendations of the oversight bodies as
mentioned
[[Page 63751]]
elsewhere in this preamble. Moreover, this information would be used in
concert with annual UPL demonstrations and state expenditure data to
improve our oversight of state expenditures and FFP. Accordingly, we
are proposing to require states to submit quarterly and annual reports
which detail the total provider payments, including base and
supplemental payments, authorized under the state plan and
demonstration authority. We are also proposing that the states submit
an additional annual report disclosing the amount of provider
contributions provided to the state to support the non-federal share of
the Medicaid payments along with the total payments received by the
contributing providers. The provider contributions include all provider
taxes, IGTs, CPEs, and any provider-related donations as described in
part 433, subpart B. This new subpart would provide definitions for
terms critical to the requirements for supplemental payment programs,
including with respect to UPL demonstrations (Sec. 447.286), establish
new data submission requirements for supplemental payments under the
state plan (Sec. 447.288), and specify the consequences that would
apply when a state fails to report required information (Sec.
447.290). We believe these proposed provisions are necessary to ensure
the proper and efficient administration of state Medicaid plans with
respect to supplemental payment programs, and generally to better
enable us to perform our oversight function with respect to the
Medicaid program.
We have a long history of establishing data reporting requirements
for states. For financial data reports such as the UPL data
demonstrations, we have long relied upon the current language in
Sec. Sec. 447.272 and 447.321, which we have discussed in
subregulatory guidance in the form of SMDLs, particularly SMDL 13-003,
to provide additional information regarding required data and the
timeline and manner in which such data is to be reported. We have also
defined reporting requirements regarding the Medicaid DSH program
through regulations in Sec. 447.299. Since codifying the DSH reporting
requirements in regulation, we have found that data reporting by states
has become far more consistent, and as a result, we have been able to
quickly identify areas where DSH payments have been made
inappropriately or when the state has made a payment outside of the
state plan methodology, and thus we have been able to more efficiently
focus our resources to those problematic areas. We have also been able
to work with states to update state plan language so that the
distribution methodology for their DSH payments is comprehensively
described in the state plan, in accordance with federal requirements.
Based in part on this experience with the usefulness of comprehensive
data reporting about state payments to providers, we are proposing
uniform reporting requirements for additional state Medicaid payments,
including supplemental payments made under the UPL. Our expectation is
that such reporting would allow CMS to focus our resources to areas
where there appear to be issues, either in the payment methodology or
the underlying financing, and provide states with technical assistance
to the extent that the issues identified may be resolved through
strengthening the state plan language so that it accurately and
comprehensively describes the state's payment rates and methodologies.
In proposed Sec. 447.284(a), we would specify that proposed new
subpart D would set forth additional requirements for supplemental
payments made under the state plan, and implement section 1902(a)(6)
and (a)(30) of the Act. Section 447.284(b) would provide that the
reporting requirements in subpart D are applicable to supplemental
payments to which a UPL applies under Sec. Sec. 447.272 or 447.321.
We are soliciting comments on the statement of basis and purpose as
proposed in Sec. 447.284.
16. Definitions (Sec. 447.286)
We are proposing to add Sec. 447.286 to define the following
terms, as they are used in proposed part 447, subpart D: Base payment,
Non-state government provider, Private provider, state government
provider, and Supplemental payment. Clear definitions of these terms
are needed so that states and other stakeholders can have a clear
understanding of what is required with respect to the proposed
reporting requirements for supplemental payments and UPL
demonstrations, and to allow us to clearly track supplemental payments
and ensure a consistent reporting and UPL demonstration process.
Specifically, we propose to define the term ``base payment'' to
mean a payment, other than a supplemental payment, made to a provider
in accordance with the payment methodology authorized in the state plan
or is paid to the provider through its participation with a Medicaid
MCO entity under the authority in part 438. Base payments are
documented at the beneficiary level in MSIS or T-MSIS and include all
payments made to a provider for specific Medicaid services rendered to
individual Medicaid beneficiaries, including any payment adjustments,
add-ons, or other additional payments received by the provider that can
be attributed to a particular service provided to the beneficiary, such
as payment adjustments made to account for a higher level of care or
complexity of services provided to the beneficiary. We believe that, in
defining a base payment to a provider, it is appropriate to start with
the most fundamental component of the payment that reimburses the
provider for furnishing a specific service to a particular beneficiary.
In some cases, the base payment may be the only payment the provider
receives. We considered not including payment adjustments, which are
payments made to providers based on certain provider-specific criteria,
add-on payments, and other per service payments apart from the most
basic payment, but we determined that it would be more appropriate to
include all payments made to a provider for specific Medicaid services
rendered to individual Medicaid beneficiaries in the proposed
definition. When states pay providers based on patient acuity,
complexity of services, characteristics of the provider, or add-on
payments, including but not limited to add-on payments for quality of
services, such payments can be directly tied to the provision of a
service to an individual Medicaid beneficiary and are available to all
providers within the Medicaid benefit category. The base payment,
including add-on amounts, includes all payment amounts intended to
fully reimburse the provider for furnishing a specific service to a
particular beneficiary, whereas supplemental payments are made as a
lump sum intended to reimburse for Medicaid services generally, rather
than particular services furnished to an individual beneficiary. We are
soliciting comment on this proposed definition and on the alternative
we considered of not including payment adjustments such as incentive
payments and other add-on payments that are paid on a per claim basis.
We propose to define non-state government provider to mean a health
care provider, as defined in Sec. 433.52, including those defined in
Sec. 447.251, that is a unit of local government in a state, including
a city, county, special purpose district, or other governmental unit in
the state that is not the state, which has access to and exercises
administrative control over state-appropriated funds from the
legislature
[[Page 63752]]
or local tax revenue, including the ability to dispense such funds. We
propose to consider the entity's access to and administrative control
over state-appropriated funds from the legislature or local tax revenue
in this definition to link the provider category to the ability of the
provider to supply the non-federal share funds in a manner consistent
with section 1903(w)(6)(A) of the Act. We anticipate that questions may
arise about whether a provider is a governmental or a private entity,
for purposes of this definition. To resolve such questions, we propose
that we would consider the totality of the circumstances, including,
but not limited to, the identity and character of any entity or
entities other than the provider that share responsibilities of
ownership or operation of the provider, and including the nature of any
relationship among such entities and the relationship between such
entity or entities and the provider. In determining whether an entity
shares responsibilities of ownership or operation of the provider, our
consideration would include, but would not be limited to, whether the
entity: (1) Has immediate authority to make decisions regarding the
operation of the provider; (2) bears the legal responsibility for risk
from losses from operations of the provider; (3) has immediate
authority over the disposition of revenue from operations of the
provider; (4) has immediate authority with regard to hiring, retention,
payment, and dismissal of personnel performing functions related to the
operation of the provider; (5) bears legal responsibility for payment
of taxes on provider revenues and real property, if any are assessed;
or (6) bears the responsibility of paying any medical malpractice
premiums or other premiums to insure the real property or other
operations, activities, or assets of the provider.
In determining whether a relevant entity (that is, the provider and
any entity or entities other than the provider that share
responsibilities of ownership or operation of the provider) is a unit
of a non-state government, we would consider the character of the
entity which would include, but would not be limited to, whether the
entity: (1) Is described in its communications to other entities as a
unit of non-state government, or otherwise; (2) is characterized as a
unit of non-state government by the state solely for the purposes of
Medicaid financing and payments, and not for other purposes (for
example, taxation); and (3) has access to and exercises administrative
control over state funds appropriated to it by the legislature and/or
local tax revenue, including the ability to expend such appropriated or
tax revenue funds, based on its characterization as a governmental
entity.
In recent years, states have proposed a number of SPAs which sought
to re-designate the UPL ownership category of a provider and to allow
that provider to make an IGT, up to the applicable UPL, to fund the
non-federal portion of a new Medicaid supplemental payment. Oftentimes,
a hallmark of these proposals has been the sale of some asset of the
provider (such as the provider's license or the facility's
certification) for some nominal fee, with the private entity (the
``seller'') otherwise retaining critical responsibilities of ownership,
and with the IGT, in practical reality, coming from the private
entity's funds. This approach is inconsistent with the statute and
regulations, particularly sections 1902(a)(30)(A) and 1903(w)(6)(A) of
the Act and implementing regulations at Sec. Sec. 433.51, 447.272 and
447.321.
Based on our experience with such SPAs, it appears that some states
have sought to manipulate the characterization of providers' ownership
to achieve problematic Medicaid financing arrangements. In arrangements
we have observed, the operator essentially functioned as the owner and
the operator of the facility. Accordingly, we believe a more effective
approach to appropriately categorizing providers for purposes of the
UPL would be to consider the totality of the circumstances relevant to
the character of the provider, rather than attempting to parse more
narrowly whether features of particular entities purported to be the
provider's owner and/or operator mean that the provider is properly
categorized as a unit of non-state government, which our experience has
borne out may be more susceptible to manipulation. We understand that
the business models of health care providers and their facilities are
layered and complex. However, as discussed above, we are troubled by
instances we have observed in which some states have attempted to re-
characterize facilities as non-state government owned or operated,
where such characterization was not supported by the actual structure
and operation of the facility, in an ultimate effort to generate more
federal Medicaid revenue without corresponding financial participation
from the state. We believe such arrangements violate applicable
statutes and regulations, are inconsistent with the fiscal integrity of
the Medicaid program, and are generally abusive of the federal-state
partnership that Congress has prescribed for the Medicaid program.
We propose to define private provider to mean a health care
provider as defined in Sec. 433.52, including those defined in Sec.
447.251, that is not a state government provider or a non-state
government provider. This is intended to be a catch-all for remaining
health care providers in the state, that are not state government
providers or non-state government providers, for purposes of this
section. We are soliciting comments on this proposed definition of
private provider.
We propose to define state government provider to mean a health
care provider, as defined in Sec. 433.52, including those defined in
Sec. 447.251, that is a unit of state government or a state university
teaching hospital. Similar to the proposed definition of non-state
government provider, we propose that, in determining whether a provider
is a state government provider, we would consider the totality of the
circumstances, including, but not limited to, the identity and
character of any entity or entities other than the provider that share
responsibilities of ownership or operation of the provider, and
including the nature of any relationship among such entities and the
relationship between such entity or entities and the provider. The
factors that we propose to consider, without limitation, include those
discussed above regarding the proposed definition of non-state
government provider. And similar to that proposed definition, in
determining whether a relevant entity is a state government or state
university teaching hospital, we propose that our consideration would
include, without limitation, the factors discussed above in connection
with the proposed definition of non-state government provider.
Regarding the proposed definitions of non-state government
provider, private provider, and state government provider, we
understand that health care facilities often enter into business
relationships with other entities to perform various functions,
including, but not limited to, the care of beneficiaries. We recognize,
and do not wish to interfere with, legitimate business relationships
between providers and other entities, or among such other entities in
relation to the provider. In fact, we believe that the current
definitions of non-state government-owned or operated, state
government-owned or operated, and privately-owned and operated may have
inadvertently distorted such relationships by encouraging new or
[[Page 63753]]
different business relationships between providers and other entities,
or among such other entities in relation to a provider, with no useful
purpose other than to manipulate Medicaid financing in problematic
ways. As such, we are proposing to identify a provider as a non-state
government provider or state government provider in consideration of
the totality of the circumstances, including, but not limited to, the
identity and character of any entity or entities other than the
provider that share responsibilities of ownership or operation of the
provider, and including the nature of any relationship among such
entities and the relationship between such entity or entities and the
provider. These proposed definitions are intended to work together with
the UPL rules and the provisions governing non-federal share financing
and provider-related donations to safeguard the fiscal integrity of the
Medicaid program.
We propose to define ``supplemental payment'' to mean a Medicaid
payment to a provider that is in addition to the base payments to the
provider, other than DSH payments under part 447, subpart E, made under
state plan authority or demonstration authority. Supplemental payments
cannot be attributed to a particular provider claim for specific
services provided to an individual recipient and are often made to the
provider in a lump sum on a monthly, quarterly, or annual basis apart
from payments for a provider claim, and therefore, cannot be directly
linked to a provider claim for specific services provided to an
individual Medicaid beneficiary. In short, supplemental payments are
any payments to a provider other than Base payments or DSH payments
under part 447, subpart E. Supplemental payments are lump sum payments
made to the provider at various intervals depending on the state
program, including supplemental payments made through section 1115
demonstrations such as uncompensated care pools and delivery system
reform incentive payments (DSRIP). We are not making determinations
about those particular intervals at which payments are distributed to
providers other than to require that states specify such information as
proposed in Sec. 447.252(d) of this proposed rule. We have
historically considered DSH payments under part 447, subpart E as being
distinct payments authorized separately in the statute in section 1923
of the Act which are separate from Medicaid supplemental payments. The
DSH payments serve the specific purpose of taking into account the
situation of hospitals that serve a disproportionate number of low-
income patients with special needs, including Medicaid beneficiaries
and the uninsured. Serving these patients may cause hospitals to incur
higher costs, including significant uncompensated care costs for
serving low income populations. Supplemental payments and DSH payments
are paid under separate authorities in the Act. Supplemental payments
are authorized in section 1902(a)(30)(A) of the Act, which requires
that the state plan provide methods and procedures to assure that
payments are consistent with efficiency, economy, and quality of care
and DSH payments are authorized in section 1923 of the Act. Therefore,
supplemental payments and DSH payments are not required to be tied to
the same statutory purpose.
We are requesting comment on the revisions to Sec. 447.272,
including each of the revised provider category definitions included in
this section.
17. Reporting Requirements for UPL Demonstrations and Supplemental
Payments (Sec. 447.288)
We are proposing to add Sec. 447.288 to define documentation
requirements for UPL demonstrations and for states that make
supplemental payments. As noted several times elsewhere in this
preamble, the GAO has frequently cited the lack of adequate Medicaid
provider payment data as a deficiency that compromises CMS oversight
and recommended we take concrete steps to ensure the timely submission
of accurate state payment data. In 2015, one GAO report concluded that
``[w]ithout good data on payments to individual providers, a policy and
criteria for assessing whether the payments are economical and
efficient, and a process for reviewing such payments, the federal
government could be paying states hundreds of millions, or billions,
more than what is appropriate'' (U.S. Gov't Accountability Office, GAO-
15-322, Medicaid: CMS Oversight of Provider Payments Is Hampered by
Limited Data and Unclear Policy, 46 (2015)). Accordingly, this
proposals represents an effort to address the concerns raised by GAO
and to create a more robust audit trail for state payments to providers
to allow for better CMS oversight. We believe that this proposed
provision is necessary to ensure the proper and efficient operation of
the Medicaid state plan, in a manner that complies with the
requirements of sections 1902(a)(4), (a)(6) and (a)(30)(A) of the Act.
In new Sec. 447.288(a), we propose that, beginning October 1, of the
first year following the year in which the final rule may take effect,
and annually thereafter, by October 1 of each year, in accordance with
the requirements of Sec. 447.288 and in the manner and format
specified by the Secretary, each state would be required to submit a
demonstration of compliance with the applicable UPL for each of the
following services for which the state makes payment: Inpatient
hospital, as specified in Sec. 447.272; outpatient hospital, as
specified in Sec. 447.321; nursing facility, as specified in Sec.
447.272; ICF/IID, as specified in Sec. 447.272; and institution for
mental diseases (IMD), as specified in Sec. 447.272. The submission of
UPLs for these facilities and services is consistent with existing CMS
regulations in Sec. Sec. 447.272 and 447.321, as well as CMS guidance
document SMDL #13-003. Under these regulations and policy guidance,
states are already providing UPL demonstrations for the above
referenced services to demonstrate that payments are consistent with
economy, efficiency, and quality of care as required in section
1902(a)(30)(A) of the Act. These demonstrations are submitted annually,
or any time a state submits a SPA that proposes to amend the payment
rate or methodology for one of the aforementioned facilities or service
categories. Of note, as discussed in greater detail below, we are
proposing to remove the psychiatric residential treatment facilities
(PRTF) and clinic UPLs, which would not be included in the annual
reporting requirements.
We are proposing to add Sec. 447.288(b) to define UPL
demonstration standards. When demonstrating the UPL, states would be
required to use the data sources and adhere to the data standards, and
acceptable UPL methodologies specified in this section. We believe that
these proposed requirements would assist CMS and states in determining
the Medicaid inpatient and outpatient facility payment rates are
consistent with economy, efficiency and quality of care under section
1902(a)(30)(A) of the Act.
Over time, we have received numerous requests for feedback on the
use of specific data elements and on acceptable UPL methodologies. We
are hopeful these proposed provisions, which, except as noted below,
would codify current policy, would enhance states' understanding of
acceptable UPL demonstration standards, as well as improve the quality
of UPL submissions.
We are proposing no longer to require states to submit UPL
demonstrations for PRTFs and clinics. PRTFs are facilities subject to
the payment limits defined in
[[Page 63754]]
Sec. 447.325, which states that the state Medicaid agency may pay the
customary charges of the provider but must not pay more than the
prevailing charges in the locality for comparable services under
comparable circumstances. The reason for this proposed change is two-
fold. First, the payment limit in Sec. 447.325 limits the state's
payment to a provider to the provider's customary charges or, if less,
the prevailing charges in the locality for comparable services under
comparable circumstances. Providers determine what they will charge for
items and services furnished. To pay a provider's charge under the
state plan, a state plan could simply provide that its payments will
not exceed the provider's customary charge, provided the state plan
also describes a comprehensive methodology for ensuring that payments
do not exceed the prevailing charges in the locality for comparable
services under comparable circumstances. Second, in our experience,
states do not make supplemental payments to these facilities, and such
provider's base payments are generally equal to the provider's charge.
As such, the UPL is less of a calculation, as with other inpatient-type
services, and more of a confirmation the state pays no more than the
provider's charge under the state plan, which can be accomplished
through a review of the state plan. We will continue to review
compliance with the Sec. 447.325 through a review of the SPA
submissions as has been our historical practice. The removal of the
clinic UPL is discussed in more detail below under Sec. 447.321 of
this preamble.
In proposed Sec. 447.288(b), we propose to specify detailed UPL
demonstration standards for demonstrating that Medicaid FFS payments
are made in aggregate amounts that are less than or equal to the
aggregate cost or Medicare payment amounts. The purpose of the proposed
provisions is to ensure uniform reporting of UPL data and a full
picture of Medicaid payments within each provider category for each
category of services subject to a UPL in a given year. The proposed
provisions are intended to specify that states may not pick-and-choose
the most beneficial data for each provider within a provider category,
but instead to select a UPL methodology and apply a single methodology
to all providers within a UPL provider category and service type.
In proposed paragraph (b)(1), we propose defining the data sources
for the UPL calculations, which is the Medicare-equivalent cost and
charge data and Medicare-equivalent payment and charge data for
purposes of the UPL as our primary data sources for the UPL. As noted
elsewhere in this proposed rule, the term ``Medicare equivalent'' means
the Medicare equivalent to the Medicaid data, payment, or services.
Therefore, the term Medicare equivalent payment means the amount that
would be paid for Medicaid services furnished by the group of providers
if those services were provided to Medicare beneficiaries and paid
under Medicare payment principles. Likewise, a reference to Medicare
equivalent charges in reference to a UPL calculation means the Medicare
charges for the same Medicaid services subject to the UPL.
In proposed paragraph (b)(1)(i), we would require that cost and
charge data for all providers must be from either Medicare cost
reports, or state-developed cost reports using either Medicare cost
reporting principles specified in part 413 or the cost allocation
requirements specified in 45 CFR part 75, which implements requirements
in 2 CFR part 200, as specified in 2 CFR 200.106. Cost and charge data
must: Include only data with dates of service that are no more than 2
years prior to the dates of service covered by the UPL demonstration;
and represent costs and charges specifically related to the service
subject to the UPL demonstration. As such, each UPL must use costs and
charges related to the relevant category of Medicaid services listed in
paragraph (a) of Sec. 447.288; and include either Medicare costs and
Medicare charges, or total provider costs and total charges, in order
to develop a cost-to-charge ratio as described in paragraph (b)(3)(i).
The selection must be consistently applied for all providers within the
provider category subject to the UPL so that all costs and charges for
all providers within a provider category are uniform in the UPL
demonstration to ensure uniformity in reporting as discussed above.
These requirements are consistent with historical practices related to
the collection of information for UPLs and were part of the CMS UPL
templates submitted to OMB for approval under control number 0938-1148
(CMS-10398 #13 and #24).
At paragraph (b)(1)(ii), we propose to define Medicare payment
demonstrations as using Medicare payment and charge data for all
providers from either Medicare cost reports, Medicare payment systems
for the specific provider type specified in title 42, chapter IV,
subchapter B of the CFR, as applicable, or imputed per diem rates based
on Medicare provider payments. ``Imputed'' per diem rates, as discussed
in more detail in paragraph (b)(3)(ii)(C), are payments that are
calculated by dividing total Medicare payments by Medicare days from
the provider census data to calculate an estimated Medicare price per
day. The state then is able to multiply this Medicare price per day for
each provider by the provider's Medicaid days (also from the provider
census), and then sum these products within a service class and
provider category to calculate a Medicaid UPL.
The proposed provision goes on to specify that when using Medicare
payment and charge data, the data must: Include only data with dates of
service that are no more than 2 years prior to the dates of service
covered by the UPL demonstration; include only Medicare payments and
charges, or Medicare payment and the provider's Medicare census data,
specifically related to the service subject to the UPL demonstration;
and use either gross Medicare payments and Medicare charges, which
includes deductibles and co-insurance but excludes reimbursable bad
debt from the Medicare payment, or net Medicare payments and Medicare
charges, which excludes deductibles and coinsurance and includes
reimbursable bad debt, as reported on a Medicare cost report. The
selection of gross or net Medicare payment must be consistent within
the ratio for each provider category subject to the UPL. These
requirements are consistent with historical practices related to the
collection of information for UPLs and were part of the CMS UPL
templates submitted to OMB for approval under control number 0938-1148
(CMS-10398 #13 and #24).
For the Medicare payment systems for the specific provider type, we
are referring to the prospective payment systems (PPS) in effect for
the Medicare program such as the inpatient prospective payment system
(IPPS), outpatient prospective payment system (OPPS), skilled nursing
facility (SNF) PPS, and any future applicable Medicare PPSs such as the
patient driven payment model (PDPM) for SNFs. The requirement that the
payment data use data with dates of service that are no more than 2
years prior to the dates of service covered by the UPL demonstration
would allow states to use Medicare payment data from a prior period to
demonstrate the UPL, particularly in years where Medicare is
transitioning to a new payment system. Because states have the
flexibility to use data that is no more than 2 years old, states using
Medicare payment-based demonstrations would not be required to
immediately switch over to using data from a newly implemented Medicare
payment system, such as PDPM, to demonstrate
[[Page 63755]]
compliance with the UPL if the state is not in a position to do so, but
would be able to transition to using that system over a 2-year period.
There is no requirement in statute or regulations that mandates states
use specific Medicare payment systems in Medicaid for provider
payments. Since the UPL is an estimate of the amount that Medicare
would have paid for the service, we have always offered states some
flexibility to determine UPLs using recent data that is no more than 2
years old, which, in years where Medicare has transitioned to a new
payment system, means that states could use data from the prior payment
system for up to 2 years after the Medicare transition for purposes of
the Medicaid UPL compliance demonstration.
In paragraph (b)(1)(iii), we propose to require that the Medicaid
charge data used in calculating the UPL must be derived from the
state's Medicaid billing system for services provided during the same
dates of service as the Medicare cost or Medicare payment data, as
defined above. The Medicare cost and charge or payment and charge data,
as applicable, is used to create a ratio with the Medicare cost or
payment being the numerator and the Medicare charges are the
denominator. Once that ratio is created, the Medicaid charges are
multiplied by that ratio. This is discussed in more detail below, but
the requirement that the time period of the Medicaid charge data be
from the same time period of the Medicare-equivalent data, as defined
above, is due to the fact that providers determine what they will
charge for items and services furnished to patients, which may change
from time to time. If the charges are the same for all payers, then a
reasonable estimate of the amount that Medicare would pay for the
service would require the use of the Medicaid charge data from the same
time period as the Medicare data to calculate the UPL. As discussed in
connection with paragraph (b)(3)(i), we propose that a cost-based
methodology could only be used for services where a provider applies
uniform charges to all payers.
At paragraph (b)(1)(iv), we propose to require Medicaid payment
data from a state's Medicaid billing system for services provided
during the same dates of service as the Medicare cost or Medicare
payment data, as specified in paragraph (b)(1)(i) or (ii) of this
section, as applicable, or from the most recent state plan rate year
for which a full 12 months of data are available. As with the data
requirements in paragraphs (b)(1)(i) and (ii), Medicaid payment data
must: Include only data with dates of service that are no more than 2
years prior to the dates of service covered by the UPL; include all
actual payments, as well as all projected base and supplemental
payments, excluding any payments made for services for which Medicaid
is not the primary payer, expected to be made during the time period
covered by the UPL demonstration to the providers within the provider
category, as applicable; and only be trended by an amount equal to the
changes in the Medicaid state plan payment for the applicable service.
Using either the most recent Medicaid payment data for the time period
subject to the UPL or the payment data from the same time period as the
Medicaid charge data (meaning also from the same time period as the
Medicare data) is up to the state. Under all circumstances, the
Medicaid payment data must include all payments made to the providers,
including any proposed payments or projected payments that have not yet
been made. This way, the UPL will reflect an accurate depiction of the
state's Medicaid payments during the period of the UPL demonstration.
In paragraph (b)(2), we propose to require states to apply certain
UPL methodology parameters in calculating the UPL. Specifically, the
proposed UPL methodology parameters include the following
considerations. First, projected changes in utilization must be
accounted for and reflected in the demonstration. If no service-
specific utilization projections are available, then projections for
enrollment must reflect programmatic changes such as reasonable
utilization changes due to managed care enrollment projections. For
example, a state may be aware that in the upcoming state-fiscal year,
there will be a shift to increase beneficiary enrollment in managed
care plans. Projected utilization changes to account for such large
programmatic shifts may be used instead of individually determined,
service-specific utilization changes, such as inpatient hospital
utilization, which may result in a percentage increase or decrease in
expected utilization for the relevant services undergoing a shift to
managed care. Medicare data may also be projected using Medicare trend
factors appropriate to the service and demonstration methodology, which
are Medicare payment- or cost-based, with such trend factors being
uniformly applied to all providers within a provider category. In this
way, states can anticipate and project program changes or changes in
expected costs or payments in the UPL that may either increase or
decrease the UPL or expected Medicaid payments. For example, an
appropriate trend factor with respect to inpatient hospital services,
outpatient hospital services, and SNFservices could be the CMS Market
Basket rate. This proposed change, which represents a departure from
current policy, is proposed in paragraph (b)(2)(ii), which would
require uniform application of the trending factor within the provider
category. Prior to this proposed rule, we had not formally articulated
an expectation of uniform trending of data within a provider category
and had accepted UPL demonstrations that did not apply trend factors in
a uniform manner. CMS could not determine whether the applied inflation
adjustments in those UPLs were always appropriate based on our review.
This proposed provision is intended to establish the requirements in
regulation for uniform inflation adjustments to the UPLs.
Additionally, we propose that when calculating the aggregate UPL
using a cost-based demonstration as described in paragraph (b)(3)(i),
the state may include the cost of provider assessments (such as health
care-related taxes) paid by each provider in the provider category that
is reasonably allocated to Medicaid as an adjustment to the UPL, to the
extent that such costs were not already included in the cost-based UPL.
For example, many states calculate their provider taxes on inpatient
services as a per day payment amount or a per discharge payment amount.
The state would calculate the portion of such a tax allocable to
Medicaid by multiplying the per day or per discharge tax amount by
Medicaid days or Medicaid discharges, as applicable, and include the
product of that amount in the UPL for each provider in the provider
category. When calculating the aggregate UPL using a cost-based
demonstration, states may include the Medicaid-allocated cost of health
care related taxes as an adjustment to the UPL amount on a per provider
basis. The Medicare cost report does not require states to account for
expenses related to health care related taxes as an allowable cost, as
this reporting is optional. In the Medicaid program, such expenditures
may be included as an allowable cost provided that the portion of the
cost allocated to Medicaid can be isolated from the aggregate health
care related tax payment.
For example, if a provider has 100 total bed days of which 85 were
Medicaid bed days and the provider paid $100 in health care related
taxes, the provider could account for $85 of the total tax payment. Our
current policy permits states to include the cost
[[Page 63756]]
of Medicaid's portion of health care related taxes as an allowed cost
for cost based demonstrations, but not payment based demonstrations; we
are proposing to codify that existing policy in regulation because,
historically, the Medicaid taxes have not been specifically included in
the Medicare cost report calculations. The Medicare 2552 (Hospital Cost
Report) now includes an option to include provider taxes paid under the
authority in section 1903(w) of the Act. To the extent that such taxes
are not included in the cost calculation in the Medicare cost report,
those costs should be included in the UPL. If the provider taxes are
included in the Medicare cost report, the state should not add these
costs back into the UPL calculation, which would result in double-
counting the tax payments. Our goal in allowing Medicaid provider tax
costs to be added back into the cost-based UPL calculations is to
ensure that allowable costs incurred by the providers when furnishing
services to Medicaid beneficiaries are applied to the UPL calculations
to the extent that they were not already captured in the Medicare cost
report data, but we do not want such costs to be duplicated through the
UPL and the Medicare cost report. This provision only applies to cost-
based UPL demonstrations because cost-based demonstration are
reflections of the provider's expenses related to the provision of
medical services and such amounts may vary based upon factors including
health care related-taxes in the state or other relevant jurisdiction,
while payment-based UPL demonstrations reflect only the Medicare
payment for services under the specific Medicare payment system, and
therefore, only adjustments which affect the overall payment under the
Medicare payment system can be factored into the UPL demonstration.
Finally, we propose codifying the current policy that the Medicaid
payments, in paragraph (b)(1)(iv), included in the UPL calculation must
only include payments made for Medicaid services under the specific
Medicaid service type at issue in the UPL. For example, the state must
not include payments for services other than inpatient hospital
services in the inpatient hospital UPL calculation.
In paragraph (b)(3), we propose acceptable methods of demonstrating
the UPL. First, we propose that to make a cost-based demonstration in
compliance with an applicable UPL, Medicaid covered charges are
multiplied by a cost-to-charge ratio developed for the period covered
by the UPL demonstration. The state may use a ratio of Medicare costs
to Medicare charges, or total provider costs to total provider charges
in developing the cost-to-charge ratio, but the selection must be
applied consistently to each provider within a provider type, which
references the listing of provider types in paragraph (a) of the
section. The product of Medicaid covered charges and the cost-to-charge
ratio for each provider is summed to determine the aggregate UPL. The
demonstration must show that Medicaid payments will not exceed this
aggregate UPL for the demonstration period. As explained in more detail
below, this methodology may only be used for services where a provider
applies uniform charges to all payers. Reported cost must be
appropriately allocated between payers so that only costs properly
allocated to Medicaid services are included in the demonstration.
In paragraph (b)(3)(i)(A), we propose that states may make a
retrospective, cost-based demonstration showing that aggregate Medicaid
payments paid to the providers within the provider category during the
prior state plan rate year did not exceed the costs incurred by the
providers furnishing Medicaid services within the prior state plan rate
year period. The term ``retrospective'' simply refers to Medicaid
payments that have already been paid for the prior state plan rate year
that has already ended, and for which the state does not anticate
making any new Medicaid payments. Most often these demonstrations come
from states where providers are paid using a reconciled cost
methodology under the approved Medicaid state plan, in which case the
Medicaid provider payments would be equal to those providers' cost of
Medicaid services, and the UPL would demonstrate that payments to
providers did not exceed their costs.
In paragraph (b)(3)(i)(B), we propose that states may make a
prospective, cost-based demonstration showing that prospective Medicaid
payments would not exceed the estimated, prospective cost of furnishing
the services for the upcoming state plan rate year period. As explained
in more detail below, this methodology may only be used for services
where a provider applies uniform charges to all payers. The prospective
cost demonstration is a common UPL methodology reviewed by CMS and is
often used by states to demonstrate that proposed or projected Medicaid
payments are less than a provider cost trended forward from a prior
period.
In addition to these cost-based demonstrations, we also propose
that states could use payment-based demonstrations to show compliance
with an applicable UPL, including retrospective and prospective
methodologies and including flexibility for the state to determine an
imputed Medicare payment rate to apply in either a retrospective or
prospective payment-based demonstration. We propose that the payment-
based demonstration data sources would be those identified in
paragraphs (b)(1)(ii), (iii), and (iv), and the data standards defined
in paragraph (b)(2) would apply. States could make a retrospective
payment-to-charge UPL demonstration, where Medicaid covered charges are
multiplied by a ratio of Medicare payments to Medicare charges
developed for the period covered by the UPL demonstration. The product
of Medicaid covered charges and the Medicare payment-to-charge ratio
for each provider would be summed to determine the aggregate UPL, and
the demonstration must show that Medicaid payments did not exceed this
aggregate UPL. Alternatively, we propose that states could make a
prospective payment-to-charge UPL demonstration, where Medicaid covered
charges are multiplied by a ratio of Medicare payments to Medicare
charges developed for the period covered by the UPL demonstration. The
product of Medicaid covered charges and the Medicare payment-to-charge
ratio for each provider would be summed to determine the aggregate UPL.
The demonstration must show that proposed Medicaid payments would not
exceed this aggregate UPL within the next state plan rate year
immediately following the demonstration period. Regardless of whether a
state is using a retrospective or prospecftive payment-to-charge
demonstration methodology, we propose that states could use an imputed
Medicare per diem payment rate determined by dividing total Medicare
prospective payments paid to the provider by the provider's total
Medicare patient days, which are derived from the provider's Medicare
census data. Each provider's imputed Medicare per diem payment rate
would be multiplied by the total number of Medicaid patient days for
the provider for the period. The products of this operation for each
provider are summed to determine the aggregate UPL. The demonstration
must show that Medicaid payments are not in excess of the aggregate
UPL, calculated on either a retrospective or prospective basis,
consistent with the applicable proposed methodology. This imputed
Medicare payment rate methodology is commonly used by long-term care
facilities in Medicaid, such as SNFs and IMDs, or in
[[Page 63757]]
states whose Medicaid payments are based upon existing Medicare payment
systems. For example, a state which uses the Medicare SNF PPS to
demonstrate a SNF UPL would divide total Medicare payments by total
Medicare SNF bed days. That product, per facility, would be multiplied
by the Medicaid bed days, the aggregate of which would be the aggregate
UPL. The Medicaid payments for the same time period must not exceed the
aggregate UPL.
It is important to note that any UPL methodology that requires the
use of a provider's charges to calculate the UPL may only be used to
the extent that the provider applies uniform charges to all payers.
This is because when developing a cost to charge ratio or a payment to
charge ratio, the initial ratio is multiplied by Medicaid charges to
determine the UPL amount. ``Charges'' are the amount a hospital or
provider bills for medical services, and should be the same for all
patients regardless of payer. If the charges used in the cost to charge
or Medicare payment to charge ratio are not the same as the Medicaid
charges, the calculation of the UPL would be either over- or under-
stated. We intend the UPL demonstrations to accurately depict the
Medicare cost, or what Medicare would have paid, for the same services,
and that is diminished when the underlying data is not accurate.
In new Sec. 447.288(c)(1), we propose that, at the time the state
submits its quarterly CMS-64 under Sec. 430.30(c), the state would be
required to report certain information for each supplemental payment
included on the CMS-64. The proposed reporting elements would not be
reported on the CMS-64 itself, but would accompany that submission on a
separate, supplemental report. We propose to require states to report
information sufficient to identify which providers receive which
supplemental payments under the state plan and any demonstration
authority, and to enable us to ensure that such payments to the
providers are consistent with economy, efficiency, and quality of care,
as required under section 1902(a)(30)(A) of the Act. These data
submission requirements would include provider-level data on base and
supplemental payments made under state plan and demonstration authority
by service type. This data would also be required to include the
following: The SPA transaction number or demonstration authority number
which authorizes the supplemental payment; a listing of each provider
that received a supplemental payment under state plan and/or
demonstration authority, and, for each: The provider's legal name; the
primary physical address of the location or facility where services are
provided, including street address, city, state, and ZIP code; the
National Provider Identifier (NPI); the Medicaid identification number;
the employer identification number (EIN); the service type for which
the reported payment was made; the provider specialty type (if
applicable, for example, critical access hospital (CAH), pediatric
hospital, or teaching hospital); the provider category (that is, state
government provider, non-state government provider, or private
provider); and the specific amount of the supplemental payment paid to
each provider, including the total supplemental payment made to the
provider authorized under the specified state plan and the total
Medicaid supplemental payment made to the provider under the specified
demonstration authority, as applicable.
The specific data elements described above are intended to identify
the individual providers receiving payments, the authority for the
payments, and the sum of all payments received by the individual
providers. Information such as the provider's legal name, primary
physical location or facility location where services were provided,
NPI, Medicaid identification number, and EIN are needed to identify the
specific provider accurately. When the regulation refers to the
``legal'' name, it means the business name of the facility which
appears on the provider's license and other legal documentation
authorizing the health care operations of the provider. The NPI is
required for providers, and EINs are assigned to all businesses by the
Internal Revenue Service, and must be on all Health Insurance
Portability and Accountability Act (HIPAA) electronic transactions. An
NPI is a unique 10-digit number used to identify health care providers.
The Medicaid identification number is assigned by the state and is a
unique identifier for providers participating in the Medicaid program.
In addition to the provider-identifying information, proposed Sec.
447.288(c)(1) would require the state to report the service type,
provider specialty type, and provider category. These data elements are
intended to be linked to the payment methodology in the state plan.
This information follows how states must describe supplemental payments
in the state plan, which is, first, organized by service type, then by
provider-specific information, such as specialty type and provider
category. If a state establishes a specific methodology or proposes to
make a supplemental payment to a specific ``type'' of hospital using
specified criteria, such as a non-state government teaching hospital or
CAH, such information must appear in the state plan. As the proposed
data elements are aligned with how analogous information is recorded in
the state plan, we anticipate that this information will help us ensure
that supplemental payments are being made to providers in accordance
with the qualifying criteria as established in the state plan. Finally,
we propose to require the state to report the specific amount of the
supplemental payment made to the provider, including the total
supplemental payment amount authorized under the specified state plan,
as applicable, and the total supplemental payment amount authorized
under the demonstration authority, as applicable.
In Sec. 447.288(c)(2), we propose that not later than 60 days
after the end of the state fiscal year, each state must annually report
aggregate expenditure data for all data elements included in Sec.
447.288(c)(1) plus the following: The state reporting period (state
fiscal year start and end dates); the specific amount of Medicaid
payments made to each provider, including, as applicable: The total FFS
base payments made to the provider authorized under the state plan, the
total Medicaid payments made to the provider under demonstration
authority, the total amount received from Medicaid beneficiary cost-
sharing requirements, donations, and any other funds received from
third parties to support the provision of Medicaid services, the total
supplemental payment made to the provider authorized under the
specified state plan, the total Medicaid supplemental payment made to
the provider under the specified demonstration authority, and an
aggregate total of Medicaid payments listed above made to the provider.
Section 447.288(c)(2)(iii) would also require the aggregate
reporting of the total DSH payments made to the provider, and the
Medicaid units of care furnished by the provider (for example, on a
provider-specific basis, total Medicaid discharges, days of care, or
any other unit of measurement as specified by the Secretary). This
proposed data collection effort is designed to allow us to conduct
efficient oversight of all payments made to providers on an annual
aggregate basis. The data, as reported, would be used to conduct
quarterly and annual reviews of state payments as related to payments
reported under UPL demonstrations and under the Medicaid state plan.
[[Page 63758]]
In Sec. 447.288(c)(3), we propose that, not later than 60 days
after the end of the state fiscal year, each state must annually report
aggregate and provider-level information on each provider contributing
to the state or any unit of local government any funds that are used as
a source of non-federal share for any Medicaid supplemental payment.
This proposed data submission requirement would include all of the data
elements listed in Sec. 447.288(c)(1) and (2), but would also require
information related to financial contributions to the state Medicaid
program, specifically including: The total of each health care-related
tax collected from the provider by any state authority or unit of local
government; the total of any costs certified as a CPE by the provider;
the total amount contributed by the provider to the state or a unit of
local government in the form of an IGT; the total of provider-related
donations made by the provider or entity related to a health care
provider, as defined in Sec. 433.52, including in-cash and in-kind
donations, to the state or a unit of local government, including state
university teaching hospitals; and the total funds contributed by the
provider (that is, health care-related taxes, CPEs, IGTs, provider-
related donations, and any other funds contributed to the state as the
non-federal share of a Medicaid payment). When a provider-related
entity is related to more than one entity, the state should report the
total amount of the related entity's donation for each associated
provider. These proposed data elements are intended to be itemized
based on all the various payments to a provider and contributions from
the provider, as applicable. For example, if a provider receives base
and multiple supplemental payments under various SPA authorities and
makes a provider tax contribution and an IGT as a means of funding the
non-federal share, the state must list each payment and each provider
contribution among the proposed required data reporting elements. If
there is more than one payment or more than one type of provider
contribution (for example, more than one tax or more than one IGT), the
state would be required to itemize each payment and each contribution,
as applicable. The purpose of such information from states is to
determine the totality of provider payments under the Medicaid program
and the extent of provider contributions to the non-federal share of
such Medicaid payments under the approved state plan.
We are seeking comment on all aspects of the proposals in this
section. We are soliciting comment on the proposed reporting
requirements in Sec. 447.288(c), including the specific proposed data
elements in Sec. 447.288(c)(1) through (3). In particular, we invite
comment on whether any of the proposed data elements are duplicative,
and on ways we might be able to obtain this necessary information in a
manner that appropriately balances administrative burden on states and
on us while generating the most accurate data possible.
18. Failure To Report Required Information (Sec. 447.290)
To effectively ensure that states comply with applicable federal
statutory and regulatory requirements, we must have adequate
enforcement mechanisms in place. The remedy for issues related to state
compliance with regulations is often the withholding of federal funds
to compel compliance with applicable federal requirements. We are
proposing to add Sec. 447.290 to specify an appropriate avenue of
enforcement in the event that a state does not comply with the proposed
data reporting requirements in Sec. 447.288. As discussed above, we
believe the proposed information reporting requirement under Sec.
447.288 is necessary for the proper and efficient administration of the
state Medicaid plan, especially with respect to the plan's compliance
with section 1902(a)(30)(A) of the Act, and would be properly required
under section 1902(a)(6) of the Act. Therefore, in proposed Sec.
447.290(a), we propose that the state must maintain the underlying
information supporting base and supplemental payments, including the
information required to be reported under proposed Sec. 447.288,
consistent with the requirements of Sec. 433.32, and must provide such
information for federal review upon request to facilitate program
reviews or OIG audits conducted under Sec. Sec. 430.32 and 430.33. In
proposed Sec. 447.290(b), we propose that if a state fails to timely,
completely and accurately report information required under Sec.
447.288 of this chapter, we may reduce future grant awards through
deferral in accordance with Sec. 430.40, by the amount of FFP we
estimate is attributable to payments made to the provider or providers
as to which the state has not reported properly, until such time as the
state complies with the reporting requirements. We propose that we may
defer FFP if a state submits the required report but the report fails
to comply with applicable requirements. Otherwise allowable FFP for
expenditures deferred in accordance with this proposed section would be
released when we determine that the state has complied with all
reporting requirements under proposed Sec. 447.288. The enforcement
mechanism proposed in Sec. 447.290 is similar in structure to the
mechanism that applies with respect to the DSH reporting requirements,
in Sec. 447.299(e). We are soliciting comments on the enforcement
mechanism proposed in Sec. 447.290.
19. Limitations on Aggregate Payments for DSHs Beginning October 1,
1992 (Sec. 447.297)
Current regulations require CMS to publish the annual DSH
allotments in a Federal Register. This process is not only
administratively burdensome, but is unnecessary as we routinely notify
states directly regarding annual allotment amounts and make such
information publicly available. Therefore, we are proposing to
eliminate the Sec. 447.297(c) requirement to publish annual DSH
allotments in a Federal Register notice and to provide that the
Secretary will post preliminary and final national expenditure targets
and state DSH allotments in the MBES and at Medicaid.gov (or similar
successor system or website). Additionally, we are proposing to remove
the date in which final national target and allotments are published
from April 1st to as soon as practicable. We are also proposing to
remove Sec. 447.297(e), which consists of redundant publication
requirements already identified in Sec. 447.297(b), (c), and (d), in
its entirety to align with our proposed changes Sec. 447.297(c). We
are soliciting comments related to these proposed changes.
20. Reporting Requirements (Sec. 447.299)
To improve the accuracy of identification of provider overpayments
discovered through the DSH audit process, we are proposing in Sec.
447.299 to add an additional reporting requirement for annual DSH audit
reporting required by Sec. 447.299 and to provide clarifying guidance
on the reporting of overpayments identified by the annual DSH audits
required under part 455 subpart D. We are proposing to redesignate
Sec. 447.299(c)(21) as paragraph (c)(22) of that section, and to add a
proposed new Sec. 447.299(c)(21) to require an additional data element
for the required annual DSH audit reporting. This new data element
would require auditors to quantify the financial impact of any finding
which may affect whether each hospital has received DSH payments for
which it is eligible within its hospital-specific DSH limit. If it is
not practicable to determine the actual
[[Page 63759]]
financial impact amount, we propose to require a statement of the
estimated financial impact for each audit finding identified in the
independent certified audit that is not reflected in the data elements
identified in Sec. 447.299(c)(6) through (15). For purposes of this
paragraph, audit finding means an issue identified in the independent
certified audit required under Sec. 455.304 concerning the methodology
for computing the hospital specific DSH limit and/or the DSH payments
made to the hospital, including, but not limited to, compliance with
the hospital-specific DSH limit as defined in Sec. 447.299(c)(16).
Audit findings may be related to missing or improper data, lack of
documentation, non-compliance with federal statutes and/or regulations,
or other deficiencies identified in the independent certified audit.
Actual financial impact means the total amount associated with audit
findings calculated using the documentation sources identified in Sec.
455.304(c) of this chapter. Estimated financial impact means the total
amount associated with audit findings calculated on the basis of the
most reliable available information to quantify the amount of an audit
finding in circumstances where complete and accurate information
necessary to determine the actual financial impact is not available
from the documentation sources identified in Sec. 455.304(c) of this
chapter. We understand that due to the complexity of issues that may
arise, the actual financial impact may not always be calculable;
therefore, we propose that, in the expectedly rare event that the
actual financial impact cannot be calculated, an estimated financial
impact would be required. The estimated financial impact would use the
most reliable available information (for example, related source
documentation such as data from state systems, hospitals' audited
financial statements, and Medicare cost reports) to quantify an audit
finding. We believe this additional data reporting element is necessary
to better enable our oversight of the Medicaid DSH program to better
ensure compliance with the hospital specific DSH limit in section
1923(g) of the Act. Moreover, we believe this requirement would limit
the burden on both states and CMS of performing follow-up reviews or
audits and will help ensure appropriate recovery and redistribution, as
applicable, of all DSH overpayments.
The addition of Sec. 447.299(f) would clarify reporting
requirements of DSH overpayments identified in the audit process in
accordance with part 433 subpart F, including specifying that states
must return DSH payments in excess of hospital-specific cost limits to
the federal government identified through annual DSH audits through
quarterly reporting on the Form CMS-64 as a decreasing adjustment, or
redistributed by the state to other qualifying hospitals, if
redistribution is provided for under the approved state plan. Section
447.299(g) would require states to report overpayment redistribution
amounts corresponding with the fiscal year DSH allotment, as applicable
and consistent with other federal requirements, on the Form CMS-64
within 2 years from the date of discovery and report such
redistributions through quarterly reporting on the Form CMS-64 as an
increasing adjustment. We solicit comments on the proposed rule.
21. State Plan Requirements (Sec. 447.302)
We are proposing to revise Sec. 447.302 by adding proposed new
paragraphs (a) through (d), which would establish state plan
requirements for payments for outpatient hospital services, to
implement new approval requirements for state plans and any SPAs
proposing to make supplemental payments to providers of these services
and to define a transition period for currently authorized supplemental
payments to begin to meet the proposed new requirements. These
proposals are similar to those we are making in Sec. 447.252(d) with
respect to supplemental payments for inpatient hospital, nursing
facility, and ICF/IID services. We are proposing to limit approval for
state plan supplemental payments for outpatient hospital services to a
period of not more than 3 years, and to require states to monitor a
supplemental payment program during the term of its approval to ensure
that the supplemental payment remains consistent with section
1902(a)(30)(A) of the Act. As discussed in this section and other
sections of this preamble, the proposed revisions to Sec. Sec.
447.252, 447.288(b) and 447.302 include considerable data reporting
requirements which would implement section 1902(a)(6) of the Act,
requiring the state agency to make such reports, in such form and
containing such information, as the Secretary may from time to time
require, and comply with such provisions as the Secretary may from time
to time find necessary to assure the correctness and verification of
such reports. The submission of more robust payment data would assist
us in providing proper oversight of the Medicaid program in determining
that state Medicaid payments are made in a manner consistent with
federal statute and regulations, including section 1902(a)(30)(A) of
the Act and applicable UPL requirements.
Specifically, we are proposing in Sec. 447.302(a) and (b) to
codify existing state plan requirements that the plan must provide that
the requirements of subpart F are met and that the plan must specify
comprehensively the methods and standards used by the agency to set
payment rates. We propose in Sec. 447.302(c) that CMS may approve a
supplemental payment, as defined in Sec. 447.286, provided for under
the state plan or a SPA for a period not to exceed 3 years. A state
whose supplemental payment approval period has expired or is expiring
may request a SPA to renew the supplemental payment for a subsequent
period not to exceed 3 years, consistent with the requirements of Sec.
447.302. A time limited supplemental payment allows CMS and the state
an opportunity to revisit state plan supplemental payments to ensure
that they remain consistent with efficiency, economy, and quality of
care, as required under section 1902(a)(30)(A) of the Act. Over the
years, CMS and various oversight bodies conducting financial management
reviews and audits have identified areas where unchecked supplemental
payments have resulted in payments that appeared to be excessive, and
CMS had little recourse to take action. Such audits and financial
reviews conducted by CMS or other oversight agencies can take years and
require a large number of state and federal resources to complete, and
ultimately resolve. As noted earlier in this preamble, in 2015, the GAO
issued a report entitled, ``Medicaid: CMS Oversight of Provider
Payments Is Hampered by Limited Data and Unclear Policy,'' in which it
concluded that, ``[w]ithout good data on payments to individual
providers, a policy and criteria for assessing whether the payments are
economical and efficient, and a process for reviewing such payments,
the federal government could be paying states hundreds of millions, or
billions, more than what is appropriate.'' \10\ As a result, the GAO
has recommended that, to better ensure the fiscal integrity of the
program, we should establish financial reporting at a provider-specific
level and clarify permissible methods for calculating Medicaid
supplemental payment amounts. Based on this and other oversight entity
recommendations, and
[[Page 63760]]
CMS' experience administering the Medicaid program at the federal
level, we believe that the time-limited approval of supplemental
payments is necessary for the proper and efficient operation of state
Medicaid plans to ensure the continuing consistency of supplemental
payments with applicable statutory requirements and generally to ensure
appropriate oversight.
---------------------------------------------------------------------------
\10\ U.S. Gov't Accountability Office, GAO-15-322, Medicaid: CMS
Oversight of Provider Payments Is Hampered by Limited Data and
Unclear Policy, 46 (2015), https://www.gao.gov/assets/670/669561.pdf.
---------------------------------------------------------------------------
We are not proposing to limit the number of times a state may
request, and receive approval for renewal of a supplemental payment
program, provided that each request meets all applicable requirements.
We propose that a state plan or SPA that would provide for a
supplemental payment would be required to include: (1) An explanation
of how the state plan or SPA will result in payments that are
consistent with section 1902(a)(30)(A) of the Act, including that
provision's standards with respect to efficiency, economy, quality of
care, and access along with the stated purpose and intended effects of
the supplemental payment, for example, with respect to the Medicaid
program, providers, and beneficiaries; (2) the criteria to determine
which providers are eligible to receive the supplemental payment; (3) a
comprehensive description of the methodology used to calculate the
amount of, and distribute, the supplemental payment to each eligible
provider, including specified content; (4) the duration of the
supplemental payment authority (not to exceed 3 years); (5) a
monitoring plan to ensure that the supplemental payment remains
consistent with the requirements of section 1902(a)(30)(A) of the Act
and to enable evaluation of the effects of the supplemental payment on
the Medicaid program, for example, with respect to providers and
beneficiaries; and (6) for a SPA proposing to renew a supplemental
payment for a subsequent approval period, an evaluation of the impacts
on the Medicaid program during the current or most recent prior
approval period, for example, with respect to providers and
beneficiaries, and including an analysis of the impact of the
supplemental payment on compliance with section 1902(a)(30)(A) of the
Act. For the state's comprehensive description of the methodology used
to calculate the amount, and distribution, of the supplemental payment
to each eligible provider as required under item (3), we would require
the state to provide all of the following: (1) The amount of the
supplemental payment made to each eligible provider, if known, or, if
the total amount is distributed using a formula based on data from one
or more fiscal years, the total amount of the supplemental payments for
the fiscal year or years available to all providers eligible to receive
a supplemental payment; (2) if applicable, the specific criteria with
respect to Medicaid service, utilization, or cost data from the
proposed state plan rate year to be used as the basis for calculations
regarding the amount and/or distribution of the supplemental payment;
(3) the timing of the supplemental payment to each eligible provider;
(4) an assurance that the total Medicaid payment to other inpatient and
outpatient facilities, including the supplemental payment, will not
exceed the upper limits specified in Sec. 447.325; and (5) if not
already submitted, an UPL demonstration as required by Sec. 447.321
and described in proposed Sec. 447.288.
The justification for including the state plan requirements in
Sec. 447.302 are the same as those justifications and explanations
included in the discussion with regard to Sec. 447.252. We are
proposing to require states to provide information necessary to
determine that the supplemental payments proposed in the state plan
are, and remain, consistent with the efficiency, economy, and quality
requirements under section 1902(a)(30)(A) of the Act and the parameters
concerning permissible sources of non-federal share under section
1903(w) of the Act.
Finally, in considering the 3-year approval period for supplemental
payments, we developed a transition plan to provide states with an
adequate opportunity to come into compliance with the proposed
requirements. To accomplish the policy objectives described above, we
believe we must begin to apply the proposed policies, if they are
finalized, to current state plan provisions that authorize supplemental
payments that are approved as of the effective date of the final rule.
It is no less necessary to ensure the proper and efficient operation of
the state plan and ensure that applicable requirements continue to be
met, to rigorously evaluate currently existing supplemental payment
programs, as it is to do so for new supplemental payment programs
approved prospectively. Accordingly, in proposed Sec. 447.302(d), for
state plan provisions approved 3 or more years prior to the effective
date of the final rule, we propose that the state plan authority would
expire 2 calendar years following the effective date of the final rule.
For state plan provisions approved less than 3 years prior to the
effective date of the final rule, we propose that the state plan
authority would expire 3 years following the effective date of the
final rule. We believe this is a generous timeline for transitioning to
the proposed 3-year time limit for supplemental payments under the
state plan. This timeline provides states with currently approved
supplemental payment programs with at least 2, and as many as 3 years
before a state wishing to continue the supplemental payment program
would need to seek renewal or a new approval.
We are soliciting comment on this entire section, including the
proposed state plan elements for supplemental payments, and the
proposed approval timeframe for a state's proposed supplemental
payments. For the timeframes, we are seeking input on both the 3-year
approval period and the proposed transition period for currently
approved supplemental payments. We considered proposing a 5-year
compliance transition period instead of the proposed 3-year compliance
transition period in Sec. 447.302(d). This would have increased the
amount of time states would have to bring existing, approved
supplemental payment methodologies into compliance with the provisions
of the proposed rule in Sec. Sec. 447.252 and 447.302. We decided to
propose a 3-year transition period to account for states where changes
may require legislative action as some legislatures meet on a biennial
basis and such a timeframe would provide an opportunity for all
legilslatures to address existing supplemental payment programs. We are
requesting comment on whether or not to pursue this or a lengthier
transition and approval timeline for supplemental payments.
22. Outpatient Hospital Services: Application of UPLs (Sec. 447.321)
To promote improved oversight of Medicaid program FFS expenditures
for services subject to the UPL, we are proposing changes to Sec.
447.321. Some of the proposed changes to Sec. 447.321 would formally
codify current policy, while others are newly proposed. We solicit
comment on all proposed provisions.
CMS has long regarded the UPL requirements in Sec. 447.321 and the
review of total outpatient hospital Medicaid payments in relation to a
provider's cost or the Medicare payment amounts as implementing section
1902(a)(30)(A) of the Act, which requires that states assure that
payments are consistent with efficiency, economy, and quality of care.
As stated earlier in the preamble, the aggregate application of these
UPLs has preserved state flexibility for setting provider-specific
payments while creating an overall payment ceiling as a mechanism for
[[Page 63761]]
determining economy and efficiency of payment for the services
described above, consistent with section 1902(a)(30)(A) of the Act.
We are proposing to change the title of this section to
``Outpatient Hospital Services: Application of upper payment limits''
to remove clinic services from the UPL requirements in Sec. 447.321.
The absence of benefit category in the Medicare program similar to
Medicaid ``clinic services'' has made establishing and verifying
compliance with a UPL for clinic services an overly burdensome task.
Without equivalent comparison data from Medicare, it is difficult or
impossible to establish a reasonable estimate of what Medicare would
pay for Medicaid clinic services, which otherwise would supply the UPL
for such services under Sec. 447.321. Additionally, most often,
clinics are reimbursed according to the practitioner fee schedule in
the same manner as other practitioners under the Medicaid state plan.
In these circumstances, we have determined that such payments are not
subject to the clinic UPL in any event, because these provider payments
are made under the relevant practitioner benefit in the Medicaid
program, such as physician services or dental services under sections
1905(a)(5) and (a)(10) of the Act, respectively, rather than clinic
services under section 1905(a)(9) of the Act. As with all other
inpatient and outpatient facility services, state agencies must
continue to apply Sec. 447.325 under which the agency may pay the
customary charges of the provider but must not pay more than the
prevailing charges in the locality for comparable services under
comparable circumstances.
We have proposed to revise this regulation in the past through
other proposed rules, but were unable to finalize those proposals.
Particularly, in 2007 with the proposed rule Medicaid Program;
Clarification of Outpatient Clinic and Hospital Facility Services
Definition and Upper Payment Limit (72 FR 55166), we proposed several
practical options for states to comply with clinic UPL requirements.
Namely, these options included paying at the Medicare non-facility
Resource-Based Relative Value Units System (RBRVS) FFS rate for
practitioner services in a clinic setting, or setting the rates for
services provided in the clinic at the Medicaid state plan rate for the
same services when provided by a practitioner under the state plan
where there was no Medicare comparable rate. The difficulty in applying
the proposals in that particular proposed rule, and difficulties
setting and establishing compliance with clinic UPLs since, has been
related to the subjectivity of establishing appropriate comparison
prices for services where there is no Medicare equivalent, or limiting
Medicaid providers to cost when Medicare does not collect or mandate
clinic cost reports for free-standing clinics, as is done with other
inpatient and outpatient facilities. For these reasons, we are
proposing to remove clinic services from Sec. 447.321 so the
requirements of the outpatient UPL will no longer apply to these
providers and we are requesting comment on this proposed change.
Importantly, this proposal does not mean that the requirements of
section 1902(a)(30)(A) of the Act do not continue to apply to clinic
payments--emphatically, they do. We simply are proposing to no longer
use the clinic UPL as the formal metric of compliance with the
efficiency, economy, and quality of care requirements under the
statute. We will continue to compare the Medicare RBRVS to Medicaid
clinic reimbursement rates, where applicable, to inform administrative
decisions about the state's payment rates under section 1902(a)(30)(A)
of the Act, much like we do with physician reimbursement under the
Medicaid state plan. We are soliciting comment on this particular
change in the proposed rule.
We are proposing to amend paragraph (a) to revise the current
ownership groups (state government-owned or operated, non-state
government owned or operated, and privately-owned and operated
facilities) used to establish the UPL. We propose to replace these
provider designations with ``state government providers,'' ``non-state
government providers,'' and ``private providers.'' We propose to codify
the substantive definitions of these provider designations in proposed
Sec. 447.286. As discussed below, we would define ``state government
provider'' to refer to a health care provider as defined in Sec.
433.52, including those defined in Sec. 447.251, that is a unit of
state government or state university teaching hospital; in determining
whether a provider is a unit of state government, we would consider the
totality of the circumstances, including but not limited to specific
considerations identified in proposed Sec. 447.286. Similarly, we
would define ``non-state government provider'' to refer to a health
care provider as defined in Sec. 433.52, including those defined in
Sec. 447.251, that is a unit of local government in a state, including
a city, county, special purpose district, or other governmental unit in
the state that is not the state, which has access to and exercises
administrative control over state funds appropriated to it by the
legislature and/or local tax revenue, including the ability to expend
such appropriated or tax revenue funds; in determining whether a
provider is non-state government provider, we would consider the
totality of the circumstances, including but not limited to specific
considerations identified in proposed Sec. 447.286. We would define a
``private provider'' to mean a health care provider as defined in Sec.
433.52, including those defined in Sec. 447.251, that is not a state
government provider or a non-state government provider.
The proposed changes in provider designations would reinforce the
relationship between a provider's designation and its ability (or
inability) to provide the source of non-federal share for Medicaid
payments. Under the current system of categorization by ownership or
operational interests, there can be ambiguity with respect to the
appropriate category for a provider when certain responsibilities of
ownership or operation are divided between more than one entity. For
example, there is currently the possibility that a private nursing
facility could transfer the deed to its real property to the county
government, but the private entity would continue to administer all
functions of the provider as though it were the actual owner, leaving
the county government as the owner only in name but not any function.
For the provider to make an IGT, the private entity would give funds to
the county government, such as through a lease payment for the facility
real property, to be used as the source of the non-federal share of
Medicaid payments that the state could then make back to the provider
in the form of supplemental payments. This effective self-funding of
the non-federal share of the supplemental payments by the provider
would not have been possible if the provider were categorized as
privately owned and operated, since it would have been unable to make
the IGT to support the supplemental payments back to it. In this
situation, we view this transferred amount as an impermissible source
of the non-federal share, since the funds used to support the IGT are
not obtained from state or local tax revenue and, as discussed
elsewhere in this preamble, would constitute a non-bona fide provider-
related donation.
Through the state plan review process and our review of UPL
demonstrations, we have observed that some states have re-categorized a
number of providers from privately-owned or operated facilities to a
governmentally owned or
[[Page 63762]]
operated designation, either state government-owned or operated
facilities or non-state government-owned or operated facilities. In
some instances, the change in ownership category appears to be both a
non-bona fide provider-related donation, as well as a device to permit
the state to make supplemental payments to a provider and demonstrate
compliance with the UPL, rather than reflective of an actual change in
the provider's true ownership or operational interests, in view of the
apparent continuity of the provider's business structure and
activities. We believe this shift in designation has facilitated higher
supplemental payments to certain providers, without the state incurring
additional cost to fund the non-federal share of payment where the
private operator passes funds to the new governmental owner, which
constitutes a non-bona fide provider-related donation, and those funds
are either used to make an IGT or supplant funds that are otherwise
used to make an IGT to the state to make a supplemental payment
targeted toward the private entity. We are concerned that this type of
arrangement is not consistent with the basic construct of the Medicaid
program as a cooperative federal-state partnership where each party
shares in the cost of providing medical assistance to beneficiaries.
Similar to our proposal in Sec. 447.272, we propose to amend Sec.
447.321(b) to clarify that the UPL refers to a reasonable estimate of
the amount that would be paid for the services furnished by the group
of facilities under Medicare payment principles in 42 CFR chapter IV,
subchapter B, or allowed costs established in accordance with the cost
principles as specified in 45 CFR part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles specified in 42 CFR part 413. The
specific data elements, methodology parameters, and acceptable UPL
demonstration methodologies are specified in proposed Sec. 447.288(b).
The existing regulations simply state that the UPL refers to a
reasonable estimate of the amount that would be paid for the services
furnished by the group of facilities under Medicare payment principles
in subchapter B of title 42, chapter IV, of the CFR, which provided CMS
with the ability to define UPLs as a payment limit set at the aggregate
amount that Medicare would have paid for the same Medicaid services
using either a Medicare payment methodology or Medicare cost
principles. These two methods are employed because these are the two
methods that Medicare has historically used to pay for services as
authorized under title 42, chapter IV, subchapter B, of the CFR. In
establishing this limit, we have required that states set the UPL using
these principles, then compare the aggregate Medicaid payments for the
defined period to the UPL, which is the Medicare equivalent payment or
cost amount. We are proposing to codify our existing policy related to
the use of the two methods of demonstrating the Medicaid UPL, by using
the Medicare equivalent payment amount or cost amount, and the process
for establishing and demonstrating compliance with the UPL in Sec.
477.288(b) of this proposed rule. As noted elsewhere in this proposed
rule, the term ``Medicare equivalent'' means the Medicare equivalent to
the Medicaid data, payment, or services. Therefore, the term Medicare
equivalent payment means the amount that would be paid for Medicaid
services furnished by the group of providers if those services were
provided to Medicare beneficiaries and paid under Medicare payment
principles. Likewise, a reference to Medicare equivalent charges in
reference to a UPL calculation means the Medicare charges for the same
Medicaid services subject to the UPL.
We considered proposing to define specific methods by which states
would be required to demonstrate compliance with the UPL in each of
Sec. Sec. 447.272 and 447.321, but determined that the proposed Sec.
447.288 would allow us to define necessary data elements, parameters,
and methodologies for demonstrating compliance with UPLs in one
location, for purposes of both the inpatient and outpatient UPLs under
Sec. Sec. 447.272 and 447.321, respectively. To summarize briefly,
proposed Sec. 447.288 describes the data sources, data parameters, and
methodologies that must be considered and used in demonstrating
compliance with the UPL. It describes the appropriate Medicare data and
the creation of ratios using either cost or payment data calculations,
the Medicaid charge data which multiplied by the either a ratio of
cost-to-charge (total cost or Medicare cost) or the ratio of Medicare
payment-to-charge to calculate the UPL amount and any associated
considerations (inflation adjustments, utilization adjustments, or
other cost adjustments), and the Medicaid payment data. For a detailed
discussion of these proposed UPL requirements, please refer to the
discussion above related to Sec. 447.288.
We invite comment on all proposed new and revised provisions in
this section.
23. Medicaid Practitioner Supplemental Payments (Sec. 447.406)
For a number of years, states have been making supplemental
payments that are targeted to certain practitioners, such as physicians
and other licensed professionals, under the Medicaid state plan. Most
commonly, states have targeted supplemental payments to practitioners
affiliated with and furnishing services in academic medical centers and
safety net hospitals. These payments have used what is commonly
described as an ACR calculation. The ACR is a method of calculating an
average rate paid by commercial third party payers for specific medical
service codes (usually Current Procedural Terminology (CPT) codes) to
providers and multiplying that average rate by the Medicaid claims for
each code to establish an upper limit for these practitioner
supplemental payments.
Predominantly, such ACR payments are funded by IGTs from local
government sources or state university teaching hospitals and are
generally made without consideration of improvements in access to or
quality of care. When payment is made up to the ACR, states submit data
to CMS from the top (generally five) commercial payers and provide an
explanation of the data that was extracted from providers' accounts
receivable systems. The state compares payment by Medicaid for each
billing code to the average payment amount allowed by commercial payers
for the same services. Data from each of the practitioners, group
practices, or hospital-based practitioner groups eligible to receive
the supplement payment is included in the submitted ACR calculation.
These calculations are usually completed by the provider(s) and sent to
CMS by the states through the submission of SPAs. We are proposing to
end the practically unrestricted use of ACR supplemental payments based
on concerns that the payments are not economic and efficient,
consistent with section 1902(a)(30)(A) of the Act, and that they
present a clear oversight risk because they are based on proprietary
commercial payment data and thus not verifiable or auditable. As
discussed in detail below, we are proposing to limit Medicaid
practitioner supplemental payments to 50 percent of FFS base payments
to the eligible provider for practitioner services, or 75 percent of
such payments for services provided within HHS' Health Resources and
Services Administration (HRSA)-designated geographic health
professional shortage areas (HPSAs) or
[[Page 63763]]
Medicare-defined rural areas, as specified in 42 CFR 412.64(b), as
discussed below.
When ACR-based payments were first approved in 2000, we found that
state ACR amounts were between 150 percent and 165 percent of the
Medicare rates for the same services. In recent years, however, states
have sought to make Medicaid practitioner supplemental payments based
on calculations reflecting amounts of approximately 300 percent to 400
percent of the Medicare rate. While these percentage are outliers among
states making ACR payments, those amounts were considerably larger than
we had otherwise seen. In federal FY 2018, the most recent full fiscal
year for which data was reported, states claimed approximately $1.32
billion in (total computable) expenditures for supplemental payments
made to physicians and other licensed practitioners. As states and
practitioners realized that Medicaid payments could be increased
through the use of ACR-based supplemental payment methodologies and
with funding from IGTs, states began to explore expanding the ACR-based
supplemental payments to other Medicaid participating practitioners.
Although we questioned whether making Medicaid payments at up to
400 percent of Medicare rates was consistent with economy and
efficiency as required under section 1902(a)(30)(A) of the Act, we
continued to approve ACR methodologies submitted by states consistent
with our historic view that such methodologies that relied on
commercial data were permissible under the relevant statutory
standards, and because we had not established an upper bound for
practitioner supplemental payments through rulemaking.
In this rule, except as discussed below, we are proposing to apply
the definitions applicable to base and supplemental payments defined
under newly proposed Sec. 447.286--Definitions and the proposed new
requirements in Sec. 447.302--State plan requirements. By aligning
these definitions and requirements, we are ensuring that the
terminology for base and supplemental payments for practitioner
services is consistent with other service types and that states apply
the same comprehensive descriptions and time limits to practitioner
supplemental payments as would be applied to other Medicaid service
supplemental payments. Further, we are proposing, within Sec.
447.406(c), to limit Medicaid practitioner supplemental payments
relative to base payments set under the Medicaid state plan. Notably,
lump sum provider quality incentive supplemental payments that are
targeted to a subset of providers within the state as part of a state's
delivery system reform initiative and paid based on improvements to
reported quality measures are included in the definition of
``Supplemental payment'' under proposed Sec. 447.286, for purposes of
newly proposed Sec. 447.406, and therefore, would be subject to the
limit proposed in Sec. 447.406. To the extent that value-based payment
methodologies that are part of a state's delivery system reform
initiative and that are available to all providers under a Medicaid
benefit category, including as an alternative to FFS payment rates (for
example, bundled payment methodologies, payments for episodes of care,
Medicaid shared savings methodologies), and otherwise align with the
definition of base payments in Sec. 447.286 (for example, the payment
can be attributed to a particular service provided to a Medicaid
beneficiary), we propose such payments to be base payments as defined
in Sec. 447.286. This consideration is consistent with the proposed
definitions of base and supplemental payments and will allow states
sufficient flexibility to promote quality improvement which may result
in better care and reduced program cost over time.
The proposed new limits would allow states to target supplemental
payments to practitioners: (1) Up to 50 percent of the FFS base
payments authorized under the state plan for the practitioner services
paid to the eligible provider during the period covered by the
supplemental payment, or (2) for services provided within HRSA-
designated geographic HPSA or Medicare-defined rural areas as defined
in Sec. 412.64(b), Medicaid practitioner supplemental payments could
be made up to 75 percent of the FFS base payments authorized under the
state plan for the practitioner services paid to the eligible provider
during the period covered by the supplemental payment. We are proposing
to permit additional payment for practitioner services in geopgraphic
HPSAs to allow states flexibility to increase payment rates and address
professional shortages and access to care concerns in areas where HHS
has determined such shortages exist. Likewise, we are proposing to
include Medicare-defined rural areas as defined in Sec. 412.64(b)
because states have frequently identified rural areas, some of which
may not be included in the geographic HPSAs, as having issues related
to access to care and we want to provide states with the flexibility to
make increased practitioner supplemental payments if the state
determines that such increases are needed in those areas as well.
We believe these percentages are appropriate because the ACR data
from 2016 and 2017 show that, nationally, among providers receiving an
ACR supplemental payment, total supplemental payments equaled
approximately 75 percent of the base payment rates in 2016 to
approximately 93 percent of the base payment rates in 2017 (total
supplemental payment divided by total base payments to qualifying
provider) based on data received through the state UPL demonstration
submissions. By limiting the total practitioner payment, base and
supplemental payment, to 150 percent of the base Medicaid practitioner
payment, or 175 percent of the base Medicaid practitioner payment for
services provided in a HRSA-designated geographic HPSA or a Medicare-
defined rural area, we believe that the proposed policy would not
diverge excessively from ACR supplemental payments that we historically
have approved. However, under the prior structure, the supplemental
payment was not related to the base Medicaid payment and could only be
increased based on changes to the commercial payer rates. Therefore, an
increase in the base Medicaid payment could not result in an increase
in a supplemental payment to eligible providers, as would be possible
under our proposal. If a state wants to increase a provider's
supplemental payment beyond the maximum amount that would be
permissible under the proposed provision, the state could increase
Medicaid base payment rates, which could enable the state to pay a
further 50 percent (or 75 percent) of the increase in FFS base payments
to eligible providers. We believe this approach is, first, consistent
with section 1902(a)(30)(A) of the Act, and, second, is sufficiently
consistent with the previously approved Medicaid ACRs amounts not to
excessively disturb total provider payments being made today under
previously approved ACR supplemental payment arrangements.
To provide an example of the application of the proposed Medicaid
practitioner supplemental payment limit, assume the state has proposed
to make a supplemental payment to a group of practitioners within an
area of the state that is not a HRSA-designated geographic HPSA or
Medicare-defined rural area. One of the qualifying providers received
total Medicaid FFS base payments for practitioner services of $100,000
and the state wishes to make a supplemental payment to that provider.
The proposed ceiling
[[Page 63764]]
methodology results in the following calculation: $100,000 total
Medicaid base payments x 0.50 = $50,000, which could allow the state to
make a Medicaid practitioner supplemental payment to the provider of up
to $50,000, in addition to the Medicaid FFS base payment of $100,000,
for a total payment to the provider of up to $150,000. However, if the
Medicaid practitioner supplemental payment were made to a provider for
services furnished in one of the HRSA-designated geographic HPSAs or a
Medicare-defined rural area, the supplemental payment ceiling would be
75 percent of the total base payment amount of $100,000, which would
result in the following ceiling calculation: $100,000 total Medicaid
base payment x 0.75 = $75,000, which could allow the state to make a
Medicaid practitioner supplemental payment of up to $75,000, in
addition to the Medicaid FFS base payment of $100,000, for a total
payment to the provider of up to $175,000.
In this proposed rule, we propose definitions of the terms ``base
payment'' and ``supplemental payment'' in Sec. 447.286. Per those
proposed definitions, we consider Medicaid practitioner supplemental
payments as ``supplemental'' payments under the proposed definitions.
The reason is that the base payments are payments made to a provider
for specific services provided to an individual beneficiary. While
Medicaid practitioner supplemental payments could be tied to individual
services, the calculation of the final payment amount is not dependent
upon specific services furnished to any individual beneficiary, or any
beneficiary's acuity or complexity of care received, nor is the
practitioner supplemental payment made only for complex cases. Base
payments for all practitioner services furnished by the eligible
provider are supplemented by the supplemental payment, regardless of
the level of beneficiary acuity or complexity (as typically would be
relevant to payment adjustments or add-ons that would be considered
part of the base payment). The eligible provider qualifies for these
payments based on state-developed criteria that target certain
providers, and the supplemental payments are often paid as lump sum at
the end of a quarter or at the end of year.
In proposing these requirements, we are seeking to establish an
appropriate and auditable upper bound to better ensure that
practitioner payments are consistent with economy and efficiency by
ensuring the supplemental payments have a reasonable relationship to
the base rate methodologies that have been approved by CMS on the basis
of our determination that such base rate methodologies are consistent
with statutory requirements. The ACR supplemental payments historically
have been established based on the negotiating power of various actors
in the private market and without regard to the unique circumstances of
the Medicaid program, including statutory requirements to ensure
efficiency and economy. That is, higher reported commercial payment
rates are a function of practitioners' ability to negotiate higher
rates from certain commercial payers, rather than a result of
prevailing rates generally paid to practitioners by all commercial
payers, or all payers generally, and without any necessary analysis of
economy and efficiency.
In contrast, the proposed provisions intend to tie the highest
practitioner payments in the state to the lowest (that is, payments to
practitioners that are limited to the state plan FFS base payment).
States have already determined and declared as part of their rate-
setting processes that base payments are consistent with economy and
efficiency, quality of care, and access to care requirements, as
required under section 1902(a)(30)(A) of the Act. Therefore, we believe
that setting the upper limit for targeted practitioner supplemental
payments at 50 percent or 75 percent more than the base amounts is
reasonably sufficient to allow states with flexibility, when needed, to
target payment increases while providing a basis to gauge that payments
are consistent with efficiency, economy, and quality of care and are
sufficient to enlist enough providers so that care and services are
available under the plan at least to the extent that such care and
services are available to the general population in the geographic
area. State payments must meet both tests of section 1902(a)(30)(A) of
the Act in that a base payment may be economic and efficient, but if it
is not sufficient to enlist sufficient providers in a particular area
of the state, then an increase in payments may be needed to ensure that
the rates are sufficient to enlist adequate numbers of providers in the
Medicaid program. Further, this proposed policy may encourage states to
evaluate whether Medicaid payment rates are generally consistent with
section 1902(a)(30)(A) of the Act across all practitioners within a
geographic region and evaluate whether rate increases for all
practitioners may be necessary to improve access or quality, rather
than targeting payments to certain practitioners that may be in a
position to provide the non-federal share in exchange for supplemental
payments.
Our concerns over the growing scope of practitioner supplemental
payments relate to both the payment amounts relative to Medicare rates
and the practitioners to which the states are providing the payments,
which appears to be largely driven by the source of non-federal share
used to fund the payments. As states typically rely on the providers
that receive the supplemental payments to fund the non-federal share
through IGTs, there is less incentive for the states to properly
oversee the payments and ensure that the amounts are economic and
efficient. Typically when states use appropriated funds as the source
of non-federal share there is a meaningful state interest in ensuring
value to maintain state budgets; however, when the non-federal share is
provided by the service provider (and returned with matched federal
funds through the supplemental payments) there is an inherent incentive
to maximize the amount of the payments to providers in the state. In
almost all instances, the providers were supplying the state with the
non-federal share of the Medicaid physician supplemental payments.
Without the supplemental payments, it is likely that the arrangements
through which the providers have been transferring the state share to
the state Medicaid agency to support current high levels of Medicaid
practitioner supplemental payments would cease, and therefore, the net
impact on the providers would be far less than the projected amount of
decrease in practitioner supplemental payments.
The incentive to maximize federal funds to providers and lack of
oversight interest from states is particularly problematic in the case
of practitioner supplemental payments because of the data sources used
for ACR demonstrations. The data currently used to determine
supplemental payment amounts is based entirely on proprietary
commercial payment data supplied by the practitioners who themselves
stand to benefit from the supplemental payment. In our reviews, we have
not been able to verify that the commercial payment data is correct or
genuinely representative of rates that the commercial market will bear.
We have also found, in several instances, that the data has been
manipulated to increase the potential supplemental payments by, for
instance, using comparisons to Medicaid rates paid for services within
facilities (which are generally lower than office settings) compared to
non-facility commercial rates, or by
[[Page 63765]]
foregoing appropriate adjustments to ensure that the time and
associated payments for procedures are equivalent for Medicaid and
commercial data. Since the data within the ACR demonstrations are
produced by providers (and masked to protect proprietary information),
the demonstrations are impossible to validate, difficult to interpret
and ultimately may not be auditable in accordance with Sec. 430.33. By
setting a limit based on Medicaid-based rates, as proposed under this
rule, data is readily available within state and CMS claims systems to
validate and audit the supplemental payment amounts.
We recognize that states that are already making ACR-based
supplemental payments may need time to come into compliance with the
proposed new limits, if they are finalized. For states whose state
plans currently provide for Medicaid practitioner supplemental
payments, we are proposing in Sec. 447.406(d) to provide a transition
period consistent with the one defined in Sec. 447.302(d) for the
state to submit a SPA to bring its currently approved Medicaid
supplemental practitioner payment program into compliance with the
requirements proposed in this section, including the cross-referenced
requirements in Sec. 447.302. Specifically, we propose that, for
Medicaid practitioner supplemental payments that were approved on or
before the effective date of any final rule, the state would be
required to submit and obtain CMS approval for a SPA to comply with the
requirements of this section in order to continue making such
supplemental payments. Otherwise, the authority for state plan
provisions that authorize the Medicaid practitioner supplemental
payments that are approved as of the effective date of any final rule
would be limited according to the timeframe described in Sec.
447.302(d). By the end of the transition period, a state without an
approved SPA bringing the Medicaid practitioner supplemental payment
program into compliance with the requirements of this section (and, as
incorporated by cross reference, of Sec. 447.302) would not be
authorized to continue making the supplemental payments. We believe
this approach to a transition period would help minimize burden on
states, as states with Medicaid practitioner supplemental payment
programs would have a generous period of time to bring their state
plans into compliance with the proposed new requirements. Additionally,
we propose that states would no longer be required to submit annual ACR
demonstrations for the annual UPL submission requirements outlined in
the SMDL 13-003 for states that make targeted physician supplemental
payments for physician services, further reducing the associated state
burden. Instead, CMS expects that the state plan would include a
comprehensive written statement of the Medicaid FFS base payment and
Medicaid practitioner supplemental payment methodologies, in a manner
consistent with Sec. Sec. 447.302, 447.406, and all other applicable
requirements.
We are seeking comment on all elements of this proposal, including
the level of the proposed ceiling percentages (and whether they should
be higher or lower), the option of using the Medicare rural areas and/
or HRSA-designated geographic HPSA to target eligible providers for
supplemental payments, the language regarding value-based payment
methodologies, and whether there would be other appropriate means to
give states flexibility to offer special consideration for providers in
underserved areas.
24. Definitions (Sec. 455.301)
We are proposing to revise the definition of the ``independent
certified audit'' to include the requirement for auditors to quantify
the financial impact of each audit finding, or caveat, on an individual
basis, for each hospital, per the reporting requirement in Sec.
447.299(c)(21) and under section 1923(j)(1)(B) of the Act.
Additionally, we propose to include in the definition how a
certification of the audit would include a determination of whether or
not the state made DSH payments that exceeded any hospital's specific
DSH limit in the Medicaid state plan rate year under audit.
Specifically, we are proposing to add to annual DSH reporting a
requirement for auditors to quantify the financial impact of any
finding, including those resulting from incomplete or missing data,
which may affect whether each hospital has received DSH payments for
which it is eligible within its hospital-specific DSH limit. As
previously discussed, based on the audit results we are often unable to
determine whether a DSH overpayment to a provider has occurred, the
underlying causes of the overpayments, and the amount of the
overpayments associated with each cause. This is the result of an
auditor including an audit finding indicating that the missing
information may have an impact on the calculation of total eligible
uncompensated care costs while not making a determination of the actual
financial impact of the identified issue. As a result of this lack of
quantification of the financial impact of this finding, we are unable
to determine whether an overpayment, if any, has resulted from this
audit finding. As such, revising the definition is necessary in
promoting oversight and integrity of the DSH program and ensuring the
audit and report results allow us to calculate accurate hospital-
specific limits. We are soliciting comments related to this proposed
change.
25. Process and Calculation of State Allotments for Fiscal Year After
FY 2008 (Sec. 457.609)
We are using the opportunity within this regulation to revise the
method for notifying states and the public of national CHIP allotments.
Section 2104 of the Act provides appropriations for fiscal year CHIP
allotments for FYs 1998-2027 as determined under the methodologies
provided in sections 2104(b), 2104(c), and 2104(m) of the Act as
applicable for payments to states as described in section 2105 of the
Act. Section 457.609 describes the process and calculation of state
allotments for a fiscal year after FY 2008. Section 457.609(h) provides
that CHIP Allotments for a fiscal year may be published as preliminary
or final allotments in the Federal Register as determined by the
Secretary. We have not published CHIP allotments in the Federal
Register since the FY 2013 CHIP allotments. Each year following FY
2013, states have been notified of their CHIP allotments through either
email notifications and/or through MBES/CBES. We propose to remove from
Sec. 457.609 the reference to our discretionary option to publish in
the Federal Register the national CHIP allotment amounts as determined
on an annual basis for the fiscal years specified in statute. Instead,
we are proposing to post CHIP allotments in the Medicaid and CHIP
Budget and Expenditure System (MBES/CBES) and at Medicaid.gov (or
similar successor systems or websites) annually. We believe that
posting the CHIP allotment amounts at Medicaid.gov and in the MBES/CBES
is an efficient way to make the information more easily accessible to
interested stakeholders and would be less administratively burdensome
for CMS. We are soliciting any comments related to these proposed
changes.
III. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We would consider all comments we receive
by the date and time specified in the DATES section of
[[Page 63766]]
this preamble, and, when we proceed with a subsequent document, we
would respond to the comments in the preamble to that document.
IV. Collection of Information Requirements
Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501 et
seq.), we are required to publish a 60-day notice in the Federal
Register and solicit public comment before a ``collection of
information'' requirement is submitted to the Office of Management and
Budget (OMB) for review and approval. For the purposes of the PRA and
this section of the preamble, collection of information is defined
under 5 CFR 1320.3(c) of the PRA's implementing regulations.
To fairly evaluate whether an information collection should be
approved by OMB, PRA section 3506(c)(2)(A) requires that we solicit
comment on the following issues:
The need for the information collection and its usefulness
in carrying out the proper functions of our agency.
The accuracy of our burden estimates.
The quality, utility, and clarity of the information to be
collected.
Our effort to minimize the information collection burden
on the affected public, including the use of automated collection
techniques.
We are soliciting public comment on each of the section
3506(c)(2)(A)-required issues for the following information collection
requirements (ICRs).
A. Wage Estimates
To derive average costs, we used data from the U.S. Bureau of Labor
Statistics' May 2018 National Occupational Employment and Wage
Estimates for all salary estimates (https://www.bls.gov/oes/current/oes_nat.htm). In this regard, Table 1 presents the mean hourly wage,
the cost of fringe benefits and overhead (calculated at 100 percent of
salary), and the adjusted hourly wage.
Table 1--National Occupational Employment and Wage Estimates
----------------------------------------------------------------------------------------------------------------
Fringe
Occupation Mean hourly benefits and Adjusted
Occupation title code wage ($/hr) overhead ($/ hourly wage ($/
hr) hr)
----------------------------------------------------------------------------------------------------------------
Accountants and auditors........................ 13-2011 37.89 37.89 75.78
Data Entry Keyers............................... 43-9021 16.22 16.22 32.44
Financial Specialist all other.................. 13-2099 37.30 37.30 74.60
General and Operations Managers................. 11-1021 59.56 59.56 119.12
Healthcare Support Workers all other............ 31-9099 18.80 18.80 37.60
Managers all other.............................. 11-9199 55.57 55.57 111.14
Social Science Research Assistants.............. 19-4061 24.24 24.24 48.48
----------------------------------------------------------------------------------------------------------------
As indicated, we are adjusting our employee hourly wage estimates
by a factor of 100 percent. This is necessarily a rough adjustment,
both because fringe benefits and overhead costs vary significantly from
employer to employer, and because methods of estimating these costs
vary widely from study to study. Nonetheless, we believe that doubling
the hourly wage to estimate total cost is a reasonably accurate
estimation method.
B. Proposed Information Collection Requirements (ICRs)
The following regulatory sections of this rule contain proposed
collection of information requirements (or ``ICRs'') that are subject
to OMB approval under the authority of the PRA: Sec. Sec. 433.72
(Waiver provision applicable to health care related taxes), 447.252 and
447.302 (State plan requirements), 447.288 (Reporting requirements for
UPL demonstrations and supplemental payments), and 447.299 (DSH
reporting requirements). Our analysis of the proposed requirements and
burden follow.
1. ICRs Regarding Tax Waiver Requirements (Sec. 443.72)
The following proposed changes will be submitted to OMB for
approval under control number 0938-0618 (CMS-R-148). Subject to
renewal, the control number is currently set to expire on February 28,
2021. It was last approved on February 9, 2018, and remains active.
Section 433.72 of this rule proposes to add a period of validity
for tax waivers of the broad-based and/or uniformity requirements,
which states that waivers will cease to be effective 3 years from CMS'
approval in the case of tax programs commencing on or after the rule's
effective date or 3 years from the rule's effective date in the case of
waivers approved before the rule's effective date. This change is
necessary because the provider data submitted by states to CMS, for use
in the statistical tests described at Sec. 433.68, may change over
time. As a result, the tax may be generally redistributive as required
by statute and regulation when the state requests the waiver, but may
subsequently cease to be so. Currently there are approximately 35
states that have broad based or uniformity waivers. We propose to allow
states with existing health care-related tax waivers up to 3-years from
the effective date of the final rule before they must seek re-approval.
This will provide states sufficient time to evaluate and, if necessary,
modify existing tax programs.
The ongoing burden associated with the proposed requirements
consists of the time it would take each state that has an existing tax
waiver to submit an updated version within 3-years after the effective
date of the final rule and to update the waiver every 3 years. Of the
35 states with tax waivers, we estimate that there are approximately 60
tax waivers that will have to be renewed every 3 years, or about 20 tax
waivers renewed per year by various states (0.4 tax waiver renewals per
year per state). Please note that the proposed waiver requirements are
minimal, as states are already required to monitor and update their tax
waivers to ensure compliance with federal requirements.
We estimate it would take 2 hours at $37.60/hr for a healthcare
support worker to prepare and submit an updated tax waiver. In
aggregate we estimate an ongoing annual burden of 40 hours (20 tax
waiver renewals per year x 2 hr/renewal) at a cost of $1,504 (40 hr x
$37.60/hr) or $30 per state ($1,504/51).
2. ICRs Regarding State Plan Requirements (Sec. Sec. 447.252 and
447.302)
The following proposed changes will be submitted to OMB for
approval under control number 0938-0193 (CMS-179). Subject to renewal,
the control number is currently set to expire on April 30, 2022. It was
last approved on April 9, 2019, and remains active.
[[Page 63767]]
The proposed changes to Sec. Sec. 447.252 and 447.302 would
require that states provide additional descriptors for any proposed
supplemental payments and would put a 3-year limit on the duration of
all prospectively approved supplemental payments, with a transition
period for states to seek renewal of currently approved supplemental
payments in accordance with the proposed requirements, if the state
desires to continue the supplemental payment. States would need to
provide the additional descriptors to receive state plan authority to
disburse their proposed supplemental payments. Consequently, currently
approved supplemental payment-related SPAs would have to be updated by
adding the descriptors, as outlined in section II.A.13. of this
proposed rule, state plan requirements (Sec. 447.252), and in Sec.
447.252(d) of the regulatory text. Supplemental payments are presently
authorized through the SPA process with CMS.
The ongoing burden associated with the proposed requirements
consists of the time it would take each of the 50 state Medicaid
programs, the District of Columbia, and the territories Puerto Rico, US
Virgin Islands, and Guam (hereinafter, ``states'') to specify six (6)
descriptors for all applicable SPAs that provide or would provide for a
supplemental payment. The territories the Commonwealth of the Northern
Mariana Islands (CNMI) and American Samoa have been excluded to the
extent that Medicaid services are provided under section 1902(j)
waiver. The additional SPA descriptors include: (1) An explanation of
how the state plan or SPA will result in payments that are consistent
with section 1902(a)(30)(A) of the Act; (2) the criteria to determine
which providers are eligible to receive the supplemental payment; (3) a
comprehensive description of the methodology used to calculate the
amount of, and distribute, the supplemental payment to each eligible
provider, including all of the following: The amount of the
supplemental payment made to each eligible provider, if known, or, if
the total amount is distributed using a formula based on data from one
or more fiscal years, the total amount of the supplemental payments for
the fiscal year or years available to all providers eligible to receive
a supplemental payment, if applicable, the specific criteria with
respect to Medicaid service, utilization, or cost data from the
proposed SPA year to be used as the basis for calculations regarding
the amount and/or distribution of the supplemental payment, the timing
of the supplemental payment to each eligible provider, an assurance
that the total Medicaid payment to an inpatient hospital provider,
including the supplemental payment, will not exceed the upper limits
specified in Sec. 447.271, and if not already submitted, a UPL
demonstration as required by Sec. 447.272 and described in Sec.
447.288; (4) the duration of the supplemental payment authority (not to
exceed 3 years); (5) a monitoring plan to ensure that the supplemental
payment remains consistent with the requirements of section
1902(a)(30)(A) of the Act and to enable evaluation of the effects of
the supplemental payment on the Medicaid program, for example, with
respect to providers and beneficiaries; and (6) for a SPA proposing to
renew a supplemental payment for a subsequent approval period, an
evaluation of the impacts on the Medicaid program during the current or
most recent prior approval period, for example, with respect to
providers and beneficiaries, and including an analysis of the impact of
the supplemental payment on compliance with section 1902(a)(30)(A) of
the Act.
We have attempted to mitigate any new burden by identifying the
essential descriptors that are necessary during a SPA review of
proposed state supplemental payments. The more information and
transparency provided with the SPA to implement new, or renew existing,
supplemental payments will reduce the number of questions and requests
for additional information from CMS, and therefore, could result in
more expedited approval along with increased economy and efficiency of
the Medicaid program.
To estimate the overall burden of adding the descriptors to all
supplemental payment-related SPAs we considered the total nationwide
number of active supplemental payments by states reporting for the
current 8 UPL demonstration service types for the period 2015-2017 (3
years) in the proposed 6 UPL service types (see Table 2, line A): (1)
Nursing facility; (2) outpatient hospital; (3) inpatient hospital; (4)
ICF/IID; (5) IMD; and (6) physician services excluding PRTF and clinic.
As indicated, the total number of states reporting supplemental
payment methodologies in the UPL demonstrations in the Medicaid program
for the following service types are: 37 for inpatient hospital services
(IP); 29 for outpatient facility services (OP); 49 for nursing facility
services (NF); 8 for ICF/IIDs (ICF); 0 for IMDs (IMD); and 17 for
physician services (Phys). We recognize that there are often more than
one supplemental payment SPA per state for each service type,
especially for states with more providers and service types like
inpatient hospitals and nursing facilities, while IMDs have no
supplemental payments, and therefore, no SPAs to renew or submit. To
account for this we multiplied the number of states reporting each
service type by 2 (approximately 2 SPAs per year for each service type)
to estimate the total number of SPAs submitted by the states.
In this regard, the total number of SPAs is estimated to be 280
(Table 2, line B) or 5.19 (line C) per state (280 SPAs/54 states and
territories). We estimate that each SPA is renewed every 2.5 years
(half of the time required in this proposed rule), for 2.08 (5.19 SPAs
per state/1 SPA renewal every 2.5 years) SPA renewals per state per
year.
Table 2--State Reporting of Supplemental Payment Methodologies in the UPL Demonstrations
--------------------------------------------------------------------------------------------------------------------------------------------------------
UPL demonstration types IP OP NF ICF IMD Phys Total
--------------------------------------------------------------------------------------------------------------------------------------------------------
A. Supplemental Payment Methodologies reported by States..... 37 29 49 8 0 17 140
B. SPA multiplier x 2........................................ 74 58 98 16 0 34 280
C. SPAs needed to be renewed per year per state (B/54 states) 1.37 1.07 1.81 0.30 0.00 0.67 5.19
--------------------------------------------------------------------------------------------------------------------------------------------------------
We estimate it would take 30 additional minutes (0.5 hr) at $48.48/
hr for a social science research assistant (technical staff) to add all
6 supplemental payment SPA components from Sec. Sec. 447.252 and
447.302 for each SPA submission, noting that a comprehensive payment
methodology is currently required for all SPA submissions. In
aggregate, we estimate an annual burden of 56.2 hours (2.08 SPA
renewals per state per year x 0.5 hr for additional descriptors x 54
states and territories) at a cost of $2,725 (56.2 hr x $48.48/hr). This
estimate
[[Page 63768]]
factors in the burden associated with supplemental payment SPAs for the
6 service types mentioned above and summarized in Table 2. Per state,
we estimate an average annual burden of 1.0 hours (56.2 hr/54 states
and territories) at a cost of $50 ($2,725/54 states and territories).
3. ICRs Regarding Reporting for UPL Demonstrations and Supplemental
Payments (Sec. 447.288)
The following proposed changes will be submitted to OMB for
approval under control number 0938-1148 (CMS-10398 #13 and #24).
Subject to renewal, the control number is currently set to expire on
March 31, 2021. It was last approved on March 1, 2018, and remains
active.
Section 447.288 of this rule proposes to codify our current policy
of requiring states and territories to submit annual UPL
demonstrations.
While the territories Puerto Rico, US Virgin Islands, and Guam are
included in this estimate, the Commonwealth of the Northern Mariana
Islands (CNMI) and American Samoa have been excluded from this estimate
because they provide Medicaid services under section 1902(j) waivers.
The proposed rule would also add quarterly reporting requirements
(Sec. 447.288(c)(1)) that would provide data on each provider
receiving a supplemental payment, the amount of payment(s), and the
state plan/demonstration authority authorizing the payment. The
proposed rule would also require an aggregate report (Sec.
447.288(c)(2)) of all providers receiving supplemental payments that
totals all of the supplemental payments providers receive during the
year plus all Medicaid payments, and Medicaid utilization data. Lastly,
the rule would also require a report (Sec. 447.288(c)(3)) of all of
those providers contributing to the state's non-federal share for any
supplemental payment, the state plan/demonstration authority
authorizing the payment, and the amount of the payment(s).
(1) UPL Demonstrations
The currently approved burden associated with the requirements we
are revising and putting into regulation in this proposed rule,
consists of the time it would take each of the 56 Medicaid programs (50
states, 5 territories, and the District of Columbia) to submit annual
UPL demonstrations and report supplemental payments for: Inpatient
hospital; outpatient hospital; nursing facilities; PRTF; clinic
services; other inpatient & outpatient facility providers (commonly
known as physician services); ICF/IID; and institutions for mental
disease (IMD) on the currently approved (hereinafter, ``active'') UPL
templates that are set out under CMS-10398 #13 and #24.
This proposed rule would reduce burden by eliminating the UPL
demonstrations for three service types PRTF, clinic services, and other
inpatient & outpatient facility providers (physician services) and by
eliminating 2 territories from reporting any of the items required
under Sec. 447.288. It also proposes to codify the requirements for
states to annually report UPL demonstrations as discussed in SMDL #13-
003 (March 18, 2013),\11\ which was associated with OMB approved
templates (OMB Control Number 0938-1148) and collection of information
requirements approved by OMB under control number 0938-1148 (CMS-10398
#13 and 24).
---------------------------------------------------------------------------
\11\ Center for Medicaid and CHIP Services, RE: Federal and
State Oversight of Medicaid Expenditures, State Medicaid Director's
letter SMD #13-003, accessed 4/9/2019: https://www.medicaid.gov/Federal-Policy-Guidance/Downloads/SMD-13-003-02.pdf.
---------------------------------------------------------------------------
For CMS-10398 #13 (Medicaid Accountability--Nursing Facility,
Outpatient Hospital and Inpatient Hospital Upper Payment Limits)
eliminating 2 territories from this reporting would reduce our active
burden estimates by -80 hours (40 hr/response x -2 responses) for a
burden reduction of $3,057 ([30 hr x -2 responses x $32.44/hr for a
data entry keyer] + [9 hr x -2 responses x $48.48/hr for a social
science research assistant] + [1 hr x -2 responses x $119.12/hr for a
general and operations manager]).
For CMS-10398 #24 (Medicaid Accountability--Upper Payment Limits
ICF/IID, Clinic Services, Medicaid Qualified Practitioner Services and
Other Inpatient & Outpatient Facility Providers) this would reduce our
active burden by -80 hours (40 hr/response x -2 responses) at a cost of
-$3,057 ([30 hr x -2 responses x $32.44/hr for a data entry keyer] + [9
hr x -2 responses x $48.48/hr for a social science research assistant]
+ [1 hr x -2 responses x $119.12/hr for a general and operations
manager]).
For CMS-10398 #24 this rule would also reduce our active burden by
eliminating 3 of the 5 UPL demonstrations for the service types PRTF,
Clinic Services, and Medicaid Qualified Practitioner Services and Other
Inpatient & Outpatient Facility Providers (commonly referred to as the
physician ACR). This would reduce our active burden estimates by -1,296
hours (8 hr/response x 3 service types x 54 states) for a savings of
$49,528 ([18 hr x -54 states x $32.44/hr for a data entry keyer] + [5.4
hr x -54 states x $48.48/hr for a social science research assistant] +
[0.6 hr x -54 states x $119.12/hr for a general and operations
manager]). This proposed action would thereby eliminate the PRTF,
Clinic Services, and Medicaid Qualified Practitioner Services and Other
Inpatient & Outpatient Facility Providers (commonly referred to as
physician ACR) templates along with the guidance and instruction
documents that are associated with the templates.
As indicated, the proposed burden changes will be submitted to OMB
for approval under control number 0938-1148 (CMS-10398 #13 and #24).
Since the proposed requirements impact two information collection
requests (#13 and #24), we estimate a total burden reduction of -1,456
hours (-80 hr -80 hr -1,296 hr) for a savings of $55,642 (-$3,057 -
$3,057 -$49,528).
(2) Quarterly Reporting of Expenditures Claimed for Each Supplemental
Payment (Sec. 447.288(c)(1))
In addition to the data already collected in the aggregate for all
supplemental payments and required annually for UPL demonstrations
under the CMS-10398 #13 and #24, this proposed rule would require that
states report information quarterly on expenditures claimed for each
supplemental payment made under state plan or demonstration authority
including: (1) The SPA transaction number or demonstration authority
number which authorizes the payment; (2) a listing of each provider
that received a payment under each authority by the specialty type (if
applicable, for example, CAH, pediatric hospital, or teaching
hospital); (3) the specific amount of the supplemental payment paid to
each provider including the total payment made to the provider
authorized under the specified state plan; and (4) the total Medicaid
payment made to the provider under the specified demonstration
authority.
This rule would add quarterly data reported to CMS in the form of 5
new templates mirroring the UPL demonstrations reporting by service
type of the provider. For CMS-10398 #13, this would consist of
quarterly report templates for: Nursing facilities, outpatient
hospitals, and inpatient hospitals. For CMS-10398 #24, quarterly report
templates would be added for: ICF/IID and IMD.
The quarterly reports would be required at the time the state
submits its quarterly CMS-64 (OMB control number 0938-1265) pursuant to
Sec. 430.30(c), consisting of provider level information on all
providers receiving supplemental payments, including 11
[[Page 63769]]
data elements consisting of 8 demographic elements and 3 elements
specific to supplemental payments (see (Sec. 447.288(c)(1))). The 8
demographic elements of each provider that received a supplemental
payment under each authority consist of: (1) The provider's legal name;
(2) the physical address of the location or facility where services are
provided, including street address, city, state, and ZIP code; (3) the
NPI; (4) the Medicaid identification number; (5) the EIN; (6) the
service type for which the reported payment was made;(7) the provider
specialty type (if applicable, for example, CAH, pediatric hospital, or
teaching hospital); and (8) the provider category (that is, state
government, non-state government, or private). The 3 supplemental
payment elements for payments paid to each provider consist of the
specific amount of the supplemental payment made to the provider,
including: (1) SPA transaction number or demonstration authority number
which authorizes the supplemental payment; (2) the total supplemental
payment made to the provider authorized under the specified state plan;
(3) the total Medicaid supplemental payment made to the provider under
the specified demonstration authority, as applicable.
For the supplemental payment quarterly reports, annually we
estimate it will take 20 seconds at $32.44/hr for a data entry keyer to
query states' MMIS system and/or copy and paste each data element into
the required format for reporting. The initial quarterly report would
require the full set of 11 data elements for each provider receiving a
supplemental payment with a burden of 449 hours (7,341 providers with
supplemental payments x 11 data elements x 1 report/year x 20 seconds/
3,600 seconds in an hour) and a cost of $14,566 (449 hr x $32.44/hr).
The three (3) subsequent quarterly reports would only require
reporting of the three (3) supplemental payment data elements since the
eight (8) demographic data elements would have already been reported in
the initial quarterly report. The burden associated with the subsequent
reports consists of 367 hours (7,341 providers with supplemental
payment x 3 data elements x 3 reports/year x 20 seconds/3,600) at a
cost of $11,906 (367 hr x $32.44/hr).
In aggregate, we estimate a burden of 816 hours (449 hr + 367 hr)
at a cost of $26,472 ($14,566 + $11,906).
We also expect oversight by social science research assistants and
general operations managers for each of the supplemental payment
quarterly reports. We estimate it would take 1 hour at $48.48/hr for a
social science research assistant and 30 minutes (0.5 hr) for a general
operations manager at $119.12/hr to review each of the reports. In this
regard we estimate an annual burden of 306 hours ([1 hr x 4 reports x
51 states] + [0.5 hr x 4 reports x 51 states]) at a cost of $22,040 ([1
hr x 4 reports x 51 states x $48.48/hr] + [0.5 hr x 4 reports x 51
states x $119.12/hr]).
Given the aforementioned burden estimates, we estimate a total of
1,140 hours (816 hr + 324 hr) at a cost of $49,797 ($26,460 + $23,337)
for all of the information collection requests with quarterly
reporting, including all 5 new templates. Per state we estimate 21.1
hours (1,140 hrs/54 states) and $922 (49,797/54 states) for all
quarterly reporting.
As indicated, the proposed requirements and burden will be
submitted to OMB for approval under control number 0938-1148 (CMS-10398
#13 and #24). Since the proposed requirements would impact two
information collection requests (CMS-10398 #13 and #24), the annual
quarterly reporting burden for each is broken down here: For CMS-10398
#13 (new quarterly report templates for inpatient hospitals, outpatient
hospitals, and nursing facilities) it is 1,108 hours (1,122 hr x 0.97
\12\) at a cost of $48,433 ($49,797 x 0.97); for CMS-10398 #24 (new
quarterly report templates for ICF/IID and IMD) the burden is 31.2
hours (1,122 hr x 0.027 \13\) at a cost of $1,363 ($49,797 x 0.027).
---------------------------------------------------------------------------
\12\ 97% of UPL providers receiving supplemental payments are
IP, OP, and NF provider types.
\13\ 2.7% of UPL providers receiving supplemental payments are
ICF and IMD provider types.
---------------------------------------------------------------------------
(3) Utilization Reporting Template and Guidance Documents (Sec.
447.288(b)(2))
Annually, the proposed reporting of the specific amount of Medicaid
payments made to each provider would include: (1) The total FFS base
payments made to the provider authorized under the state plan; (2) the
total Medicaid payments made to the provider under demonstration
authority; (3) the total payment or funds received from Medicaid
beneficiary cost-sharing requirements, donations, and any other funds
received from third parties to support the provision of Medicaid
services; (4) the total supplemental payment made to the provider
authorized under the specified state plan; (5) the total Medicaid
supplemental payment made to the provider under the specified
demonstration authority, and the total Medicaid payments made to the
provider as reported in the above areas; (6) the total DSH payments
made to the provider; and (7) the Medicaid units of care (for example,
on a provider-specific basis, total Medicaid discharges, days of care,
or any other measures as specified by the Secretary).
A utilization report by provider service type would be required
annually by states in this proposed rule, which includes all of the
providers reported in the Supplemental Payments Reporting Templates
(that is, all providers receiving supplemental payments), and reports
all base payments, DSH payments, and additional utilization data from
those providers. This Utilization Report includes all base payments
made to each provider in the state, with the addition of DSH and
Medicaid utilization data (23 data elements consisting of 9 demographic
elements previously reported in the quarterly reports, 10 new elements
specific to supplemental and other payments, and 4 new utilization
elements).
The 9 demographic elements, linked to the same 8 elements in the
quarterly reports plus 1 element stating the dates of the supplemental
payment period, all covering the same providers in each service type,
that received a supplemental payment under each authority listed in
Sec. 447.288(c)(1) including: (1) The provider's legal name; (2) the
physical address of the location or facility where services are
provided, including street address, city, state, and ZIP code; (3) the
NPI; (4) the Medicaid identification number; (5) the EIN; (6) the
service type for which the reported payment was made; (7) the provider
specialty type (if applicable, for example, CAH, pediatric hospital, or
teaching hospital); (8) the provider category (that is, state
government, non-state government, or private); and (9) the state
reporting period (state fiscal year start and end dates).
The 14 supplemental payment elements for Medicaid payments made to
each provider consist of the following, as applicable: (1) The SPA
transaction number or demonstration authority number which authorizes
the supplemental payment; The specific amount of Medicaid payments made
to each provider, including, as applicable; (2) the total FFS base
payments made to the provider authorized under the state plan; (3) the
total Medicaid payments made to the provider under demonstration
authority; (4) the total payment or funds received from Medicaid
beneficiary cost-sharing requirements; (5) the total payment or funds
received from Medicaid donations; (6) the total of any other funds
received from third parties to
[[Page 63770]]
support the provision of Medicaid services; (7) the total supplemental
payment made to the provider authorized under the specified state plan;
(8) the total Medicaid supplemental payment made to the provider under
the specified demonstration authority; (9) the total Medicaid payments
made to the provider as reported above (summation of 2-8 above); and
(10) the total DSH payments made to the provider. The 4 utilization
elements are comprised of: Up to four (11. through 14.) Medicaid unit
of care metrics (for example, on a provider-specific basis, total
Medicaid discharges, days of care, or any other measures as specified
by the Secretary).
There are a total of 14 new data elements. The eight demographic
elements and the SPA transaction number or demonstration authority
number which authorizes the supplemental payment were reported during
the previous quarterly CMS-64 reports submitted during the year, and
therefore, are not counted in the collection of information here.
For the annual utilization report we estimate it would take 20
seconds at $32.44/hr for a data entry keyer to query states' MMIS
system and/or copy and paste each data element into the required format
for reporting. The burden associated with preparing and submitting the
annual report consists of 571 hours (7,341 providers reported with
supplemental payments in the UPL demonstration x 14 new data elements x
1 report/year x 20 seconds/3,600 seconds per hour) at a cost of $18,523
(571 hr x $32.44/hr).
Additionally, we estimate oversight by social science research
assistants and general operations managers for the utilization annual
report. We estimate it would take 1.5 hours at $48.48/hr for a social
science research assistant and 1 hour at $119.12/hr for a general
operations manager to review the report. In this regard we estimate an
annual burden of 135 hours ([1.5 hr x 1 report x 54 states] + [1 hr x 1
report x 54 states]) at a cost of $10,359 ([1.5 hr x 1 report x 54
states x $48.48/hr] + [1 hr x 1 report x 54 states x $119.12/hr]).
Given the aforementioned burden estimates, we estimate a total of
706 hours (571 hr + 135 hr) at a cost of $28,882 ($18,522 + $10,359)
for all information collection for the utilization report. Per state,
this amounts to 13.1 hours (706 hrs/54 states) at a cost of $535
($28,882/54 states).
Since the proposed requirements impact two information collection
requests (CMS-10398 #13 and #24), we break down the cost to each, as
above. The burden for CMS-10398 #13 is 687 hours (706 hr x 0.97) at a
cost of $28,091 ($28,882 x 0.97). For CMS-10398 #24 the burden is 19.3
hours (706 hr x 0.027) at a cost of $791 ($28,882 x 0.027).
(4) Annual Non-Federal Share Reporting (Sec. 447.288(c)(3))
Section 447.288(c)(3), proposes to require that each state submit
an annual report of the aggregate and provider-level information on
each provider contributing to the state or any local unit of government
any funds that are used as a source of the non-federal share for any
Medicaid supplemental payment, including 17 data elements consisting
of: 8 new demographic elements; 8 new supplemental and other payment
elements; and 1 new summation element.
The 8 demographic elements of each provider that received a non-
federal share for any Medicaid supplemental payment under each
authority listed in Sec. 447.288(a) include: (1) The service type for
which the reported payment was made; (2) the provider specialty type
(if applicable, for example, CAH, pediatric hospital, or teaching
hospital) (3) the provider's legal name; (4) the physical address of
the location or facility where services are provided, including street
address, city, state, and ZIP code; (5) the NPI; (6) the Medicaid
identification number; (7) the EIN; and (8) the provider category (that
is, state government, non-state government, or private).
The 8 supplemental and other payment elements are comprised of: (1)
The total FFS base payments made to the provider authorized under the
state plan; (2) the total FFS supplemental payments made to the
provider authorized under the state plan; (3) the total Medicaid
payments made to the provider under demonstration authority; (4) the
total DSH payments made to the provider; (5) the total of each health
care-related tax collected from the provider by any state authority or
local unit of government; (6) the total of any costs certified as a CPE
by the provider; (7) the total amount contributed by the provider to
the state or a unit of local government entity in the form of an IGT;
and (8) the total of provider-related donations made by the provideror
by entities related to a health care provider, including in-cash and
in-kind donations, to the state or unit of local government, including
state university teaching hospitals.
The summation element would require: (1) The total funds
contributed by the provider (that is, CPEs, IGTs, provider taxes,
donations, and any other funds contributed) as reported under the
supplemental and other payment elements.
For the annual non-federal share report we estimate that all
providers will contribute to the non-federal share. We believe this to
be an overestimate, but this is the only estimate we have at this time
using the UPL demonstration data that we have available. We also
estimate that it would take 20 seconds at $32.44/hr for a data entry
keyer to query states' MMIS system and/or copy and paste each of the 17
data elements into the required format for reporting. The burden
associated with preparing and submitting the annual report consists of
2,666 hours (28,232 total providers x 17 data elements x 1 report/year
x 20 seconds/3,600 seconds per hour) at a cost of $86,485 (2,666 hr x
$32.44/hr).
Additionally, we estimate oversight by social science research
assistants and general operations managers for the non-federal share
annual report. We estimate it would take 4 hours at $48.48/hr for a
social science research assistant and 2 hours at $119.12/hr for a
general operations manager to review the report. In this regard we
estimate an annual burden of 324 hours ([4 hr x 1 report x 54 states] +
[2 hr x 1 report x 54 states]) at a cost of $23,337 ([4 hr x 1 report x
54 states x $48.48/hr] + [2 hr x 1 report x 54 states x $119.12/hr]).
Given the aforementioned burden estimates, we estimate a total of
2,990 hours (2,666 hr + 324 hr) at a cost of $109,833 ($86,497 +
$23,337) for all information collection requests for the non-federal
share report. Per state, this amounts to 55.4 hours (2,990 hr/54
states) at a cost of $2,034 ($109,833/54 states).
Since the proposed requirements impact two information collection
requests (CMS-10398 #13 and #24), the burden for CMS-10398 #13 is 2,617
hours (2,990 hr x 0.875 \14\) at a cost of $94,427 ($109,833 x 0.875).
For CMS-10398 #24 the burden is 373.5 hours (2,990 hr x 0.125 \15\) at
a cost of $13,717 ($109,833 x 0.13).
---------------------------------------------------------------------------
\14\ 87.5% of all UPL providers reported are IP, OP, and NF
provider types.
\15\ 12.5% of all UPL providers reported are ICF & IMD.
---------------------------------------------------------------------------
4. ICRs Regarding DSH Reporting Requirements (Sec. 447.299)
The following proposed changes will be submitted to OMB for
approval under control number 0938-0746 (CMS-R-266). Subject to
renewal, the control number is currently set to expire on April 30,
2022. It was last approved on April 9, 2019, and remains active.
Under Sec. 447.299 this proposed rule would require states to
provide an
[[Page 63771]]
additional data element as part of its annual DSH audit report. This
additional element would require a state auditor to quantify the
financial impact of any audit finding not captured within any other
data element under Sec. 447.299(c), which may affect whether each
hospital has received DSH payments for which it is eligible within its
hospital-specific DSH limit.
If the auditor is unable to determine the actual financial impact
amount of an audit finding, the auditor would be required to provide a
statement of the estimated financial impact for each audit finding
identified in the independent certified audit.
The proposed additional data element requires auditors to indicate
the financial impact of all findings rather than indicating that the
financial impact of any finding is unknown. We believe the additional
burden associated with the new data element would be minimal given that
auditors are already engaged in a focused review of available
documentation to quantify the aggregate amounts that comprise each of
the existing data elements required under Sec. 447.299(c).
The burden consists of the time it would take each of the states to
quantify any audit finding identified during the independent certified
audit required under section 1923(j)(2) of the Act. The territories
have been excluded from this proposed requirement since they do not
receive a DSH allotment under section 1923(f) of the Act.
To estimate the overall burden of adding this new data element to
the reporting requirement, we considered the number of annual
independent certified audits received by CMS in addition to the number
of unquantified audit findings.
This rule would require the submission of data in an electronic
spreadsheet format that would take approximately 2 hours, consisting
of: 1 hour at $111.14/hr for management and professional staff to
review the report and 1 hour at $74.60/hr for a financial specialist to
prepare the report. In aggregate we estimate an ongoing annual burden
of 102 hours (51 states x 2 hr/response x 1 response/year) at a cost of
$9,473 ((51 states x [(1 hr $111.14/hr) + (1 hr x $74.60/hr)] or $186
per state ($9,473/51 states). Additionaly we anticipate that a state
auditor would have to spend an additional hour quantifying the
financial impact of DSH findings that are classified as unknown. The
estimated annual burden would be 1 hour per state (51 states x 1 hour)
51 hours x 75.78/hr for auditors to complete the audit at a cost of
$3,865 per year (51 states x 1 hour x $75.78 per hour). The total cost
of this proposed rule would be $13,338 ($9,473 + $3,865) and 153 hours
or $262 per state and 3 hours per state.
C. Summary of Annual Burden Estimates for Proposed Requirements
Table 3 summarizes the burden for the aforementioned proposed
provisions
Table 3--Proposed Annual Recordkeeping and Reporting Requirements
--------------------------------------------------------------------------------------------------------------------------------------------------------
Total
Regulation section(s) under OMB control No. Responses Total Burden per annual Labor costs
title 42 of the CFR (CMS ID No.) Respondents (per state) responses response burden of Total cost ($)
(hours) (hours) reporting
--------------------------------------------------------------------------------------------------------------------------------------------------------
Sec. 443.72 tax waiver........ 0938-0618 (CMS-R- 51 0.4 20 2 40 37.60 1,504
148).
Sec. Sec. 447.252 and 447.302 0938-0193 (CMS- 54 1.9 126 0.5 63.2 48.48 3,064
179).
Sec. 447.288 UPL demo. (IP, 0938-1148 (CMS- 5 -5 -10 8 -80 varies -3,057
OP, NF). 10398 #13).
Sec. 447.288 UPL demo. (ICF, 0938-1148 (CMS- 5/51 -5/-3 -10/-162 8/8 -80/-1296 varies -3,057/-49,528
IMD). 10398 #24).
Sec. 447.288 SP quarterly 0938-1148 (CMS- 54 20 1,080 varies 1108 varies 48,433
reports (IP, OP, NF). 10398 #13).
Sec. 447.288 SP quarterly 0938-1148 (CMS- 54 20 1,080 varies 31 varies 1,363
reports (ICF, IMD). 10398 #24).
Sec. 447.288 Utilization 0938-1148 (CMS- 54 14 756 varies 687 varies 28,091
annual report (IP, OP, NF). 10398 #13).
Sec. 447.288 Utilization 0938-1148 (CMS- 54 14 756 varies 19 varies 791
annual report (ICF, IMD). 10398 #24).
Sec. 447.288 Non-federal share 0938-1148 (CMS- 54 17 918 varies 2,617 varies 94,427
annual report (IP, OP, NF). 10398 #13).
Sec. 447.288 Non-federal share 0938-1148 (CMS- 54 17 918 varies 374 varies 13,717
annual report (ICF, IMD). 10398 #24).
Sec. 447.299 DSH audit........ 0938-0746 (CMS-R- 51 1 51 3 153 varies 13,338
266).
---------------------------------------------------------------------------------------------------
Total....................... .................. varies 95 5,787 varies 3,637 varies 145,221
--------------------------------------------------------------------------------------------------------------------------------------------------------
For all parts of this proposed rule, we estimate there would be a
total nationwide burden of 3,637 hours at a cost of $145,221 and an
average of 67 hours (3,637 hr/54 states) at a cost of $2,847 per state
Medicaid agency per year ($145,221/54 states).
D. Requirements Not Subject to the PRA
The following regulatory sections propose changes to definitions,
policy guidance, and clarifications of existing statutes or regulatory
provisions. The changes do not have any collection of information
implications, and therefore, are not subject to the requirements of the
PRA: Sec. Sec. 430.42 (Disallowance of claims for FFP), 433.51 (State
share of financial participation), 433.52 (General definitions), 433.54
(Bona fide donations), 433.55 (Health care-related taxes defined),
433.56 (Classes of health care services and providers defined), 433.68
(Permissible health care-related taxes), 433.72 (Waiver provisions
applicable to health care-related taxes), 433.316 (When Discovery of
Overpayment occurs and its Significance), 447.201 (State plan
requirements), 447.207 (Retention of payments), 447.272 (Inpatient
services: Application of UPLs), 447.284 (Basis and purpose), 447.286
(Definitions), 447.290 (Failure to Report Required Information),
447.297 (Limitations on aggregate payments for DSHs beginning October
1, 1992), 447.321 (Outpatient hospital services: Application of UPLs),
455.301 (Definitions), 455.304 (Condition for FFP), and 457.609
[[Page 63772]]
(Process and calculation of state allotments for a fiscal year after FY
2008).
E. Submission of PRA-Related Comments
We have submitted a copy of this proposed rule to OMB for its
review of the rule's ICRs. The requirements are not effective until
they have been approved by OMB.
To obtain copies of the supporting statement and any related forms
for the proposed collections discussed above, please visit the CMS
website at www.cms.hhs.gov/PaperworkReductionActof1995, or call the
Reports Clearance Office at 410-786-1326.
We invite public comments on these potential ICRs. If you wish to
comment, please submit your comments electronically as specified in the
DATES and ADDRESSES section of this proposed rule and identify the rule
(CMS-2393-P) the ICR's CFR citation, and OMB control number.
V. Regulatory Impact Analysis
A. Statement of Need
This proposed rule would impact states' reporting on payment
methods and procedures to assure consistency with efficiency, economy,
and quality of care as required by section 1902(a)(30)(A) of the Act.
CMS, and other federal oversight entities, have found that current
regulations and guidance do not adequately assure that states are
complying with the efficiency, economy and quality of care requirements
of section 1902(a)(30)(A) of the Act, and this rule is intended to
address those deficiencies. We view this proposed rule as one approach
to add additional accountability and transparency for Medicaid
payments, and to provide CMS with certain information on supplemental
payments to Medicaid providers, including supplemental payments
approved under either Medicaid state plan or demonstration authority,
establish new state plan requirements for amendments proposing
supplemental payments, and otherwise ensure the proper and efficient
operation of the Medicaid state plan. This proposed rule would address
the funding of these supplemental and other Medicaid payments through
states' uses of health care-related taxes and bona fide provider-
related donations.
Medicaid DSH payments and requirements are addressed in this
proposed rule. We propose to add additional specificity to the
reporting requirements of the annual DSH audit conducted by an
independent auditor to enhance federal oversight of the Medicaid DSH
program. Additionally, we seek to improve the accurate identification
of and collection efforts related to overpayments identified through
the annual DSH independent certified audits by specifying the date of
discovery and standards for redistribution of DSH payments made to
providers in excess of the hospital-specific limit.
The proposed rule also seeks to alleviate the administrative burden
of publishing the annual DSH and CHIP allotments in the Federal
Register, of which we simultaneously notify states directly by
providing notification through other, more practical means. Finally, we
propose changes to the disallowance reconsideration procedures in order
to modernize the process by relying on an electronic, rather than a
hard-copy paper process.
B. Overall Impact
We have examined the impacts of this proposed rule as required by
Executive Order 12866 on Regulatory Planning and Review (September 30,
1993), Executive Order 13563 on Improving Regulation and Regulatory
Review (January 18, 2011), the Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96-354), section 1102(b) of the Act,
section 202 of the Unfunded Mandates Reform Act of 1995 (March 22,
1995; Pub. L. 104-4), Executive Order 13132 on Federalism (August 4,
1999), and Executive Order 13771 on Reducing Regulation and Controlling
Regulatory Costs (January 30, 2017).
Executive Orders 12866 and 13563 direct agencies to assess all
costs and benefits of available regulatory alternatives and, if
regulation is necessary, to select regulatory approaches that maximize
net benefits (including potential economic, environmental, public
health and safety effects, distributive impacts, and equity). Section
3(f) of Executive Order 12866 defines a ``significant regulatory
action'' as an action that is likely to result in a rule: (1) Having an
annual effect on the economy of $100 million or more in any 1 year, or
adversely and materially affecting a sector of the economy,
productivity, competition, jobs, the environment, public health or
safety, or state, local or tribal governments or communities (also
referred to as ``economically significant''); (2) creating a serious
inconsistency or otherwise interfering with an action taken or planned
by another agency; (3) materially altering the budgetary impacts of
entitlement grants, user fees, or loan programs or the rights and
obligations of beneficiaries thereof; or (4) raising novel legal or
policy issues arising out of legal mandates, the President's
priorities, or the principles set forth in the Executive Order.
We estimate these provisions to meet the criteria for economic
significance based upon the analysis of certain provisions in the
proposed rule, as discussed in more detail below. The proposed
reporting requirements largely contain data already available to states
in their own fiscal management and claims processing systems, and
merely requires states to report the data to us. Additional information
on setting goals for supplemental payments and evaluating the positive
and negative aspects of these goals over time, while these requirements
are consistent and necessary to ensure compliance with section
1902(a)(30)(A) of the Act, which requires payments be consistent with
efficiency, economy, and quality of care, they will require state
Medicaid programs to develop and consider various compliance options.
Moreover, the reporting requirements and supplemental payment
evaluations are generally consistent with current state oversight and
review activities of each state's Medicaid program, and states have the
flexibility within their reviews to use their existing data or build
upon that data when reviewing supplemental payments to providers, in
order to formulate goals and evaluate the effectiveness of these
payments. In fact, the policies in this proposed rule are intended to
focus on state efforts in monitoring and overseeing data and
methodologies concerning supplemental and other payments as well as
sources of non-federal share to enhance states' ability to comply with
section 1902(a)(30)(A) of the Act and our ability to ensure such
compliance.
C. Anticipated Effects
1. Effects of Reporting Requirements on State Medicaid Programs
For all parts of this proposed rule we estimate there would be a
total nationwide burden of 3,637 hours at a cost of $145,221 and an
average of 67 hours (3,637 hr/54 states) at a cost of $2,847 per state
Medicaid agency per year ($145,221/54 states) per state and District of
Columbia Medicaid agency per year (see section IV. of this proposed
rule, Collection of Information Requirements, for details on this cost
assessment and a breakdown of the burden from the various parts of this
proposed rule).
The proposed rule adds several reporting requirements, including:
[[Page 63773]]
Sec. Sec. 447.252 and 447.302, which would add goals, evaluations, and
3-year renewable authorizations on any supplemental payment
methodology, providing a transition schedule for SPAs to be updated.
Section 447.288, would add 4 quarterly reports with data on
expenditures claimed for each supplemental payment made under state
plan or demonstration authority by provider, and an annual report with
2 sections--one section with a roll up of the quarterly data with added
Medicaid utilization measures and one section with information on all
providers contributing to the state or any other governmental entity
any portion of the non-federal share of the supplemental payment and
the total of their contributions.
This regulation codifies states reporting annual UPL demonstrations
that CMS discussed in an SMDL issued on March 18, 2013 (SMDL #13-003)
regarding annual submission of Medicaid UPLs. In this proposed rule,
Sec. 447.288(a) would decrease burden by eliminating the UPL
demonstrations for three service types--PRTF, clinic services, and
other inpatient & outpatient facility providers (physician services),
note that the UPL demonstrations for the territories the Commonwealth
of the Northern Mariana Islands (CNMI) and American Samoa are excluded
from this estimate because they provide Medicaid services under section
1902(j) waivers. This OMB approved UPL demonstration (OMB Control
Number: 0938-1148, CMS-10398 (#13) (#24)) will be updated accordingly.
For Sec. 447.206 on Payments funded by CPEs made to providers that
are units of government, states would be required to develop processes
that are already used by CMS and routinely asked of states to comply
with section 1902(a)(30)(A) of the Act that requires Medicaid state
plan methods and procedures relating to the payment for services that
are consistent with efficiency, economy, and quality of care. These
collections of information are already routinely asked of states under
existing OMB control numbers, so no additional burden or economic
impact is anticipated.
2. Effects on Small Businesses and Other Providers
This rule establishes requirements that are solely the
responsibility of state Medicaid agencies, which are not small
entities. Therefore, the Secretary certifies this proposed rule would
not, if promulgated, have a significant economic impact on a
substantial number of small entities.
3. Effects on the Medicaid Program
The fiscal impact on the Medicaid program from the implementation
of the policies in the proposed rule is unknown. The provision that
would have the most direct impact on current provider payments is the
Medicaid practitioner supplemental payment requirements proposed in
Sec. 447.406. To summarize, this provision would limit Medicaid
practitioner base plus supplemental payments to 150 percent of the FFS
base payments authorized under the state plan for the practitioner
services within a defined geographic area that would otherwise be paid
to the targeted practitioners, or for services provided within HRSA-
designated geographic HPSA or Medicare-defined rural geographical
areas, Medicaid practitioner base plus supplemental payments may not
exceed 175 percent of the FFS base payments authorized under the state
plan for the practitioner services within a defined geographic area
that would otherwise be paid to the targeted practitioners.
To analyze the impact of this proposed change, CMS reviewed the
2017 Medicaid physician UPL demonstrations which were submitted by
states that make supplemental payments to physicians and other
practitioners. In 2017, 21 states made approximately $478 million in
physician supplemental payments compared with $512 million in Medicaid
FFS base payments to the practitioners eligible to receive the
supplemental payments, which equals $990 million in total payments for
the qualifying providers that received a supplemental payment. To
measure the impact, we would multiply the total Medicaid FFS base
payments ($512 million) by 150 percent which would equal $768 million
in total Medicaid FFS payments with the net Medicaid physician
supplemental payment amount of $256 million. The estimated impact of
this proposed provision is a reduction in payments of $222 million in
total computable Medicaid reimbursement ($478 million minus $256
million equals $222 million). However, this potential decrease in
Medicaid reimbursements could be mitigated if states take action to
increase Medicaid provider base payments, which would thereby increase
the amount that could be paid out in Medicaid practitioner supplemental
payments. Depending on state action in response to this provision, we
estimate that the impact on Medicaid reimbursements could range from $0
to $222 million. Similarly, we do not have sufficient data to predict
or quantify the impact of the proposed provisions on health-care
related taxes, although we would expect that states may modify existing
state tax policy or arrangements where those taxes or arrangements
would be newly be considered health-care related under the proposed
provisions. We invite comments from states, providers, and other
stakeholders on the estimates and potential state responses to these
provisions. There are some considerations that limit the effect of the
proposed change. First, the proposed rule phases out these supplemental
payments over a 5 to 7-year period based on when the supplemental
payment was last approved. The supplemental payments, as currently
approved in the plan, would begin to be incrementally removed from the
state plan after the provision is finalized. Second, Medicaid
practitioner supplemental payments would only be limited by the amount
of the Medicaid FFS base payments. If a state wanted to increase the
amount of the supplemental payment, the state would have the option
under the proposed rule to increase the base payment that is paid to
all providers within a geographic area of the state and thereby also
increase what the state could pay in supplemental payments to targeted
providers under the state plan. Third, in almost all instances, the
providers were supplying the state with the non-federal share of the
Medicaid practitioner supplemental payments. Without the supplemental
payments, it is likely that the arrangements through which the
providers have been transferring the state share to the state Medicaid
agency to support current high levels of Medicaid practitioner
supplemental payments would cease, and therefore, the net impact on the
providers would be far less than the projected amount of decrease in
practitioner supplemental payments. Finally, the projected impact does
not include any consideration for Medicaid physician base plus
supplemental payments that could be paid under the proposal in HRSA-
designated geographic HPSA or in Medicare's rural geographic areas up
to 175 percent of the Medicaid FFS base payment rate. If any of the
providers included in the state's physician UPL demonstrations are in
those areas, the net impact of the proposed change would be reduced.
We would also point out that the data obtained from the quarterly
and annual reports would support the evaluation of varying payment
streams impacting providers' services and quality and would allow for
greater oversight on supplemental payments, including
[[Page 63774]]
payments that could exceed the UPL; DSH payments; and generally provide
better fiduciary oversight of the Medicaid program.
D. Alternatives Considered
In developing this proposed rule, the following alternatives were
considered:
1. Not Proposing the Rule
We considered not proposing this rule and maintaining the status
quo. However, we believe this proposed rule would lead to better
accountability and transparency for supplemental payments. We do not
currently have the necessary data at the state and provider level to
perform adequate analysis and oversight of supplemental payments, and
this proposed rule would allow us to do so.
2. Eliminating Supplemental Payments
We considered proposing a rule that would eliminate supplemental
payments. However, this option could have been a huge burden on states
to revise payment methodologies, cost reports, and fee schedules. Also,
this option would have eliminated an important avenue for states
potentially to reward providers that show improvement in performance or
quality metrics, and to address urgent access problems that may arise.
At this time, we believe our concerns about accountability and
transparency around supplemental payments may be addressed through the
proposed policies and do not require the draconian step of eliminating
state flexibility by prohibiting such payments altogether.
3. Requiring Equal Distribution of Supplemental Payments
We considered proposing to require equal distribution of
supplemental payments to all providers of the relevant class of
services. This option would have eliminated states' ability to target
supplemental payments to one or a small number of providers, and thus
could have more closely linked supplemental payments to services
provided. However, we opted to not propose this provision at this time
as this proposal would have increased burden on state Medicaid agencies
by requiring revision of payment methodologies and tracking
supplemental payments for all providers of services within the relevant
class.
4. Requiring DSH-Like Audits of Supplemental Payments
We considered proposing to require independent certified audits of
all Medicaid supplemental payments, similar to the audit requirement
for all DSH payments. Under this alternative, for states to receive FFP
for supplemental payments, an independent certified audit would be
required to verify that all supplemental payments were appropriate.
However, we decided not to propose this alternative at this time, due
to the need for more and better data to understand the complex nature
of supplemental payments so that we may better understand the
particular audit structure and requirements needed to effectively
monitor supplemental payment programs.
5. Mandating a Provider-Specific UPL
We considered proposing a provider-specific UPL for certain
services. However, imposing such a provision at this time could have
disrupted current public financing methods and would also have imposed
a burden on states to revise longstanding payment methodologies.
6. Setting 5-Year Renewable Authorizations for Supplemental Payments
and a 5-Year Compliance Transition Period
Another alternative we considered was to propose 5-year renewable
authorizations for supplemental payments, instead of the proposed 3-
year renewable authorizations. The 5-year renewal period for
supplemental payments would have decreased administrative burden on
both the states and federal government, as opposed to the 3-year
renewal period, as we would expect to see less frequent SPA re-
submissions and CMS SPA reviews, respectively; in our judgment, the
effort spent on reviewing, evaluating, and working with states to
improve supplemental payment SPAs is a worthwhile effort toward the end
of more fiscal accountability in the Medicaid program. Also, the 3-year
renewal period is consistent with the 3-year approval period for
health-care related tax waivers proposed in Sec. 433.72 of this
proposed rule.
We also considered proposing a 5-year compliance transition period
instead of the proposed 3-year compliance transition period in
Sec. Sec. 447.252(e) and 447.302(d). This would have increased the
amount of time states would have to bring existing, approved
supplemental payment methodologies into compliance with the provisions
of the proposed rule in these two sections. We decided to propose a 3-
year transition period to account for states where changes may require
legislative action as some legislatures meet on a biennial basis, and
therefore, would make compliance with a 3-year transition period
compatible. We are requesting comment on whether or not to pursue an
expanded transition period of 5 years instead of the proposed 3-year
transition period.
7. Setting 5-Year or 1-Year Deadline for Tax Waiver Renewals
We considered proposing 5 years, or 1 year, as the length of the
approval period for tax waivers before states would need to submit
another request. However, we settled on 3 years because we believe that
it would help ensure fiscal accountability and the fiscal integrity of
the Medicaid program by ensuring that provider data for the classes to
be taxed is up to date, while at the same time avoiding undue
regulatory burden on states.
8. Requiring Both the P1/P2 and the B1/B2 Tests for Non-Uniform Health
Care-Related Taxes
In evaluating how to eliminate tax structures that are problematic
because they place an undue burden on the Medicaid program, we
considered requiring the P1/P2 statistical test in Sec. 433.68(e)(1)
in addition to the B1/B2 statistical test in Sec. 433.68(e)(2), for
states requesting a waiver of the uniformity requirement (whether or
not the state is also requesting a waiver of the broad-based
requirement). Under this alternative, a state that requests a waiver of
the uniformity requirement would need to have its tax pass both the P1/
P2 test in addition to the B1/B2 test currently required. We believe
that this statistical test could serve as a broad tool to prohibit tax
structures that would inappropriately burden the Medicaid program in
ways not explicitly prohibited in current regulation. However, we
decided against this approach to balance preserving an appropriate
degree of flexibility for states in designing tax programs with
ensuring that state taxes are not imposed primarily on Medicaid
providers and services. We believe that the categorical prohibitions
against tax structures that unduly burden Medicaid which we are
proposing to add in Sec. 433.68(e)(3) offer sufficient protection to
the financial health of the title XIX program.
In addition, we considered proposing a list of acceptable
commonalities that states could permissibly use to define taxpayer
groups. However, we believe that this could be overly restrictive to
states and impede their flexibility to structure their tax programs in
ways that suit local circumstances while still complying with all
applicable federal requirements. We are soliciting comment on
additional prohibitions
[[Page 63775]]
against unduly burdening the Medicaid program that might also be added
to this section to avoid such arrangements.
9. Audit Requirement To Quantify Financial Impact of Audit Findings
We considered proposing to require auditors to clarify the impact
of audit findings and caveats within the existing data element report
by incorporating finding amounts into existing data elements (for
example, Total Medicaid Uncompensated Care). However, this option may
not enable auditors to effectively capture financial impacts of
specific issues and such finding might not be readily transparent to
states, CMS, and hospitals; therefore, we opted to include this as an
additional data element on the DSH report.
10. Clarifying the Discovery Date for DSH Overpayments and
Redistribution Requirements
We considered proposing to use the date that the auditor submits
the independent certified audit to the state as the date of discovery
for DSH overpayments identified through the independent certified
audit, but ultimately decided to consider the date that a state submits
the independent certified audit to CMS as the discovery date. The
earlier date would start the clock for state repayment of FFP without
regard to possible work that may need to occur between states and
auditors to finalize the audit and associated reporting prior to
submission to CMS.
11. Technical Changes to Publishing DSH and CHIP Allotments
We considered continuing the requirement to publish the DSH and
CHIP allotments in the Federal Register. However, we believe this is
unnecessary as states are already informed regarding their annual DSH
and CHIP allotments prior to the publication of the Federal Register
notice that we now provide and, in our experience, we have not received
public comment regarding the notice.
12. Accounting Statement
As required by OMB Circular A-4 (available at https://www.whitehouse.gov/omb/circulars_a004_a-4), we have prepared an
accounting statement in Table 1 showing the classifaction of the
transfers associated with the provisions of this proposed rule.
Table 1--Accounting Statement: Classification of Estimated Transfers
[$ In millions]
----------------------------------------------------------------------------------------------------------------
Units
-----------------------------------------------
Category Lower bound Upper bound Discount rate Period
Year dollars (%) covered
----------------------------------------------------------------------------------------------------------------
Transfers.......................
-------------------------------------------------------------------------------
Annualized Monetized reductions 0 -222 2017 7 2020
in Costs.......................
0 -222 2017 3 2020
rrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrrr
From Whom to Whom............... Medicaid to Medicaid Providers.
----------------------------------------------------------------------------------------------------------------
The RFA requires agencies to analyze options for regulatory relief
of small entities, if a rule has a significant impact on a substantial
number of small entities. The great majority of hospitals and most
other health care providers and suppliers are small entities, either by
being nonprofit organizations or by meeting the SBA definition of a
small business (having revenues of less than $8.0 million to $41.5
million in any one year). Individuals and states are not included in
the definition of a small entity. As its measure of significant
economic impact on a substantial number of small entities, HHS uses a
change in revenue of more than 3 to 5 percent. We do not believe that
this threshold will be reached by the provisions in this proposed rule.
In addition, section 1102(b) of the Act requires us to prepare a
regulatory impact analysis if a rule may have a significant impact on
the operations of a substantial number of small rural hospitals. This
analysis must conform to the provisions of section 603 of the RFA. For
purposes of section 1102(b) of the Act, we define a small rural
hospital as a hospital that is located outside of a metropolitan
statistical area and has fewer than 100 beds. This rule will not have a
significant impact on the operations of a substantial number of small
rural hospitals.
Section 202 of the Unfunded Mandates Reform Act of 1995 (UMRA) also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any 1 year of $100
million in 1995 dollars, updated annually for inflation. In 2018, that
threshold is approximately $150 million. This rule does not contain
mandates that will impose spending costs on state, local, or tribal
governments in the aggregate, or by the private sector, in excess of
the threshold.
Executive Order 13132 establishes certain requirements that an
agency must meet when it issues a proposed rule that imposes
substantial direct requirement costs on state and local governments,
preempts state law, or otherwise has Federalism implications. This rule
does not impose substantial direct costs on state or local governments
or preempt state law.
Executive Order 13771, titled Reducing Regulation and Controlling
Regulatory Costs, was issued on January 30, 2017, requires that the
costs associated with significant new regulations ``to the extent
permitted by law, be offset by the elimination of existing costs
associated with at least two prior regulations.'' This rule, if
promulgated, is not expected to be subject to the requirements of E.O.
13771 because it is expected to result in no more than de minimis
costs.
E. Conclusion
If the policies in this proposed rule are finalized, states would
be required to send us more detailed data on payments, including
supplemental and DSH payments, Medicaid utilization data, provider
taxes and donations, and CPEs and IGTs; implement new reviews of
supplemental payment methodologies and tax waivers and periodically
seek authorization for their renewal (if desired by the state); and
provide a narrative to be sent in along
[[Page 63776]]
with supplemental payment SPA submissions on the goals and evaluation
of the payments.
In addition, states would also be allowed to tax services of health
insurers excluding services of MCOs, as a permitted class without
experiencing a reduction in medical assistance expenditures, be
prohibited from unduly burdening Medicaid with taxes that are not
generally redistributive, and be required to renew tax waivers every 3
years, with updated provider data, or sooner if the state changes the
definitions of taxpayer groups or tax rates in a non-uniform manner.
The analysis above, together with the remainder of this preamble,
provides a regulatory impact analysis. In accordance with the
provisions of Executive Order 12866, this proposed rule was reviewed by
the Office of Management and Budget.
List of Subjects
42 CFR Part 430
Administrative practice and procedure, Grant programs-health,
Medicaid, Reporting and recordkeeping requirements.
42 CFR Part 433
Administrative practice and procedure, Child support, Claims, Grant
programs--health, Medicaid, Reporting and recordkeeping requirements.
42 CFR Part 447
Accounting, Administrative practice and procedure, Drugs, Grant
programs-health, Health facilities, Health professions, Medicaid,
Reporting and recordkeeping requirements, Rural areas.
42 CFR Part 455
Fraud, Grant programs--health, Health facilities, Health
professions, Investigations, Medicaid, Reporting and recordkeeping
requirements.
42 CFR Part 457
Administrative practice and procedure, Grant programs--health,
Health insurance, Reporting and recordkeeping requirements.
For the reasons set forth in the preamble, the Centers for Medicare
& Medicaid Services proposes to amend 42 CFR chapter IV as set forth
below:
PART 430--GRANTS TO STATES FOR MEDICAL ASSISTANCE PROGRAMS
0
1. The authority citation for part 430 is revised to read as follows:
Authority: 42 U.S.C. 1302.
0
2. Section 430.42 is amended by revising paragraphs (b)(2)(i)(A)
introductory text, (b)(2)(i)(B) and (C), (c)(3), (c)(4)(i), (c)(6), and
(d)(1) to read as follows:
Sec. 430.42 Disallowance of claims for FFP.
* * * * *
(b) * * *
(2) * * *
(i) * * *
(A) A request to the Administrator that includes the following:
* * * * *
(B) A copy of the request to the Regional Office.
(C) Send all requests for reconsideration via electronic mail
(email) or electronic system specified by the Administrator.
Submissions are considered made on the date they are received by the
Administrator via email or electronic system specified by the
Administrator.
* * * * *
(c) * * *
(3) At the Administrator's option, CMS may request from the State
any additional information or documents necessary to make a decision.
The request for additional information must be sent via email or
electronic system specified by the Administrator. Submissions are
considered made on the date they are received by the Administrator via
email or electronic system specified by the Administrator.
(4) * * *
(i) If the Administrator finds that the materials are not in
readily reviewable form or that additional information is needed, he or
she must notify the State via email or electronic system specified by
the Administrator that it has 15 business days from the date of receipt
of the notice to submit the readily reviewable or additional materials.
Notifications are considered made and received on the date they are
sent by the Administrator via email or electronic system specified by
the Administrator.
* * * * *
(6) The final written decision shall constitute final CMS
administrative action on the reconsideration and shall be (within 15
business days of the decision) sent to the State agency via email or
electronic system specified by the Secretary. Notification is
considered made on the date it is sent by the Administrator via email
or electronic system specified by the Administrator.
* * * * *
(d) * * *
(1) A State may withdraw the request for reconsideration at any
time before the notice of the reconsideration decision is made without
affecting its right to submit a notice of appeal to the Board. The
request for withdrawal must be in writing and sent to the
Administrator, with a copy to the Regional Office, via email or
electronic system specified by the Administrator. Notification of the
State's withdrawal of its request for reconsideration is considered
made on the date it is received by the Administrator via email or
electronic system specified by the Administrator.
* * * * *
PART 433--STATE FISCAL ADMINISTRATION
0
3. The authority citation for part 433 is revised to read as follows:
Authority: 42 U.S.C. 1302.
0
4. Section 433.51 is revised to read as follows:
Sec. 433.51 State share of financial participation.
(a) State or local funds may be considered as the State's share in
claiming Federal financial participation (FFP) if they meet the
conditions specified in paragraphs (b) and (c) of this section.
(b) State or local funds that may be considered as the State's
share are any of the following:
(1) State General Fund dollars appropriated by the State
legislature directly to the State or local Medicaid agency.
(2) Intergovernmental transfer of funds from units of government
within a State (including Indian tribes), derived from State or local
taxes (or funds appropriated to State university teaching hospitals),
to the State Medicaid Agency and under its administrative control,
except as provided in paragraph (d) of this section.
(3) Certified Public Expenditures, which are certified by a unit of
government within a State as representing expenditures eligible for FFP
under this section, and which meet the requirements of Sec. 447.206 of
this chapter.
(c) The State or local funds are not Federal funds, or are Federal
funds authorized by Federal law to be used to match other Federal
funds.
(d) State funds that are provided as an intergovernmental transfer
from a unit of government within a State that are contingent upon the
receipt of funds by, or are actually replaced in the accounts of, the
transferring unit of government from funds from unallowable sources,
would be considered to be a provider-related donation that is non-bona
fide under Sec. Sec. 433.52 and 433.54.
0
5. Section 433.52 is amended--
[[Page 63777]]
0
a. By adding the definitions of ``Medicaid activity'', ``Net effect'',
``Non-Medicaid activity'', and ``Parameters of a tax'' in alphabetical
order;
0
b. In the definition of ``Provider-related donation'' by revising
paragraphs (2) and (3) and adding paragraph (4); and
0
c. By adding the definition of ``Taxpayer group'' in alphabetical
order.
The additions and revision read as follows:
Sec. 433.52 General definitions.
* * * * *
Medicaid activity means any measure of the degree or amount of
health care items or services related to the Medicaid program or
utilized by Medicaid beneficiaries. Such a measure could include, but
would not necessarily be limited to, Medicaid patient bed days, the
percentage of an entity's net patient revenue attributable to Medicaid,
Medicaid utilization, units of medical equipment sold to individuals
utilizing Medicaid to pay for or supply such equipment or Medicaid
member months covered by a health plan.
Net effect means the overall impact of an arrangement, considering
the actions of all of the entities participating in the arrangement,
including all relevant financial transactions or transfers of value, in
cash or in kind, among participating entities. The net effect of an
arrangement is determined in consideration of the totality of the
circumstances, including the reasonable expectations of the
participating entities, and may include consideration of reciprocal
actions without regard to whether the arrangement or a component of the
arrangement is reduced to writing or is legally enforceable by any
entity.
Non-Medicaid activity means the degree or amount of health care
items or services not related to the Medicaid program or utilized by
Medicaid beneficiaries. Such a measure could include, but would not
necessarily be limited to, non-Medicaid patient bed days, percentage of
an entity's net patient revenue not attributable to Medicaid, the
percentage of patients not utilizing Medicaid to pay for health care
items or services, units of medical equipment sold to individuals not
utilizing Medicaid funds to pay for or supply such equipment, or non-
Medicaid member months covered by a health plan.
Parameters of a tax means the grouping of individuals, entities,
items or services, on which the State or unit of government imposes a
tax.
Provider-related donation * * *
(2) Any transfer of value where a health care provider or provider-
related entity assumes an obligation previously held by a governmental
entity and the governmental entity does not compensate the private
entity at fair market value will be considered a donation made
indirectly to the governmental entity. Such an assumption of obligation
need not rise to the level of a legally enforceable obligation to be
considered a donation, but will be considered by examining the totality
of the circumstances and judging the arrangement's net effect.
(3) When an organization receives less than 25 percent of its
revenues from providers and/or provider-related entities, its donations
will not generally be presumed to be provider-related donations. Under
these circumstances, a provider-related donation to an organization
will not be considered a donation made indirectly to the State.
However, if the donations from a provider or entities related to a
provider to an organization are subsequently determined to be indirect
donations to the State or unit of local government for administration
of the State's Medicaid program, then such donations will be considered
to be provider-related donations.
(4) When the organization receives more than 25 percent of its
revenue from donations from providers or provider-related entities, the
organization always will be considered as acting on behalf of health
care providers if it makes a donation to the State. The amount of the
organization's donation to the State, in a State fiscal year, that will
be considered to be a provider-related donation will be based on the
percentage of the organization's revenue during that period that was
received as donations from providers or provider-related entities.
Taxpayer group means one or more entities grouped together based on
one or more common characteristics for purposes of imposing a tax on a
class of items or services specified under Sec. 433.56.
0
6. Section 433.54 is amended by revising paragraph (c)(3) to read as
follows:
Sec. 433.54 Bona fide donations.
* * * * *
(c) * * *
(3) The State (or other unit of government) receiving the donation
provides for any direct or indirect payment, offset, or waiver, such
that the provision of that payment, offset, or waiver directly or
indirectly guarantees to return any portion of the donation to the
provider (or other party or parties responsible for the donation). Such
a guarantee will be found to exist where, considering the totality of
the circumstances, the net effect of an arrangement between the State
(or other unit of government) and the provider (or other party or
parties responsible for the donation) results in a reasonable
expectation that the provider, provider class, or a related entity will
receive a return of all or a portion of the donation. The net effect of
such an arrangement may result in the return of all or a portion of the
donation, regardless of whether the arrangement is reduced to writing
or is legally enforceable by any party to the arrangement.
* * * * *
0
7. Section 433.55 is amended by revising paragraph (c) to read as
follows:
Sec. 433.55 Health care-related taxes defined.
* * * * *
(c) A tax is considered to be health care-related if the tax is not
limited to health care items or services, but the treatment of
individuals or entities providing or paying for those health care items
or services is different than the tax treatment provided to individuals
or entities that are providers or payers of any health care items or
services that are not subject to the tax, or other individuals or
entities that are subject to the tax. In determining whether
differential treatment exists, consideration will be given to the
parameters of the tax, as well as the totality of the circumstances
relevant to which individuals, entities, items, or services are subject
and not subject to the tax, and the tax rate applicable to each.
Differential treatment includes, but is not limited to:
(1) Tax programs in which some individuals or entities providing or
paying for health care items or services are selectively incorporated,
but others are excluded. Selective incorporation means that the State
or other unit of government includes some, but not all, health care-
related items or services and these items or services are not
reasonably related to the other items or services being taxed.
Reasonably related means that there exists a logical or thematic
connection between the items or services being taxed. Examples of such
a connection include, but are not limited to, industry, such as
electronics; geographical area, such as city or county; net revenue
volume; or number of employees. For example, if the State imposes a tax
on all telecommunication services and inpatient hospital services, this
would constitute differential treatment as inpatient hospital services
are selectively incorporated. However, if the State imposes a tax on
revenue from
[[Page 63778]]
all professional services, which includes medical professional service
revenue, this alone would not constitute differential treatment.
(2) Differential treatment of individuals or entities providing or
paying for health care items or services included in the tax, and other
entities also included in the tax. For example, if the State taxes all
businesses in the State, but places a higher tax rate on hospitals and
nursing facilities than on other businesses, this would result in
differential treatment.
* * * * *
0
8. Section 433.56 is amended--
0
a. In paragraph (a)(18), removing the phrase ``services; and'' and
adding in its place the phrase ``services;'';
0
b. Redesignating paragraph (a)(19) as paragraph (a)(20); and
0
c. Adding a new paragraph (a)(19).
The addition reads as follows:
Sec. 433.56 Classes of health care services and providers defined.
(a) * * *
(19) Services of health insurers (other than services of managed
care organizations as specified in paragraph (a)(8) of this section);
and
* * * * *
0
9. Section 433.68 is amended by--
0
a. Revising paragraph (e) introductory text;
0
b. Adding paragraph (e)(3); and
0
c. Revising paragraph (f)(3).
The revisions and addition read as follows:
Sec. 433.68 Permissible health care-related taxes.
* * * * *
(e) Generally redistributive. A tax will be considered to be
generally redistributive if it meets the requirements of this paragraph
(e). If the State requests waiver of only the broad-based tax
requirement, it must demonstrate compliance with paragraphs (e)(1) and
(3) of this section. If the State requests waiver of the uniform tax
requirement, whether or not the tax is broad-based, it must demonstrate
compliance with paragraphs (e)(2) and (3) of this section.
* * * * *
(3) Requirement to avoid imposing undue burden on health care items
or services reimbursed by Medicaid, as well as providers of such items
or services. This paragraph (e)(3) applies on a per class basis. A tax
must not impose undue burden on health care items or services paid for
by Medicaid or on providers of such items and services that are
reimbursed by Medicaid. A tax is considered to impose undue burden
under this paragraph if taxpayers are divided into taxpayer groups and
any one or more of the following conditions apply:
(i) The tax excludes or places a lower tax rate on any taxpayer
group defined by its level of Medicaid activity than on any other
taxpayer group defined by its relatively higher level of Medicaid
activity.
(ii) Within each taxpayer group, the tax rate imposed on any
Medicaid activity is higher than the tax rate imposed on any non-
Medicaid activity (except as a result of excluding from taxation
Medicare or Medicaid revenue or payments as described in paragraph (d)
of this section).
(iii) The tax excludes or imposes a lower tax rate on a taxpayer
group with no Medicaid activity than on any other taxpayer group,
unless all entities in the taxpayer group with no Medicaid activity
meet at least one of the following:
(A) Furnish no services within the class in the State.
(B) Do not charge any payer for services within the class.
(C) Are Federal provider of services within the meaning of Sec.
411.6 of this chapter.
(D) Are a unit of government.
(iv) The tax excludes or imposes a lower tax rate on a taxpayer
group defined based on any commonality that, considering the totality
of the circumstances, CMS reasonably determines to be used as a proxy
for the taxpayer group having no Medicaid activity or relatively lower
Medicaid activity than any other taxpayer group.
(f) * * *
(3) The State (or other unit of government) imposing the tax
provides for any direct or indirect payment, offset, or waiver such
that the provision of that payment, offset, or waiver directly or
indirectly guarantees to hold taxpayers harmless for all or any portion
of the tax amount. A direct guarantee will be found to exist where,
considering the totality of the circumstances, the net effect of an
arrangement between the State (or other unit of government) and the
taxpayer results in a reasonable expectation that the taxpayer will
receive a return of all or any portion of the tax amount. The net
effect of such an arrangement may result in the return of all or any
portion of the tax amount, regardless of whether the arrangement is
reduced to writing or is legally enforceable by any party to the
arrangement.
0
10. Section 433.72 is amended by adding paragraphs (c)(3) and (4) and
(d) to read as follows:
Sec. 433.72 Waiver provisions applicable to health care-related
taxes.
* * * * *
(c) * * *
(3) For waivers approved on or after [final rule effective date] a
waiver will cease being effective 3 years from the date that the waiver
was approved by CMS.
(4) For waivers approved before [final rule effective date] a
waiver will cease to be effective [3 years from final rule effective
date].
(d) Ongoing compliance with waiver conditions. For a State to
continue to receive tax revenue (within specified limitations) without
a reduction in FFP under a waiver approved under paragraph (b) of this
section, the State must meet all of the following requirements:
(1) Ensure that the tax program for which CMS approved the waiver
under paragraph (b) of this section continues to meet the waiver
conditions identified in paragraphs (b)(1) through (3) of this section
at all times during which the waiver is in effect.
(2) Request and receive approval for a new waiver, subject to
effective date requirements in paragraph (c) of this section, if either
of the following tax program modifications occurs:
(i) The State or other unit of government imposing the tax modifies
the tax in a non-uniform manner, meaning the change in tax or tax rate
does not apply in an equal dollar amount or percentage change to all
taxpayers.
(ii) The State or other unit of government imposing the tax
modifies the criteria for defining the taxpayer group or groups subject
to the tax.
0
11. Section 433.316 is amended by--
0
a. Redesignating paragraphs (f) through (h) as paragraphs (g) through
(i), respectively; and
0
b. Adding a new paragraph (f).
The addition reads as follows:
Sec. 433.316 When discovery of overpayment occurs and its
significance.
* * * * *
(f) Overpayments identified through the disproportionate share
hospital (DSH) independent certified audit. In the case of an
overpayment identified through the independent certified audit required
under part 455, subpart D, of this chapter, CMS will consider the
overpayment as discovered on the earliest of the following:
(1) The date that the State submits the independent certified audit
report required under Sec. 455.304(b) of this chapter to CMS.
[[Page 63779]]
(2) Any of the dates specified in paragraphs (c)(1) through (3) of
this section.
* * * * *
PART 447--PAYMENTS FOR SERVICES
0
12. The authority citation for part 447 is revised to read as follows:
Authority: 42 U.S.C. 1302 and 1396r-8.
0
13. Section 447.201 is amended by adding paragraph (c) to read as
follows:
Sec. 447.201 State plan requirements.
* * * * *
(c) The plan must provide for no variation in fee-for-service
payment for a Medicaid service on the basis of a beneficiary's Medicaid
eligibility category, enrollment under a waiver or demonstration
project, or FMAP rate available for services provided to an individual
in the beneficiary's eligibility category.
0
14. Section 447.206 is added to subpart B to read as follows:
Sec. 447.206 Payments funded by certified public expenditures made
to providers that are units of government.
(a) Scope. This section applies only to payments made to providers
that are State government providers or non-State government providers,
as defined in Sec. 447.286, where such payments to such providers are
funded by a certified public expenditure, as specified in Sec.
433.51(b)(3) of this chapter.
(b) General rules. (1) Payments are limited to reimbursement not in
excess of the provider's actual, incurred cost of providing covered
services to Medicaid beneficiaries using reasonable cost allocation
methods as specified in 45 CFR part 75 and 2 CFR part 200, or, as
applicable, to Medicare cost principles specified in part 413 of this
chapter.
(2) The State must establish and implement documentation and audit
protocols, which must include an annual cost report to be submitted by
the State government provider or non-State government provider to the
State agency that documents the provider's costs incurred in furnishing
services to beneficiaries during the provider's fiscal year.
(3) Only the certified amount of the expenditure may be claimed for
Federal financial participation.
(4) The certifying entity of the certified public expenditure must
receive and retain the full amount of Federal financial participation
associated with the payment, consistent with the cost identification
protocols in the Medicaid State plan and in accordance with Sec.
447.207.
(c) Other criteria for the use of certified public expenditures.
(1) A State must implement processes by which all claims for medical
assistance are processed through Medicaid management information
systems in a manner that identifies the specific Medicaid services
provided to specific enrollees.
(2) The most recently filed cost reports as specified in paragraph
(b)(2) of this section must be used to develop interim payments rates,
which may be trended by an applicable health care-related index.
(3) Final settlement must be performed annually by reconciling any
interim payments to the finalized cost report for the State plan rate
year in which any interim payment rates were made, and final settlement
must be made no more than 24 months from the cost report year end,
except under circumstances identified in 45 CFR 95.19.
(4) If the final settlement establishes that the provider received
an overpayment, the Federal share in recovered overpayment amounts must
be credited to the Federal Government, in accordance with part 433,
subpart F, of this chapter.
(d) State plan requirements. If certified public expenditures are
used as a source of non-Federal share under the State plan, the State
plan must specify cost protocols in the service payment methodology
applicable to the certifying provider that meet all of the following:
(1) Identify allowable cost, using either of the following:
(i) A Medicare cost report, as described in part 413 of this
chapter.
(ii) A State-developed Medicaid cost report prepared in accordance
with the cost principles in 45 CFR part 75 and 2 CFR part 200.
(2) Define an interim rate methodology for interim payments to
providers for services furnished.
(3) Describe an attestation process by which the certifying entity
will attest that the costs are accurate and consistent with 45 CFR part
75 and 2 CFR part 200.
(4) Include, as necessary, a list of the covered Medicaid services
being furnished by each provider certifying a certified public
expenditure.
(5) Define a reconciliation and final settlement process consistent
with paragraphs (c)(3) and (4) of this section.
0
15. Section 447.207 is added to subpart B to read as follows:
Sec. 447.207 Retention of payments.
(a) Payments. Payment methodologies must permit the provider to
receive and retain the full amount of the total computable payment for
services furnished under the approved State plan (or the approved
provisions of a waiver or demonstration, if applicable). The Secretary
will determine compliance with this paragraph (a) by examining any
associated transactions that are related to the provider's total
computable Medicaid payment to ensure that the State's claimed
expenditure, which serves as the basis for Federal financial
participation, is consistent with the State's net expenditure, and that
the full amount of the non-Federal share of the payment has been
satisfied. Associated transactions may include, but are not necessarily
limited to, the payment of an administrative fee to the State for
processing provider payments or, in the case of a non-State government
provider, for processing intergovernmental transfers. In no event may
such administrative fees be calculated based on the amount a provider
receives through Medicaid payments or amounts a unit of government
contributes through an intergovernmental transfer as funds for the
State share of Medicaid service payments.
(b) [Reserved]
0
16. Section 447.252 is amended by adding paragraphs (d) and (e) to read
as follows:
Sec. 447.252 State plan requirements.
* * * * *
(d) CMS may approve a supplemental payment, as defined in Sec.
447.286, provided for under the State plan or a State plan amendment
(SPA) for a period not to exceed 3 years. A State whose supplemental
payment approval period has expired or is expiring may request a SPA to
renew the supplemental payment for a subsequent period not to exceed 3
years, consistent the requirements of this section. For any State plan
or SPA that provides or would provide for a supplemental payment, the
plan or plan amendment must specify all of the following:
(1) An explanation of how the State plan or SPA will result in
payments that are consistent with section 1902(a)(30)(A) of the Act,
including that provision's standards with respect to efficiency,
economy, quality of care, and access, along with the stated purpose and
intended effects of the supplemental payment, for example, with respect
to the Medicaid program, providers, and beneficiaries.
(2) The criteria to determine which providers are eligible to
receive the supplemental payment.
(3) A comprehensive description of the methodology used to
calculate the
[[Page 63780]]
amount of, and distribute, the supplemental payment to each eligible
provider, including all of the following:
(i) The amount of the supplemental payment made to each eligible
provider, if known, or, if the total amount is distributed using a
formula based on data from one or more fiscal years, the total amount
of the supplemental payments for the fiscal year or years available to
all providers eligible to receive a supplemental payment.
(ii) If applicable, the specific criteria with respect to Medicaid
service, utilization, or cost data from the proposed State plan rate
year to be used as the basis for calculations regarding the amount and/
or distribution of the supplemental payment.
(iii) The timing of the supplemental payment to each eligible
provider.
(iv) An assurance that the total Medicaid payment to an inpatient
hospital provider, including the supplemental payment, will not exceed
the upper limits specified in Sec. 447.271.
(v) If not already submitted, an upper payment limit demonstration
as required by Sec. 447.272 and described in Sec. 447.288.
(4) The duration of the supplemental payment authority (not to
exceed 3 years).
(5) A monitoring plan to ensure that the supplemental payment
remains consistent with the requirements of section 1902(a)(30)(A) of
the Act and to enable evaluation of the effects of the supplemental
payment on the Medicaid program, for example, with respect to providers
and beneficiaries.
(6) For a SPA proposing to renew a supplemental payment for a
subsequent approval period, an evaluation of the impacts on the
Medicaid program during the current or most recent prior approval
period, for example, with respect to providers and beneficiaries, and
including an analysis of the impact of the supplemental payment on
compliance with section 1902(a)(30)(A) of the Act.
(e) The authority for State plan provisions that authorize
supplemental payments that are approved as of [effective date of the
final rule], are limited as follows--
(1) For State plan provisions approved 3 or more years prior to
[effective date of the final rule], the State plan authority will
expire [date that is 2 calendar years following the effective date of
the final rule].
(2) For State plan provisions approved less than 3 years prior to
[effective date of the final rule], the State plan authority will
expire [date that is 3 calendar years following the effective date of
the final rule].
* * * * *
0
17. Section 447.272 is amended by revising paragraphs (a)(1) through
(3) and (b)(1) to read as follows:
Sec. 447.272 Inpatient services: Application of upper payment
limits.
(a) * * *
(1) State government provider as defined using the criteria set
forth in Sec. 447.286.
(2) Non-State government provider as defined using the criteria set
forth at Sec. 447.286.
(3) Private provider as defined in Sec. 447.286.
(b) * * *
(1) Upper payment limit refers to a reasonable estimate of the
amount that would be paid for the services furnished by the group of
facilities under Medicare payment principles in subchapter B of this
chapter, or allowed costs established in accordance with the cost
principles as specified in 45 CFR part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles specified in part 413 of this
chapter. Data elements, methodology parameters, and acceptable upper
payment limit demonstration methodologies are specified in Sec.
447.288(b).
* * * * *
0
18. Subpart D is added to read as follows:
Subpart D--Payments for Services
Sec.
447.284 Basis and purpose.
447.286 Definitions.
447.288 Reporting requirements for upper payment limit
demonstrations and supplemental payments.
447.290 Failure to report required information.
Subpart D--Payments for Services
Sec. 447.284 Basis and purpose.
(a) This subpart sets forth additional requirements for
supplemental payments made under the State plan and implements sections
1902(a)(6) and (a)(30) of the Act.
(b) The reporting requirements in this subpart are applicable to
supplemental payments to which an upper payment limit applies under
Sec. 447.272 or Sec. 447.321.
Sec. 447.286 Definitions.
For purposes of this subpart--
Base payment means a payment, other than a supplemental payment,
made to a provider in accordance with the payment methodology
authorized in the State plan or that is paid to the provider through
its participation with a Medicaid managed care organization. Base
payments are documented at the beneficiary level in MSIS or T-MSIS and
include all payments made to a provider for specific Medicaid services
rendered to individual Medicaid beneficiaries, including any payment
adjustments, add-ons, or other additional payments received by the
provider that can be attributed to a particular service provided to the
beneficiary, such as payment adjustments made to account for a higher
level of care or complexity of services provided to the beneficiary.
Non-State government provider means a health care provider, as
defined in Sec. 433.52 of this chapter, including those defined in
Sec. 447.251, that is a unit of local government in a State, including
a city, county, special purpose district, or other governmental unit in
the State that is not the State, which has access to and exercises
administrative control over State funds appropriated to it by the
legislature or local tax revenue, including the ability to dispense
such funds. In determining whether an entity is a non-State government
provider, CMS will consider the totality of the circumstances,
including, but not limited to, the following:
(1) The identity and character of any entity or entities other than
the provider that share responsibilities of ownership or operation of
the provider, and including the nature of any relationship among such
entities and the relationship between such entity or entities and the
provider. In determining whether an entity shares responsibilities of
ownership or operation of the provider, our consideration would
include, but would not be limited to, whether the entity:
(i) Has the immediate authority for making decisions regarding the
operation of the provider;
(ii) Bears the legal responsibility for risk from losses from
operations of the provider;
(iii) Has immediate authority for the disposition of revenue from
operations of the provider;
(iv) Has immediate authority with regard to hiring, retention,
payment, and dismissal of personnel performing functions related to the
operation of the provider;
(v) Bears legal responsibility for payment of taxes on provider
revenues and real property, if any are assessed; or
(vi) Bears the responsibility of paying any medical malpractice
premiums or other premiums to insure the real property or operations,
activities, or assets of the provider.
[[Page 63781]]
(2) In determining whether a relevant entity is a unit of a non-
State government, we would consider the character of the entity which
would include, but would not be limited to, whether the entity:
(i) Is described in its communications to other entities as a unit
of non-State government, or otherwise.
(ii) Is characterized as a unit of non-State government by the
State solely for the purposes of Medicaid financing and payments, and
not for other purposes (for example, taxation).
(iii) Has access to and exercises administrative control over State
funds appropriated to it by the legislature and/or local tax revenue,
including the ability to expend such appropriated or tax revenue funds,
based on its characterization as a governmental entity.
Private provider means a health care provider, as defined in Sec.
433.52 of this chapter, including those defined in Sec. 447.251 of
this chapter, that is not a State government provider or a non-State
government provider.
State government provider means a health care provider, as defined
in Sec. 433.52 of this chapter, including those defined in Sec.
447.251 of this chapter, that is a unit of State government or a State
university teaching hospital, which has access to and exercises
administrative control over State-appropriated funds from the
legislature or State tax revenue, including the ability to dispense
such funds. In determining whether a provider is a State government
provider, CMS will consider the totality of the circumstances,
including, but not limited to, the following:
(1) The identity and character of any entity or entities other than
the provider that share responsibilities of ownership or operation of
the provider, and including the nature of any relationship among such
entities and the relationship between such entity or entities and the
provider. In determining whether an entity shares responsibilities of
ownership or operation of the provider, our consideration would
include, but would not be limited to, whether the entity:
(i) Has the immediate authority for making decisions regarding the
operation of the provider;
(ii) Bears the legal responsibility for risk from losses and
litigation from operations of the provider;
(iii) Has immediate authority for the disposition of revenue and
profit from operations of the provider;
(iv) Has immediate authority with regard to acquisition, retention,
payment, and dismissal of personnel performing functions related to the
operation of the provider;
(v) Bears legal responsibility for payment of taxes on provider
revenues and real property, if any are assessed; or
(vi) Bears the responsibility of paying any medical malpractice
premiums or other premiums to insure the real property or operations,
activities, or assets of the provider;
(2) In determining whether a relevant entity is a unit of a State
government, we would consider the character of the entity which would
include, but would not be limited to, whether the entity:
(i) Is described in its communications to other entities as a unit
of State government, or otherwise;
(ii) Is characterized as a unit of State government by the State
solely for the purposes of Medicaid financing and payments, and not for
other purposes (for example, taxation); and
(iii) Has access to and exercises administrative control over State
funds appropriated to it by the legislature and/or local tax revenue,
including the ability to expend such appropriated or tax revenue funds,
based on its characterization as a governmental entity.
Supplemental payment means a Medicaid payment to a provider that is
in addition to the base payments to the provider, other than
disproportionate share hospital (DSH) payments under subpart E of this
part, made under State plan authority or demonstration authority.
Supplemental payments cannot be attributed to a particular provider
claim for specific services provided to an individual beneficiary and
are often made to the provider in a lump sum.
Sec. 447.288 Reporting requirements for upper payment limit
demonstrations and supplemental payments.
(a) Upper payment limit demonstration reporting requirements.
Beginning October 1, [first year following the year the final rule
takes effect] and annually thereafter, by October 1 of each year, in
accordance with the requirements of this section and in the manner and
format specified by the Secretary, each State must submit a
demonstration of compliance with the applicable upper payment limit for
each of the following services for which the State makes payment:
(1) Inpatient hospital, as specified in Sec. 447.272.
(2) Outpatient hospital, as specified in Sec. 447.321.
(3) Nursing facility, as specified in Sec. 447.272.
(4) Intermediate care facility for individuals with intellectual
disabilities (ICF/IID), as specified in Sec. 447.272.
(5) Institution for mental diseases (IMD), as specified in Sec.
447.272.
(b) Upper payment limit demonstration standards. When demonstrating
the upper payment limit (UPL), States must use the data sources
identified in paragraph (b)(1) of this section, adhere to the data
standards specified in paragraph (b)(2) of this section, and use the
acceptable methods of demonstrating the UPL specified in paragraph
(b)(3) of this section.
(1) UPL methodology data sources. The data sources identified in
this paragraph (b)(1) are as follows:
(i) Medicare cost demonstrations. Medicare cost demonstrations use
cost and charge data for all providers, from either a Medicare cost
report or a State-developed cost report which uses either Medicare cost
reporting principles specified in part 413 of this chapter or the cost
allocation requirements specified in 45 CFR part 75. Cost and charge
data must:
(A) Include only data with dates of service that are no more than 2
years prior to the dates of service covered by the upper payment limit
demonstration;
(B) Represent costs and charges specifically related to the service
subject to the UPL demonstration; and
(C) Include either Medicare costs and Medicare charges, or total
provider costs and total provider charges, to develop a cost-to-charge
ratio as described in paragraph (b)(3)(i) of this section. The
selection must be consistently applied for all providers within the
provider category subject to the upper payment limit.
(ii) Medicare payment demonstrations. Medicare payment
demonstrations use Medicare payment and charge data for all providers
from Medicare cost reports; Medicare payment systems for the specific
provider type specified in subchapter B of this chapter, as applicable;
or imputed provider payments, specified in paragraph (b)(3)(ii)(C) of
this section. When using Medicare payment and charge data, the data
must:
(A) Include only data with dates of service that are no more than 2
years prior to the dates of service covered by the upper payment limit
demonstration;
(B) Include only Medicare payment and charges, or Medicare payment
and Medicare census data, specifically related to the service subject
to the UPL demonstration; and
(C) Use either gross Medicare payments and Medicare charges, which
includes deductibles and co-insurance in but excludes reimbursable bad
debt from the Medicare payment, or net Medicare payments and Medicare
charges, which excludes deductibles
[[Page 63782]]
and coinsurance from and includes reimbursable bad debt in the Medicare
payment, as reported on a Medicare cost report. The selection must be
consistently applied for all providers within the provider category
subject to the upper payment limit.
(iii) Medicaid charge data and Medicaid census data from a State's
Medicaid billing system for services provided during the same dates of
service as the Medicare cost or Medicare payment data, as specified in
paragraph (b)(1)(i) or (ii) of this section, as applicable.
(iv) Medicaid payment data from a State's Medicaid billing system
for services provided during the same dates of service as the Medicare
cost or Medicare payment data, as specified in paragraph (b)(1)(i) or
(ii) of this section, as applicable, or from the most recent State plan
rate year for which a full 12 months of data are available. Such
Medicaid payment data must:
(A) Include only data with dates of service that are no more than 2
years prior to the dates of service covered by the upper payment limit
demonstration;
(B) Include all actual payments and all projected base and
supplemental payments, excluding any payments made for services for
which Medicaid is not the primary payer, expected to made during the
time period covered by the upper payment limit demonstration to the
providers within the provider category, as applicable, during the State
plan rate year; and
(C) Only be trended to account for changes in relevant Medicaid
State plan payments, except as provided in paragraph (b)(2)(i) of this
section.
(2) UPL methodology data standards. The data standards specified in
this paragraph (b)(2) are as follows:
(i) Projected changes in Medicaid enrollment and utilization must
be reflected in the demonstration. At a minimum, the demonstration must
be adjusted to account for projected changes in Medicaid enrollment and
utilization to reflect programmatic changes, such as reasonable
utilization changes due to managed care enrollment projections.
(ii) Medicare cost or payment data may be projected using Medicare
trend factors appropriate to the service and demonstration methodology,
with such trend factors being uniformly applied to all providers within
a provider category.
(iii) When calculating the aggregate upper payment limit using a
cost-based demonstration as described in paragraph (b)(3)(i) of this
section, the State may include the cost of health care-related taxes
paid by each provider in the provider category that is reasonably
allocated to Medicaid as an adjustment to the upper payment limit, to
the extent that such costs were not already included in the cost-based
UPL.
(iv) Medicaid payment data described in paragraph (b)(1)(iv) of
this section that is included in the upper payment limit demonstration
must only include payments made for the applicable Medicaid services
under the specific Medicaid service type at issue in the upper payment
limit.
(3) Acceptable UPL demonstration methods. The State must
demonstration compliance with an applicable UPL using a method
described in this paragraph (b)(3).
(i) Cost-based demonstrations. Cost-based demonstration data
sources are identified in paragraphs (b)(1)(i), (iii), and (iv) of this
section and data standards defined in paragraph (b)(2) of this section.
To make a cost-based demonstration of compliance with an applicable
upper payment limit, Medicaid covered charges are multiplied by a cost-
to-charge ratio developed for the period covered by the upper payment
limit demonstration. The State may use a ratio of Medicare costs to
Medicare charges, or total provider costs to total provider charges in
developing the cost-to-charge ratio, but the selection must be applied
consistently to each provider within a provider type identified in
paragraph (a) of this section. The product of Medicaid covered charges
and the cost-to-charge ratio for each provider is summed to determine
the aggregate upper payment limit. The demonstration must show that
Medicaid payments will not exceed this aggregate upper payment limit
for the demonstration period. This methodology may only be used for
services where a provider applies uniform charges to all payers. This
demonstration may use one of the following demonstration types:
(A) A retrospective demonstration showing that aggregate Medicaid
payments paid to the providers within the provider category during the
prior State plan rate year did not exceed the costs incurred by the
providers furnishing Medicaid services within the prior State plan rate
year period.
(B) A prospective demonstration showing that prospective Medicaid
payments would not exceed the estimated cost of furnishing the services
for the upcoming State plan rate year period.
(ii) Payment-based demonstrations. Payment-based demonstration data
sources are identified in paragraphs (b)(1)(ii), (iii), and (iv) of
this section and data standards defined in paragraph (b)(2) of this
section. To make a payment-based demonstration of compliance with an
applicable UPL, the State may use one of the following demonstration
types:
(A) A retrospective payment-to-charge UPL demonstration where
Medicaid covered charges are multiplied by a ratio of Medicare payments
to Medicare charges developed for the period covered by the UPL
demonstration. The product of Medicaid covered charges and the Medicare
payment-to-charge ratio for each provider is summed to determine the
aggregate UPL. The demonstration must show that Medicaid payments did
not exceed this aggregate UPL;
(B) A prospective payment-to-charge UPL demonstration where
Medicaid covered charges are multiplied by a ratio of Medicare payments
to Medicare charges developed for the period covered by the UPL
demonstration. The product of Medicaid covered charges and the Medicare
payment-to-charge ratio for each provider is summed to determine the
aggregate UPL. The demonstration must show that proposed Medicaid
payments would not exceed this aggregate UPL within the next State plan
rate year immediately following the demonstration period; or
(C) A payment-based UPL demonstration using an imputed Medicare per
diem payment rate determined by dividing total Medicare prospective
payments paid to the provider by the provider's total Medicare patient
days, which are derived from the provider's Medicare census data. Each
provider's imputed Medicare per diem payment rate is multiplied by the
total number of Medicaid patient days for the provider for the period.
The products of this operation for each provider are summed to
determine the aggregate UPL. The demonstration must show that Medicaid
payments are not excess of the aggregate UPL, calculated on either a
retrospective or prospective basis, consistent with the methodology
described in paragraph (b)(3)(ii)(A) or (B) of this section, as
applicable.
(c) Supplemental payment reporting requirements. (1) At the time
the State submits its quarterly CMS-64 under Sec. 430.30(c) of this
chapter, the State must report all of the following information for
each supplemental payment included on the CMS-64 on a supplemental
report to accompany the CMS-64:
(i) The State plan amendment transaction number or demonstration
authority number which authorizes the supplemental payment.
(ii) A listing of each provider that received a supplemental
payment under
[[Page 63783]]
the SPA or demonstration authority, and for each provider, under each
authority listed in paragraph (a) of this section:
(A) The provider's legal name.
(B) The physical address of the location or facility where services
are provided, including street address, city, State, and ZIP code.
(C) The National Provider Identifier (NPI).
(D) The Medicaid identification number.
(E) The employer identification number (EIN).
(F) The service type for which the reported payment was made.
(G) The provider specialty type (if applicable, for example,
critical access hospital (CAH), pediatric hospital, or teaching
hospital).
(H) The provider category (that is, State government provider, Non-
state government provider, or Private provider).
(iii) The specific amount of the supplemental payment made to the
provider, including:
(A) The total supplemental payment made to the provider authorized
under the specified State plan, as applicable.
(B) The total Medicaid supplemental payment made to the provider
under the specified demonstration authority, as applicable.
(2) Not later than 60 days after the end of the State fiscal year,
each State must annually report aggregate and provider-level
information on base and supplemental payments made under State plan and
demonstration authority, as applicable, by service type. This reporting
must include all of the following:
(i) The SPA transaction number or demonstration authority number
which authorizes the supplemental payment, as applicable.
(ii) A listing of each provider that received a supplemental
payment under each authority listed in paragraph (a) of this section
by:
(A) The provider's legal name.
(B) The physical address of the location or facility where services
are provided, including street address, city, State, and ZIP code.
(C) The NPI.
(D) The Medicaid identification number.
(E) The EIN.
(F) The service type for which the reported payment was made.
(G) The provider specialty type (if applicable, for example, CAH,
pediatric hospital, or teaching hospital).
(H) The provider category (that is, State government provider, non-
State government provider, or Private provider).
(I) The State reporting period (State fiscal year start and end
dates).
(iii) The specific amount of Medicaid payments made to each
provider, including, as applicable:
(A) The total fee-for-service base payments made to the provider
authorized under the State plan.
(B) The total Medicaid payments made to the provider under
demonstration authority.
(C) The total amount received from Medicaid beneficiary cost-
sharing requirements, donations, and any other funds received from
third parties to support the provision of Medicaid services.
(D) The total supplemental payment made to the provider authorized
under the specified State plan.
(E) The total Medicaid supplemental payment made to the provider
under the specified demonstration authority.
(F) The total Medicaid payments made to the provider as reported
under paragraphs (c)(2)(iii)(A) through (E) of this section.
(G) The total disproportionate share hospital (DSH) payments made
to the provider.
(H) The Medicaid units of care furnished by the provider, as
specified by the Secretary (for example, on a provider-specific basis,
total Medicaid discharges, days of care, or any other unit of
measurement as specified by the Secretary).
(3) Not later than 60 days after the end of the State fiscal year,
each State must annually report aggregate and provider-level
information on each provider contributing to the State or any unit of
local government any funds that are used as a source of non-Federal
share for any Medicaid supplemental payment, by:
(i) The service type for which the reported payment was made.
(ii) The provider specialty type (if applicable, for example, CAH,
pediatric hospital, or teaching hospital).
(iii) The provider's legal name.
(iv) The physical address of the location or facility where
services are provided, including street address, city, State, and ZIP
code.
(v) The NPI.
(vi) The Medicaid identification number.
(vii) The EIN.
(viii) The provider category (that is, State government, non-State
government, or private).
(ix) The total fee-for-service base payments made to the provider
authorized under the State plan.
(x) The total fee-for-service supplemental payments made to the
provider authorized under the State plan.
(xi) The total Medicaid payments made to the provider under
demonstration authority.
(xii) The total DSH payments made to the provider.
(xiii) The total of each health care-related tax collected from the
provider by any State authority or unit of local government.
(xiv) The total of any costs certified as a certified public
expenditures (CPE) by the provider.
(xv) The total amount contributed by the provider to the State or a
unit of local government in the form of an intergovernmental transfers
(IGT).
(xvi) The total of provider-related donations made by the provider
or by entities related to a health care provider, including in-cash and
in-kind donations, to the State or a unit of local government,
including State university teaching hospitals.
(xvii) The total funds contributed by the provider reported in
paragraphs (c)(3)(xiii) through (xvi) of this section.
Sec. 447.290 Failure to report required information.
(a) The State must maintain the underlying information supporting
base and supplemental payments, including the information required to
be reported under Sec. 447.288, consistent with the requirements of
Sec. 433.32 of this chapter, and must provide such information for
Federal review upon request to facilitate program reviews or Department
of Health and Human Services' Office of Inspector General (OIG) audits
conducted under Sec. Sec. 430.32 and 430.33 of this chapter.
(b) If a State fails to timely, completely and accurately report
information required under Sec. 447.288, CMS may reduce future grant
awards through deferral in accordance with Sec. 430.40 of this
chapter, by the amount of Federal financial participation (FFP) CMS
estimates is attributable to payments made to the provider or providers
as to which the State has not reported properly, until such time as the
State complies with the reporting requirements. CMS may defer FFP if a
State submits the required report but the report fails to comply with
applicable requirements. Otherwise allowable FFP for expenditures
deferred in accordance with this section will be released when CMS
determines that the State has complied with all reporting requirements
under Sec. 447.288.
Sec. 447.297 [Amended]
0
19. Section 447.297 is amended--
0
a. In paragraph (b) by removing the phrase ``published by April 1 of
each Federal fiscal year,'' and adding in its
[[Page 63784]]
place the phrase ``posted as soon as practicable''
0
b. In paragraph (c) by removing the phrase ``publish in the Federal
Register'' and adding in its place the phrase ``post in the Medicaid
Budget and Expenditure System and at Medicaid.gov (or similar successor
system or website)'' and by removing the phrase ``publish final State
DSH allotments by April 1 of each Federal fiscal year,'' and adding in
its place the phrase ``post final State DSH allotments as soon as
practicable in each Federal fiscal year,''
0
c. In paragraph (d)(1) by removing the phrase ``by April 1 of each
Federal fiscal year'' and adding in its place the phrase ``as soon as
practicable for each Federal fiscal year'' and by removing the phrase
``prior to the April 1 publication date'' and adding in its place the
phrase ``prior to the posting date''
0
20. Section 447.299 is amended by--
0
a. Redesignating paragraph (c)(21) as paragraph (c)(22)
0
b. Adding new paragraph (c)(21) and paragraphs (f) and (g).
The additions read as follows:
Sec. 447.299 Reporting requirements.
* * * * *
(c) * * *
(21) Financial impact of audit findings. The total annual amount
associated with each audit finding. If it is not practicable to
determine the actual financial impact amount, state the estimated
financial impact for each audit finding identified in the independent
certified audit that is not reflected in data elements described in
paragraphs (c)(6) through (15) of this section. For purposes of this
paragraph (c)(21), audit finding means an issue identified in the
independent certified audit required under Sec. 455.304 of this
chapter concerning the methodology for computing the hospital specific
DSH limit and/or the DSH payments made to the hospital, including, but
not limited to, compliance with the hospital-specific DSH limit as
defined in paragraph (c)(16) of this section. Audit findings may be
related to missing or improper data, lack of documentation, non-
compliance with Federal statutes and/or regulations, or other
deficiencies identified in the independent certified audit. Actual
financial impact means the total amount associated with audit findings
calculated using the documentation sources identified in Sec.
455.304(c) of this chapter. Estimated financial impact means the total
amount associated with audit findings calculated on the basis of the
most reliable available information to quantify the amount of an audit
finding in circumstances where complete and accurate information
necessary to determine the actual financial impact is not available
from the documentation sources identified in Sec. 455.304(c) of this
chapter.
* * * * *
(f) DSH payments found in the independent certified audit process
under part 455, subpart D, of this chapter to exceed hospital-specific
cost limits are provider overpayments which must be returned to the
Federal Government in accordance with the requirements in part 433,
subpart F, of this chapter or redistributed by the State to other
qualifying hospitals, if redistribution is provided for under the
approved State plan. Overpayment amounts returned to the Federal
Government must be separately reported on the Form CMS-64 as a
decreasing adjustment which corresponds to the fiscal year DSH
allotment and Medicaid State plan rate year of the original DSH
expenditure claimed by the State.
(g) As applicable, States must report any overpayment
redistribution amounts on the Form CMS-64 within 2 years from the date
of discovery that a hospital-specific limit has been exceeded, as
determined under Sec. 433.316(f) of this chapter in accordance with a
redistribution methodology in the approved Medicaid State plan. The
State must report redistribution of DSH overpayments on the Form CMS-64
as separately identifiable decreasing adjustments reflecting the return
of the overpayment as specified in paragraph (f) of this section and
increasing adjustments representing the redistribution by the State.
Both adjustments should correspond to the fiscal year DSH allotment and
Medicaid State plan rate year of the related original DSH expenditure
claimed by the State.
0
21. Section 447.302 is revised to read as follows:
Sec. 447.302 State plan requirements.
(a) The plan must provide that the requirements of this subpart are
met.
(b) The plan must specify comprehensively the methods and standards
used by the agency to set payment rates.
(c) CMS may approve a supplemental payment, as defined in Sec.
447.286, provided for under the State plan or a State plan amendment
for a period not to exceed 3 years. A State whose supplemental payment
approval period has expired or is expiring may request a State plan
amendment to renew the supplemental payment for a subsequent period not
to exceed 3 years, consistent the requirements of this section. For any
State plan or State plan amendment that provides or would provide for a
supplemental payment, the plan or plan amendment must specify all of
the following:
(1) An explanation of how the State plan or State plan amendment
will result in payments that are consistent with section 1902(a)(30)(A)
of the Act, including that provision's standards with respect to
efficiency, economy, quality of care, and access along with the stated
purpose and intended effects of the supplemental payment, for example,
with respect to the Medicaid program, providers and beneficiaries.
(2) The criteria to determine which providers are eligible to
receive the supplemental payment.
(3) A comprehensive description of the methodology used to
calculate the amount of, and distribute, the supplemental payment to
each eligible provider, including all of the following:
(i) The amount of the supplemental payment made to each eligible
provider, if known, or, if the total amount is distributed using a
formula based on data from one or more fiscal years, the total amount
of the supplemental payments for the fiscal year or years available to
all providers eligible to receive a supplemental payment.
(ii) If applicable, the specific criteria with respect to Medicaid
service, utilization, or cost data from the proposed State plan payment
year to be used as the basis for calculations regarding the amount and/
or distribution of the supplemental payment.
(iii) The timing of the supplemental payment to each eligible
provider.
(iv) An assurance that the total Medicaid payment to other
inpatient and outpatient facilities, including the supplemental
payment, will not exceed the upper limits specified in Sec. 447.325.
(v) If not already submitted, an upper payment limit demonstration
as required by Sec. 447.321 and described in Sec. 447.288.
(4) The duration of the supplemental payment authority (not to
exceed 3 years).
(5) A monitoring plan to ensure that the supplemental payment
remains consistent with the requirements of section 1902(a)(30)(A) of
the Act and to enable evaluation of the effects of the supplemental
payment on the Medicaid program, for example, with respect to providers
and beneficiaries.
(6) For a SPA proposing to amend or renew a supplemental payment
for a subsequent approval period, an evaluation of the impacts on the
Medicaid program during the current or most recent prior approval
period, for
[[Page 63785]]
example, with respect to providers and beneficiaries, and including an
analysis of the impact of the supplemental payment on compliance with
section 1902(a)(30)(A) of the Act.
(d) The authority for State plan provisions that authorize
supplemental payments that are approved as of [effective date of the
final rule], is limited as follows--
(1) For State plan provisions approved 3 or more years prior to
[effective date of the final rule], the State plan authority will
expire [date that is 2 calendar years following the effective date of
the final rule].
(2) For State plan provisions approved less than 3 years prior to
[effective date of the final rule], the State plan authority will
expire [date that is 3 calendar years following the effective date of
the final rule].
0
22. Section 447.321 is amended by revising the section heading and
paragraphs (a) and (b)(1) to read as follows:
Sec. 447.321 Outpatient hospital services: Application of upper
payment limits.
(a) Scope. This section applies to rates set by the agency to pay
for outpatient services furnished by hospitals within one of the
following categories:
(1) State government provider, as defined using the criteria set
forth at Sec. 447.286.
(2) Non-State government provider, as defined using the criteria
set forth at Sec. 447.286.
(3) Private provider, as defined using the criteria set forth at
Sec. 447.286.
(b) * * *
(1) Upper payment limit refers to a reasonable estimate of the
amount that would be paid for the services furnished by the group of
facilities under Medicare payment principles in subchapter B of this
chapter, or allowed costs established in accordance with the cost
principles as specified in 45 CFR part 75 and 2 CFR part 200, or, as
applicable, Medicare cost principles specified at 42 CFR part 413. Data
elements, methodology parameters, and acceptable upper payment limit
demonstration methodologies are defined in Sec. 447.288(b).
* * * * *
0
23. Section 447.406 is added to read as follows:
Sec. 447.406 Medicaid practitioner supplemental payment.
(a) General. This section applies to Medicaid practitioner
supplemental payments, which, for purposes of this section, are
supplemental payments as defined in Sec. 447.286 that are authorized
under the State plan for practitioner services and targeted to specific
practitioners under a methodology specified in the State plan. This
section does not apply to value-based payment methodologies that are
part of a State's delivery system reform initiative, are attributed to
a particular service provided to a Medicaid beneficiary, and that are
available to all providers, including as an alternative to fee-for-
service payment rates.
(b) Medicaid practitioner supplemental payment standards. A
Medicaid practitioner supplemental payment must meet the requirements
specified in Sec. 447.302, including the transition period
requirements in paragraph (d) of that section, as well as the
requirements specified in this section.
(c) Medicaid practitioner supplemental payment limit. Medicaid
practitioner supplemental payments may not exceed--
(1) 50 percent of the total fee-for-service base payments
authorized under the State plan paid to an eligible provider for the
practitioner services during the relevant period; or
(2) For services provided within HRSA-designated geographic health
professional shortage areas (HPSA) or Medicare-defined rural areas as
specified in 42 CFR 412.64(b), 75 percent of the total fee-for-service
base payments authorized under the State plan paid to the eligible
provider for the practitioner services during the relevant period.
PART 455--PROGRAM INTEGRITY: MEDICAID
0
24. The authority citation for part 455 continues to read as follows:
Authority: 42 U.S.C 1302.
0
25. Section 455.301 is amended by revising the definition of
``Independent certified audit'' to read as follows:
Sec. 455.301 Definitions.
* * * * *
Independent certified audit means an audit that is conducted by an
auditor that operates independently from the Medicaid agency or subject
hospitals and is eligible to perform the disproportionate share
hospital (DSH) audit. Certification means that the independent auditor
engaged by the State reviews the criteria of the Federal audit
regulation and completes the verification, calculations and report
under the professional rules and generally accepted standards of audit
practice. This certification includes a review of the State's audit
protocol to ensure that the Federal regulation is satisfied, an opinion
for each verification detailed in the regulation, a determination of
whether or not the State made DSH payments that exceeded any hospital's
hospital-specific DSH limit in the Medicaid State plan rate year under
audit, and the financial impact of each audit finding on a hospital-
specific basis. The certification also identifies any data issues or
other caveats or deficiencies that the auditor identified as impacting
the results of the audit.
* * * * *
PART 457--ALLOTMENTS AND GRANTS TO STATES
0
26. The authority for part 457 continues to read as follows:
Authority: 42 U.S.C. 1302.
0
27. Section 457.609 is amended by revising paragraph (h) to read as
follows:
Sec. 457.609 Process and calculation of State allotments for a fiscal
year after FY 2008.
* * * * *
(h) CHIP fiscal year allotment process. The national CHIP allotment
and State CHIP allotments will be posted in the Medicaid Budget and
Expenditure System and at Medicaid.gov (or similar successor system or
website) as soon as practicable after the allotments have been
determined for each Federal fiscal year.
Dated: September 12, 2019.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
Dated: November 7, 2019.
Alex M. Azar II,
Secretary, Department of Health and Human Services.
[FR Doc. 2019-24763 Filed 11-12-19; 4:15 pm]
BILLING CODE 4120-01-P